0001564590-21-028166.txt : 20210517 0001564590-21-028166.hdr.sgml : 20210517 20210517071054 ACCESSION NUMBER: 0001564590-21-028166 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 75 CONFORMED PERIOD OF REPORT: 20210331 FILED AS OF DATE: 20210517 DATE AS OF CHANGE: 20210517 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Altimmune, Inc. CENTRAL INDEX KEY: 0001326190 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 202726770 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-32587 FILM NUMBER: 21927519 BUSINESS ADDRESS: STREET 1: 910 CLOPPER ROAD STREET 2: SUITE 201S CITY: GAITHERSBURG STATE: MD ZIP: 20878 BUSINESS PHONE: 2406541450 MAIL ADDRESS: STREET 1: 910 CLOPPER ROAD STREET 2: SUITE 201S CITY: GAITHERSBURG STATE: MD ZIP: 20878 FORMER COMPANY: FORMER CONFORMED NAME: PHARMATHENE, INC DATE OF NAME CHANGE: 20071016 FORMER COMPANY: FORMER CONFORMED NAME: HEALTHCARE ACQUISITION CORP DATE OF NAME CHANGE: 20050505 10-Q 1 alt-10q_20210331.htm 10-Q alt-10q_20210331.htm

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

(Mark One)

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2021

or

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from                  to                 

Commission file number 001-32587

 

ALTIMMUNE, INC.

(Exact Name of Registrant as Specified in its Charter)

 

 

Delaware

 

20-2726770

(State or Other Jurisdiction of

Incorporation or Organization)

 

(I.R.S. Employer

Identification No.)

 

910 Clopper Road Suite 201S, Gaithersburg, Maryland

 

20878

(Address of Principal Executive Offices)

 

(Zip Code)

 

(240) 654-1450

(Registrant’s Telephone Number, Including Area Code)

 

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common stock, par value $0.0001 per share

ALT

The NASDAQ Global Market

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes      No

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    Yes      No 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer

 

Accelerated filer

Non-accelerated filer

 

Smaller reporting company

 

 

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).    Yes      No  

As of May 14, 2021 there were 38,396,843 shares of the registrant’s common stock, par value $0.0001 per share, outstanding.

 

 


 

 

 

 

 

ALTIMMUNE, INC.

TABLE OF CONTENTS

 

 

 

 

Page

 

 

 

 

PART I. FINANCIAL INFORMATION

 

 

 

 

 

 

Item 1.

Financial Statements

 

1

 

 

 

 

 

Consolidated Balance Sheets as of March 31, 2021 (unaudited) and December 31, 2020

 

1

 

 

 

 

 

Consolidated Statements of Operations and Comprehensive Loss for the three months ended March 31, 2021 and 2019 (unaudited)

 

2

 

 

 

 

 

Consolidated Statements of Changes in Stockholders’ Equity for the three months ended March 31, 2021 and 2020 (unaudited)

 

3

 

 

 

 

 

Consolidated Statements of Cash Flows for the three months ended March 31, 2021 and 2020 (unaudited)

 

4

 

 

 

 

 

Notes to Consolidated Financial Statements (unaudited)

 

5

 

 

 

 

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

14

 

 

 

 

Item 3.

Quantitative and Qualitative Disclosures about Market Risk

 

18

 

 

 

 

Item 4.

Controls and Procedures

 

18

 

 

 

 

 

 

 

PART II. OTHER INFORMATION

 

 

 

 

 

 

Item 1.

Legal Proceedings

 

19

 

 

 

 

Item 1A.

Risk Factors

 

19

 

 

 

 

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

 

19

 

 

 

 

Item 3.

Defaults Upon Senior Securities

 

19

 

 

 

 

Item 4.

Mine Safety Disclosures

 

19

 

 

 

 

Item 5.

Other Information

 

19

 

 

 

 

Item 6.

Exhibits

 

20

 

 

 

 

 

Signatures

 

21

 

 

 

 

 

 

 


 

 

 

PART I. FINANCIAL INFORMATION

 

Item 1. Financial Statements

ALTIMMUNE, INC.

CONSOLIDATED BALANCE SHEETS

 

 

 

March 31, 2021

 

 

December 31, 2020

 

 

 

(unaudited)

 

 

 

 

 

ASSETS

 

 

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

149,932,387

 

 

$

115,917,807

 

Restricted cash

 

 

34,174

 

 

 

34,174

 

Total cash, cash equivalents and restricted cash

 

 

149,966,561

 

 

 

115,951,981

 

Short-term investments

 

 

76,574,768

 

 

 

100,005,558

 

Accounts receivable

 

 

4,801,428

 

 

 

4,610,202

 

Tax refund receivable

 

 

7,898,067

 

 

 

7,762,793

 

Prepaid expenses and other current assets

 

 

5,950,999

 

 

 

1,926,675

 

Total current assets

 

 

245,191,823

 

 

 

230,257,209

 

Property and equipment, net

 

 

5,198,052

 

 

 

1,056,920

 

Right of use asset

 

 

866,336

 

 

 

903,825

 

Intangible assets, net

 

 

12,879,247

 

 

 

12,823,846

 

Other assets

 

 

115,300

 

 

 

73,413

 

Total assets

 

$

264,250,758

 

 

$

245,115,213

 

LIABILITIES AND STOCKHOLDERS’ EQUITY

 

 

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

 

 

Accounts payable

 

$

418,243

 

 

$

612,293

 

Accrued expenses and other current liabilities

 

 

9,405,649

 

 

 

11,408,154

 

Total current liabilities

 

 

9,823,892

 

 

 

12,020,447

 

Contingent consideration

 

 

6,270,000

 

 

 

5,390,000

 

Other long-term liabilities

 

 

1,719,438

 

 

 

1,828,443

 

Total liabilities

 

 

17,813,330

 

 

 

19,238,890

 

Commitments and contingencies (Note 16)

 

 

 

 

 

 

 

 

Stockholders’ equity:

 

 

 

 

 

 

 

 

Common stock, $0.0001 par value; 200,000,000 shares authorized;

38,257,180 and 37,142,946 shares issued and outstanding at March 31, 2021 and December 31, 2020, respectively

 

 

3,810

 

 

 

3,697

 

Additional paid-in capital

 

 

462,417,706

 

 

 

417,337,742

 

Accumulated deficit

 

 

(210,944,707

)

 

 

(186,420,599

)

Accumulated other comprehensive loss, net

 

 

(5,039,381

)

 

 

(5,044,517

)

Total stockholders’ equity

 

 

246,437,428

 

 

 

225,876,323

 

Total liabilities and stockholders’ equity

 

$

264,250,758

 

 

$

245,115,213

 

 

The accompanying notes are an integral part of the unaudited consolidated financial statements.

 

 

 

 

 

1


 

 

 

ALTIMMUNE, INC.

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS

(unaudited)

 

 

 

For the Three Months Ended

March 31,

 

 

 

2021

 

 

2020

 

Revenues

 

$

837,516

 

 

$

2,212,694

 

Operating expenses:

 

 

 

 

 

 

 

 

Research and development

 

 

11,877,900

 

 

 

7,187,531

 

General and administrative

 

 

3,821,420

 

 

 

2,331,917

 

Total operating expenses

 

 

15,699,320

 

 

 

9,519,448

 

Loss from operations

 

 

(14,861,804

)

 

 

(7,306,754

)

Other income (expense):

 

 

 

 

 

 

 

 

Interest expense

 

 

(11,671

)

 

 

(1,885

)

Interest income

 

 

42,499

 

 

 

151,569

 

Other (expense) income, net

 

 

(33,132

)

 

 

25,542

 

Total other (expense) income, net

 

 

(2,304

)

 

 

175,226

 

Net loss before income tax benefit

 

 

(14,864,108

)

 

 

(7,131,528

)

Income tax benefit

 

 

 

 

 

3,245,879

 

Net loss

 

 

(14,864,108

)

 

 

(3,885,649

)

Other comprehensive income (loss) – unrealized gain (loss) on investments

 

 

5,136

 

 

 

(32,435

)

Comprehensive loss

 

$

(14,858,972

)

 

$

(3,918,084

)

Net loss per share, basic and diluted

 

$

(0.38

)

 

$

(0.26

)

Weighted-average common shares outstanding, basic and diluted

 

 

38,914,990

 

 

 

15,110,585

 

 

The accompanying notes are an integral part of the unaudited consolidated financial statements.

 

 

2


 

 

 

ALTIMMUNE, INC.

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY

(unaudited)

 

 

 

Common Stock

 

 

Additional

Paid-In

 

 

Accumulated

 

 

Accumulated

Other

Comprehensive

 

 

Total

Stockholders’

 

 

 

Shares

 

 

Amount

 

 

Capital

 

 

Deficit

 

 

Loss

 

 

Equity

 

Balance at December 31, 2020

 

 

37,142,946

 

 

$

3,697

 

 

$

417,337,742

 

 

$

(186,420,599

)

 

$

(5,044,517

)

 

$

225,876,323

 

Stock-based compensation

 

 

 

 

 

 

 

 

1,218,351

 

 

 

 

 

 

 

 

 

1,218,351

 

Vesting of restricted stock awards including withholding, net

 

 

(6,349

)

 

 

1

 

 

 

(92,507

)

 

 

 

 

 

 

 

 

(92,506

)

Issuance of common stock from Employee Stock Purchase Plan

 

 

8,733

 

 

 

1

 

 

 

106,000

 

 

 

 

 

 

 

 

 

106,001

 

Retirement of common stock in exchange for common stock warrant

 

 

(1,000,000

)

 

 

(100

)

 

 

(7,539,900

)

 

 

(9,660,000

)

 

 

 

 

 

(17,200,000

)

Issuance of common stock warrant in exchange for retirement of common stock

 

 

 

 

 

 

 

 

17,200,000

 

 

 

 

 

 

 

 

 

17,200,000

 

Issuance of common stock in at the market offering, net

 

 

2,110,800

 

 

 

211

 

 

 

34,178,020

 

 

 

 

 

 

 

 

 

34,178,231

 

Issuance of common stock upon cashless exercise of warrants

 

 

1,050

 

 

 

 

 

 

10,000

 

 

 

 

 

 

 

 

 

10,000

 

Unrealized income on short-term investments

 

 

 

 

 

 

 

 

 

 

 

 

 

 

5,136

 

 

 

5,136

 

Net loss

 

 

 

 

 

 

 

 

 

 

 

(14,864,108

)

 

 

 

 

 

(14,864,108

)

Balance at March 31, 2021

 

 

38,257,180

 

 

$

3,810

 

 

$

462,417,706

 

 

$

(210,944,707

)

 

$

(5,039,381

)

 

$

246,437,428

 

 

 

 

 

 

 

 

 

Common Stock

 

 

Additional

Paid-In

 

 

Accumulated

 

 

Accumulated

Other

Comprehensive

 

 

Total

Stockholders’

 

 

 

Shares

 

 

Amount

 

 

Capital

 

 

Deficit

 

 

Loss

 

 

Equity

 

Balance at December 31, 2019

 

 

15,312,167

 

 

$

1,508

 

 

$

187,914,916

 

 

$

(137,376,122

)

 

$

(5,020,156

)

 

$

45,520,146

 

Stock-based compensation

 

 

 

 

 

 

 

 

214,921

 

 

 

 

 

 

 

 

 

214,921

 

Vesting of restricted stock awards including withholding, net

 

 

(5,974

)

 

 

1

 

 

 

(17,080

)

 

 

 

 

 

 

 

 

(17,079

)

Issuance of common stock from Employee Stock Purchase Plan

 

 

38,809

 

 

 

3

 

 

 

56,736

 

 

 

 

 

 

 

 

 

56,739

 

Issuance of common stock upon exercise of warrants

 

 

14,500

 

 

 

2

 

 

 

39,972

 

 

 

 

 

 

 

 

 

39,974

 

Unrealized loss on short-term investments

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(32,435

)

 

 

(32,435

)

Net loss

 

 

 

 

 

 

 

 

 

 

 

(3,885,649

)

 

 

 

 

 

(3,885,649

)

Balance at March 31, 2020

 

 

15,359,502

 

 

$

1,514

 

 

$

188,209,465

 

 

$

(141,261,771

)

 

$

(5,052,591

)

 

$

41,896,617

 

 

The accompanying notes are an integral part of the unaudited consolidated financial statements.

 

3


 

 

 

ALTIMMUNE, INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS

(unaudited)

 

 

 

Three Months Ended March 31,

 

 

 

2021

 

 

2020

 

CASH FLOWS FROM OPERATING ACTIVITIES:

 

 

 

 

 

 

 

 

Net loss

 

$

(14,864,108

)

 

$

(3,885,649

)

Adjustments to reconcile net loss to net cash used in operating activities:

 

 

 

 

 

 

 

 

Change in fair value of contingent consideration liability

 

 

880,000

 

 

 

1,750,000

 

Stock-based compensation expense

 

 

1,218,351

 

 

 

214,921

 

Depreciation and amortization

 

 

74,298

 

 

 

73,356

 

Unrealized losses on foreign currency exchange

 

 

33,376

 

 

 

24,939

 

Changes in operating assets and liabilities:

 

 

 

 

 

 

 

 

Accounts receivable

 

 

(191,226

)

 

 

(973,557

)

Prepaid expenses and other current assets

 

 

(4,200,624

)

 

 

(214,893

)

Accounts payable

 

 

(194,050

)

 

 

911,397

 

Accrued expenses and other liabilities

 

 

(2,189,903

)

 

 

1,112,718

 

Tax refund receivable

 

 

(135,274

)

 

 

(3,360,633

)

Net cash used in operating activities

 

 

(19,569,160

)

 

 

(4,347,401

)

CASH FLOWS FROM INVESTING ACTIVITIES:

 

 

 

 

 

 

 

 

Proceeds from sales and maturities of short-term investments

 

 

30,912,000

 

 

 

13,700,000

 

Purchases of short-term investments

 

 

(7,476,074

)

 

 

(7,099,263

)

Purchases of property and equipment, net

 

 

(4,208,790

)

 

 

(18,131

)

Cash paid for internally developed patents

 

 

(62,041

)

 

 

(19,390

)

Net cash provided by investing activities

 

 

19,165,095

 

 

 

6,563,216

 

CASH FLOWS FROM FINANCING ACTIVITIES:

 

 

 

 

 

 

 

 

Payments of deferred offering costs

 

 

134,413

 

 

 

 

Proceeds from exercises of warrants

 

 

 

 

 

39,974

 

Proceeds from issuance of common stock in at the market offering, net

 

 

34,178,231

 

 

 

 

Proceeds from issuance of common stock from Employee Stock Purchase Plan

 

 

106,001

 

 

 

56,739

 

Net cash provided by financing activities

 

 

34,418,645

 

 

 

96,713

 

Net increase in cash and cash equivalents and restricted cash

 

 

34,014,580

 

 

 

2,312,528

 

Cash, cash equivalents and restricted cash at beginning of period

 

 

115,951,981

 

 

 

8,996,860

 

Cash, cash equivalents and restricted cash at end of period

 

$

149,966,561

 

 

$

11,309,388

 

 

 

 

 

 

 

 

 

 

SUPPLEMENTAL NON-CASH FINANCING ACTIVITIES:

 

 

 

 

 

 

 

 

Fair value of common stock retired in exchange for issuance of common stock warrant

 

$

17,200,000

 

 

$

 

 

The accompanying notes are an integral part of the unaudited consolidated financial statements.

 

 

4


 

 

ALTIMMUNE, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(unaudited)

1. Nature of Business and Basis of Presentation

Nature of Business

Altimmune, Inc., headquartered in Gaithersburg, Maryland, United States, together with its subsidiaries (collectively, the “Company” or “Altimmune”) is a clinical stage biopharmaceutical company incorporated under the laws of the State of Delaware.

The Company is focused on developing intranasal vaccines, immune modulating therapies, and treatments for liver disease. The Company’s diverse pipeline includes proprietary intranasal vaccines for COVID-19 (AdCOVID), anthrax (NasoShield) and influenza (NasoVAX); an intranasal immune modulating therapeutic for COVID-19 (T-COVID); and next generation peptide therapeutics for NASH (ALT-801) and chronic hepatitis B (HepTcell). Since its inception, the Company has devoted substantially all of its efforts to business planning, research and development, recruiting management and technical staff, and raising capital, and has financed its operations through the issuance of common and preferred stock, long-term debt, and proceeds from research grants and government contracts. The Company has not generated any revenues from the sale of any products to date, and there is no assurance of any future revenues from product sales.

Basis of Presentation

The accompanying unaudited consolidated financial statements are prepared pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”) regarding interim financial reporting. Accordingly, they do not include all of the information and disclosures required by accounting principles generally accepted in the United States (“U.S. GAAP”) for complete consolidated financial statements and should be read in conjunction with the audited consolidated financial statements for the year ended December 31, 2020 included in the Annual Report on Form 10-K which was filed with the SEC on February 25, 2021. In the opinion of management, the Company has prepared the accompanying unaudited consolidated financial statements on the same basis as the audited consolidated financial statements, and these consolidated financial statements include all adjustments, consisting only of normal recurring adjustments, necessary for a fair presentation of the results of the interim periods presented. The operating results for the interim periods presented are not necessarily indicative of the results expected for the full year 2021 or any future years or periods.

The accompanying unaudited consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation.

The accompanying unaudited consolidated financial statements have been prepared on the basis of continuity of operations, realization of assets, and the satisfaction of liabilities in the ordinary course of business. The financial statements do not include any adjustments relating to the recoverability and classification of recorded assets and liabilities that might be necessary should we be unable to continue as a going concern.

2. Summary of Significant Accounting Policies

During the three months ended March 31, 2021, there have been no significant changes to the Company’s summary of significant accounting policies contained in the Company’s Annual Report on Form 10-K for the year ended December 31, 2020 as filed with the SEC, except for the recently adopted accounting standard for income taxes.

Use of Estimates

The preparation of these financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. The extent to which the COVID-19 pandemic may directly or indirectly impact the Company’s business, financial condition, and results of operations is highly uncertain and subject to change. The Company considered the potential impact of the COVID-19 pandemic on the Company’s estimates and assumptions and determined that there was not a material impact to the Company’s unaudited consolidated financial statements as of and for the three months ended March 31, 2021. However, actual results could differ from those estimates and there may be changes to the Company’s estimates in future periods.

Recently Issued Accounting Pronouncements - Adopted

In December 2019, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2019-12, Income Taxes (Topic 740), Simplifying the Accounting for Income Taxes (“ASU No. 2019-12”). ASU 2019-12 amends the approaches and methodologies in accounting for income taxes during interim periods and makes changes to certain income tax classifications. The new standard allows exceptions to the use of the incremental approach for intra-period tax allocation, when there is a loss from continuing operations and income or a gain from other items, and to the general methodology for calculating income taxes in an interim period, when a year-to-date loss exceeds the anticipated loss for the year. The standard also requires franchise or similar taxes partially based on income to be reported as income tax and the effects of enacted changes in tax laws or rates to be included in the annual effective tax rate computation from the date of enactment. Lastly, in any future acquisition, the Company would be required to evaluate when the step-up in the tax basis of

5


 

goodwill is part of the business combination and when it should be considered a separate transaction. The Company adopted the standard as of January 1, 2021 and has evaluated the effects of this standard and determined that the adoption did not have a material impact on the Company’s consolidated financial statements.

3. Fair Value Measurements

The Company’s assets and liabilities measured at fair value on a recurring basis at March 31, 2021 consisted of the following:

 

 

Fair Value Measurement at March 31, 2021

 

 

 

Total

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

Assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash equivalents - money market funds

 

$

13,962,902

 

 

$

13,962,902

 

 

$

 

 

$

 

Short-term investments

 

 

76,574,768

 

 

 

 

 

 

76,574,768

 

 

 

 

Total

 

 

90,537,670

 

 

 

13,962,902

 

 

 

76,574,768

 

 

 

 

Liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Contingent consideration liability (see Note 8)

 

 

6,270,000

 

 

 

 

 

 

 

 

 

6,270,000

 

Total

 

$

6,270,000

 

 

$

 

 

$

 

 

$

6,270,000

 

 

The Company’s assets and liabilities measured at fair value on a recurring basis at December 31, 2020 consisted of the following:

 

 

 

Fair Value Measurement at December 31, 2020

 

 

 

Total

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

Assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash equivalents - money market funds

 

$

90,389,473

 

 

$

90,389,473

 

 

$

 

 

$

 

Short-term investments

 

 

100,005,558

 

 

 

 

 

 

100,005,558

 

 

 

 

Total

 

 

190,395,031

 

 

 

90,389,473

 

 

 

100,005,558

 

 

 

 

Liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Contingent consideration liability (see Note 8)

 

 

5,390,000

 

 

 

 

 

 

 

 

 

5,390,000

 

Warrant liability

 

 

10,000

 

 

 

 

 

 

 

 

 

10,000

 

Total

 

$

5,400,000

 

 

$

 

 

$

 

 

$

5,400,000

 

The warrant liability is included in Other long-term liabilities in the consolidated balance sheet at December 31, 2020. The warrant liability was valued using the Monte Carlo simulation valuation model with Level 3 inputs.

Short-term investments have been initially valued at the transaction price and subsequently valued, at the end of each reporting period, utilizing third party pricing services or other market observable data (Level 2). The pricing services utilize industry standard valuation models, including both income and market-based approaches and observable market inputs to determine value.

Short-term investments had quoted prices at March 31, 2021 as shown below:

 

 

 

March 31, 2021

 

 

 

Amortized Cost

 

 

Unrealized Gain (Loss)

 

 

Market Value

 

United States treasury securities

 

$

16,029,965

 

 

$

2,995

 

 

$

16,032,960

 

Commercial paper and corporate debt securities

 

 

33,412,043

 

 

 

(1,935

)

 

 

33,410,108

 

Asset backed securities

 

 

2,111,239

 

 

 

(278

)

 

 

2,110,961

 

Certificate of deposit

 

 

25,020,739

 

 

 

 

 

 

25,020,739

 

Total

 

$

76,573,986

 

 

$

782

 

 

$

76,574,768

 

 

Short-term investments had quoted prices at December 31, 2020 as shown below:

 

 

December 31, 2020

 

 

 

Amortized Cost

 

 

Unrealized Gain (Loss)

 

 

Market Value

 

United States treasury securities

 

$

20,052,757

 

 

$

1,843

 

 

$

20,054,600

 

Commercial paper and corporate debt securities

 

 

47,521,344

 

 

 

(5,440

)

 

 

47,515,904

 

Asset backed securities

 

 

7,414,619

 

 

 

(757

)

 

 

7,413,862

 

Certificate of deposit

 

 

25,021,192

 

 

 

 

 

 

25,021,192

 

Total

 

$

100,009,912

 

 

$

(4,354

)

 

$

100,005,558

 

 

6


 

 

The fair value of contingent payments classified as a liability is based on the regulatory milestones described in Note 8 and estimated using the Monte Carlo simulation valuation model with Level 3 inputs.

The assumptions used to estimate the fair value of contingent payments that are classified as a liability at March 31, 2021 include the following significant unobservable inputs:

 

Unobservable input

 

Value or Range

 

 

Weighted Average

 

Expected volatility

 

117.4%

 

 

117.4%

 

Risk-free interest rate

 

0.09%

 

 

0.09%

 

Cost of capital

 

30%

 

 

30%

 

Discount for lack of marketability

 

16%-19%

 

 

18%

 

Probability of payment

 

63%

 

 

63%

 

Projected year of payment

 

2022

 

 

2022

 

 

If applicable, the Company will recognize transfers into and out of levels within the fair value hierarchy at the end of the reporting period in which the actual event or change in circumstance occurs. There were no transfers into and out of any of the levels of the fair value hierarchy as of March 31, 2021 and December 31, 2020.

 

Separate disclosure is required for assets and liabilities measured at fair value on a recurring basis from those measured at fair value on a non-recurring basis. Assets recorded at fair value on a non-recurring basis, such as property and equipment and intangible assets are recognized at fair value when they are impaired. As of March 31, 2021 and December 31, 2020, the Company had no significant assets or liabilities that were measured at fair value on a non-recurring basis.

 

4. Property and Equipment, Net

 

 

 

March 31, 2021

 

 

December 31, 2020

 

Furniture, fixtures and equipment

 

$

185,878

 

 

$

125,538

 

Laboratory equipment

 

 

1,041,752

 

 

 

959,585

 

Computers and telecommunications

 

 

250,516

 

 

 

220,316

 

Software

 

 

64,409

 

 

 

64,409

 

Leasehold improvements

 

 

1,415,608

 

 

 

1,285,883

 

Construction-in-progress

 

 

4,000,000

 

 

 

 

Property and equipment, at cost

 

 

6,958,163

 

 

 

2,655,731

 

Less: accumulated depreciation and amortization

 

 

(1,760,111

)

 

 

(1,598,811

)

Property and equipment, net

 

$

5,198,052

 

 

$

1,056,920

 

As of March 31, 2021, construction-in-progress primarily includes costs related to the procurement of long-lead equipment and build out of the suite associated with the Company's manufacturing collaboration with Lonza Houston, Inc. (“Lonza”) described in Note 16. Depreciation expense related to property and equipment was approximately $67,658 and $59,505, for the three months ended March 31, 2021 and 2020, respectively.

5. Intangible Assets

The Company’s intangible assets consisted of the following:

 

 

 

March 31, 2021

 

 

 

Estimated

Useful Lives

 

Gross

Carrying

Value

 

 

Accumulated

Amortization

 

 

Net Book

Value

 

Internally developed patents

 

6-20 years

 

$

946,828

 

 

$

(486,548

)

 

$

460,280

 

Acquired licenses

 

16-20 years

 

 

285,000

 

 

 

(285,000

)

 

 

 

Total intangible assets subject to amortization

 

 

 

 

1,231,828

 

 

 

(771,548

)

 

 

460,280

 

IPR&D assets

 

Indefinite

 

 

12,418,967

 

 

 

 

 

 

12,418,967

 

Total

 

 

 

$

13,650,795

 

 

$

(771,548

)

 

$

12,879,247

 

 

7


 

 

 

 

December 31, 2020

 

 

 

Estimated

Useful Lives

 

Gross

Carrying

Value

 

 

Accumulated

Amortization

 

 

Net Book

Value

 

Internally developed patents

 

6-10 years

 

$

884,787

 

 

$

(479,908

)

 

$

404,879

 

Acquired licenses

 

16-20 years

 

 

285,000

 

 

 

(285,000

)

 

 

 

Total intangible assets subject to amortization

 

 

 

 

1,169,787

 

 

 

(764,908

)

 

 

404,879

 

IPR&D assets

 

Indefinite

 

 

12,418,967

 

 

 

 

 

 

12,418,967

 

Total

 

 

 

$

13,588,754

 

 

$

(764,908

)

 

$

12,823,846

 

Amortization expense of intangible assets was $6,640 and $13,851 for the three months ended March 31, 2021 and 2020, respectively. As of March 31, 2021, the weighted average amortization period remaining for intangible assets was 12.3 years. Amortization expense was classified as research and development expenses in the accompanying unaudited consolidated statements of operations and comprehensive loss.

6. Operating Leases

The Company rents office and laboratory space in the United States. The Company also leases office equipment under a non-cancellable equipment lease through December 2022. Rent expense during the three months ended March 31, 2021 and 2020 under all of the Company’s operating leases was $130,138 and $87,599, respectively. Rent expense includes short-term leases and variable lease costs that are not included in the lease obligation.

Short-term leases are leases having a term of twelve months or less. The Company recognizes short-term leases on a straight-line basis and does not record a related lease asset or liability for such leases.

The office space leases provide for increases in future minimum annual rental payments as defined in the lease agreements. The office space lease also includes an option to renew the lease as of the end of the term. The Company has determined that the lease renewal option is not reasonably certain of being exercised.

The cash paid for operating lease liabilities for the three months ended March 31, 2021 and 2020 was $117,354 and $95,714, respectively.

Supplemental other information related to the operating leases balance sheet information was as follows:

 

 

 

March 31, 2021

 

 

December 31, 2020

 

Operating lease obligations (see Note 7 and 9)

 

$

1,739,559

 

 

$

1,824,840

 

Operating lease right-of-use assets

 

$

866,336

 

 

$

903,825

 

Weighted-average remaining lease term (years)

 

 

4.1

 

 

 

4.3

 

Weighted-average discount rate

 

 

7.3

%

 

 

7.3

%

  

7. Accrued Expenses

Accrued expenses and other current liabilities consist of the following:

 

 

 

March 31, 2021

 

 

December 31, 2020

 

Accrued professional services

 

$

612,212

 

 

$

1,350,194

 

Accrued payroll and employee benefits

 

 

1,182,658

 

 

 

2,351,599

 

Accrued interest

 

 

13,744

 

 

 

13,016

 

Accrued research and development

 

 

7,211,778

 

 

 

7,316,876

 

Lease obligation, current portion (see Note 6)

 

 

365,504

 

 

 

356,716

 

Deferred revenue

 

 

19,753

 

 

 

19,753

 

Total accrued expenses

 

$

9,405,649

 

 

$

11,408,154

 

 

8. Contingent Consideration

The Company entered into an Agreement and Plan of Merger and Reorganization, dated July 8, 2019, by and among the Company, Springfield Merger Sub, Inc., Springfield Merger Sub, LLC, Spitfire Pharma, Inc. and David Collier, as the Stockholder Representative (the “Spitfire Merger Agreement”) to acquire all of the equity interests of Spitfire Pharma, Inc. (“Spitfire”). Spitfire was a privately held, preclinical pharmaceutical company developing a novel dual GLP-1/glucagon receptor agonist for the treatment of non-alcoholic steatohepatitis.  

The transaction closed on July 12, 2019. The Company issued 1,887,250 unregistered shares of its common stock (the “shares”) as upfront consideration to certain former securityholders of Spitfire (collectively, the “Spitfire Equityholders”), representing an amount equal to $5.0 million less working capital and transaction expense adjustment amounts as defined in the agreement.

8


 

The acquisition of Spitfire was accounted for as an asset acquisition instead of a business combination because substantially all of the fair value of the gross assets acquired was concentrated in a single identifiable asset or group of similar identifiable assets, and therefore, the asset was not considered a business. The Company expensed the acquired intellectual property as of the acquisition date as in-process research and development with no alternative future uses. 

The Spitfire Merger Agreement also includes future contingent payments up to $88.0 million in cash and shares of the Company’s common stock as follows (each, a “Milestone Event”):

 

a one-time payment of $5.0 million (the “IND Milestone Consideration Amount”) within sixty days of the submission of an Investigational New Drug Application (“IND”) to the United States Food and Drug Administration (the “FDA”) or other applicable governmental authority in a foreign jurisdiction, which IND has not been rejected or placed on clinical hold by the FDA or such applicable foreign governmental authority within time specified in the Merger Agreement;

 

a one-time payment of $3.0 million (the “Phase 2 Milestone Consideration Amount” and together with the IND Milestone Consideration Amount, the “Regulatory Milestones”) within sixty days of the initiation of a Phase 2 clinical trial of a product candidate anywhere in the world; and

 

payments of up to $80.0 million upon the achievement of specified worldwide net sales (the “Sales Milestones”) of all products developed using the technology acquired in the License Agreement within ten years following the approval of a new drug application filed with the FDA.

The Regulatory Milestones will be payable in shares of the Company’s Common Stock, with the number of shares of the Company’s Common Stock to be issued in connection with each milestone amount, if any, are dependent on the share price at the time of achievement. The number of any shares issued in consideration for the IND Milestone Consideration Amount will be determined based on lower of (A) the average of the closing prices of our Common Stock as reported on the Nasdaq Global Market for the twenty (20) consecutive trading days prior to the IND Reference Date or (B) $2.95. The value of any shares issued in consideration for the Phase 2 Milestone Consideration Amount shall be determined based the lower of (A) on the average of the closing trading prices of our Common Stock as reported on the Nasdaq Global Market for the twenty (20) consecutive trading days immediately preceding the date of the occurrence of the Phase 2 Milestone Event or (B) $3.54.

The future contingent payments related to the Regulatory Milestones are stock-based payments accounted for under FASB Accounting Standards Codification Topic 480, Distinguishing Liabilities From Equity (“ASC 480”). Such stock-based payments are subject to a lock-up whereby 50% of the shares are released at 3 months and 50% are released at 6 months. The future contingent payments related to the Sales Milestones are predominately cash-based payments accounted for under FASB Accounting Standards Codification Topic 450, Contingencies. Accordingly, the Company will recognize the Sales Milestones when the contingency is resolved and the amount is paid or payable.

The Company estimates the future contingent consideration for the Regulatory Milestones based upon a Monte Carlo simulation valuation model that is risk adjusted based on the probability of achieving the milestones and a discount for lack of marketability. The Company remeasures the fair value of the contingent consideration at each reporting period. During the fourth quarter of 2020, the Company achieved the IND Milestone and paid the obligation in shares according to the calculation above. Below is a summary of the contingent consideration activity:

 

 

Three Months Ended March 31,

 

 

 

2021

 

 

2020

 

Beginning balance

 

$

5,390,000

 

 

$

2,750,000

 

Change in fair value

 

 

880,000

 

 

 

1,750,000

 

Ending balance

 

$

6,270,000

 

 

$

4,500,000

 

 

As of March 31, 2021, the increase in fair value was primarily attributable to an increase in the closing share price of the Company’s common stock and in the probability of milestone achievement. As of March 31, 2020, the increase in fair value was primarily due to an increase in the probability of milestone achievement. Any changes in fair value have been recorded within research and development expense during the respective periods presented.

9. Other Long-Term Liabilities

The Company’s other long-term liabilities are summarized as follows:

 

 

 

March 31,

2021

 

 

December 31,

2020

 

Lease obligation, long-term portion (see Note 6)

 

$

1,374,055

 

 

$

1,468,124

 

Conditional economic incentive grants

 

 

250,000

 

 

 

250,000

 

Other

 

 

95,383

 

 

 

110,319

 

Total other long-term liabilities

 

$

1,719,438

 

 

$

1,828,443

 

 

9


 

 

10. Common Stock

Public Offering

On July 16, 2020, the Company offered and sold (i) 3,369,564 shares of common stock, at a price to the public of $23.00 per share, and (ii) pre-funded warrants of the Company to purchase 1,630,436 shares of common stock at an exercise price equal to $0.0001 per share (the “Pre-Funded Warrants”), at a price to the public of $22.9999 per share of common stock underlying the Pre-Funded Warrants (equal to the public offering price per share of Common Stock, minus the exercise price of each Pre-Funded Warrant). The Pre-Funded Warrants are exercisable at any time, provided that each Pre-Funded Warrant holder will be prohibited from exercising such Pre-Funded Warrants into shares of the Company’s common stock if, as a result of such exercise, the holder, together with its affiliates, would own more than 4.99% of the total number of shares of the Company’s common stock then issued and outstanding, which percentage may change at the holders’ election to any other number less than or equal to 19.99% upon 61 days’ notice to the Company. The gross proceeds of this offering were approximately $132.2 million, which includes the exercise in full of the underwriters’ option to purchase an additional 750,000 shares of common stock, before deducting underwriting discounts and commissions and offering expenses during the third quarter of 2020. The net proceeds of this offering were approximately $124.0 million, after deducting underwriting discounts and commissions and offering expenses payable by the Company.

The Company has assessed the Pre-Funded Warrants for appropriate equity or liability classification and determined that the Pre-Funded Warrants are freestanding instruments that do not meet the definition of a liability pursuant to ASC 480 and do not meet the definition of a derivative pursuant to FASB Accounting Standards Codification Topic 815, Derivatives and Hedging (“ASC 815”). The Pre-Funded Warrants are indexed to the Company’s common stock and meet all other conditions for equity classification under ASC 480 and ASC 815. Accordingly, the Pre-Funded Warrants are classified as equity and are accounted for as a component of additional paid-in capital at the time of issuance. As of March 31, 2021, no Pre-Funded Warrants were exercised.

At-the-Market Offerings

On February 25, 2021, the Company entered into an Equity Distribution Agreement (the “2021 Agreement”) with Piper Sandler & Co., Evercore Group L.L.C., and B. Riley Securities, Inc., serving as sales agents (the “Sales Agents”) with respect to an at-the-market offering program under which the Company may offer and sell, from time to time at its sole discretion, shares of its common stock, par value $0.0001 per share (the “Common Stock”), having an aggregate offering price of up to $125.0 million (the “Shares”) through the Sale Agents (the “2021 Offering”). Any Shares offered and sold in the 2021 Offering will be issued pursuant to the Company’s Registration Statement on Form S-3 filed with the Securities and Exchange Commission (the “SEC”) on December 31, 2020, which was declared effective on January 11, 2021, the prospectus supplement relating to the 2021 Offering filed with the SEC on February 25, 2021 and any applicable additional prospectus supplements related to the 2021 Offering that form a part of the Registration Statement.

As of March 31, 2021, the Company has sold 2,110,800 shares of Common Stock under the 2021 Agreement resulting in approximately $34.2 million in net proceeds, with $89.7 million remaining available to be sold under the 2021 Agreement. As of March 31, 2021, the Company recorded approximately $0.1 million of offering costs which offset the proceeds received from the shares sold through March 31, 2021 and recognized approximately $0.1 million of deferred offering costs which will offset future proceeds received under the 2021 Agreement.

On March 27, 2020, the Company entered into an Equity Distribution Agreement (the “2020 Agreement”) with JMP Securities LLC, serving as placement agent (the “Placement Agent”) with respect to an at-the-market offering program under which the Company may offer and sell, from time to time at its sole discretion, shares of its common stock, par value $0.0001 per share (the “Common Stock”), having an aggregate offering price of up to $50.0 million (the “Shares”) through the Placement Agent (the “2020 Offering”). Any Shares offered and sold in the 2020 Offering were issued pursuant to the Company’s Registration Statement on Form S-3 filed with the SEC on April 4, 2019, which was declared effective on April 12, 2019, the prospectus supplement relating to the 2020 Offering filed with the SEC on March 27, 2020 and any applicable additional prospectus supplements related to the 2020 Offering that form a part of the Registration Statement. The aggregate market value of Shares eligible for sale in the 2020 Offering and under the 2020 Agreement were subject to the limitations of General Instruction I.B.6 of Form S-3, to the extent required under such instruction. The Company offered Shares having an aggregate offering price of $18.9 million pursuant to the prospectus supplement filed with the SEC on March 27, 2020. On June 1, 2020, the Company filed an amendment to the 2020 Agreement which amended the prospectus supplement dated March 27, 2020 to increase the aggregate offering price to $50.0 million. No Shares were sold under the 2020 Agreement during the three months ended March 31, 2020. As of March 31, 2021, the 2020 Agreement was fully utilized and no Shares were sold under the 2020 Agreement during the three months ended March 31, 2021.    

Exchange Agreement

On February 25, 2021, the Company entered into an exchange agreement (the “Exchange Agreement”) with an Investor and its affiliates (the “Exchanging Stockholders”), pursuant to which the Company exchanged an aggregate of 1,000,000 shares of the Company’s common stock, par value $0.0001 per share, owned by the Exchanging Stockholders for pre-funded warrants (the “Exchange Warrants”) to purchase an aggregate of 1,000,000 shares of common stock (subject to adjustment in the event of any stock dividends and splits, reverse stock split, recapitalization, reorganization or similar transaction, as described in the Exchange Warrants), with an exercise price of $0.0001 per share. The Exchange Warrants do not expire and are exercisable at any time except that the Exchange Warrants cannot be exercised by the Exchanging Stockholders if, after giving effect thereto, the Exchanging Stockholders would beneficially own more than 9.99% of the Company’s common stock, subject to certain exceptions. In accordance with FASB Accounting Standards Codification Topic 505, Equity, the

10


 

Company recorded the retirement of the common stock exchanged as a reduction of common shares outstanding and a corresponding debit to additional paid-in-capital and accumulated deficit at the fair value of the Exchange Warrants on the issuance date. The Exchange Warrants are classified as equity in accordance with ASC 480 and the fair value of the Exchange Warrants was recorded as a credit to additional paid-in-capital is not subject to remeasurement. The Company determined that the fair value of the Exchange Warrants is substantially similar to the fair value of the retired shares on the issuance date due to the negligible exercise price for the Exchange Warrants. As of March 31, 2021, none of the Exchange Warrants have been exercised.

11. Warrants

A summary of warrant activity during the three months ended March 31, 2021 is as follows:

Warrants outstanding, December 31, 2020

 

 

1,777,611

 

 

Exchanges (see Note 10)

 

 

1,000,000

 

 

Exercises

 

 

(1,420

)

 

Warrants outstanding, March 31, 2021

 

 

2,776,191

 

 

As of March 31, 2021, all of the common stock warrants that were previously classified as a liability were exercised in full.   

12. Stock-Based Compensation

Stock Options

The Company’s stock option awards generally vest over four years and typically have a contractual life of ten years. At March 31, 2021, there was $10.1 million of unrecognized compensation cost related to stock options, which is expected to be recognized over a weighted-average period of 2.9 years. During the three months ended March 31, 2021, the Company granted 669,000 stock options with a weighted average exercise price of $16.73 and per share weighted average grant date fair value of $13.76.

Information related to stock options outstanding at March 31, 2021 is as follows:

 

 

Number

of Stock

Options

 

 

Weighted-

average

Exercise

Price

 

 

Weighted-

average

Remaining

Contractual

Term

(Years)

 

 

Aggregate

Intrinsic

Value

 

Outstanding

 

 

2,293,367

 

 

$

8.11

 

 

 

6.0

 

 

$

16,651,695

 

Exercisable

 

 

773,781

 

 

$

5.35

 

 

 

5.8

 

 

$

7,855,753

 

Unvested

 

 

1,519,586

 

 

$

9.51

 

 

 

6.0

 

 

$

8,795,942

 

Restricted Stock

At March 31, 2021, the Company had unvested restricted stock of 134,545 shares with total unrecognized compensation expense of $0.5 million, which the Company expects to recognize over a weighted average period of approximately 1.7 years. During the three months ended March 31, 2021, the Company released 20,181 shares of common stock from restriction as a result of the vesting of restricted stock.

In February 2021, the Company granted 181,279 shares of restricted stock units which vest over four years. At March 31, 2021, the Company had unvested restricted stock units of 196,279 shares with total unrecognized compensation expense of $2.8 million, which the Company expects to recognize over a weighted average period of approximately 3.8 years.

2019 Employee Stock Purchase Plan

Under the Employee Stock Purchase Plan, employees purchased 8,733 shares for $0.1 million during the three months ended March 31, 2021. During the three months ended March 31, 2021, the Company recognized compensation expense of $0.1 million.

11


 

Stock-based Compensation Expense

Stock-based compensation expense is classified in the unaudited consolidated statements of operations and comprehensive loss for the three months ended March 31, 2021 and 2020 as follows:

 

 

 

For the Three Months Ended

March 31,

 

 

 

2021

 

 

2020

 

Research and development

 

$

321,338

 

 

$

29,000

 

General and administrative

 

 

897,013

 

 

 

185,921

 

Total

 

$

1,218,351

 

 

$

214,921

 

 

13. U.S. Government Contracts and Grants

In June 2020, the Company was awarded $4.7 million from the U.S. Army Medical Research & Development Command (“USAMRDC”) to fund our Phase 1/2 clinical trial of T-COVID. The competitive award was granted by USAMRDC in collaboration with the Medical Technology Enterprise Consortium (“MTEC”), a 501(c)(3) biomedical technology consortium working in partnership with the Department of Defense (“DoD”). Under the contract, MTEC will pay the Company a firm fixed fee based upon the achievement of certain milestones for conduct and completion of a Phase 1/2 study and research and development work on the replication-deficient adenovirus 5 (“RD-Ad5”) vector vaccine platform. For the three months ended March 31, 2021, the Company has recognized approximately $0.5 million of grant revenue under the contract.

In July 2016, the Company signed a five-year contract with BARDA. The contract, as amended, has a total value of up to $133.7 million and is used to fund clinical development of NasoShield. Under the contract, BARDA pays the Company a fixed fee and reimburses certain costs for the research and development of an Ad5-vectored, protective antigen-based intranasal anthrax vaccine through cGMP manufacture and conduct of a Phase 1 clinical trial dose ranging assessment of safety and immunogenicity. The contract consists of an initial base performance period providing approximately $27.8 million in funding for the period July 2016 through June 2021. BARDA has seven options to extend the contract to fund certain continued development and manufacturing activities for the anthrax vaccine, including Phase 2 clinical studies. Each option, if exercised by BARDA, would provide additional funding ranging from approximately $1.1 million to $34.4 million for a three-year period beginning in 2021. For the three months ended March 31, 2021 and 2020, the Company has recognized approximately $0.2 million and $1.6 million, respectively, of grant revenue under the current BARDA contract.

14. Income Taxes

Due to a full valuation allowance, the Company did not record an income tax benefit for the three months ended March 31, 2021.  

With respect to the prior year, on March 27, 2020, President Donald Trump signed into law the Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”). The CARES Act provided both stimulus measures and a number of tax provisions, including: temporary changes regarding the utilization and carry back of net operating losses, temporary changes to the prior and future limitations on interest deductions, technical corrections from prior tax legislation for tax depreciation of qualified improvement property, and certain refundable employee retention credits. As of March 31, 2020, the Company recognized a tax benefit of $3.2 million related to the carry back of losses back to obtain a refund of its 2016 tax liability.

15. Net Loss Per Share

Because the Company has reported a net loss attributable to common stockholders for all periods presented, basic and diluted net loss per share attributable to common stockholders are the same for all periods presented.

Basic net loss per share attributable to common stockholders is computed by dividing the net loss attributable to common stockholders by the weighted average numbers of shares of common stock outstanding for the period. Basic shares outstanding includes the weighted average effect of the Company’s outstanding pre-funded warrants, the exercise of which requires little or no consideration for the delivery of shares of common stock.

Diluted net loss per share is calculated by adjusting weighted average shares outstanding for the dilutive effect of common stock equivalents outstanding for the period. As such, all unvested restricted stock, common stock warrants, and stock options have been excluded from the computation of diluted weighted average shares outstanding because such securities would have an anti-dilutive impact for all periods presented.

12


 

Potential common shares issuable upon conversion, vesting or exercise of unvested restricted stock, common stock warrants, and stock options that are excluded from the computation of diluted weighted-average shares outstanding, as they are anti-dilutive, are as follows:

 

 

 

For the Three Months Ended

March 31,

 

 

 

2021

 

 

2020

 

Common stock warrants

 

 

145,755

 

 

 

10,370,206

 

Common stock options

 

 

2,307,264

 

 

 

1,423,612

 

Restricted stock

 

 

330,824

 

 

 

215,413

 

 

16. Commitments and Contingencies

Spitfire Acquisition

As disclosed in Note 8, the Company is obligated to make payments of up to $80.0 million upon the achievement of specified worldwide net sales of all products developed using the technology acquired from Spitfire Pharma Inc. within ten years following the approval of a new drug application filed with the FDA.

PER.C6 License Agreement Expansion

On April 2, 2020, the Company entered into Amendment No. 3 to the Second Restated License Agreement (the “Amendment”), by and between the Company and Janssen Vaccines & Prevention B.V. (formerly known as Crucell Holland B.V.) (as amended by Amendment No. 1 to Second Restated License Agreement and Amendment No. 2 to Second Restated License Agreement, together with the Amendment, the “License Agreement”). Pursuant to the Amendment, the field of licenses granted to the Company for the use of the PER.C6 cell line under the License Agreement is expanded to cover COVID-19 caused by SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2), in addition to the existing licenses related to Bacillus anthracis and influenza virus. All capitalized terms not defined herein shall have the meanings assigned to them in the Amendment or the License Agreement, as applicable.

Pursuant to the Amendment, the Company agreed to pay certain additional development-based milestone payments through approval of licensed products by the FDA for the treatment or prevention of COVID-19, up to an aggregate amount of $1.2 million. The Company also agreed to pay royalty payments as a percentage of net sales of products to a royalty stacking reduction and minimum annual royalty payments, until the expiration of the term of the License Agreement, as amended. As of March 31, 2021, no payments were made under the License Agreement.

Lonza Manufacturing Agreement

In March 2021, the Company expanded its manufacturing collaboration with Lonza in connection with the Manufacturing Agreement entered into in November 2020 for the manufacture of AdCOVID. Under the expanded agreement, the Company has committed approximately $23.0 million to Lonza to procure long-lead equipment and construct a dedicated manufacturing suite for clinical and commercial production of AdCOVID. This work is expected to be completed during the fourth quarter of 2021. As of March 31, 2021, the Company capitalized approximately $4.0 million to construction-in-progress related to the equipment purchase and build out of the suite under the expanded agreement.

Summit Biosciences Development and Manufacturing Agreement

In March 2021, the Company entered into a development and manufacturing agreement with Summit Biosciences, Inc. (“Summit”) to manufacture a metered nasal spray presentation of AdCOVID. Under the agreement, the Company has committed approximately $6.7 million to Summit for the clinical manufacturing of AdCOVID multidose nasal spray. This work is expected to be completed by the end of 2021. As of March 31, 2021, the Company recorded approximately $1.4 million to prepaid expenses under the agreement.

Litigation

In December 2019, a complaint was filed by Dr. De-Chu Christopher Tang (“Plaintiff”) against the Company, which the Company removed to the United States District Court for the Eastern District of Texas. The Plaintiff amended the complaint in February 2020 to include Vipin K. Garg and David J. Drutz as defendants, in addition to the Company (Dr. Garg, Dr. Drutz, and the Company are collectively referred to as “Defendants”). On November 6, 2020, Defendants filed a motion for summary judgment on the basis of lack of personal jurisdiction, insufficient service of process, and failure to state a claim. The court ruled on that motion on March 25, 2021, which dismissed the case on the basis of lack of personal jurisdiction. As the outcome of this legal proceeding is certain at this time, the Company has not accrued any liability associated with this action.

The Company is a party in various other contractual disputes, litigation, and potential claims arising in the ordinary course of business none of which are currently reasonably possible or probable of material loss.

13


 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

The following discussion and analysis of our financial condition and results of operations should be read together with our consolidated financial statements and related notes appearing elsewhere in this quarterly report on Form 10-Q and our consolidated financial statements and related notes for the year ended December 31, 2020 included in our annual report on Form 10-K, which was filed with the Securities and Exchange Commission on February 25, 2021.

This quarterly report on Form 10-Q contains forward-looking statements that involve substantial risks and uncertainties. The words “expect,” “anticipate,” “intend,” “plan,” “believe,” “estimate,” “may,” “will,” “should,” “could,” “target,” “strategy,” “intend,” “project,” “guidance,” “likely,” “usually,” “potential,” or the negative of these words or variations of such words, similar expressions, or comparable terminology are intended to identify such forward-looking statements, although not all forward-looking statements contain these identifying words. There are a number of important risks and uncertainties that could cause our actual results to differ materially from those indicated by forward-looking statements. We may not actually achieve the plans, intentions or expectations disclosed in our forward-looking statements, and you should not place undue reliance on our forward-looking statements. Actual results or events could differ materially from the plans, intentions and expectations disclosed in the forward-looking statements we make. We have included important factors in the cautionary statements included in this quarterly report on Form 10-Q, particularly in the section entitled “Risk Factors” in Part II, Item 1A, that could cause actual results or events to differ materially from the forward-looking statements that we make. Our forward-looking statements do not reflect the potential impact of any future acquisitions, mergers, dispositions, joint ventures or investments that we may make.

We have based the forward-looking statements included in this quarterly report on Form 10-Q on information available to us on the date of this quarterly report, and we assume no obligation to update any such forward-looking statements, other than as required by law. Although we undertake no obligation to revise or update any forward-looking statements, whether as a result of new information, future events or otherwise, you are advised to consult any additional disclosures that we may make directly to you or through reports that we, in the future, may file with the SEC, including annual reports on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K.

Overview

      Altimmune, Inc. is a clinical stage biopharmaceutical company focused on developing intranasal vaccines, immune modulating therapies and treatments for liver disease. Our diverse pipeline includes proprietary intranasal vaccines for COVID-19 (AdCOVID), anthrax (NasoShield) and influenza (NasoVAX); an intranasal immune modulating therapeutic for COVID-19 (T-COVID); and next generation peptide therapeutics for non-alcoholic steatohepatitis (“NASH”) (ALT-801) and chronic hepatitis B (HepTcell).

Impact of COVID-19

      We are closely monitoring how the spread of the coronavirus disease (“COVID-19”) is affecting our employees, business, preclinical studies and clinical trials. In response to the COVID-19 pandemic, we have closed our executive offices with certain employees continuing their work outside of our offices and travel for all employees has been restricted. Essential laboratory staff continue to work onsite with enhanced safety measures. We are continuing our regular interactions with the FDA and other regulatory agencies and based on current information, we do not anticipate COVID-19 to materially affect our regulatory timelines for NasoShield, T-COVID, AdCOVID, ALT-801 and HepTcell.

      Although operations have not been materially affected by the COVID-19 pandemic as of and for the three months ended March 31, 2021, at this time, however, there is significant uncertainty relating to the trajectory of the pandemic and the impact of related responses, and disruptions caused by the COVID-19 pandemic may result in difficulties or delays in initiating, enrolling, conducting or completing our planned and ongoing trials and the incurrence of unforeseen costs as a result of disruptions in clinical supply or preclinical study or clinical trial delays. The impact of COVID-19 on our future results will largely depend on future developments, which are highly uncertain and cannot be predicted with confidence, such as the ultimate geographic spread of the disease, the duration of the pandemic, travel restrictions and social distancing in the United States and other countries, business closures or business disruptions, the ultimate impact on financial markets and the global economy, and the effectiveness of actions taken in the United States and other countries to contain and treat the disease. In addition, a recurrence of COVID-19 cases could cause other widespread or more severe impacts depending on where infection rates are highest. We continue to monitor developments as we deal with the disruptions and uncertainties relating to the COVID-19 pandemic. See “Risk Factors— Our business, results of operations and financial condition may be adversely affected by the widespread outbreak of an illness or any other communicable disease, or any other public health crisis, including the ongoing coronavirus disease (COVID-19) pandemic.” in Part II, Item 1A of this Quarterly Report on Form 10-Q.

U.S. Government Contracts and Grants

       In June 2020, we were awarded $4.7 million from the U.S. Army Medical Research & Development Command (“USAMRDC”) to fund our Phase 1/2 clinical trial of T-COVID. The competitive award was granted by USAMRDC in collaboration with the Medical Technology Enterprise Consortium (“MTEC”), a 501(c)(3) biomedical technology consortium working in partnership with the Department of Defense (“DoD”). Under the contract, MTEC pays us a firm fixed fee based upon the achievement of certain milestones for conduct and

14


 

completion of a Phase 1/2 study and research and development work on the replication-deficient adenovirus 5 (RD-Ad5) vector vaccine platform. For the three months ended March 31, 2021, we have recognized approximately $0.5 million of grant revenue under the contract.

In July 2016, we signed a five-year contract with Biomedical Advanced Research and Development Authority (“BARDA”). The contract, as amended, has a total value of up to $133.7 million and is used to fund clinical development of NasoShield. Under the contract, BARDA pays us a fixed fee and reimburses certain costs for the research and development of an Ad5-vectored, protective antigen-based intranasal anthrax vaccine through cGMP manufacture and conduct of a Phase 1 clinical trial dose ranging assessment of safety and immunogenicity. The contract consists of an initial base performance period providing approximately $27.8 million in funding for the period July 2016 through December 2020. BARDA has seven options to extend the contract to fund certain continued development and manufacturing activities for the anthrax vaccine, including Phase 2 clinical trials. Each option, if exercised by BARDA, would provide additional funding ranging from approximately $1.1 million to $34.4 million for a three-year period beginning January 2021. For the three months ended March 31, 2021 and 2020, we have recognized approximately $0.2 million and $1.6 million, respectively, of grant revenue under the current BARDA contract.

Critical Accounting Policies and Significant Judgment and Estimates

Management’s Discussion and Analysis of Financial Condition and Results of Operations is based upon our unaudited consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the U.S. and the rules and regulations of the SEC for interim financial reporting. The preparation of these financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues, expenses, and the disclosure of contingent liabilities in our consolidated financial statements. We base our estimates and judgments on historical experience, knowledge of current conditions, and expectations of what could occur in the future given available information.

There have been no changes in our critical accounting policies and significant judgment and estimates as disclosed in our annual report on Form 10-K for the year ended December 31, 2020 except for recently adopted accounting standards (See Note 2 to the consolidated financial statements appearing in Item 1 of this report). For more information regarding our critical accounting policies, we encourage you to read the discussion contained in Item 7 under the heading “Critical Accounting Policies and Significant Judgments and Estimates” and Note 2 “Summary of Significant Accounting Policies” included in the notes to the consolidated financial statements contained in our annual report on Form 10-K for the year ended December 31, 2020.

Results of Operations

Comparison of the three months ended March 31, 2021 and 2020:

 

 

 

For the Three Months Ended

March 31,

 

 

2021

 

 

2020

 

 

Increase (Decrease)

Revenue

 

$

837,516

 

 

$

2,212,694

 

 

$

(1,375,178

)

 

 

(62

)

%

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Research and development

 

 

11,877,900

 

 

 

7,187,531

 

 

 

4,690,369

 

 

 

65

 

 

General and administrative

 

 

3,821,420

 

 

 

2,331,917

 

 

 

1,489,503

 

 

 

64

 

 

Total operating expenses

 

 

15,699,320

 

 

 

9,519,448

 

 

 

6,179,872

 

 

 

65

 

 

Loss from operations

 

 

(14,861,804

)

 

 

(7,306,754

)

 

 

(7,555,050

)

 

 

(103

)

 

Other income (expense):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest expense

 

 

(11,671

)

 

 

(1,885

)

 

 

(9,786

)

 

 

(519

)

 

Interest income

 

 

42,499

 

 

 

151,569

 

 

 

(109,070

)

 

 

(72

)

 

Other (expense) income, net

 

 

(33,132

)

 

 

25,542

 

 

 

(58,674

)

 

 

230

 

 

Total other (expense) income, net

 

 

(2,304

)

 

 

175,226

 

 

 

(177,530

)

 

 

(101

)

 

Net loss before income tax benefit

 

 

(14,864,108

)

 

 

(7,131,528

)

 

 

(7,732,580

)

 

 

(108

)

 

Income tax benefit

 

 

 

 

 

3,245,879

 

 

 

(3,245,879

)

 

 

(100

)

 

Net loss

 

$

(14,864,108

)

 

$

(3,885,649

)

 

$

(10,978,459

)

 

 

(283

)

%

Revenue

Revenue consists primarily of research grants in the United States from MTEC for our T-COVID product candidate and BARDA for our NasoShield vaccine product candidate. These grants consist of firm fixed fee contracts based on milestones and cost reimbursement contracts, with a fixed fee based on either costs incurred or milestones met.

Revenue decreased by $1.4 million, or 62%, for the three months ended March 31, 2021, as compared to the same period in 2020. The decrease was primarily the result of:

 

a decrease of $2.0 million in BARDA revenue due to timing of clinical trials and development activities on the NasoShield program; and

 

an increase of $0.5 million in MTEC revenue attributable to a clinical trial and development work on the T-COVID program.

15


 

 

Research and development expenses

Research and development operating expense increased by $4.7 million, or 65%, for the three months ended March 31, 2021, as compared to the same period in 2020. The increase was primarily the result of:

 

an increase of $5.4 million due to development activities for the COVID-19 programs, which include AdCOVID and T-COVID; and

 

a decrease of $1.5 million due primarily to a decrease in the fair value of contingent consideration liability with respect to the acquisition of ALT-801 and development activities for ALT-801.

General and administrative expenses

General and administrative expense increased by $1.5 million, or 64%, for the three months ended March 31, 2021, as compared to the same period in 2020 due primarily to an increase in stock compensation expense and other labor related costs.

Total other (expense) income, net

Total other (expense) income, net decreased by $0.2 million during the three months ended March 31, 2021, as compared to the same period in 2020. The decrease is primarily due to changes in interest income.

Income tax benefit

Income tax benefit decreased by $3.2 million during the three months ended March 31, 2021, as compared to the same period in 2020. In both 2020 and 2021, we had a valuation allowance against all of our deferred tax assets, but in 2020 a benefit was recognized related to a net operating loss carryback refund claim pursuant to the Coronavirus Aid, Relief, and Economic Security Act.

Liquidity and Capital Resources

Overview

Our primary sources of cash during the three months ended March 31, 2021 were from sales of equity, maturities of short-term investments and cash receipts of revenue from our BARDA and MTEC contracts. Our cash, cash equivalents, restricted cash and short-term investments were $226.5 million at March 31, 2021. We believe, based on the operating cash requirements and capital expenditures expected for 2021 and 2022, our cash on hand and short-term investments at March 31, 2021, together with expected revenue from our government sponsored contracts and tax refunds, are sufficient to fund operations for at least a twelve-month period from the issuance date of our March 31, 2021 consolidated financial statements.

We have not generated any revenues from the sale of any products to date, and there is no assurance of any future revenues from product sales. Our sources of revenue have consisted of grant revenues under our arrangements with BARDA for the development of NasoShield, MTEC for a clinical trial and development work on T-COVID, and to a lesser degree from other licensing arrangements. We have incurred significant losses since we commenced operations. As of March 31, 2021, we had accumulated losses of $210.9 million since our inception. In addition, we have not generated positive cash flows from operations. We have had to rely on a variety of financing sources, including the issuance of debt and equity securities. As capital resources are consumed to fund our research and development activities, we may not have sufficient capital to fund our plan of operations. In order to address our capital needs, including our planned clinical trials, we must continue to actively pursue additional equity or debt financing, government funding, and monetization of our existing programs through partnership arrangements or sales to third parties.

In June 2020, we were awarded $4.7 million from the U.S. Army Medical Research & Development Command (“USAMRDC”) to fund our Phase 1/2 clinical trial of T-COVID. The competitive award was granted by USAMRDC in collaboration with the Medical Technology Enterprise Consortium (“MTEC”), a 501(c)(3) biomedical technology consortium working in partnership with the Department of Defense (“DoD”). Under the contract, MTEC pays us a firm fixed fee based upon the achievement of certain milestones for conduct and completion of a Phase 1/2 study and research and development work on the replication-deficient adenovirus 5 (“RD-Ad5”) vector vaccine platform. Through March 31, 2021, we have collected approximately $1.6 million in cash under the contract.

In July 2016, we signed a five-year contract with BARDA. The contract, as amended, has a total value of up to $133.7 million and is used to fund clinical development of NasoShield. Under the contract, BARDA pays us a fixed fee and reimburses certain costs for the research and development of an Ad5-vectored, protective antigen-based intranasal anthrax vaccine through cGMP manufacture and conduct of a Phase 1 clinical trial dose ranging assessment of safety and immunogenicity. The contract consists of an initial base performance period providing approximately $27.8 million in funding for the period July 2016 through December 2020. BARDA has seven options to extend the contract to fund certain continued development and manufacturing activities for the anthrax vaccine, including Phase 2 clinical trials. Each option, if exercised by BARDA, would provide additional funding ranging from approximately $1.1 million to $34.4 million for a three-year period beginning January 2021. Through March 31, 2021, we have collected approximately $24.9 million in cash under the current BARDA contract.

16


 

Cash Flows

The following table provides information regarding our cash flows for the three months ended March 31, 2021 and 2020:

 

 

Three Months Ended March 31,

 

 

 

2021

 

 

2020

 

Net cash provided by (used in):

 

 

 

 

 

 

 

 

Operating activities

 

$

(19,569,160

)

 

$

(4,347,401

)

Investing activities

 

 

19,165,095

 

 

 

6,563,216

 

Financing activities

 

 

34,418,645

 

 

 

96,713

 

Net increase in cash and cash equivalents and restricted cash

 

$

34,014,580

 

 

$

2,312,528

 

Operating Activities

Net cash used in operating activities was $19.6 million for the three months ended March 31, 2021 compared to $4.3 million during the three months ended March 31, 2020. Our sources of cash provided by operations during the three months ended March 31, 2021 were primarily cash receipts of revenue generated by our BARDA and MTEC contracts. The primary uses of cash from our operating activities include payments for labor and labor-related costs, professional fees, research and development costs associated with our clinical trials, and other general corporate expenditures. The increase in cash used in operations of $15.2 million year over year is due to an increase in net loss as adjusted for non-cash items of $10.8 million and changes in working capital accounts of $4.4 million.

Investing Activities

Net cash provided by investing activities was $19.2 million for the three months ended March 31, 2021 compared to $6.6 million during the three months ended March 31, 2020. The net cash provided by investing activities during the three months ended March 31, 2021 was primarily due to net proceeds from short-term investment activity, partially offset by purchases of property and equipment. The net cash provided by investing activities during the three months ended March 31, 2020 was primarily due to net proceeds from short-term investment activity.

Financing Activities

Net cash provided by financing activities during the three months ended March 31, 2021 was $34.4 million compared to $0.1 million for the three months ended March 31, 2020. The net cash provided by financing activities during the three months ended March 31, 2021 was primarily the result of the receipt of $34.2 million in proceeds from the issuance of common stock from our at-the-market offering program and $0.1 million in proceeds from the issuance of common stock from our Employee Stock Purchase Plan. The net cash provided by financing activities during the three months ended March 31, 2020 was primarily the result of proceeds from the issuance of common stock from our Employee Stock Purchase Plan and exercise of warrants.

Financing

Public Offering

On July 16, 2020, we offered and sold (i) 3,369,564 shares of our common stock, at a price to the public of $23.00 per share, and (ii) pre-funded warrants to purchase 1,630,436 shares of our common stock at an exercise price equal to $0.0001 per share (the “Pre-Funded Warrants”), at a price to the public of $22.9999 per share of common stock underlying the Pre-Funded Warrants (equal to the public offering price per share of Common Stock, minus the exercise price of each Pre-Funded Warrant). The Pre-Funded Warrants are exercisable at any time, provided that each Pre-Funded Warrant holder will be prohibited from exercising such Pre-Funded Warrants into shares of our common stock if, as a result of such exercise, the holder, together with its affiliates, would own more than 4.99% of the total number of shares of our common stock then issued and outstanding, which percentage may change at the holders’ election to any other number less than or equal to 19.99% upon 61 days’ notice to us. The gross proceeds of this offering were approximately $132.2 million, which includes the exercise in full of the underwriters’ option to purchase an additional 750,000 shares of common stock, before deducting underwriting discounts and commissions and offering expenses during the third quarter of 2020. The net proceeds of this offering were approximately $124.0 million, after deducting underwriting discounts and commissions and offering expenses payable by the Company.

At-the-Market Offerings

On February 25, 2021, we entered into an Equity Distribution Agreement (the “2021 Agreement”) with Piper Sandler & Co., Evercore Group L.L.C., and B. Riley Securities, Inc., serving as sales agents (the “Sales Agents”) with respect to an at-the-market offering program under which we may offer and sell, from time to time at its sole discretion, shares of our common stock, par value $0.0001 per share (the “Common Stock”), having an aggregate offering price of up to $125.0 million (the “Shares”) through the Sale Agents (the “2021 Offering”). As of March 31, 2021, we sold 2,110,800 shares of Common Stock under the 2021 Agreement resulting in approximately $34.2 million in net proceeds, with $89.7 million remaining available to be sold under the 2021 Agreement.

On March 27, 2020, we entered into an Equity Distribution Agreement (the “2020 Agreement”) with JMP Securities LLC, serving as placement agent (the “Placement Agent”) with respect to an at-the-market offering program under which we may offer and sell, from time to time at our sole discretion, shares of our common stock, par value $0.0001 per share (the “Common Stock”), having an aggregate offering price of up to $50.0 million (the “Shares”) through the Placement Agent (the “2020 Offering”). We offered Shares having an aggregate offering price of

17


 

$18.9 million pursuant to the prospectus supplement filed with the SEC on March 27, 2020. On June 1, 2020, we filed an amendment to the 2020 Agreement which amended the prospectus supplement dated March 27, 2020 to increase the aggregate offering price to $50.0 million. As of March 30, 2021, the 2020 Agreement was fully utilized.

Current Resources

We have financed our operations to date principally through our equity offerings and proceeds from issuances of our preferred stock, common stock, and warrants. At March 31, 2021, we had $150.0 million of cash, cash equivalents and restricted cash and $76.6 million of short-term investments. Accordingly, management believes that the Company has sufficient capital to fund its plan of operations for at least a twelve-month period from the issuance date of our March 31, 2021 financial statements. However, in order to address our capital needs in the long-term, including our planned clinical trials, we must continue to actively pursue additional equity or debt financing, government funding, and monetization of our existing programs through partnership arrangements or sales to third parties.

Off-Balance Sheet Arrangements

As of March 31, 2021, we did not have any relationships with unconsolidated entities or financial partnerships, such as entities often referred to as “special purpose” entities, which would have been established for the purpose of facilitating off-balance sheet arrangements or other contractually narrow or limited purposes.

Item 3. Quantitative and Qualitative Disclosures about Market Risk

As a “smaller reporting company” as defined by Item 10 of Regulation S-K, we are not required to provide the information required by this Item.

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

Our management, with the participation of our principal executive officer and principal financial officer, evaluated the effectiveness of our disclosure controls and procedures pursuant to Rule 13a-15 under the Securities Exchange Act of 1934, as amended (“the “Exchange Act”) as of the end of the period covered by this Quarterly Report on Form 10-Q.

Based on this evaluation, our principal executive officer and principal financial officer concluded that, as of March 31, 2021, our disclosure controls and procedures were effective to provide reasonable assurance that information we are required to disclose in reports that we file or submit under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate, to allow timely decisions regarding required disclosure.

Changes in Internal Control Over Financial Reporting

There were no changes in our internal control over financial reporting (as defined in Rule 13a-15(f) and Rule 15d-15(f) under the Exchange Act) during the quarter ended March 31, 2021 identified in connection with the evaluation thereof by our management, including the Chief Executive Officer and Chief Financial Officer, that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

18


 

PART II. OTHER INFORMATION

Item 1. Legal Proceedings

In December 2019, a complaint was filed by Dr. De-Chu Christopher Tang (“Plaintiff”) against us in the United States District Court for the Eastern District of Texas. The Plaintiff amended the complaint in February 2020 to include Vipin K. Garg and David J. Drutz as defendants, in addition to the Company (Dr. Garg, Dr. Drutz, and the Company are collectively referred to as “Defendants”). See Note 16 to the consolidated financial statements appearing in Item 1 of this report for further details.

Item 1A. Risk Factors

There have been no material changes from the risk factors disclosed in our Annual Report on Form 10-K filed with the SEC on February 25, 2021.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

On February 25, 2021, we entered into an exchange agreement (the “Exchange Agreement”) with entities affiliated with Venrock Healthcare Capital Partners III, L.P. (the “Exchanging Stockholders”), pursuant to which we exchanged an aggregate of 1,000,000 shares of our common stock, par value $0.0001 per share, (the “Common Stock”) owned by the Exchanging Stockholders for pre-funded warrants (the “Exchange Warrants”) to purchase an aggregate of 1,000,000 shares of Common Stock (subject to adjustment in the event of stock splits, recapitalizations and other similar events affecting common stock), with an exercise price of $0.0001 per share. The Exchange Warrants are exercisable at any time, except that the Exchange Warrants will not be exercised by the Exchanging Stockholders if, upon giving effect or immediately prior thereto, the Exchanging Stockholders would beneficially own more than 9.99% of the total number of issued and outstanding Common Stock, which percentage may change at the holders’ election to any other number less than or equal to 19.99% upon 61 days’ notice to us. The holders of the Exchange Warrants will not have the right to vote on any matter except to the extent required by Delaware law. The Exchange Warrants were issued in reliance of Section 3(a)(9) of the Securities Act of 1933, as amended.

Item 3. Default upon Senior Securities

None.

Item 4. Mine Safety Disclosures

Not applicable.

Item 5. Other Information

None.

19


 

Item 6. Exhibits

 

 

 

Exhibit Index

 

 

 

 

 

 

 

Exhibit No.

 

Description

 

 

 

 

 

 

4.1

 

Form of Pre-funded Warrant (incorporated by reference to Exhibit 4.1 to the Registrant’s Form 8-K, filed on February 25, 2021)

 

 

 

 

 

10.1

  

Amendment No. 6 to the Second Restated License Agreement, effective as of January 22, 2021, between Janssen Vaccines & Prevention B.V. (formerly Crucell Holland B.V.) and Altimmune, Inc.

 

 

 

 

 

10.2 §

 

Statement of Work, dated March 9, 2021, by and between Altimmune, Inc. and Lonza Houston Inc.

 

 

 

 

 

31.1

  

Certification of Principal Executive Officer Pursuant to SEC Rule 13a-14(a)/15d-14(a)

 

 

 

 

31.2

  

Certification of Principal Financial Officer Pursuant to SEC Rule 13a-14(a)/15d-14(a)

 

 

 

 

32.1

  

Certification Pursuant to Section 1350 of Chapter 63 of Title 18 of the United States Code

 

 

 

 

32.2

  

Certification Pursuant to Section 1350 of Chapter 63 of Title 18 of the United States Code

 

 

 

 

101.INS

  

XBRL Instance Document

 

 

 

 

101.SCH

  

XBRL Taxonomy Extension Schema Document

 

 

 

 

101.CAL

  

XBRL Taxonomy Extension Calculation Linkbase Document

 

 

 

 

101.DEF

  

XBRL Taxonomy Extension Definition Linkbase Document

 

 

 

 

101.LAB

  

XBRL Taxonomy Extension Label Linkbase Document

 

 

 

 

101.PRE

  

XBRL Taxonomy Extension Presentation Linkbase Document

 

 

 

  

This certification will not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liability of that section. Such certification will not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except to the extent specifically incorporated by reference into such filing.

 

§

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment.

 

20


 

 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused the report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 

ALTIMMUNE, INC.

 

 

 

 

Dated: May 17, 2021

By:

 

/s/ Vipin K. Garg

 

Name:

 

Vipin K. Garg

 

Title:

 

President and Chief Executive Officer (Principal Executive Officer)

 

 

 

 

Dated: May 17, 2021

By:

 

/s/ Will Brown

 

Name:

 

Will Brown

 

Title:

 

Chief Financial Officer (Principal Financial and Accounting Officer)

 

 

 

 

 

 

21

EX-10.1 2 alt-ex101_6.htm EX-10.1 alt-ex101_6.htm

 

 

 

Exhibit 10.1

AMENDMENT NO. 6 TO SECOND RESTATED LICENSE AGREEMENT

This Amendment No. 6 (“Amendment No. 6”) to the Second Restated License Agreement is made and entered into on the date of the last signature below by and between:

Janssen Vaccines & Prevention B.V., a company under Dutch law with limited liability, with registered address at Archimedesweg 4, 2333 CN Leiden, The Netherlands (“Janssen Vaccines”); and

Altimmune, Inc., a Delaware corporation, having offices located at 910 Clopper Road, Suite 201S, Gaithersburg Maryland (MD) 20878, Unites States (“Altimmune”).

Each party hereinafter individually referred to as “Party” and collectively as “Parties”.

 

WHEREAS Altimmune (Vaxin) and Janssen Vaccines (Crucell) entered into a Second Restated License Agreement effective as of October 4, 2005 (as amended, the Agreement”);

WHEREAS Altimmune and Janssen Vaccines entered into the Amendment No. 1 to Second Restated License Agreement effective as of September 25, 2015;

WHEREAS Altimmune and Janssen Vaccines entered into the Amendment No. 2 to Second Restated License Agreement effective as of September 20, 2016;

WHEREAS Altimmune and Janssen Vaccines entered into the Amendment No. 3 to Second Restated License Agreement effective as of April 2, 2020;

WHEREAS Altimmune and Janssen Vaccines entered into the Amendment No. 4 to Second Restated License Agreement effective as of July 28, 2020;

WHEREAS Altimmune and Janssen Vaccines entered into the Amendment No. 5 to Second Restated License Agreement effective as of October 22, 2020;

WHEREAS Altimmune is adding two additional STRATEGIC PARTNERS; and

 

WHEREAS Altimmune and Janssen Vaccines desire to further amend the Agreement on the terms and conditions set forth below in accordance with Section 14.1 of the Agreement.

NOW THEREFORE, the Parties agree as follows:

 

1.

Definitions and Cross References. Unless otherwise specified herein, each capitalized term shall have the meaning assigned to it in the Agreement and each reference to a Section or Article shall refer to the corresponding Section or Article in the Agreement.

 

 

2.

Exhibit 1.1 of the Agreement. Exhibit 1.1 of the Agreement (attached hereto) is hereby deleted in its entirety and replaced with a new Exhibit 1.1. as set forth on Exhibit A of this Amendment No. 6, including to add the following under the header Approved STRATEGIC PARTNERS:

 

Page 1 of 3

 

 


 

 

 

MassBiologics and WuXi.

 

 

3.

The Agreement is amended only to the extent necessary to give full effect to this Amendment No. 6. All other terms and conditions of the Agreement shall remain in full force and effect.

 

 

4.

Each signatory to this Amendment No. 6 personally represents that, to the best of his/her knowledge, he/she has authority to legally bind his/her respective Party to this Amendment No. 6.

 

 

5.

This Amendment No. 6 may be executed in counterparts and when bearing the signatures of all required parties hereto it shall constitute one and the same Amendment No. 6. The Parties agree that exchanged PDF copies of a signature or any other electronically generated signature used in execution of this Amendment No. 6 (including by means of services such as Adobe eSign services) shall constitute a binding original of this Amendment No. 6   for all purposes.

 

 

IN WITNESS WHEREOF, the Parties hereto have caused this Amendment No. 6        to be duly executed on the dates written below.

 

Janssen Vaccines & Prevention B.V.

Altimmune, Inc.

 

/s/ Maarten Santman

_____________________

 

/s/ Will Brown

____________________

Name: Maarten Santman

Name: Will Brown

Function: Legal Director

Function: Chief Financial Officer

Date: 22 January 2021

Date: 21 January 2021

 

 

Page 2 of 3

 


 

 

Exhibit A EXHIBIT 1.1

 

Approved REGISTERED AFFILIATES: none Approved STRATEGIC PARTNERS:

 

-

Batavia Bioservices B.V.

 

Manufacturer of the VACCINE for VAXIN in the FIELD of prevention and/or treatment of human infectious diseases caused by infectious agents in Batavia's own facilities

 

 

-

Fujifilm Diosynth Biotechnologies

 

Manufacturer of the VACCINE for ALTIMMUNE in the FIELD of prevention and/or treatment of human infectious diseases caused by infectious agents Fujifilm Diosynth Biotechnologies facility located in College Station, TX.

 

 

-

Emergent BioSolutions

 

Manufacturer of the VACCINE for ALTIMMUNE in the FIELD of prevention and/or treatment of human infectious diseases caused by infectious agents in Emergent's own facilities located in Baltimore, MD.

 

 

-

Vigene Biosciences, Inc.

 

Manufacturer of the VACCINE for ALTIMMUNE in the FIELD of prevention and/or treatment of human infectious diseases caused by infectious agents in Vigene’s own facilities located in Rockville, MD.

 

 

-

Brammer Bio, LLC (aka Patheon Viral Vector Services), part of Thermo Fisher Scientific

 

 

Manufacturer of the VACCINE for ALTIMMUNE in the FIELD of prevention and/or treatment of human infectious diseases caused by infectious agents in Brammer’s own facilities in Alachua, FL and Cambridge and Lexington, MA

 

 

-

Lonza Houston Inc.

 

Manufacturer of the VACCINE for ALTIMMUNE in the FIELD of prevention and/or treatment of human infectious diseases caused by infectious agents in Lonza’s own facilities located in Houston, Texas, USA.

 

 

-

MassBiologics – the University of Massachusetts, a not-for-profit, public institution of higher education, established pursuant to Chapter 75 of the Massachusetts General Laws, as represented solely on behalf of MassBiologics of the University of Massachusetts Medical School

 

 

Manufacturer of the VACCINE for ALTIMMUNE in the FIELD of prevention and/or treatment of human infectious diseases caused by infectious agents in MassBiologics own facilities located in Mattapan and Fall River, Massachusetts, USA.

 

-

WuXi - WuXi Biologics and through its subsidiary WuXi Vaccines Manufacturer of the VACCINE for ALTIMMUNE in the FIELD of prevention

 

and/or treatment of human infectious diseases caused by infectious agents in

WuXi facilities located in King of Prussia, Pennsylvania, USA.

 

Page 3 of 3

 

 

EX-10.2 3 alt-ex102_226.htm EX-10.2 alt-ex102_226.htm

 

 

Exhibit 10.2

 

Confidential Treatment Requested — Certain Portions of this Exhibit, Marked as [***], Have Been Omitted Pursuant to a Pending Request for Confidential Treatment and Have Been Filed Separately with the Securities and Exchange Commission

 

Statement of Work

This Statement of Work SOW A-04 (this "SOW") is effective as of March 8, 2021 (the "Effective Date") and is agreed to by Altimmune Inc. ("Altimmune") and Lonza Houston Inc. ("Lonza" and also referred to as the “Facility”) pursuant to the Manufacturing Services Agreement, dated November 5, 2020 by and between Altimmune and LONZA (as amended, the "Agreement"), and is incorporated therein and made a part of such Agreement. In the event of a conflict between the terms and conditions of this SOW and the Agreement, the terms and conditions of the Agreement shall control unless otherwise provided herein.

 

 

1.

Project Scope

This SOW describes activities to be performed by Lonza and the Lonza-designated sub-contractors set forth below in collaboration with Altimmune to engineer, construct, and qualify a Dedicated Suite (herein “[***]”) to meet Altimmune’s requirements to manufacture the GMP Ad5 viral vaccine (the “Product”).  [***] shall be for the sole use of Altimmune or its permitted assignees (in accordance with the assignment clause of the Agreement) unless otherwise agreed to in writing by Altimmune.

[***] will be designed for the target [***] perfusion based process as outlined in Attachment I, being optimized under SOW A-1, and scaled appropriately under SOW A-2. Any significant modifications to the design of the Project, process, or equipment list may result in a delay to the timeline and project cost.

 

 

2.

Project Deliverables and Activities

 

A.

Pursuant to this SOW, Lonza shall perform the following Services in furtherance of the project:

 

 

i.

Engineering Services

 

1.

Lonza will provide engineering management services to construct [***], a cGMP [***] Dedicated Suite in Lonza’s Pearland – 1 (PL-1) facility located at 14905 Kirby Drive, Pearland, TX 77047. [***] shall be sized to ensure adequate manufacturing of the Product as defined by the Process Flow Diagram in Attachment 1; the manufacturing shall be covered under a commercial supply Agreement. The clean room design and build out meets/will meet cGMP requirements of both FDA and EU Regulatory Authorities. Deliverables under this SOW will include:

 

a.

Build out of [***] used for the execution of the Product which includes design, bidding and permitting, construction activities, and fieldwork.  

 

b.

Procurement, installation of all remaining Product process equipment, including back-up equipment, that were not previously procured under SOW A-3.

 

 

ii.

Validation Services

 


 

 

 

 

1.

Lonza will provide services to qualify [***] and the Product process equipment to be used to manufacture the GMP Ad5 viral vaccine.  Suite and equipment qualification will be performed by Lonza or Lonza designated subcontractors as set forth in this SOW. Deliverables under this SOW to be delivered will include:

 

a.

Validation Protocols required for suite validation, including, but not limited to: Master Validation Plan (MVP), calibration, and equipment Installation and Operational Qualifications (IOQ)

 

b.

Calibration, as appropriate, of Product process equipment

 

c.

IOQ of Product process equipment to be used in [***].

 

d.

Commissioning and qualification of [***]:

 

i.

HVAC and associated utilities system qualification(s).

 

ii.

Separate Personnel and Material In Airlocks and a combined Exit Airlock. and Grade C cGMP manufacturing space.

 

iii.

Environmental Monitoring Process Qualification of [***].

 

3.

Key Assumptions

 

 

A.

All tasks executed and priced under this SOW are for the engineering, construction, and qualification of [***] to be used to execute the Product process as outlined in Attachment 1.  [***] will be able to accommodate the Product process as described in the Engineering Study Report provided by Lonza in November 2020.

 

B.

Construction of [***], detailed design, purchase of and installation of equipment, validation of suite and qualification of equipment, and EMPQ will be performed under this SOW.  The scope of this SOW is limited to the aforementioned services (“Services”). All other services, (e.g., cGMP Manufacturing) will be addressed under subsequent contracts or agreements (as applicable).

 

 

4.

Protocols and Reports

LONZA will draft a Protocol describing the work to be conducted by LONZA. If required, Altimmune will review the Protocol and provide approval signature or other written communication, which authorizes LONZA to proceed with the work proposed.

As LONZA issues Protocols, Altimmune will review and provide written comments, if any on each Protocol within seven (7) calendar days from issuance, with a goal of final written approval by Altimmune within fourteen (14) calendar days after first issuance of the Protocol. A maximum of 2 review cycles within this timeframe is targeted. If Altimmune does not meet these timeframes, LONZA’s scheduled commitments may be impacted and the related costs will be borne by Altimmune.

Upon completion of the work described in each Protocol and if required, LONZA will generate a Report detailing the methods, materials and results obtained. No official Report will be generated for the work conducted in the absence of an approved Protocol; however, data generated by such work may be shared by LONZA with Altimmune as it becomes available.

LONZA will target issuance of a Report within approximately thirty (30) calendar days from completion of the work described in the applicable Protocol. If Altimmune approval is required, Altimmune will target review and provide comments, if any, on each Report within fourteen (14) calendar days from issuance of the Report by LONZA, with a goal of final written approval by Altimmune within thirty (30) calendar days after first issuance of the Report by LONZA.

 

 


 

 

(rest of page intentionally left blank)

 

 

5.

Financial Terms

As per Section 9 “Financial Terms” of the Agreement.

Payment Total under this SOWA-4: $[***] USD

Payment Schedule

Altimmune will pay to Lonza such invoices in accordance with the payment terms listed below:

Project Component

Activity Description

Amount (USD)

Invoicing Terms

Initial Investment

Drafting of Capital Allocation Request (CAR)

Assemble an Engineering and Construction Team

Consign on-site facilities

Procure the following long-lead equipment:

o[***]

o[***]

o[***]

o[***]

o[***]

o[***]

Perform basic and detailed design

Perform detailed fabrication design and procure building materials for critical path items, including but not limited to: electrical systems, clean room wall and ceiling panels, piping and ductwork

Begin early construction activities as appropriate

[***]

[***]

Suite Construction and Utilities

Executing the construction of Altimmune Product process cGMP [***] suite.

This includes, but is not necessary limited to, brick and mortar construction, structural and material procurement, electrical, HVAC, and piping installation and procurement.

Anticipated delivery of HVAC ductwork is in [***].

Anticipated completion of suite construction is [***]

Anticipated completion of EMPQ is [***]

[***]

[***]

 

[***]

 

[***]

 

[***]

Process/ Equipment Procurement, Installation, and Qualification

Lonza will purchase and own the Altimmune  Process-specific Altimmune funded equipment specified in Attachment 2 to be used during the performance of technology transfer activities and Product production on behalf of and at the sole expense of Altimmune.

All Altimmune funded equipment will be owned by Lonza and assigned a Lonza equipment asset number per Lonza procedures and calibrated/qualified according to Lonza’s equipment qualification program or the supplementation of a vendor qualification program.

Lonza will create or revise existing cGMP documentation for the Altimmune funded equipment, including but not limited to: New Equipment Checklists; Equipment Part Numbers and Specifications; Equipment Identification numbers; Operation; Maintenance, and Cleaning SOPs; and reports required by Lonza Quality Assurance and Lonza Validation.

The Altimmune funded equipment will be labeled and entered into Lonza's equipment metrology system for calibration and maintenance tracking purposes.

All procured and installed equipment will be qualified and/or validated and/or calibrated for use in the execution of Altimmune’s Product process tech transfer activities and cGMP manufacturing.

Anticipated issuance of PO’s for [***] Equipment in Attachment 2 is [***].

Anticipated completion of suite construction is [***].

Anticipated completion of EMPQ is [***].

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

[***]

 

 

 

 

 

 

 

 

 

 

[***]

 

 

 

[***]

 

 

 

[***]

 

 

 

[***]

 

 


 

 

Suite Environment Monitoring Performance Qualification

Suite Environmental Monitoring Performance Qualification (Documentation, Suite Cleaning, and Environmental Monitoring)

Anticipated completion of the EMPQ report is [***]

[***]

[***]

 

Pricing Assumptions

 

Total price includes all associated labor for each activity in the Project Scope.

 

Regulatory services are excluded from this SOW.

 

 

6.

Key Assumptions and Additional Terms

 

A.

Equipment Performance Qualification (PQ) and Process Performance Qualifications (PPQ) are excluded from this SOW and will be included in a separate contract. The equipment PQ will occur in parallel with subsequent manufacturing batches (to be defined) prior to clinical/commercial manufacturing.

 

 


 

 

 

B.

Lonza’s Executive Committee has approved this Project prior to the Effective Date. Parties shall use reasonably commercial efforts to sign this SOW A-4 by [***].  

 

C.

All Services performed under this SOW may be performed by Lonza, by Lonza’s Affiliates, or by any Third Party contractor acting on Lonza’s behalf.

 

D.

Fees for the Services rendered under this SOW A-4 will not exceed $[***] USD (fees for the Project will not exceed $[***] USD including the $[***] USD in SOW A-3) without prior written approval from Altimmune.  Lonza shall provide a written justification to Altimmune for any fees in excess of this amount and such overruns will only be reimbursed by Altimmune if they are necessitated by a Change Order to this SOW and are approved by Altimmune in writing prior to being incurred by Lonza; otherwise, Lonza shall bear all such overruns at its sole cost and expense.

 

i.

As noted herein, any significant modifications to the design of the Project, process, or equipment list may result in a change to the Project cost. Any increase in costs as a result of such changes shall be borne by Altimmune and shall be documented in a Change Order.

 

7.

Estimated Project Timeline

Services under this SOW are expected to commence on or about the Effective Date and continue leading up until the start of GMP manufacturing. The Term of this SOW shall remain active in accordance with the Term section below.

Completion of construction includes Operational Qualification (OQ) of the suite including all utilities, [***] equipment IOPQ, and completion of EMPQ. Project completion or completion of the SOW is defined as completion of the IOPQ and EMPQ reports.

 

8.

Project Team

The project team will meet on a regular basis, as needed, but not less than every 2 weeks either in person or by teleconference, to review data and make directional changes if necessary in order to facilitate success and meeting the estimated timeline as defined. Altimmune will receive regular updates (weekly or as needed) via teleconference regarding the above estimated timeline. LONZA will manage the project team at the operational level to make commercially reasonable efforts to ensure there is limited turnover within the project team.

 

9.

Term and Termination

The term of this SOW will commence on the Effective Date and will continue up until the start of Engineering Runs (“the Term”), unless terminated prior to that date as provided in this section (Term and Termination).  

This SOW is non-cancellable except in the following instances:

 

A.

Termination of Product: If Altimmune terminates due to Altimmune’s termination of the Product,   Altimmune will pay to LONZA a cancellation fee [***] (the “Cancellation Fee”).  The invoice for the Cancellation Fee shall reflect the amounts already paid by Altimmune to LONZA under the Payment Schedule.

In the event of such a termination, if LONZA contracts a replacement project with another customer for the Suite within 12 months, LONZA shall reimburse Altimmune for [***] of the price Lonza paid to equipment vendors for Altimmune funded equipment that can be utilized for the other

 

 


 

 

customer. The estimated cost of equipment is approximately $[***], however for the purpose of reimbursement, the actual equipment costs will be reconciled by invoices from equipment vendors.

 

B.

Termination due to Material Breach: Either Party may terminate this Agreement, by written notice to the other Party, for any material breach of this Agreement by the other Party, if such breach is not cured within thirty (30) days after the breaching Party receives written notice of such breach from the non-breaching Party; provided, however, that if such breach is not capable of being cured within such thirty-day period and the breaching Party has commenced and diligently continued actions to cure such breach within such thirty-day period (except in the case of a payment default) the cure period shall be extended to 180 days, so long as the breaching Party is making diligent efforts to do so. Such termination shall be effective upon expiration of such cure period. The effect of a termination for an uncured material breach by Lonza shall be governed by Section 14.5 of the Master Services Agreement.

In the event of an uncured material breach by Altimmune, Altimmune will pay to LONZA a cancellation fee [***] (the “Cancellation Fee”).  The invoice for the Cancellation Fee shall reflect the amounts already paid by Altimmune to LONZA under the Payment Schedule.

For the avoidance of doubt, notwithstanding anything else in the Agreement, in the event of a conflict between the terms of this section (Term and Termination) and the Agreement, the Parties hereby agree that the terms of this section (Term and Termination) shall control.

 

10.

Suspension or Delay

In the event of any suspension or delay (i) caused or requested in writing by Altimmune, (ii) caused by a delay in the Altimmune provided material, (iii) caused by a delay of materials procured or intended to be procured by Lonza (other than for Lonza negligence), or (iv) caused by a delay in subcontracted Services, ), and upon receiving prompt written notice thereof, Altimmune will pay all reasonable costs incurred by LONZA during the suspension or delay, including without limitation, LONZA’s out-of-pocket expenses related to the purchase of unmarketable materials which have become unusable by reason of such suspension or delay, all non-cancellable commitments which incur costs during the suspension or delay, labor charges, suite fees for suites previously reserved that cannot be reallocated, and all work in process including all professional services rendered through the term of suspension or delay. For all other delays outside of the reasonable control of either Party (despite exercising commercially reasonable efforts), the Parties shall share in the costs fifty / fifty incurred as a result of the delay or suspension.  Within 30 days of the end of each calendar month during the duration of the suspension or delay, LONZA shall submit an invoice for such costs.

Suspensions or delays may be withdrawn by written notice from Altimmune, specifying the effective date and scope of the withdrawal, provided that any date to restart LONZA’s performance hereunder shall be mutually agreed to by the Parties.

 

 

11.

List of Attachments

Attachment 1: Process Flow Diagram

Attachment 2: Process Specific Equipment

 

 


 

 

 

12.

Key Contact Information

Any supplemental information required in addition to this SOW should be addressed to the following contact:

[***]

[***]

 

 

 

 

 

(rest of page intentionally left blank)


 

 


 

 

 

 

 

IN WITNESS WHEREOF, the parties have executed this SOW as of the Commencement Date signed by the parties hereto.

 

ALTIMMUNE INC.

By: /s/ Vipin Garg                      

Name: Vipin Garg

Title: President and CEO

Date: March 8, 2021

 

LONZA HOUSTON INC.

By: /s/ Thomas Fellner                  

Name: Thomas Fellner

Title: VP, Global Head of Sales and Program Management

Date: March 9, 2021

 

 

 

 

 

 

 


 

 


 

 

 

Attachment 1: Process Flow Diagram

[***]

 

 

[***]

 

 

[***]

 

[***]

 

[***]

 

Attachment 2: Process Specific Equipment

[***]

 

 

 

 

EX-31.1 4 alt-ex311_11.htm EX-31.1 alt-ex311_11.htm

Exhibit 31.1

Certification of Principal Executive Officer

Pursuant to SEC Rule 13a-14(a)/15d-14(a)

I, Vipin K. Garg, certify that:

1.

I have reviewed this report on Form 10-Q of Altimmune, Inc. for the period ended March 31, 2021;

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.

The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b)

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c)

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d)

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.

The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

 

 

 

 

 

 

Dated: May 17, 2021

 

/s/ Vipin K. Garg

 

 

Name: Vipin K. Garg

 

 

Title: President and Chief Executive Officer

(Principal Executive Officer)

 

 

EX-31.2 5 alt-ex312_10.htm EX-31.2 alt-ex312_10.htm

Exhibit 31.2

Certification of Principal Financial Officer

Pursuant to SEC Rule 13a-14(a)/15d-14(a)

I, Will Brown, certify that:

1.

I have reviewed this report on Form 10-Q of Altimmune, Inc. for the period ended March 31, 2021;

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.

The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b)

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c)

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d)

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.

The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

 

 

 

 

 

 

Dated: May 17, 2021

 

/s/ Will Brown

 

 

Name: Will Brown

 

 

Title: Chief Financial Officer

(Principal Financial Officer)

 

EX-32.1 6 alt-ex321_7.htm EX-32.1 alt-ex321_7.htm

Exhibit 32.1

Certification Pursuant to Section 1350 of Chapter 63

of Title 18 of the United States Code

In connection with the quarterly report on Form 10-Q of Altimmune, Inc. (the “Company”) for the period ended March 31, 2021, as filed with the Securities and Exchange Commission (the “Report”), I, Vipin K. Garg, President and Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:

1.

The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934.

2.

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

 

/s/ Vipin K. Garg

Vipin K. Garg

President and Chief Executive Officer

May 17, 2021

A signed original of this written statement required by Section 906 of the Sarbanes-Oxley Act of 2002 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

This certification is being furnished pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, or otherwise subject to the liability of that section. This certification will not be deemed to be incorporated by reference into any filing under the Securities Act of 1933 or the Securities Exchange Act of 1934.

EX-32.2 7 alt-ex322_9.htm EX-32.2 alt-ex322_9.htm

Exhibit 32.2

Certification Pursuant to Section 1350 of Chapter 63

of Title 18 of the United States Code

In connection with the quarterly report on Form 10-Q of Altimmune, Inc. (the “Company”) for the period ended March 31, 2021, as filed with the Securities and Exchange Commission (the “Report”), I, Will Brown, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:

1.

The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934.

2.

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

 

/s/ Will Brown

Will Brown

Chief Financial Officer

May 17, 2021

A signed original of this written statement required by Section 906 of the Sarbanes-Oxley Act of 2002 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

This certification is being furnished pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, or otherwise subject to the liability of that section. This certification will not be deemed to be incorporated by reference into any filing under the Securities Act of 1933 or the Securities Exchange Act of 1934.

GRAPHIC 8 gkiizvlofxze000001.jpg GRAPHIC begin 644 gkiizvlofxze000001.jpg M_]C_X 02D9)1@ ! 0$ 8 !@ #_VP!# @&!@<&!0@'!P<)"0@*#!0-# L+ M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7& MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$ P$! 0$! M 0$! 0 $" P0%!@<("0H+_\0 M1$ @$"! 0#! <%! 0 0)W $" M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$ MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4 MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,! (1 Q$ /P#W^BBB@ HH MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH * M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH * M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH * M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH * M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH * M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB M@ HHHH **** "BBB@ HHHH ***CFGAMHS)/*D48ZL[!0/Q- -V)**Y?4?B!X M>T__%ESD6.F >C3/G]!_C73#"5I[1.2ICL/3WE]V MIZ?17B5U\1_$5P"$N(H <_ZN,9'XG-9%QXHURZW>=JET=PP0'Q_*NB.6U'NT MCCEG%%?"FSZ$HKYNDU"]F $MW<.!TW2$X_6H_M$__/:3_OHUI_9;_F_ R_MI M?R?C_P ^E:*^:OM$_\ SVD_[Z-21ZC?1+MCO+A%/.%E8#^=']EO^;\ _MI? MR?C_ , ^D:*^?8/%6O6V/*U6Y&!@9?=Q^-:]K\2O$-O@22PSJ.HDC&3^(Q6< MLMJK9IFL,XHOXDT>UT5YG9?%D85;[3#GNT+_ -#_ (UU&G>._#^H[56]$$A_ M@N!L_7I^M.P]3X9?H=)13(Y8YHQ)%(KHW1E.0?QI]W $F,K"G+M]!_4U48RD M[15R9SC!-5Q-6L_?E<2BNATWP3K^J /%8M%&>CSG8/UY-=78_"8\-J&IX]4@3^I_P * MFIBJ,-Y&E+!8BK\,?T/,Z*]NM/ASX=MB&:VDG8?\]9"1^0P*V;?PYHMK@PZ7 M:(0, ^4,X^M$9%I/_W[-?1JVT"* M%6"-5' 08%28'I63S3M'\399+WG^'_!/FXV-XJEFM9P!R28SQ4!5@,E2!]* M^F" 1@@$&HGM;>1"CP1,IZ@H"*%FG>/X@\E[3_#_ ()\UT5]"W'AK1+HL9M+ MM&+=3Y0!_,5BWGPV\/763'%-;,>\4AQ^1S6LLOA:9XI17I-_\ M)IERVGZDC^B3I@_F/\*Y/4_!^NZ4"UQ82-&/^6D7SK^G2NJGBJ-3X9'%5P5> ME\43/T_6-1TJ7S+&\E@/HK<'ZCH:[;2/BI=PXCU6U6=?^>D7RM^70_I7GI!! MP1@CUI*=3#TZOQ(FCBJU'X)'T'I'B;2=;5?L5VC2$9,3?*X_"M>OF='>)P\; M,CJ9*+B[,]B,HR7-%W04444B@HHHH M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H MHHH *:[I&C.[!449+,< "JNIZI9Z/9/=WLRQQ*._5CZ =S7C/BGQK>^(I&AC M+6]@#\L(/+^[>OTKIP^%G6>FB[G'B\;3PRUU?8ZCQ3\2@FZST(AFZ-=$<#_= M']37FEQ<37<[SW$KRRN;^0VK5AIM[JEP(+&VDGD/9!T^I[?C7<^'/AE/55Q-6K\3/< MH8.C1^".O?J%%%%8'4%%%% !1110 4444 %%%% !1110!CZKX6T;6 3=V,9D M_P">B#:WYBO/];^%UY;AI=(G%RG_ #QDPK_@>A_2O6**Z*6*JTOA>AR5\%1K M?$M>Z/FR[LKJPN&@NX)()5ZJZX-05]%ZIHVGZU;>1?VR3*/ND\,OT/45Y?XC M^&UYIX>YTIFN[<')BQ^\4?\ LU>M0Q\*FDM&>'BA[R_$XNSO;FPN5N M+2=X9EZ.AP:]2\+?$>&\V6>M%89S@)< 81_KZ']/I7D[*58JP(8'!!'(I*WK M8>%96E]YRX;%U+>$_'EWH;):WA:XT_H%SEH_P#= M]O:O8;*]MM1M([JTF66%QD,I_P \UX6(PTZ+UV[GTV%QE/$1O'?L6****YSK M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH * M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH * M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH * MR]>UZS\/:7DFU%X51U=NP'O7A&N:Y>: M_J+WEV_M'&/NQKZ"NS"85UG=_"CS\?CEAX\L?B9)XA\17GB/4#YKV7PWX/T[PY$&C7S[LCYKAQS]%]!6MINF6FDV M26EE"L42#L.2?4GN:MUXF)QDZNBT1])@\OA07-+67];!1117$>B%%%% !111 M0 4444 %%%% !17$^*O'(TRX^Q:9YNPRJ_[/N:Z'0==M=>T];B!@)% MXEB)Y1O\/0USPQ5*=1THO5$J2;L:M%%%=!04444 %%%% !1110!ROB?P-8>( M UQ'BVOL<2J.'_WAW^O6O'M7T:^T2]-K?0F-^JM_"X]0>XKZ+K/UG1;+7;%K M2]B#*1\KC[R'U!KNPV-E2]V6J/,QF70K>]#27YGSK6_X8\57GAJ\+Q?O;60_ MO8"< ^X]#2>)O"UYX;O2DBM):N?W4X'##T/H?:L&O:]RM#NF?._O,/4[21]& M:3JUIK6GQWEE('C;J.ZGN"/6KU?/_AKQ)=^'-16>%BT#D":$GAQ_CZ&O=M.U M&UU6QCO+.420R#(([>Q]#7A8K"NA+39GT^!QL<3&STDMRU1117(=P4444 %% M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444 M4 %%%% !1110 V1_+B9R,[03BO-C\3KS)QIT&,\?.:]&N?\ CUF_W#_*OGT] M37CYKB:M%P]F[7O^AE4DUL=W_P +.O/^@=!_WV:EMOB5=374,3Z="%=PI(?U8L?^0A;?]=5_F*\F.8XJZ]_\C/GD>_]J*0=!2U]<=(4444 %%%% !11 M10 44C,J*69@JCJ2< 5#]MM?^?F'_OX*3:6X$]%0?;;7_GYA_P"_@J2.:*;/ ME2H^.NU@<4GUJW7.TT[,ZTU)70 M4444AA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4 M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11 M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4 M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11 M10 4444 %07EW!86PJ>O'?B%XJ_M6^.F6 M)-56+E;6/#3R>@]![FOH?\F7?!G@V7Q%_P#*D\7^-#9F33=-DS<#B6<'A/9??^5>:DEB2Q)) M.23WKP\QS&UZ5)Z]68SGT0A))R3DFKNE:K=:/?)=VC[77J.S#T/M5*BO C*4 M)*4=S(]RT#7K77[$3P';(O$L1/*'_#WK5KP;2-6NM%OTN[5\,O#*>CCT->R: M#KUKKU@+BW.UUXDB)Y0_X>]?58#'QQ$>67Q?F;PG?1FK1117HF@4444 %%%% M !1110!7OK&VU*SDM+N)989!AE/^>M>'^+?"EQX:OAR9+*4GR9?_ &4^]>\5 M3U/3+75["2RO(A)%(/Q4]B/0UU87$RHR\CBQN#CB8?WELSYQKIO!OBJ3PYJ. MV4EK&8@3)UV_[0]Q6?XAT&Y\.ZH]G,JF'J M76C1]+Q2QSPI-$X>-U#*RG@@]Z?7E7PW\5?9YAHE[)^ZD/\ HS-_"W]WZ'_/ M6O5:^=KT949\K/K<+B(XBFIKYA1116)T!1110 4444 %%%% !1110 4444 % M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 17/\ QZS?[A_E M7SZ>IKZ"N?\ CUF_W#_*OGT]37@9WO#Y_H8U>@58L?\ D(6W_75?YBJ]6+'_ M )"%M_UU7^8KPX_$C(]^'04M(.@I:^[.L**** "BBB@ HHHH XWXD2R1^'X4 M1V59)P' /WA@G!KRJO4OB7_R K;_ *^!_P"@FO+:^5S9_P"TOT1SU/B"NK^' MLLB>*$178(\3;E!X;'3-'T445],?&'3^ M4DT[Q3:IO(AN#Y4BYX.>GZU[G7SQX M=_Y&/3O^OA/YU]#UXN9Q2J)^1]'DTFZ4HOHPHHHKS3V HHHH **** "BBB@ MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *** M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***ANKF*RM)KF=@L42% MW8]@*$KB;25V9C M\3[27)'9'M99A/90]I+XG^""BBBO//5"BBB@ HHHH **** "BBD)"C)H "9IVFR9N#\LTRG_5_[(]_Y4>,?&/V7S-.TZ0&X(VRS*?]6/[H M]_?M7FI))R>2:\+,E2>O5F4Y]$!))R3DFBCJ<"O2?!G@SR/+U/4X_P![ M]Z&%A]W_ &C[^U>1AL-/$3Y8F48N3(O"W@9&M#>:O"6,JXCMSP5!_B/OZ5S' MB7PU<:!=]Y+20_NIL=?8^AKVJJM_8V]_:26US$)(9!AU/\Q[U]!5RNDZ*A#1 MKK_F;.FK:'@57M)U:ZT:^2[M'VL.&4]''H:O^)?#5QX?N^\EI(?W4V.OL?>L M*OG)1J4*EGHT8:IGN>A:[:Z]8"XMSM<<2Q$\H?\ #WK4KP;2=6NM&OTN[1]K M#AE/1QZ&O9="UVUUZQ%Q;G:Z\2Q$\H?\/>OID M:!1110 4444 %%%% &)XI\/0^(](>V;"SI\T$G]UO\#TKP6YMIK.YDMIT*2Q M,5=2.017TK7G/Q,\->? -;M8_P!Y$-MP!W7LWX5Z6 Q/)+V1FF$]I'VT M=UOZ?\ \L5F1@RDAE.01V->Z>"O$:^(-$4RN#>6^$G'<^C?C_/->%5M^%->? MP_KL-UEOL[?).H[J?\.M>AC*'MJ>FZV/)P&*]A5UV>Y[_134=98UD1@R, RD M="#3J^=/K0HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH MHH **** "BBB@ HHHH **** (KG_ (]9O]P_RKY]/4U]!7/_ !ZS?[A_E7SZ M>IKP,[WA\_T,:O0*L6/_ "$+;_KJO\Q5>K%C_P A"V_ZZK_,5X_#H* M6D'04M?=G6%%%% !1110 4444 <5\2_^0%;?]? _]!->6UZE\2_^0%;?]? _ M]!->6U\KFW^\OT1SU/B"NH^'_P#R-8#@ YZ"O7Z**QKXB=9IRZ'3AL+## MQ:AU"BBBL#I"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** " MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ** M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** " MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ** M** "BBB@ KSOXHZ[Y%E%HT#_ +R?]Y-@]$'0?B?Y5Z#+*D,3RR,%1%+,3V K MY[\0:J^M:Y=7S'B1_D'HHX _*N_+Z//4YGLCR\UQ'LZ/(MY?D9E=)X*\/G7M M>C61,VD&))R>A'9?Q/\ 6N;KW/P'H@T;PW"77%Q=8FER.1GH/P'\S7I8VM[* MEINSQ\OPWMZROLM6=, %4*H & !VI:**^>/K HHHH **** "BBB@ HHHH 0 MG R:X/QCXQ^R[].TZ3-P?EEE4_ZOV'O[]J7QCXR^R[].TV3_ $C[LLJG_5^P M]_Y5YH22IHZT5Z3X,\&>1Y>IZG'^]^] M#"P^[_M-[^U>1AL-/$3Y8F48N3L'@SP9Y CU/4X_WOWH8&'W?]IO?VKOJ**^ MMP^'A0AR0.F,4E9!1116XRK?6-O?VDEM=1"2"0893V]Q[UX_XE\-7'A^[YS) M:2']U-CK['WKVJJE[8V]]:26MU&)+>088'M[CTKAQN"CB8]I+9D3AS'@=7M) MU:ZT:_2[M'VL.&4]''H?:K_B;PU<>'[S!S):2']U-C]#Z&L*OEI1J4*EGHT< M^J9[GH6NVNO6 N+<[7'$D1/*'_#WK4KP;2=6NM&ODN[1]K+PRGHX]#7LNA:[ M:Z]8"XMSM<<2Q$\H?\/>OI*5 \;J592."#U%/HH ^?O%&AR:!KL]F0?))WPM_>0]/\/PK&KV;XD: M(-1T#[=&N;BR.[@GY=/RKMZ\#\'ZP=%\2VMP6Q#(?*E_P!UO\#@_A7OE>3C MJ/LZMULSWLLQ'M:-GO'3_(****XCT0HHHH **** "BBB@ HHK/O-,7/C77KEPWVYHL#&(E"BH/^$LU[_H)S_F M*YGG-&^D63[5'MU%>"2:MJ,LK2O?7)=CDGS3UJ[_ ,)9KP&/[3G_ #%2LZI] M8L/:H]NHKQFV\;:];;O]-,N[_GJH;'TK=L_B;.HQ>V"/P.8FP2>_6MZ>;8>6 M]T-5(GI-%8FE^+-(U8HD-T$F8?ZJ7Y6_P-;=>A"I"HN:#NBTT]@HHHJQA111 M0 4444 %%%% $5S_ ,>LW^X?Y5\^GJ:^@KG_ (]9O]P_RKY]/4UX&=[P^?Z& M-7H%6+'_ )"%M_UU7^8JO5BQ_P"0A;?]=5_F*\./Q(R/?AT%+2#H*6ONSK"B MBB@ HHK@_&7BO4]&UA+2R:)8_*#DLF222?\ "L,1B(4(<\]A-I*[.\HKR'_A M8.O?\]8?^_0H_P"%@Z]_SUA_[]"N'^V,/Y_U\R/:Q.I^)?\ R K;_KX'_H)K MRVMG5_%&I:W;+;WKQM&K[QM3!SC']:QJ\3'5XUZW/#8RF[NZ"NH^'_\ R-]T5Y#_P +!U[_ M )ZP_P#?H4?\+!U[_GK#_P!^A7T7]L8?S_KYFWM8GKU%>0_\+!U[_GK#_P!^ MA1_PL'7O^>L/_?H4?VQA_/\ KYA[6)Z]17*>"/$%]KL%V;TH6B9=I5<<&NKK MT*-:-:"J1V9:=U<****U&%%%,EEC@B>65U2-!EF8X % #Z*Q_P#A*M!_Z"UI M_P!_!1_PE6@_]!:T_P"_@J_9S[,S]M3_ )E]YL450L];TO4)O)L[^WFDQG8C M@G%7ZEIIV9<9*2NG<****0PHHHH **** "BBB@ HJC=:UIED!]IO[:+/0-(, MUB7GQ#\.VA8+=M.P' A0D'\>E:1I5)?"FS*=>E#XI)'4T5PC?%31@N5M;MCZ M;0/ZU5F^+5F%'D:7.6SSO=0/TS6JP==_9,'F&&7VST6BO/HOBQIK;1+I]TG' M)!4C^=:%K\2_#\_$CSP'./GCR/S%)X6LMXLJ..P\MIH[&BLZRUW2M1;;::A; MS-C.U7&?RK1K!Q:=F=,9*2O%W"BBBD,**** "BJ=UJVG6()NKZWBP<8>0 _E M6+=^/O#EHQ4WWG,!_P L4+?K5QI3E\*;,IUJBT5YW#\6;(K^_P!,N%;/ M\#J1^N*T;;XG:!,2)?M$'H6CR#^5)X2NMXCCC\-+::.SHK-L?$&D:D/]$U"W MD.,E0^"/P-:58.+B[-'3&49*\7<****104444 %%%% !1110 4444 %%%% ! M1152YU73[1"]Q>V\2CKND II-[";2U9;HKFYO'GAN&0H=11R!U12P_/%5G^) M'AM&Q]IF;W6%JU6'JO[+^XQ>*H+>:^\ZVBN*B^*&@.[!Q=1J.C&+.?R-78OB M%X;EV_Z<4W?WXV&/KQ0\-66\62L9AWM-?>=115"TUO2[Y2;74+:7'7;(,U?K M)IK*H+>:^\ZZB MN'3XI:&SJ'BNT4]6V X_6KL7Q%\-R_\ +W(G^_$PJGAJRWBR5C,.]IHZNBLV MS\0:1?G%KJ-M(?02#/Y5I5BXM:,WC*,E>+N%%%%(H**** "BBB@ HHHH **R M/$'B*T\.6D5Q=I*ZR/L41C)SC-<[_P +3T7_ )][O_OD?XUM##U9KFC&Z.>I MBJ-.7+.5F=S17#?\+3T7_GWN_P#OD?XUO>'O%-AXD28V8D5H2-ZR+@X/0T3P M]6"YI1T"GBZ-27+"2;-NBBBL3H"BBB@ HHHH **** "BBLS7==M/#VG_ &R\ MWE"P1509))IQBY.RW)E*,(N4G9(TZ*X;_A:>B_\ /O=_]\C_ !H_X6GHO_/O M=_\ ?(_QK?ZI7_E9S?7L-_.CN:*P/#WBZP\233Q6B3(\*AF\Q0,@UOUC.$H/ MEDK,Z*=2-2/-!W04445)84444 %%%% !115&^UK3--_X_+Z"$^CN,_E32;=D M*4E%7;+U%<==?$OP_;X\IY[@GKLCQC\\5B3_ !:7Y_L^E$_W3)+C\\"NB.$K MRVB3(Z/#P/R(JW'\5-95<26UFY]0K#^ MM#RZLNP+-L.][_<>P45YQ9_%FV8@7FFR1C'WHG#<_CBNJTSQCH6K/Y=O?(LA M&=DOR']:PGAJL/BB=5/&4*FD9(W:*,Y&116!TA1110 4444 %%%% !1110 4 M444 %%%07=[;6,!FNYXX8Q_%(V!0DWHA-I*[)Z*XK4OB;HMH62U66[<#@H-J MD_4USUS\6+UF'V73H47OYCEB?RQ75#!5Y;1..IF.&AHY7]#U:BO&)/B?X@<, M%%FF>A6(Y'YFF0_$SQ%$"&>VER>KP_X$5K_9U:W0Q_M;#WZ_<>U45Y-;?%?4 M%D'VFPMY$QSL8J?ZUT>F_$[1KLJMVLMFY')8;ES]164\%7A]DVIYCAIZ*5O4 M[:BH;:[M[R$2VT\J"BBB@84444 %%%% !1110 4444 M %%%% ')?$353IOA>2)&Q+=MY*_3JWZ?SKQ*NZ^*.I&YU^&Q5LI:Q9(!_B;D M_IBN%KZ# T^2BGWU/E,SK>TQ#71:&[X/TC^V?$MK;LN84;S9?]U>?U.!^->^ M]!@5Y[\*]+\G3;K4G7YIW\M#_LCK^O\ *O0J\W'U>>KR]$>SE='V=#F>\M0H MHHKA/2"BJU_?VVFV4EW=RK%#&,LQ_E]:\Q7XH77_ D7G-%_Q*C\GDX&X#^] MGU]NG\ZWHX>I53<5LBH+.\M]0M([JUE66&095E[U/6+33LS MH335T%%%%(85P?C+QE]EWZ;ILF9^DLRG_5^P]_?M1XR\9_9?,TW3),S?=EF4 M_<]A[_RKS0DDY)R37AYCF-KTJ3UZLRG/H@)).3R31U.!1UKTGP9X,\CR]3U. M/][]Z&!A]W_:;W]J\?#8:>(GRQ,HQIQ_O?O0PL/N_P"T??VK MOJ**^MP^'A0AR0.F,4E9!1116XPHHHH **** *E[96U]9O:7<8DMY!@@]J\@ M\3>&;CP_>8.9+20_NIO:CR,&JM[96]_:/9W<8EAD&"#_G@^]<.-P4<3 M'M);,B<.8\"J]I.K76C7Z7=H^UAPRGHX]#5_Q+X9N/#]W@YDM)#^ZFQ^A]ZP MJ^6E&I0J6>C1SZIGN>A:[:Z]8"XMSM=>)8B>4/\ A[UJ5X-I.K76C7R7=H^U MAPRGHX]#[5[+H6NVNO6(N+<[7'$D1/*'_#WKZ7 8]8A$[Z,U**** M](T"BL;Q)XDM/#>GF><[YFXAA!Y<_P!![UQ?A7XCRS:B]MK;H(YWS%,!@1D_ MPGV]ZWAAJDX.<5HCEJ8RC3J*G)ZO^M3TVBD!! (.0>AI:P.H;)&LL;1NH9'! M5@>X-?//B#2VT;7;NQ8'$JQK]_]S*?<=;Q_(\UKWKP7JIU?PM:3.V9HQY,GU7C^6#7@M>C_ M HU(I=WNFLWRR*)D!/<<'],?E7=F%/GHW['F956Y*_+TEH>IT445X)]0%%% M% !1110 4444 <]XWN)K;PK=/!(T;$JI93@X) ->-$DG)))]37L'C[_D4KG_ M 'T_]"%>/5\SG+?MTO+_ #,*NX4445Y)D%%%% !1110 4444 )!R*Z?0_&^ MIZ4R13N;JU!P4D.6 ]C7,45I2K5*4N:#L--K8]XTC5[36K%;JT?*GAE/WD/H M15^O"]#URZT*_6YMFRIXDC)X<>A_QKV;2-5MM9T]+RU8E&X93U4]P:^HP..C MB8V>DD=$)\Q>HHHKT"PHHHH **** (KG_CUF_P!P_P J^?3U-?05S_QZS?[A M_E7SZ>IKP,[WA\_T,:O0*L6/_(0MO^NJ_P Q5>K%C_R$+;_KJO\ ,5X_#H*6D'04M?=G6%%%% !7D_Q'_Y&5/^O=?YFO6*\H^(X(\2QD@X-NN#^)KR M\W_W;YHSJ?" M?_##_4:C_O)_(UZ!7UV6_P"ZQ^?YG33^$****[BPK%\7?\BEJG_7!JVJQ?%W M_(I:I_UP:KI?&O4RK?PI>C/G^BBBOJ3XDZ7P%_R.=A]6_P#037NM>%> O^1S ML/JW_H)KW6O$S+^*O0^ER?\ @/U_1!1117G'K!1110 5B:OXLT;14;[5>(TH M_P"6,1W/^0Z?C7GOCOQ5JZ:Y=Z9!=-!:QX7;%P6XSR>O>N#)))).2>237J4, MOYTI3>C/%Q6;#L>_: M#XLTOQ#%_HLNR=5R\,G#+_C^%+JWBS1=&!%U>H9 <>5&=S_D.E> J[(VY&*L M.X.#2$DG).2:X/[,AS7OH>I_;-3DMRJ_?_@'I&J?%:9\II=BL8Z>9.CNBBY:YMUX,,QR,>@/45S=%3.G&:M)7- M*=6=-W@['O/A[QCI?B%=D+^3= @E'J/?U%>-B\%[-<\-CZ' YDJS]G5TE^9V=%%%><> ML%%%% !1110 4UY$B1GD9511DLQP!6/XKUJ70- FOX8EDE5E50W0$GJ:\7UG MQ/JVNN?MMTQC[0I\J#\._P"-=>&P80,?05G$D]23]:2BNM14=D<$IRD[R=PHHHIDA M1110 H)!R#BMW2/&.MZ-\MO>-)%_SRF^=?PST_"L&BIG",U:2N7"I.F[P=CV M;PY\1-/UE<9J M/Q5U&8E=/M(;9>S2'>W]!7G]%;4\!1ANKG/6S3$5-G9>1KWWBC6]1/\ I.I7 M#+_=5MH_(5DLS.WX_G7< A@"""#T(KYFKMO!?CB31I$L-0=I-/8X5SR8?_L?:O+Q. M7I+FI?<>W@\U;:A7^_\ S/9**;'(DL:R1L&1AE6!R"*=7DGNA1110 4444 < M!\5_^0)9?]?'_LIKR2O6_BO_ ,@2R_Z^/_937DE>_E_\!'RV:_[R_D%>E_"7 M_6ZG_NI_6O-*]+^$O^MU/_=3^M5COX$OZZD9;_O4?G^1Z?1117SQ]8%%%% ! M1110 4444 %<+\5/^1;M_P#KX'\C7=5POQ4_Y%NW_P"O@?R-=&$_CQ.3'?[M M/T/'Z***^D/CST/X3?\ (4U#_KBO_H5>KUY1\)O^0IJ'_7%?_0J]7KY_'_QW M\CZO*_\ =H_/\PHHHKC/0"BBB@"O=WUK80F6[N(H(Q_%(P KA]7^*5C;%XM, MMFNG' E<[4S].I_2N'\;W5Q<>+M02:9W6*79&I/"@ <"N=KV MQ>:U5-PIJUCH=3\;:]JF1+>M%&C"$8*T5 M8\F=6=1WF[A1115&84444 %%%% !1110!TN@>-]6T)TC\TW-H#S!*<\?[)[5 MZ[H'B33_ !%:":TD E _>0,?G3ZCT]Z^?:M:?J%UI=]'>6G4C4BIQ>C"BBBI+"BBB@ HHHH ***\U^('C-XGDT737*L.+B93 MR/\ 9']36M&C*M/EB88C$0H0YY&AXK^(<&E/)8Z8%N+Q?E:0\I&?ZFO*K_4[ M[4YC+>W4L[DY^=L@?0=JJ45]!0PT**]W?N?+8G&5<1*\GIV"BBBMSD"BBB@ MHHHH NZ;JU_I%P)[&YDA<==IX/U'0UZCX8^(]MJ3)::L$MKD\+*.(W_P->0T M5A7PU.LO>6O%:[??VEKU]>9R)9F*_3/'Z8K. MR<"BM+P]9_VAXAT^U[23KN^@.3^@KZG2$/)'Q6M2?FW^9[IX/O73AL-*O+R.3&8 MR.&CWD]D'BSQ9<^);W^**RC/[J'/_CQ]ZYRBG^5)Y7F^6WE[MN_'&?3/K7T$ M(1IQ48['RM2I.K)SD[LZ+PCXNN/#=WL?=+82'][%GI_M+[_SKVZSO+?4+2.Z MM95EAD&59>]?-E=+X1\77'AN[V/NEL)#^]BST_VE]_YUPXS!JHN>&_YGHY?F M#HOV=3X?R_X![K7!>,O&?V;?IFF2?OONS3*?N>P]_?M3/%7CJ(V@M-&FWM,F M7G7^ 'L/?^5><=3DU\/F68.#=&GOU?Z'T$JB:]T"23D\DT4=3@5Z3X,\&>1Y M>IZG'^]^]#"P^[_M'W]J\?#8:>(GRQ,XQ65O MJ%K)9W<8DAD&,'_/45X_XF\-7'A^\PCCT-7_$WA MJX\/WF#F2TD/[J7'Z'WK"KY:4:E"I9Z-'/JF>YZ%KMKKU@+BW.UQQ+$3RA_P M]ZB\2>)+3PWIYGG(>9N(80>7/^'O7CFG:U+>6KX<<%#T<>A]JS]7U>[U MO4)+V]DWR-T'91V 'I7W&2PGC:?M*BLE^/I^IRXS,51CRQ^+\@U?5[O6]0DO M+V3?(W0=E'H!Z51HI2K+C((R,C(ZBOJDE%61\W*3D^9[GH?@7QR;0QZ5JLN; M<_+#.Q_U?^R?;W[5ZJ"",@Y!Z&OF:O0_ WCHV9CTK59UEV8VM2JO3HSU>N>\;Z?_:7A*]C"Y>-?.3ZKS_+-=""",@Y M!IDJ"6)XVZ.I4_C7EPDX24ET/Y4=!@5YV*RZ.(JJV;;@#.Y<^O//ZURFJ^ M6T]6EA"W<0/6+[V/\ =_PS7KM%2""0001U!I*]9\6^#X=5MVN[)$BO4!) &!*/0^_O7DQ!!( M(P1U!KYW%X2>&GRRVZ,PE%Q85TW@OQ VCZJL,K'[)/UZUM5]K3FJD%-;,ZD[JX4445 M8PHHHH BN?\ CUF_W#_*OGT]37T%<_\ 'K-_N'^5?/IZFO SO>'S_0QJ] JQ M8_\ (0MO^NJ_S%5ZL6/_ "$+;_KJO\Q7AQ^)&1[\.@I:0=!2U]V=84444 %1 MR012D&2)'QTW*#4E%%K@0?8[7_GVA_[X%'V.U_Y]H?\ O@5/12Y5V X;XD6\ M$6B6S1PQHWGXRJ@'[IKS&O4OB7_R K;_ *^!_P"@FO+:^6S56Q+]$<]3X@KI MO <<IE6_A2]&?/]%%%?4GQ)TO@+_D<[#ZM_Z":]UKPKP%_P C MG8?5O_037NM>)F7\5>A]+D_\!^OZ(****\X]8**** /"?'G_ ".>H?[R_P#H M(KFZZ3QY_P CGJ'^\O\ Z"*YNOIZ'\*/HCXO$_QI^K_,*L6MA=WT@CM;:69C MVC0FJ]?0/A-$7PMII5%!-NN2!C-98K$.A%-*]S? X18F;BW:QY/:?#SQ'='F MS6 8ZRR ?I6U!\)KYMIN-2MTS]X(A;'\J]7HKRY9A6>VA[4,IP\=[OYGG(^$ MMIQG59SZ_NA_C3_^%36/_03N/^_8KT.BL_KE?^8V_L_#?R?F>Y$\LPTEI&WH?.%]IM M[IDWE7MK+ ^]5*^D-0T^UU2S>UO(5EB<8(8=/<>AKQ7QCX4?PU?J M8F>2RF_U3L.0>ZGWKTL-C8UGRRT9X^-RZ6'7/%WB8%20P2W$@CAB M>1RFRJK' :7"?SK=MOA5JT@S/= MVL/L"6/\J]>HKSY9C6>UD>K#**$?BNSS>/X26^P>9JTI?OMA&/YU)_PJ:QQ_ MR$[C_OV*]$HK+Z[7_F-_[.PW\GYGG3_"6T(^359P?>('^M8M]\+-7MT+VMQ; MW./X]R9Y9AI+X;'SCJ&E7^E3>3?6LD#]MXX/T/>J=?2- M_I]IJ=H]M>0)-"XY5A_+TKQ7QGX3;PU?*T+%[&EA<;&L^66 MC/&QN72H+GB[Q_(YBI;:YFL[J*YMW*31,'1AV(J*BNYJ^AYJ;3NCZ"\,ZY'X M@T2&]7B3&V9/[KCK^%;%>1?"[6#:ZQ-ICL!%=+N7)Z.O^(S^5>NU\WBJ/LJK MBMCZ_!5_;T5)[]0HHHKG.L**** .1^)/_(FS?]=8_P"=>)U[9\2?^1-F_P"N ML?\ .O$Z]W+?X/S/F?0I.K45-=3EK73;Z]_P"/6SGF]TC)%;MK\/\ Q'=<_8?)&,YF<+7N M,<:1($C144= HP*=7DSS.;^%6/=IY-37QR;/(K?X5:O(F9[NUA/]W);^E3CX M37V.=3M\^R-7JU%8O'U^YT+*\,NGXGE)^$U[CC4[?_OAJHW?POUR#)@>VN0! MGY7VG]:]DHH685UU"6589K16^9\Z:AHFIZ4Q6]LIH<'&YE^7\^E4*^F)(TE0 MI(BNIZJPR#7FGC+X?1I#)J.C1[=@W2VPYS[K_A7=0S",WRS5CS<5E4J<>>F[ MK\3S*BBBO1/'"BE&,\]*]C\.^!_#;6%M?K&]X)45U,S9'3T'%85\1&@KR.K" MX2>)DU!['D$-O/<.$@ADD9C@!%))K8L_!GB"]&8M,F52<9DP@_6O=K:SM;., M1VUO%"HZ!$ J>O.GF)6+-H=T^1@O;,3S[K_4?C7IM?-EG=265[#=1?ZR%P MZ_4&OHG3;Z/4M-MKV+[D\8<#TS7B9A04)\ZV9]+E.)=2FZ25ZW\5_^0)9?]?'_ +*:\DKW\O\ X"/ELU_W ME_(*]+^$O^MU/_=3^M>:5Z7\)?\ 6ZG_ +J?UJL=_ E_74C+?]ZC\_R/3Z** M*^>/K HHHH **** "BBB@ KA?BI_R+=O_P!? _D:[JN%^*G_ "+=O_U\#^1K MHPG\>)R8[_=I^AX_1117TA\>>A_";_D*:A_UQ7_T*O5Z\H^$W_(4U#_KBO\ MZ%7J]?/X_P#COY'U>5_[M'Y_F%%%%<9Z 4444 > ^,?^1QU7_KN?Y"L.MSQC M_P CCJO_ %W/\A6'7U%'^''T1\5B/XT_5_F%;NG^#=>U+:T.GR+&Q'SR_(/K MS6&OWU^M?2=G_P >5O\ ]5B4N&H$VFP,I_O22L3^A%65\%>&T7 TF#\HK)UZK^T_O-UAJ*V@ON1 M@MX*\-NN#I,'X9'\C5"Y^&_ARX;*6\T''2*4_P!*6&HRW@O MN/+-4^%,\:M)I=\)<#(BF&TG\1Q7!7^FWFEW)M[VWD@E'9QU^GK7TA67KNA6 M6OZ>UK=Q@G!\N0#YHV]17;0S&<7:IJCS\3E-.2O2T?X'SS15W5],GT;5)["Y M'[R)L9'1AV(]C5*O9335T?.RBXNSW-GPQKLOA_6HKQ,F(_),G]Y#U_+K7OT4 MJ3PI-$P:-U#*P[@]*^:*]H^&NJ?;O#(MG?,MHYCY/.T\C_#\*\S,J*<541[. M3XAJ3HO9ZH[*BBBO'/H HHHH **** .<\:>(/^$?T%Y(B/M4_P"[AYZ''+?A M_A7A+NTCL[L69CDDG))KJ/'^L#5O$TJQN6@MAY2<\9'WB/Q_E7+5]#@J/LJ5 MWNSY3,<2ZU9I;+0*5$:1U1%+,QP !DDTE>Q> O"$>EV4>IWL6Z^F7*JX_P!4 MO^)K3$8B-&',S'"866)GRQVZLYW0?AA=W:)<:M,;6,_\L4&9,>YZ#]:[JQ\$ M^'K!4V:='(ZG.^;YR3^/'Z5T%%>'5Q=6H]6?34<#0I+2-WW9472]/1U=;&V5 ME.01$N1^E.ETZQFD,DMG;NYZLT0)/Z59HKGYGW.GDCV,"^\%>']063S-.BC= M^3)#\A!]>.*X+7OAC>V2&?2I3>1@9,3#$@^G8UZY1712Q=6F]&UDU"PC6/4(P68 8$P[@_[7H:\;(()! M&".HKW,/B(UXW1\UB\+/#3Y9;=&"L58,I((.01VKW3P1XA_M_0U:9LW=OB.; MGEO1OQKPJND\#ZP=(\36[-)MMYSY4H[8/0_@:SQE#VM/3=&N7XET:ROL]&>[ M4445\\?6!1110 4444 %%%% !7(_$FY^S^$)D!YFD2/I[Y_I775Y]\6)2NC6 M,0?&^35V'PTMA/XOC<@?N(7D&?7[O] M:X^O1OA+#F_U*?(^6)%QCGDD_P!*]S%RY:$F?-X"/-B8+S_(]4JM?W]MIME) M=W(^+/%ESXEO?XHK*,_NH<_^ M/'WKQ<-AI5Y>1]%C,9'#1[R>R#Q9XLN?$M[_ !1649_=0Y_\>/O_ "KG**Z# MPKX5NO$M]M7,=G&?WTV.GL/4U[WN4(=DCYC][B:O>3#PKX5NO$M]M7,=G&?W MTV.GL/4U[*WAS2VT+^QOLJBSVX"]P?[V?[WO5O3]/M=+L8[.SB$<,8P ._N? M4U:KPL3BY5976B6Q]+A,#"A"SU;W_P CP/Q1X7N_#5]Y&8QMS]T]15Y3N *\YZ8K,K7\-:M!H^LP7 M5U;"X@4\H?X?]H>XKRLYR&.,?MJ.D^OG_P $G!8SV;Y)_#^1Z+X,\&>0(]3U M./\ >_>A@8?=_P!IO?VKOJ@L[RWU"TCNK65989!E67O4]<%##0P\.2*/IXI6 MT"BBBMB@HHHH **** "BBB@ HHHH **** "D(R,4M% %:\LH-1LY+2[B$D3C M# _S'H:\9\5:%)X9O?+9Q)#+DPMGDCT(]17JWB3Q):>'-/,\Y#S-Q#"#RY_P M]Z\+U75+O6=0DO;R0O*Y_!1V ]!6D,HIXUJ=5:+\?+T/*S'&1HKDC\7Y%1W+ MMN8\TVBNU\$^"9-;E6_OU9-/0\#H9CZ#V]Z^BE*GAZ?9(^?I4JE>IRQU;$\$ M^"9-;E6_OU9-/0\#H9CZ#V]Z[_Q3X-L]>TY4@1+>[@3; ZC P/X3[?RKI(HD MAB6*)%2-!M55& !3Z\.KBZDZG.G:VQ]/1P%*G2=-J]]SYMO;*YTZ\DM+N)HI MHSAE:J]>[>+?"5OXDL]R[8KZ,?NI<=?]EO;^5>(WME<:=>26EW$T4T9PRFO9 MPV)C7CYGS^,P MA%?,U>A^!?')LS'I6JRYMS\L,['_ %?^R?;W[5QXW!7_ 'E/YH[\NS&UJ55Z M=&<_X[MA:^,;\#&'82 #W KG*[CXHQ;?$L,V5*RVZD8]B:X>N_#2YJ,7Y'F8 MR/+7FO,]Y\#W/VGP=IS9SLC\L\8^Z2/Z5T-<9\,9O,\)^7O#>5.ZX_NYP?ZU MV=?/XB/+5DO,^JPDN:A!^2"BBBL3H"BBB@ HHHH **** "BBB@ HHHH ***C M^T0@X,T>1VW"BZ0$E%9K^(-(C=D?4K8,IP1Y@X-)_P )'HW_ $$[7_OX*S]M M3_F7WBNC3KR/Q_IJV/B$SQJ%CNE\SC^]T->GVVL:;=LRV]]!(RC)"N.*Y'XE M>5+I=G(DJ,R3$8!!X(_^M7#F485<,VGMJ14LXGF=%%%?*G.>B?#&\^6^L25' M(E4=SV/]*]#KR7X=S+'XG"-G,L+JOUX/\A7K5?595/FPR7:Z.FF_="BBBO2+ M"BBB@"*Y_P"/6;_LW^X?Y5\^GJ:\#.]X?/]#&KT"K%C M_P A"V_ZZK_,57JQ8_\ (0MO^NJ_S%>''XD9'OPZ"EI!T%+7W9UA1110 444 M4 %%%% '%?$O_D!6W_7P/_037EM>I?$O_D!6W_7P/_037EM?*YM_O+]$<]3X M@KJ/A_\ \C7#_P!OT445]F M=04444 %%%% !1110 5B^+O^12U3_K@U;58OB[_D4M4_ZX-5TOC7J95OX4O1 MGS_1117U)\2=+X"_Y'.P^K?^@FO=:\*\!?\ (YV'U;_T$U[K7B9E_%7H?2Y/ M_ ?K^B"BBBO./6"BBB@#PGQY_P CGJ'^\O\ Z"*YNND\>?\ (YZA_O+_ .@B MN;KZ>A_"CZ(^+Q/\:?J_S"OH+PK_ ,BKIG_7NO\ *OGVOH+PK_R*NF?]>Z_R MKAS/X(^IZ63?Q)>AL4445XQ]$%%%% !1110 5C^*-'37- N;1@/,V[XF]''3 M_"MBBJC)QDI+H3."G%QELSYF8%6*L,$'!%)6SXKM19>*=1@!R!,6!^O/]:QJ M^IA+FBI=SXF<7"3B^A>T:[-AK5E=!BOE3*Q(],\U]%JP90RG((R#7S.IVL#Z M'-?1VES?:=)LYL@^9"C<'U KRLTCK&1[>2RTG'T+=%%%>2>Z%%%% !1110 5 MC>*-%77= N+/ ,N-\)]''3_#\:V:*J,G&2DNA,X*<7&6S/F9T:-V1U*LIP0> MQI*V?%=LEGXJU*&/.T3$C/OS_6L:OJ(2YHJ7<^)J1Y)N/8O:->-I^LV=VI(, M4RL<>F>?TKZ+5@RAAT(R*^9@2#D'!'0U]':3.;K1[.=A@R0HQ'X5Y>:1^&1[ M>2S^.'H7****\D]T**** .1^)/\ R)LW_76/^=>)U[9\2?\ D39O^NL?\Z\3 MKW%Z?YA7=_"O_D8KC_KW/\Q7"5W?PK_Y&*X_Z]S_ #%;XO\ M@2.; ?[S#U/7Z***^;/KPHHHH **** "BBB@#P[Q[H:Z-XCD,2@6]T/.C [9 M/(_/^=R?#"^%QX9:V)!:VF*X[X/(_K7C=>E_"68>;J<&.=J/G\Q48^-Z#?8TRN;CB M4N]ST^BBBOGSZH**** "BBB@ HHHH \-\>:&-%\1R&)<6UT/-CP.!GJ/P/\ M,5R]>O?%6T$N@6UUGYH)\8]0P_\ K"O(:^CP=1U**;W/D.5Z1\)KK%SJ5J1]Y$D!^A(/\Q48^/-0?D:9 M7/EQ*7<]2HHHKY\^J"BBB@#@/BO_ ,@2R_Z^/_937DE>M_%?_D"67_7Q_P"R MFO)*]_+_ . CY;-?]Y?R"O2_A+_K=3_W4_K7FE>E_"7_ %NI_P"ZG]:K'?P) M?UU(RW_>H_/\CT^BBBOGCZP**** "BBB@ HHHH *X7XJ?\BW;_\ 7P/Y&NZK MA?BI_P BW;_]? _D:Z,)_'B/T445](?'GH?PF_Y"FH?]<5_]"KU M>O*/A-_R%-0_ZXK_ .A5ZO7S^/\ X[^1]7E?^[1^?YA1117&>@%%%% '@/C' M_D<=5_Z[G^0K#K<\8_\ (XZK_P!=S_(5AU]11_AQ]$?%8C^-/U?YBK]]?K7T ME9_\>-O_ -=FFT?F>ODN\_E^I/1117D M'O!1110 4444 %%%% 'G7Q3T99+XU DB812^ZGH?P/\Z\JKW_ ,7V_P!J M\(ZI'G&(& 5[N75'*EROH?,YM24*_,NJ"N^^%5Z8M7AZQ1$CC//;]:T*XGXGWOV?PREN,YN)@O![#DUK0ASU( MQ,,34]G1E/LCQQF+NSLEWE^RC=-*(U;OA1S^I_2O0J\#'U'.LUV/JLKHJGAU+J]0HHHK MB/1"BBB@ HHHH *\5^(NB?V7X@-S$F+>\S(,#@/_ !#^OXU[57)_$/2_[1\+ M32J#YEJ?.7'<=_TKKP57V=5=GH<.8T/:T'W6IXC1T.1117T)\D>^>#M6.L^& M;2X=@TRKYXDU"P..0LR\_@?Z5Z?7S>*I^SJRBC['! M5?:T(R>X4445SG4%%%% !1110 5YO\6_^/72O]^3^2UZ17FOQ1I."-NZ7 M/UPN/ZUU8+^/'^NAPYE_NL_E^:/+Z])^&=S::9I.KZC=RB*-&168GC !(Q[\ MUYM4GVB86QMQ(WDE]Y3/!;&,U[M>E[6'(?-8:O["I[2U[&_XL\67/B6]_BBL MHS^ZAS_X\?>NP]33]RA#LD+][B:O>3#PKX M5NO$M]M7,=G&?WTV.GL/4U[AI^GVNEV,=G9Q".&,8 '?W/J:-.TZUTJQCL[. M(1PQC [^Y]35JO!Q6*E7EY'T^"P4<-'O)[L****Y3M"JFI:9::O826=Y$)( M7'([@^H/8U;HIIM.Z$TI*S/ O%'A>Z\-7_ER9DM9#^YF X8>A]#6%7T?J>F6 MFKV$EG>1"2&0?B#ZCT->'>*/"]WX:O\ RY,R6LA_Q]TMA(?WL6>G^TOO\ SKVZRO;?4+2.ZM95 MEAD&59:^;*Z7PCXNN/#=WL?=+82'][%GI_M+[_SJ<9@U47/#?\QY?F#HOV=3 MX?R_X![K14%G>V^H6D=U:RK+#(,JR]ZGKQ&FG9GTJ::N@HHHI#"BBB@ HHHH M **** "BBB@ K&\2>)+3PYIYGG.^9N(80>7/^'O1XD\26GAO3S/.=\S<0P@\ MN?Z#WKPS5]7N];U"2]O9-\C=!V4=@!Z5W83".L^:7P_F>;C\>J"Y(?%^0:OJ M]WK>H27M[(7D;H.RCL /2J-%=IX)\$OKWO7M3G"C"[T M2/G:=.IB*EEJV+X)\$OKWO7L44:0Q+%$BI&@VJJC H MBBCAB6*)%2-!M55& !3Z^?Q&(E6E=['U6$PD,-#ECOU84445SG4%W\J\1O;*XTZ\DM+N)HIHSAE- M?08;$QKQ\SY3&8.6&EWB]F.NM0NKV*WCN93(+=/+C+=0NC:KX\TG3 MF:*%FNIEXQ']W/UKC[WXB:O<>8MN(K=&&!M7++^)KD:*\&MF>(J/1V7D8NI) MFE<>(-7NI?-EU"X+8Q\KD#\A6>9'))+L2>I)IM%<4IREK)W)N%%%%2( 2.AQ M2EB>I)I** "BBB@#I? 7_(WVO^[)_P"@&O8J\=\!?\C?:_[LG_H!KV*OILF_ MW=^OZ(Z*7PA1117K&@4444 17/\ QZS?[A_E7SZ>IKZ"N?\ CUF_W#_*OGT] M37@9WO#Y_H8U>@58L?\ D(6W_75?YBJ]6+'_ )"%M_UU7^8KPX_$C(]^'04M M(.@I:^[.L**** "BBB@ HHHH XKXE_\ ("MO^O@?^@FO+:]2^)?_ " K;_KX M'_H)KRVOEI\05U'P_\ ^1KA_P"N;_RKEZZCX?\ _(UP_P#7-_Y5 MS8/_ 'B'JB8_$CU^BBBOLSJ"BBB@ HHHH **** "L7Q=_P BEJG_ %P:MJL7 MQ=_R*6J?]<&JZ7QKU,JW\*7HSY_HHHKZD^).E\!?\CG8?5O_ $$U[K7A7@+_ M )'.P^K?^@FO=:\3,OXJ]#Z7)_X#]?T04445YQZP4444 >$^//\ D<]0_P!Y M?_017-UTGCS_ )'/4/\ >7_T$5S=?3T/X4?1'Q>)_C3]7^85]!>%?^15TS_K MW7^5?/M?07A7_D5=,_Z]U_E7#F?P1]3TLF_B2]#8HHHKQCZ(**** "BBB@ H MHHH \'\<_P#(YZC_ +X_]!%<[71>.?\ D<]1_P!\?^@BN=KZBA_"CZ(^+Q/\ M:?J_S"OH7PS_ ,BQIO\ U[I_*OGJOH7PS_R+&F?]>Z?RK@S/X(^IZ>2_Q)>A MJT445XQ]"%%%% !1110 4444 >%>/H1#XTU!0<[BK_FH-OHCP]_P BYIW_ M %[I_*N+,_@B>CDOQR]#2HHHKQCZ$**** .1^)/_ ")LW_76/^=>)U[9\2?^ M1-F_ZZQ_SKQ.O=RW^#\SYG-_]X7I_F%=W\*_^1BN/^O<_P Q7"5W?PK_ .1B MN/\ KW/\Q6^+_@2.; ?[S#U/7Z***^;/KPHHHH **** "BBB@#C_ (F?\B=) M_P!=H_YUXK7M7Q,_Y$^3_KO'_.O%:]W+?X/S/F,W_P!X^2"N]^%/_(?N_P#K MW_\ 9A7!5WOPI_Y#]W_U[_\ LPK;&?P)'/@/]YAZGKM%%%?.'UX4444 %%%% M !1110!Q_P 2XV?P?(R](YD9OIG']:\5KW#XB_\ (E7G^]'_ .ABO#Z]S+7^ MY?J?-9PK5T_+_,*] ^%'_(:OO^N _P#0J\_KT#X4?\AJ^_ZX#_T*M\9_ DM_%?\ Y EE_P!?'_LI MKR2O?R_^ CY;-?\ >7\@KTOX2_ZW4_\ =3^M>:5Z7\)?];J?^ZG]:K'?P)?U MU(RW_>H_/\CT^BBBOGCZP**** "BBB@ HHHH *X7XJ?\BW;_ /7P/Y&NZKA? MBI_R+=O_ -? _D:Z,)_'BKU\_C_X[^1]7E?\ NT?G^84445QGH!1110!X M#XQ_Y''5?^NY_D*PZW/&/_(XZK_UW/\ (5AU]11_AQ]$?%8C^-/U?YBK]]?K M7TE9_P#'C;_]-O\ ]OHGQ!_R+FI_]>LG_ M *":^=J]C*_AD?/YU\9A?X\/5?F>[4445\P?9A1110 5Y?\6KAO.TVVS\NUY/QX%>H5Y# M\5I&/B*UC)^5;4$#ZLW^ KLP"O71Y^:2MAG\C@Z**.G-?0'RA[QX&MA;>#M/ M79L+H9#[[B3FNBJCHL3P:'8Q.,.D"*1Z' J]7RU67--OS/MZ,>6G&/9(**** M@T"BBB@ HHHH *ANX%NK.:W;[LJ%#CW&*FHH3L#5U8^:KF%K>ZE@8$-&Y0@^ MQQ45;7BV 6WBO4HP00)R1@>O/]:Q:^JA+FBI=SX>I'DFX]F=9\.;G[/XPMUV MY$R-'].,_P!*]NKY]\*SO;^*=-D0@'SU'/H>#7T$.E>-F4;54_(^AR>5Z+CV M84445YQZX4444 %%%% !7F_Q;_X]=*_WY/Y+7I%);[:N8[.,_OIL=/8>IKW#3]/M=*L8[.SB$<,8P . M_N?4T:?I]KI=C'9V<0CAC& !W]SZFK5?/XK%2KR\CZO!8*.&CWD]V%%%%PDLKR(20R#D=P>Q![&K=%--IW0FE)69X%XG\,7?A MJ_\ +DS):R']S.!PP]#Z&L*OH_4M,M-7L)+.\B$D,@Y'<'U'H:\-\4>%[KPU M?^7)F2UD.89P.&'H?0U[N#QBJKEE\7YGS./P#H/GA\/Y%CPCXNN/#=WL?=+8 M2'][%Z?[2^_\Z]NL[RWU"TCNK65989!E67O7S972^$?%UQX;N]C[I;"0_O8L M]/\ :7W_ )U.,P:J+GAO^967Y@Z+]G4^'\O^ >ZT5!97MOJ%G'=6LJRPR#*L MM3UXC33LSZ1--704444AA1110 4444 %8WB3Q):>&]/,\YWS-Q#"#RY_P]Z/ M$GB2T\.:>9YSOF;B&$'ES_A[UX9J^KW>MZA)>WDA>1N@[*.P ]*[L)A'6?-+ MX?S/-Q^/5![UO4)+R]DWR-T'91Z >E4:*[3P3X)?6Y5O[]633T M/ Z&8^@]O>O:G.%&%WHD?.TZ=3$5++5L/!/@F36Y5O[]633T/ Z&8^@]O>O8 MXHDAB6*)%2-!M55& !1'&D,2Q1(J1H-JJHP *?7S^(Q$JTKO8^JPF$AAH@4445SG6%%%% !1110 5D>(M;BT+29+E MF7SB-L*'^)JUZ\;\::TVK:[(B/FVMB8XP.F>Y_.N+'XKZO2NMWL1.5D85W=S MWUS)<7,C22N1GV'2NW#9?6Q"YEHN[*C!L\GM-.O;]PEK:RRDG VJ<9^M: M]KX)UZYW?Z'Y6W_GJP&?I7L<<4<2[8T5%]%&*?7JPR6FOCDV:*DNIY"/A]KQ M('EP#_MI6A_PK*^_Y_X/^^37IU%;QRG#+>[^8_9Q/(W^'NN+(RJL#*#PWF=: MS-7\,ZCH<$Z M)E325SS"BBBO ,3I? 7_ "-]K_NR?^@&O8J\=\!?\C?:_P"[)_Z :]BKZ;)O M]W?K^B.BE\(4445ZQH%%%% $5S_QZS?[A_E7SZ>IKZ"N?^/6;_ M!G>\/G^AC5Z!5BQ_Y"%M_P!=5_F*KU8L?^0A;?\ 75?YBO#C\2,CWX=!2T@Z M"EK[LZPHHHH **** "BBB@#BOB7_ ,@*V_Z^!_Z":\MKU+XE_P#("MO^O@?^ M@FO+:^5S;_>7Z(YZGQ!74?#_ /Y&N'_KF_\ *N7KJ/A__P C7#_US?\ E7-@ M_P#>(>J)C\2/7Z***^S.H**** "BBB@ HHHH *Q?%W_(I:I_UP:MJL7Q=_R* M6J?]<&JZ7QKU,JW\*7HSY_HHHKZD^).E\!?\CG8?5O\ T$U[K7A7@+_D<[#Z MM_Z":]UKQ,R_BKT/I$^//^1SU#_>7_T$5S== M)X\_Y'/4/]Y?_017-U]/0_A1]$?%XG^-/U?YA7T%X5_Y%73/^O=?Y5\^U]!> M%?\ D5=,_P"O=?Y5PYG\$?4]+)OXDO0V****\8^B"BBB@ HHHH **** /!_' M/_(YZC_OC_T$5SM=%XY_Y'/4?]\?^@BN=KZBA_"CZ(^+Q/\ &GZO\PKZ%\,_ M\BQIG_7NG\J^>J^A?#/_ "+&F?\ 7NG\JX,S^"/J>GDO\27H:M%%%>,?0A11 M10 4444 %%%% 'AWQ$_Y'>^_W8__ $!:Y:NI^(G_ ".]]_NQ_P#H"URU?38; M^#'T/C<9_O$_5A7T1X>_Y%S3O^O=/Y5\[U]$>'O^1[EO M\'YGS.;_ .\+T_S"N[^%?_(Q7'_7N?YBN$KN_A7_ ,C%OT445\V?7A1110 4444 %%%% ''_ !,_Y$^3_KO'_.O%:]J^)G_( MGR?]=X_YUXK7NY;_ ?F?,9O_O'R05WOPI_Y#]W_ ->__LPK@J[WX4_\A^[_ M .O?_P!F%;8S^!(Y\!_O,/4]=HHHKYP^O"BBB@ HHHH **** .5^(O\ R)5Y M_O1_^ABO#Z]P^(O_ ")5Y_O1_P#H8KP^O;RS^$_7_(^;SG^.O3]6%>@?"C_D M-7W_ %P'_H5>?UZ!\*/^0U??]8'K5%%%?.'UX4444 < M!\5_^0)9?]?'_LIKR2O6_BO_ ,@2R_Z^/_937DE>_E_\!'RV:_[R_D%>E_"7 M_6ZG_NI_6O-*]+^$O^MU/_=3^M5COX$OZZD9;_O4?G^1Z?1117SQ]8%%%% ! M1110 4444 %<+\5/^1;M_P#KX'\C7=5POQ4_Y%NW_P"O@?R-=&$_CQ.3'?[M M/T/'Z***^D/CST/X3?\ (4U#_KBO_H5>KUY1\)O^0IJ'_7%?_0J]7KY_'_QW M\CZO*_\ =H_/\PHHHKC/0"BBB@#P'QC_ ,CCJO\ UW/\A6'6YXQ_Y''5?^NY M_D*PZ^HH_P ./HCXK$?QI^K_ #%7[Z_6OI*S_P"/&W_ZYK_*OFU?OK]:^DK/ M_CQM_P#KFO\ *O.S3:/S/7R7>?R_4GHHHKR#W@HHHH **** "BBB@#.\0?\ M(N:G_P!>LG_H)KYVKZ)\0?\ (N:G_P!>LG_H)KYVKV,K^&1\_G7QP^85TG@+ M_D=M-_WG_P#0&KFZZ3P%_P CMIO^\_\ Z U=^(_A2]&>9A?X\/5?F>[4445\ MP?9A1110 5X[\5/^1JA_Z]$_]">O8J\=^*G_ "-4/_7HG_H3UW9?_'/-S;_= MGZHX>@<&BBO>/ECI%\>>(U4*-0( &!\B_P"%+_PGWB3_ *")_P"^%_PKFJ*R M]A2_E7W&_P!:K_SO[SI?^$^\2?\ 01/_ 'PO^%'_ GWB3_H(G_OA?\ "N:H MH]A2_E7W!]:K_P [^]G2_P#"?>)/^@B?^^%_PH_X3[Q)_P!!$_\ ?"_X5S5% M'L*7\J^X/K5?^=_>SI?^$^\2?]!$_P#?"_X4?\)]XD_Z")_[X7_"N:HH]A2_ ME7W!]:K_ ,[^]G2_\)]XD_Z")_[X7_"C_A/O$G_01/\ WPO^%27=W)YDTGWFQC-5J**U225D8MMN[)[&5H+^WF3[R2JP MS[&OHVTE:>R@E8 ,\:L<>I&:^Z>[DM_?[:$U%%%>2>Z%%%% !1110 5R7Q(MO/\'SO@$PR))G/3G' M]:ZVLWQ!:?;O#VH6V.7@;'U R/U%:T9E*/=,^=ZZ[X;7/V?QA M"A/$\3Q]/;=_[+7(UHZ!>_V=K]A=G[L4ZEOIG!_2OHZT>>G*/D?(8>?)6C+L MT?1-% ((R.0:*^7/M0HHHH **** "BBB@ HHHH *J:GIEIJ]A)9WD0DAD'([ M@^H]#5NBFFT[H32DK,\#\4>%[OPU?>7)F2UD/[F<#AAZ'T-8-?1^IZ9::O82 M65Y$)(9!R.X/8CT->&^)_#%WX:O_ "Y,R6LA_&[O8^Z6PD/[V+/3_ &E]_P"=>W6=Y;ZA:1W5K*LL M,@RK+WKYLKI?"/BZX\-WFQ]TMA(?WL7I_M+[_P ZG&8-5%SPW_,K+\P=%^SJ M?#^7_ /=:*@L[VWU"TCNK65989!E67O4]>(TT[,^D335T%%%%(85C>)/$EIX M9YSOF;B&$'ES_A[UX9J^KW>MZA)>WLF M^1N@[*.P ]*[L)A'6?-+X3SO:G.%&%WHD?.TZ=3$5++5L7P3X)DUN5 M;^_5DT]#PO0S'T'M[U[%%&D,2Q1(J1H-JJHP *(HTAB6*)%2-!A548 %/KY_ M$8B5:5WL?583"0PT.6._5A1117.=04444 %%%% !1110 444R:58())7.%12 MQ)[ 4 >$^.+K[7XPU!@J:\G-U>SW!ZRR,Y_$YID<9EE2-?O. MP4?C7U-./)!1['Q%6?M*CEW9[MX(MA:^#M.7:!OC\PX.?O$G^M=#4%C;BTL+ M>W48$4:H/P%3U\S4ES3M?$*\-OX=, 3/GN%SGI@@UY+7S6R7.UV^IKP,[WA\_T,:O0*L6/_(0MO\ KJO\Q5>K%C_R M$+;_ *ZK_,5X_#H*6D'04M?=G6%%%% !1110 4444 <5\2_P#D!6W_ M %\#_P!!->6UZE\2_P#D!6W_ %\#_P!!->6U\KFW^\OT1SU/B"NH^'__ "-< M/_7-_P"5IE6_A2]&?/]%%%?4GQ) MTO@+_D<[#ZM_Z":]UKPKP%_R.=A]6_\ 037NM>)F7\5>A]+D_P# ?K^B"BBB MO./6"BBB@#PGQY_R.>H?[R_^@BN;KI/'G_(YZA_O+_Z"*YNOIZ'\*/HCXO$_ MQI^K_,*^@O"O_(JZ9_U[K_*OGVOH+PK_ ,BKIG_7NO\ *N',_@CZGI9-_$EZ M&Q1117C'T04444 %%%% !1110!X/XY_Y'/4?]\?^@BN=KHO'/_(YZC_OC_T$ M5SM?44/X4?1'Q>)_C3]7^85]"^&?^18TS_KW3^5?/5?0OAG_ )%C3/\ KW3^ M5<&9_!'U/3R7^)+T-6BBBO&/H0HHHH **** "BBB@#P[XB?\CO??[L?_ * M M^_W8_P#T!:Y:OIL-_!CZ'QN,_P!XGZL*^B/#W_(N:=_U[I_* MOG>OHCP]_P BYIW_ %[I_*N+,_@B>CDOQR]#2HHHKQCZ$**** .1^)/_ ")L MW_76/^=>)U[9\2?^1-F_ZZQ_SKQ.O=RW^#\SYG-_]X7I_F%=W\*_^1BN/^O< M_P Q7"5W?PK_ .1BN/\ KW/\Q6^+_@2.; ?[S#U/7Z***^;/KPHHHH **** M"BBB@#C_ (F?\B?)_P!=X_YUXK7M7Q,_Y$^3_KO'_.O%:]W+?X/S/F,W_P!X M^2"N]^%/_(?N_P#KW_\ 9A7!5WOPI_Y#]W_U[_\ LPK;&?P)'/@/]YAZGKM% M%%?.'UX4444 %%%% !1110!ROQ%_Y$J\_P!Z/_T,5X?7N'Q%_P"1*O/]Z/\ M]#%>'U[>6?PGZ_Y'S><_QUZ?JPKT#X4?\AJ^_P"N _\ 0J\_KT#X4?\ (:OO M^N _]"KHQG\"1R9?_O,#UJBBBOG#Z\**** . ^*__($LO^OC_P!E->25Z]\5 M8G;P]:R@?*EP WMD'%>0U[^7_P !'RV:K_:7Z(*]+^$O^MU/_=3^M>:5Z7\) M?];J?^ZG]:K'?P)?UU(RW_>H_/\ (]/HHHKYX^L"BBB@ HHHH **** "N%^* MG_(MV_\ U\#^1KNJX3XJL!X>ME)Y:X&/R-=&$_CQ.3'_ .[3]#R"BBBOI#X\ M]#^$W_(4U'_KBO\ Z%7J]>8?"6)O-U.; VA43/OR:]/KY_'O]^SZS+%;"Q^? MYA1117&=X4444 > ^,?^1QU7_KN?Y"L.MSQC_P CCJO_ %W/\A6'7U%'^''T M1\5B/XT_5_F*OWU^M?25G_QXV_\ US7^5?-J_?7ZU])6?_'C;_\ 7-?Y5YV: M;1^9Z^2[S^7ZD]%%%>0>\%%%% !1110 4444 9WB#_D7-3_Z]9/_ $$U\[5] M$^(/^1 O M^1VTW_>?_P! :N_$?PI>C/,PO\>'JOS/=J***^8/LPHHHH *\>^*@_XJB ^M MHO\ Z$U>PUYA\6K=!+IER$ (_^@3< M?D*]]HJ/[3J=D:?V-1_F?X'@7_"&>(_^@3^T4?VG M4[(/[&H_S/\ \"_X0SQ'_T";C\A1_PAGB/_ *!-Q^0KWVBC^TZG9!_8U'^9 M_@>!?\(9XC_Z!-Q^0H_X0SQ'_P! FX_(5[[11_:=3L@_L:C_ #/\#P+_ (0S MQ'_T";C\A1_PAGB/_H$W'Y"O?:*/[3J=D']C4?YG^!XEHG@_7HMV#I2T5RXC$2KM.2V.["X2&&347>X4445SG4%%%% !1110 4=:* M* /G;7['^S=?OK/&!%,P7Z9R/TQ6=7>?%/3OL^NP7RKA;F+#'_:7C^6*X.OI MZ$_:4HR/C,52]E6E#LSZ$\,WXU/PW870;+-$%?\ WAP?U%:U>:8 M[A]#6%7T?J>F6FKV$EG>1"2&0?B#ZCT->'>*/"]WX:OO+DS):R M']S.!PP]#Z&O=P>,55Q9Z? M[2^_\Z]NLKVWU"TCNK65989!E66OFRNE\(^+KCPW=['W2V$A_>Q>G^TOO_.I MQF#51<\-_P RLOS!T7[.I\/Y?\ ]UK&\2>)+3PYIYGG(>9N(80>7/^'O5?5_ M&&EZ9HB:DDRS^>N;>-#S(?Z =Z\4U?5[O6]0DO;V3?(W0=E'8 >E<.$P;JN\ M]$CTL=F$:,>6&LG^ :OJ]WK>H27MY(7D;H.RCL /2J-%=IX)\$R:W*M_?JR: M>AX'0S'T'M[U[4YPHPN]$CYZG3J8BI9:MB^"?!,FMRK?WZLFGH>!T,Q]![>] M>Q11)#$L42*D:#:JJ, "B*)(8EBB14C0;551@ >E/KY_$8B5:5WL?583"0PT M.6._5A1117.=04444 %%%% !1110 4444 %9?)3ZMQ_+- M='7EGQ6U3S+NSTM&XB4S2#W/ _3/YUT82G[2M%')CJOLL/*7R^\\XK>\&6/] MH>++"(C*K)YC?1>?Z5@UZ3\*--W3WNI.OW (4)]3R?Z?G7NXJIR49,^9P5+V MM>,?,]1HHHKYH^Q"BBB@ HHHH **** .)^)7_('MO^NA_I7EU>P>/+-+GPQ- M*49G@(=<=N1G]*\?KY?-XM8B_=(YZGQ!7J7PUEB;1;B-1B59LN<=G4445]:=(4444 %%%% !7# M_$W_ )!%E_UW_P#937<5P_Q-_P"019?]=_\ V4UQ9A_NLR9_"SS"BBBOD#E. ME\!?\C?:_P"[)_Z :]BKQWP%_P C?:_[LG_H!KV*OILF_P!W?K^B.BE\(444 M5ZQH%%%% $5S_P >LW^X?Y5\^GJ:^@KG_CUF_P!P_P J^?3U->!G>\/G^AC5 MZ!5BQ_Y"%M_UU7^8JO5BQ_Y"%M_UU7^8KPX_$C(]^'04M(.@I:^[.L**** " MBBB@ HHHH XKXE_\@*V_Z^!_Z":\MKU7XDQN_A^%U4E4G!8CL,$5Y57RN;?[ MR_1'/4^(*ZCX?_\ (UP_]ZUXF9? MQ5Z'TN3_ ,!^OZ(****\X]8**** /"?'G_(YZA_O+_Z"*YNND\>?\CGJ'^\O M_H(KFZ^GH?PH^B/B\3_&GZO\PKZ"\*_\BKIG_7NO\J^?:^@O"O\ R*NF?]>Z M_P JXEDW\27H;%%%%>,?1!1110 4444 %%%% '@_CG_D<]1_WQ_Z" M*YVNB\<_\CGJ/^^/_017.U]10_A1]$?%XG^-/U?YA7T+X9_Y%C3/^O=/Y5\] M5]"^&?\ D6-,_P"O=/Y5P9G\$?4]/)?XDO0U:***\8^A"BBB@ HHHH **** M/#OB)_R.]]_NQ_\ H"URU=3\1/\ D=[[_=C_ /0%KEJ^FPW\&/H?&XS_ 'B? MJPKZ(\/?\BYIW_7NG\J^=Z^B/#W_ "+FG?\ 7NG\JXLS^")Z.2_'+T-*BBBO M&/H0HHHH Y'XD_\ (FS?]=8_YUXG7MGQ)_Y$V;_KK'_.O$Z]W+?X/S/FG^85W?PK_Y&*X_Z]S_ #%<)7=_"O\ Y&*X_P"O<_S%;XO^!(YL!_O,/4]? MHHHKYL^O"BBB@ HHHH **** ./\ B9_R)\G_ %WC_G7BM>U?$S_D3Y/^N\?\ MZ\5KW_"G_D/W?_7O_P"S M"ML9_ D<^ _WF'J>NT445\X?7A1110 4444 %%%% '*_$7_D2KS_ 'H__0Q7 MA]>X?$7_ )$J\_WH_P#T,5X?7MY9_"?K_D?-YS_'7I^K"O0/A1_R&K[_ *X# M_P!"KS^O0/A1_P AJ^_ZX#_T*NC&?P)')E_^\P/6J***^?YUX=7T;JUD-1T>\LR ?.A9 ">Y''ZXKYT=&C=D8893@ MCWKVLLG>#CV9\[G,+5(S[H;7<_"V\$'B*:W:3:)X3A?[Q!S_ "S7#5I^']3. MCZ]9WP)"QR#?CNIX/Z5VUX<]*43SL+4]G6C-]&?0]%-CD26-9(V#(X#*1T(- M.KY@^S"BBB@ HHHH **** "O,_BU=_+IMF".K2D=_0?S->F5X1XYU9=7\47, MD;;H8<0QGU Z_KFN[+Z;E6OV/-S6JH8=QZLYRBBBO>/ECUOX46[1Z)>W!4A9 M9P%/KM'_ ->N_K \%Z<=,\)V,+Y$CIYK@GH6YQ^6*WZ^:Q,^>K*2[GV6#@Z= M"$7V"BBBL#I"BBB@#P'QC_R..J_]=S_(5AUN>,?^1QU7_KN?Y"L.OJ*/\./H MCXK$?QI^K_,5?OK]:^DK/_CQM_\ KFO\J^;5^^OUKZ2L_P#CQM_^N:_RKSLT MVC\SU\EWG\OU)Z***\@]X**** "BBB@ HHHH SO$'_(N:G_UZR?^@FOG:OHG MQ!_R+FI_]>LG_H)KYVKV,K^&1\_G7QP^85TG@+_D=M-_WG_] :N;KI/ 7_([ M:;_O/_Z U=^(_A2]&>9A?X\/5?F>[4445\P?9A1110 5Q?Q.LS<>%A.JY-O, MKGZ'Y?ZUVE9^NZ63#/FQ$+[-V_6M:,^2I&7F8XFG[2C*'='SK13G1H MW9&&&4D$>]-KZ<^+/0/A5J/DZO=6#N0L\>]%[;E_^L?TKUJOG#2]0ETK4[>^ M@.)(7##W'Z_(L4 M445YQZX4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!RGQ"T MK^T_"TTB#,MJ?.7 [#J/RKQ"OIAT62-HW&58$$>H-?/GB/26T37KJQ((1'S& M3W0\@_E7L9;5NG3?J?/YQ0M)55UT9+X3U8Z+XDM+HG$1;RY?]T\'_'\*]_!! M (Y!KYFKV[X?Z[_;'AY(97SA]#6%7NOC;4=)LM!EBU2-9O M.!$4 /S,WJ/3'K7A1Z\5]#@ZTJM.\E_P3Y/'X>%"KRP>_3L*6) !)('0>E)1 M7:^"?!,FMRK?WZLFGH>!T,Q]![>];U:L:4>:1S4:,ZTU""U$\$^"9-;E6_OU M9-/0\#H9CZ#V]Z]CBB2&)8HD5(T&U548 %$<:0Q+%$BI&@VJJC I]?/8C$2 MK2N]CZS"82&&ARQWZL****YSJ"BBB@ HHHH **** "BBB@ HHHH 9+*D$+RR M'"(I9CZ 5\\:WJ3ZOK5W?.?];(2H]%Z ?EBO4?B7KOV#1UTV%L3WGWL=HQU_ M/I^=>/5[.6T;1=1]3YW-\1S35)=-PKWWP=I0TCPQ9P%=LKKYLO\ O-S^G _" MO(O!FC'6O$MM"RDP1'S9O]T=OQ.!7O51F=7:FO4UR:A\55^B"BBBO)/="BBB M@ HHHH **** *NHVHOM-N;4D@2QLG'N*\%EC>&5XI%*NC%6![$5]"5Y7\0-# M:RU/^T8E_<7)^; ^Z_\ ]>O&SB@Y055=#*JM+G&5-:74UE=Q7,#E98V#*14- M%?.)M.Z,3W'0?$%GKUH)(' F4#S(C]Y3_A6M7S_:7EQ87*7%K*T4J'(9379Z M7\2;N':FHVZSIT,D?RM^70_I7T>&S>$DHUM'WZ&T:BZGIM%E'%4)?#-?>:8VHQ.,XQ&=Q_(5F77Q$T6#;Y(GN,]=J8Q^=*>+H0^*:^\7,NYUU>?\ Q+OK M9[:ULDE5KA)-[(.JC!'-9.I_$34[O*6:):1^H^9OS/\ A7(.[R.SNQ9F.2Q. M2:\?'YG3J4W2IZWZF&8G3> ?^1OM?]R3_ -!->PUP/PZT,PPR M:O,N&D!2$$?P]S^-=]7U654I4\/[W5W.FFK1"BBBO2+"BBB@"*Y_X]9O]P_R MKY]/4U]!7/\ QZS?[A_E7SZ>IKP,[WA\_P!#&KT"K%C_ ,A"V_ZZK_,57JQ8 M_P#(0MO^NJ_S%>''XD9'OPZ"EI!T%+7W9UA1110 4444 %%%% '.>.D=_"5W ML4M@HQP.@##FO&Z]]U*U6^TRZM6SB6)D^4\\BO!'1HY&C=2KJ2&![$5\YG4& MJL9]U^1A56MQM;'A:^&G>)+.=G"1E]CDC/!XK'HKR*OO78VNOZ3>,5M]0MW8#)&\ XK[&CBZ-:*<9? M(Z5),T:*ISZKI]M$99KV!$'4F05D7_CC0[),K=?:7(R%A&[]>@K2=>E!7E)( M;:1T=%8/AKQ*GB-;IDMFA$+@#+9W ]/H:WJJG4C4BIP=TP3NKH****L85B^+ MO^12U3_K@U;58OB[_D4M4_ZX-5TOC7J95OX4O1GS_1117U)\2=+X"_Y'.P^K M?^@FO=:\*\!?\CG8?5O_ $$U[K7B9E_%7H?2Y/\ P'Z_H@HHHKSCU@HHHH \ M)\>?\CGJ'^\O_H(KFZZ3QY_R.>H?[R_^@BN;KZ>A_"CZ(^+Q/\:?J_S"OH+P MK_R*NF?]>Z_RKY]KZ"\*_P#(JZ9_U[K_ "KAS/X(^IZ63?Q)>AL4445XQ]$% M%%% !1110 4444 >#^.?^1SU'_?'_H(KG:Z+QS_R.>H_[X_]!%<[7U%#^%'T M1\7B?XT_5_F%?0OAG_D6-,_Z]T_E7SU7T+X9_P"18TS_ *]T_E7!F?P1]3T\ ME_B2]#5HHHKQCZ$**** "BBB@ HHHH \.^(G_([WW^['_P"@+7+5U/Q$_P"1 MWOO]V/\ ] 6N6KZ;#?P8^A\;C/\ >)^K"OHCP]_R+FG?]>Z?RKYWKZ(\/?\ M(N:=_P!>Z?RKBS/X(GHY+\ MV?$G_D39O^NL?\Z\3KW%Z?YA7=_"O_D8KC_KW/\ ,5PE=W\* M_P#D8KC_ *]S_,5OB_X$CFP'^\P]3U^BBBOFSZ\**** "BBB@ HHHH X_P") MG_(GR?\ 7>/^=>*U[5\3/^1/D_Z[Q_SKQ6O=RW^#\SYC-_\ >/D@KO?A3_R' M[O\ Z]__ &85P5=[\*?^0_=_]>__ +,*VQG\"1SX#_>8>IZ[1117SA]>%%%% M !1110 4444 C_]#%>'U[A\1?\ D2KS_>C_ /0Q7A]>WEG\ M)^O^1\WG/\=>GZL*] ^%'_(:OO\ K@/_ $*O/Z] ^%'_ "&K[_K@/_0JZ,9_ M D)Y_+3;;W'[Z/TYZC\\U[I7*^/ M/#QUW0R\";KNVS)'ZL.Z_P"?2NO!5O95==F<&8X=UJ+MNM3P^B@@@X(P117T M)\F>M_#GQ3%=6*:-=R;;J$8A+'_6)Z?4?RKOZ^:(I9()4EB=DD0[E93@@UZ9 MX>^)Z[$MM;C(8#'VF,9S_O+_ %'Y5Y&+P4N;GI_K'^E>)=3DU/>7EQ?W_AL.J$+=3Y?&8N M6)J ^,?^1QU7_KN?Y"L.MSQC_R..J_]=S_(5AU]11_AQ]$?%8C^-/U?YBK] M]?K7TE9_\>-O_P!-O_US7^5>=FFT?F>ODN\_E^I/ M1117D'O!1110 4444 %%%% &=X@_Y%S4_P#KUD_]!-?.U?1/B#_D7-3_ .O6 M3_T$U\[5[&5_#(^?SKXX?,*Z3P%_R.VF_P"\_P#Z U O^1VTW_>?_T! MJ[\1_"EZ,\S"_P >'JOS/=J***^8/LPHHHH **** /#_ !_HITCQ+*Z#]Q=_ MOD]B?O#\_P"=UI6>Z/E,QPSHUFUL]1*[3P)XP&AW!L;YV^P3'AL_ZIO7Z'O7%T5T5: M4:L7&1R4:TZ,U.&Y]+0S17$*30R+)&XRKJ<@BI*\#T#Q?JOAXA+:7S+;.3!) MROX>GX5Z/I?Q,T6\55O/,LI<<[EW)^!']17AUL#5IOW5='TN'S.C55I/E?F= MK15"VUO2[Q5-MJ%M)O\ NA91D_A5[?7_P 5M/C#+8V,\[8^5I"$&?U-<;K'CS7-75HC<"V@;_EG -O' MH3U-=5/ 5I[JQQ5P/XATJ/5(M--[&;N4X6-3GGT..E:=>!^#23 MXQTPDY)G'\C7OE1B\.J$E%.^AI@<5+$P"*ZMY()D#Q2*5=2."#6M&JZ5 M131AB**K4G3?4^::Z#P=KQ\/Z_%.Y/V:7]W,!_=/?\#S53Q%HTN@ZU/8R [5 M.Z)O[R'H:RJ^D:C5A;HSY!.="I?9IGTRK!U#*05(R".]+7!?#?Q,+^Q_L>Y? M_2;=?W1)^^GI]1_*N]KYJM2=*;@S["A6C6IJ<>H4445F;!1110 4444 %%%% M !1110 5C>)/$EIX;T\SSG?,W$,(/+G^@]Z/$GB2T\-Z>9YSOF;B&$'ES_A[ MUX9J^KW>MZA)>7LA>1N@[*/0#TKNPF$=9\TOA_,\W'X]4%R0^+\@U?5[O6]0 MDO;V3?(W0=E'8 >E4:*[3P3X)DUN5;^_5DT]#P.AF/H/;WKVISA1A=Z)'SM. MG4Q%2RU;#P3X)DUN5;^_5DT]#P.AF/H/;WKV.*)(8EBB14C0;551@ 411)#$ ML42*D:#:JJ, "GU\_B,1*M*[V/JL)A(8:'+'?JPHHHKG.H**** "BBB@ HHH MH **** "BBB@ J.XGBM;>2XG<)%&I9V/0 5)7FOQ,\3!4_L*U?+-AKE@>@ZA M?ZG\*VH475FH(PQ->-"FYLX3Q'K4FOZY<7S9",=L2G^%!T']?QK*HK?\'Z"V MOZ]# RYMHCYDY_V1V_'I7T;<:4/)'R"4Z]2V[;/1_AOH9TW0C?2KB>]PV#V0 M?=_/K7:4BJJ(J(H55& . *6OFJM1U)N;ZGV-"DJ--4UT"BBBLS4**** "BB MB@ HHHH *IZIIEOJ^G2V5R"8Y!U'53V(JY12E%25GL!X3K6CW.B:B]I<#IRC M@<.OJ*SJ]XU71[+6;0V]Y$&'\+C[R_0UYGKO@34-+W36F;NV'.5'SJ//Y'/*FUL&YO$%]\V4LXSF63_V4>]:WA_P!=7K>=JH>V@'2/\ C?\ MP%>EV=G;V%LMO:Q+%$HX517L8'+)3:G55EV[FD*;>K'P0QVT$<$*A8XU"JH[ M 5)117TB5M$;A1110 4444 17/\ QZS?[A_E7SZ>IKZ"N?\ CUF_W#_*OGT] M37@9WO#Y_H8U>@58L?\ D(6W_75?YBJ]6+'_ )"%M_UU7^8KPX_$C(]^'04M M(.@I:^[.L**** "BBB@ HHHH *\H\?:"]AJC:C$"UO=-ECCA']/QZUZO574- M/MM4LI+2[C#Q..1W!]1[UR8S#+$4G#KT)E'F1X%16_XA\*WN@S,Y4RV9;"3J M/T/H:P*^1J4ITI)F7\5>A]+D_\!^OZ(****\X]8**** /"?'G_(YZA_O+_P"@BN;K MI/'G_(YZA_O+_P"@BN;KZ>A_"CZ(^+Q/\:?J_P PKZ"\*_\ (JZ9_P!>Z_RK MY]KZ"\*_\BKIG_7NO\JXEDW\27H;%%%%>,?1!1110 4444 %%%% ' M@_CG_D<]1_WQ_P"@BN=KHO'/_(YZC_OC_P!!%<[7U%#^%'T1\7B?XT_5_F%? M0OAG_D6-,_Z]T_E7SU7T+X9_Y%C3/^O=/Y5P9G\$?4]/)?XDO0U:***\8^A" MBBB@ HHHH **** /#OB)_P CO??[L?\ Z M)^K"OHCP]_R+FG?]>Z?RKYWKZ(\/?\BYIW_7NG\JXLS^")Z. M2_'+T-*BBBO&/H0HHHH Y'XD_P#(FS?]=8_YUXG7MGQ)_P"1-F_ZZQ_SKQ.O M=RW^#\SYG-_]X7I_F%=W\*_^1BN/^O<_S%<)7=_"O_D8KC_KW/\ ,5OB_P"! M(YL!_O,/4]?HHHKYL^O"BBB@ HHHH **** ./^)G_(GR?]=X_P"=>*U[5\3/ M^1/D_P"N\?\ .O%:]W+?X/S/F,W_ -X^2"N]^%/_ "'[O_KW_P#9A7!5WOPI M_P"0_=_]>_\ [,*VQG\"1SX#_>8>IZ[1117SA]>%%%% !1110 4444 'U[A\1?^1*O/\ >C_]#%>'U[>6?PGZ_P"1\WG/\=>GZL*] M ^%'_(:OO^N _P#0J\_KT#X4?\AJ^_ZX#_T*NC&?P)')E_\ O,#UJBBBOG#Z M\**** "BBB@#ROXA>#C!*^LZ;#^Y;FYC3^$_W@/0]Z\YKZ990RE6 *D8(/>O M./%?PW68O>Z$JH^,O:D\,?\ 9/8^W2O6P>.22IU/O/"Q^6MMU:*]5_D>6T5+ M<6T]I.\%Q$\4J'#(XP145>LG<\)IIV8^.62)]\;LC#H5.#6E'XFUR)=J:M=X M]Y2?YUE44G",MT5&=SL6/ZU'116EK&3;>X44Y$:1U1%+, MQP !DFO0?"_PVGN76ZUM6@@'*VX.';_>]![=:RJUH4E>;-J&'J5Y1XT^)LX8?ZXCL/;UKV95"J%4 *!@ #@4R""*V@2""-8XD&U548 % M25X&(Q$JT[O8^JPF%CAH?R_4GHHHKR#W@HHHH **** " MBBB@#.\0?\BYJ?\ UZR?^@FOG:OHGQ!_R+FI_P#7K)_Z":^=J]C*_AD?/YU\ M9A?X\ M/5?F>[4445\P?9A1110 4444 %>=^._ _P!L\S5M*B_T@'),^9B""01@CJ*2O9_%7P_M-:W75ALM;XG+'^"3ZCL M?<5Y3JVAZCHEQY-_;-$3]UNJM]#WKWZ&*IUEIOV/EL3@JN'?O*Z[F=11170< M85,+RZ P+F8#_?-0T463&FUL3_;;K_GYF_[^&D-Y=$8-S,?^!FH:*5D/F?<4 MDDY)R32444R0HHI0I8@*"2>@ H W/!G_ ".&E_\ 78?R->^UX]X*\(ZP-?;KF]M06C ZNO=?\ "O$2"#@]:^FJ\B^( MOA7^S[LZO9QXM9V_?*/^6;GO]#_.O5R_$V_=2^1X>:X2Z]O#Y_YG%6-]<:;? M0WEJY2:)MRG_ #VKWSPYKUOXATF.\AP'^[+'GE&[BOGNMOPQXCN/#>J+<1Y> M!_EFBSPR_P"([5UXS#>VC=;HX,OQGU>=I?"_ZN>_T56L;ZVU*RCN[25989!E M6'^>M6:\!IIV9]4FFKH****0PHHHH **** "L;Q)XDM/#FGF>]'B3Q)9^&]/,\YWS-Q#"#RY_H/>O#-7U>\UO4)+V]DWR-T'91V 'I7=A,( MZSYI?#^9YN/QZH+DA\7Y!J^KW>MZA)>WLA>1N@[*.P ]*HT5VO@GP3)KAF/H/;WKVISA1A=Z)'SM.G4Q%2RU;$\$^"7UN5;^_5DT]#P.AF/H M/;WKV.*)(8EBB14C0;551@ 4111PQ+%$BI&@VJJC I]?/XC$2K2N]CZK"82 M&&ARQWZL****YSJ"BBB@ HHHH **** "BBB@ HHHH ***HZOJUKHNFRWMVX5 M$'"YY<]@/>FDV[(4I**N]C.\6^)(O#FD-+D-=2Y6",]SZ_05X1//+(J:?"MA MT<;RR+'&I9V("J!R2:]W\'>'5\.Z(L3@&ZF_>3M[_P!WZ#_&N0^&WA7>RZY> MQ_*/^/53W/=_\*]0K@S#$\S]E'9;GJ95A.1>VGN]O0****\P]D**** "BBB@ M HHHH **** "BBB@ HHHH R-2\,:1JN3<6B"0_\ +2/Y6_2N6OOAE&Q+6%\4 MR?NRKD ?45Z!17+5P5"KK.)+BF>1-\/=>4,0D!QZ2]:S_P#A$=?_ .@9-^G^ M->VT5Q2R:@]FT3[)'C%MX*UZXEV?86BXSNE8 5HVWPXU>60B>6W@4#AMV[)^ ME>K454>OFUZY17)B<'3Q-N?H3**EN>1?\ "O=>_P"><'_?VIK3P!KD=[ [ MK J+(K,?,S@ UZO17,LHPZ=]2?9Q =****]0T"BBB@ HHHH **** "BBB@!' M19$*.H92,$$9!KEM3\ Z1?NTD(>TD;_GG]W\JZJBLJM&G55JBN)I/<\JN_AQ MJT4N+:6"=#_$6VD?A62_@_7T=E_LV4X.,J00?UKVNBO.GD]!O1M$.DCQJV\$ M:_C3IQIQ48*R1:5@HHHJQA65XFMYKOPUJ$$ M$9DE>%@J+U)K5HIQ?*TR9QYHN+ZGSW_PC&N_] B]_P"_+4?\(QKO_0(O?^_+ M5]"45Z7]IS_E1Y']C4OYF>-^"= U>U\5V=Q<:=( MKNM+F:/0PN%CAH.$7<****P.D**** /&/&VAZM<>++R>#3;J6)R"KQQ,P/ [ MBN?_ .$=UO\ Z!%__P" [_X5]#T5Z,,QG"*C9:'DU,IISFYN3U/G@>'-;)Q_ M9%]S_P!.[_X5[MH%K+9>'["VG7;+%"JNN>AQTK1HK'$8N5=)-6L=&$P,,-)R MB[W"BBBN0[@HHHH **** "BBB@#QGQMX?U>7Q7>3PZ=E<] M_P ([K?_ $"+_P#\!W_PKZ'HKT89C.,5&RT/)J913G-SYGJ?/ \.ZV3_ ,@B M_P#_ '?_"O=M @EMO#^GP3(4D2!593U!Q6C16.(QX M4445R'<%%%% !1110 4444 >/>/M#U6Y\775Q;Z=,UXGL?\ NG\J^F**[L-C71AR\MSS<7ER MQ-3GYK?(^9]C_P!T_E7>_"NWF_MRZF\I_*6#:7QP"2,"O6Z*NMF#J0<.7M M>*;'_NG\J^F**[L-C71AR\MSS<7ERQ-3GYK?(^9]C_W3^5=]\*HI!KEVY1@H M@QG''45ZU15ULP=2#AR[^9E0RI4:BJ<][>7_ 0HHHKSCUPHHHH **** "BB MB@#F/B#&\O@N]$:,Q!0D*,\!QFO#MC_W3^5?3%%=N&QCH1<;7/.QF7K$S4^: MVEMCYGV/_=/Y5Z!\*(W&L7S%&"^0!G''6O6**TK9@ZD'#EW\S+#Y4J-15.>] MO+_@A1117G'K!1110 4444 %%%% &9JOA_2]:3;?VB2$=''##\1S7#ZE\*$. M7TR_*^D/M&FW48/0F(X_.OHFBNN.9U%NDS@GDU)_#)H^;O[/O?\ GSN/ M^_1_PJ:VT35;MREOIUU(1UQ$W%?1=%4\TETB0LEC?6?X'A%IX$\1WC$#3VB M."TS!172V'PGF8AM0U!$&>4@7/'U/^%>I45C/,*TMM#HIY3AX_%=F-I'A71] M$PUG:+YN,>:_S-^9Z?A6S117'*4I.\G<]&$(P7+%604445)04444 %%%% !1 M110!YCX@^'6JZGK]Y?6]Q:^5/)O4.Q!''3I69_PJO6_^?BS_ .^V_P *]AHK MLCCJT4HI['GSRS#SDY-/7S/(%^%FM!AFYL\9_OM_A7K<$9BMXXRM_\ /Q9_]]M_A7L%%;T<34HIJ'4Y<1@Z6(:=3H>/?\*K MUO\ Y^+/_OMO\*V/"_P^U/1_$-KJ%S<6QB@+$JA))RI'H/6O2:*UECJTHN+> MYC#+,/"2DD[KS"BBBN,] **** "BBB@ HHHH *@NK.VOH3#=01S1GJKKD5/1 M0FUJA-)JS.%U7X8:5=LTEC-)9N3G:/F3\NH_.N3O/ACKUNP\CR+E3GE'VD?G M7LU%==/'5H:7OZG#5RW#U'>UO0^?I?">OPAB^DW7'7;'N_E6?_9][_SYW'_? MIO\ "OI&BNE9G/K$Y)9+#I-GS=_9][_SYW'_ 'Z/^%3V^A:M=?ZC3;N09QE8 M6Q^>*^BJ*'FDND1+)8WUG^!X+;^"?$=P^U=+F7U,A"C]36M:?"_7)P3.]M;\ MXPS[C]>*]DHK.6957M9&TX-2T4)V!JZLSP;Q;X8G\-ZD4P6LY2 M3!+ZCT/N*YZOHS5M)M-:T^2RO8P\;]#W4]B#V->&^)/#=WX;U P3C?"_,,P' M#C^A]J][!XM55RR^+\SY?,,"Z$N>'PO\"[X.\62^'+_;*7>PE.)8Q_"?[P]_ MYU[797UMJ-I'=6DRRP2#*NM?-M=#X6\6WGAJY.P>=:2']Y 3^H]#2QF#57WX M;_F5@,P=']W4^'\CWFBJ.DZO9:U9+=V,PDC/!'0J?0CL:O5X;33LSZ6,E)7C ML%%%%(85C>)/$EIX;T\SSG?,W$,(/+G_ ]ZEU[7K/P]IS7=VW/2.,'YI&]! M7A.M:Q=:[JP%=N$PCK/FE\)YV/QRP\>6/Q/\!NKZO=ZWJ$ MEY>R;Y&Z#LH] /2J-%=IX)\$OKWO7MSG"C"[T2/G*=. MIB*EEJV'@GP3)KWO7L<4:0Q+%$BI&@PJJ, "B*-(8EB MB14C0;551@ 4^OG\1B)5I7>Q]5A,)##0Y8[]6%%%%N:_8^'[(W-[)@G/EQC[SGT _K3C%R=EN3*<81YI.R)]5 MU6TT:PDO;V41Q)^;'T [FO#_ !1XEN?$FIM,Y9+5#B"$GA1ZGW-,\1^);WQ) M>^="_"4GB&^$T MZE=.A;]XV<;S_=']:K^%/"ESXEO?XH[*,_OIL?\ CH]Z]OL+"VTRRCM+2(10 MQC"J/YGWJ<;BU37)#?\ (K+L ZS]I4^'\_\ @$Z(D4:QQJ%11A5 P *=117A MGTP4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4 M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11 M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4 M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11 M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %4=6 MTFTUK3Y+*]CWQOT/=3V(/8U>HIIM.Z%**DK/8\ \2>&;WPY?-%.I>W8_NIP/ ME[/1_F?-8[+I4??IZQ_(P]&UN^T*]%U8S%&Z,IY5QZ$5[%X9\:Z M?XA18F(MKX#F%C][W4]_YUX92JS(P9258'((."*VQ&%A66NC[G/A,=4P[LM5 MV/IFLO7M>L_#VG-=W;<](XP?FD;T'^->:>'_ (E7NG1"WU.,WL*KA'SB0>F3 MW%M6S:G[*]/XG^ :[KMYX@U% MKN\?V2,?=C7T%9E%=IX)\$R:W*M_?JR:>AX'0S'T'M[UZLYPH0N]$CPZ=.IB M:EEJV'@GP3)KWO7L<44<,2Q1(J1H-JJHP *(HDAB6*) M%2-!A548 %/KP,1B)5I7>Q]5A,)##0Y8[]6%%%%(--T*W,M_/ M]3V^@KIH86I6V6G*/'MCH8:VM=MU?=-@/RQG_:/]*\@U M/5+S5[U[N^F:69NYZ >@'854)).2'PL**TW[GS>*QM3$/WM%V"NC M\*^$;OQ)=JQ#16*']Y.1U]E]36IX1\ 7&KLE[J2O!8Y!5#PTO^ ]Z]=M;6"R MM8[:VB6*&,;411P!7-B\Y3W_(Z\#EKJ6J5=(_F,L+"VTRRCM+.(10QC"J M/YGU-6:**\5MMW9]&DDK(****0PHHHH **** "BBB@ HHHH **** "BBB@ H MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H MHHH **** "BBB@ HHHH **** "D90RE6 *D8((X-+10!YWXH^&T5T6N]$"0R M]6MCPC?[I[?3I7F%W9W-A5?VRR8^ZXX9 M?H:]'#X^4/=J:K\3R<7E<*GO4M'^!\[T5W&N_#34M/WS::WVVW'.T#$BCZ=_ MP_*N)DC>*1HY$9'4X*L,$5Z].M"HKP=SP*U"I1=JBL6M+DL8M1ADU&&2:U5L MO'&<%O\ ZU>XZ-XGT'4H8XK&[BCVC:L#_(0/0 _TKP*C.#D5CB<+&ON[&^$Q MLL->R33/IJBO --\6ZYI0"VNH2^6/^6+_#]MGS-5MB0<$(VX_I6+=_$_0H%/V=;FY;L%CVC]:UCAZLMHLQGBJ$ M/BFCM:*\HO\ XKWT@9;"PA@ST>5BY'X<"N3U+Q/K6K$_:]0F9#_ IVK^0XKJ MIY=5E\6AQ5K/+KYI7JZ1]U>7^9)/<374S33RO+(QRSNQ)/XU M'4D$$US,L,$3RR,<*B+DFN[T'X8WMV4GU>3[+#U\E>9&'OV6NBI6ITE[SLY]!7JOA;X=6VFE+O5@ES=#E8NL<9_] MF/Z5UNEZ/8:-;"WL+9(4[DL'R_D?,]%>\ZCX'\/ZEN: M2P6*0]7@.P_D./TKF+WX30-S8ZDZ'^[,F1^8KNAF-&6^AYM3*<1'X;,\MHKM M+KX8Z]"3Y)MIQG^&3!_6LB;P;XB@.'TJ'/3]RW^%'-%=04)/9%"BM^'P5XBG) M"Z7,N.I?"_S-:]K\+]ZC+)S]V)0H_,YKI].\&:!IFTPZ?'(X_CF^<_KQ7-/,:,?AU.RGE->7Q6 M1XKIGA_5=7<+96,TJDXW[<(/^!'BNYTCX5.=LFKW@7_IC!R?Q8_X5Z EX-101.INS 9 alt-20210331.xml XBRL INSTANCE DOCUMENT xbrli:shares iso4217:USD iso4217:USD xbrli:shares xbrli:pure 0001326190 2021-01-01 2021-03-31 0001326190 2021-05-14 0001326190 2021-03-31 0001326190 2020-12-31 0001326190 2020-01-01 2020-03-31 0001326190 us-gaap:CommonStockMember 2020-12-31 0001326190 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001326190 us-gaap:RetainedEarningsMember 2020-12-31 0001326190 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0001326190 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-03-31 0001326190 us-gaap:CommonStockMember 2021-01-01 2021-03-31 0001326190 us-gaap:RetainedEarningsMember 2021-01-01 2021-03-31 0001326190 us-gaap:CommonStockMember alt:MarketOfferingMember 2021-01-01 2021-03-31 0001326190 us-gaap:AdditionalPaidInCapitalMember alt:MarketOfferingMember 2021-01-01 2021-03-31 0001326190 alt:MarketOfferingMember 2021-01-01 2021-03-31 0001326190 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-01 2021-03-31 0001326190 us-gaap:CommonStockMember 2021-03-31 0001326190 us-gaap:AdditionalPaidInCapitalMember 2021-03-31 0001326190 us-gaap:RetainedEarningsMember 2021-03-31 0001326190 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-03-31 0001326190 us-gaap:CommonStockMember 2019-12-31 0001326190 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0001326190 us-gaap:RetainedEarningsMember 2019-12-31 0001326190 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-12-31 0001326190 2019-12-31 0001326190 us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-03-31 0001326190 us-gaap:CommonStockMember 2020-01-01 2020-03-31 0001326190 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-01-01 2020-03-31 0001326190 us-gaap:RetainedEarningsMember 2020-01-01 2020-03-31 0001326190 us-gaap:CommonStockMember 2020-03-31 0001326190 us-gaap:AdditionalPaidInCapitalMember 2020-03-31 0001326190 us-gaap:RetainedEarningsMember 2020-03-31 0001326190 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-03-31 0001326190 2020-03-31 0001326190 us-gaap:MoneyMarketFundsMember us-gaap:FairValueMeasurementsRecurringMember 2021-03-31 0001326190 us-gaap:MoneyMarketFundsMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member 2021-03-31 0001326190 us-gaap:FairValueMeasurementsRecurringMember 2021-03-31 0001326190 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member 2021-03-31 0001326190 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member 2021-03-31 0001326190 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member 2021-03-31 0001326190 us-gaap:MoneyMarketFundsMember us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0001326190 us-gaap:MoneyMarketFundsMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member 2020-12-31 0001326190 us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0001326190 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member 2020-12-31 0001326190 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member 2020-12-31 0001326190 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member 2020-12-31 0001326190 us-gaap:USTreasurySecuritiesMember 2021-03-31 0001326190 alt:CommercialPaperAndCorporateDebtSecuritiesMember 2021-03-31 0001326190 us-gaap:AssetBackedSecuritiesMember 2021-03-31 0001326190 us-gaap:CertificatesOfDepositMember 2021-03-31 0001326190 us-gaap:USTreasurySecuritiesMember 2020-12-31 0001326190 alt:CommercialPaperAndCorporateDebtSecuritiesMember 2020-12-31 0001326190 us-gaap:AssetBackedSecuritiesMember 2020-12-31 0001326190 us-gaap:CertificatesOfDepositMember 2020-12-31 0001326190 us-gaap:MeasurementInputPriceVolatilityMember us-gaap:FairValueInputsLevel3Member 2021-03-31 0001326190 srt:WeightedAverageMember us-gaap:MeasurementInputPriceVolatilityMember us-gaap:FairValueInputsLevel3Member 2021-03-31 0001326190 us-gaap:MeasurementInputRiskFreeInterestRateMember us-gaap:FairValueInputsLevel3Member 2021-03-31 0001326190 srt:WeightedAverageMember us-gaap:MeasurementInputRiskFreeInterestRateMember us-gaap:FairValueInputsLevel3Member 2021-03-31 0001326190 alt:MeasurementInputCostOfCapitalMember us-gaap:FairValueInputsLevel3Member 2021-03-31 0001326190 srt:WeightedAverageMember alt:MeasurementInputCostOfCapitalMember us-gaap:FairValueInputsLevel3Member 2021-03-31 0001326190 srt:MinimumMember us-gaap:MeasurementInputDiscountForLackOfMarketabilityMember us-gaap:FairValueInputsLevel3Member 2021-03-31 0001326190 srt:MaximumMember us-gaap:MeasurementInputDiscountForLackOfMarketabilityMember us-gaap:FairValueInputsLevel3Member 2021-03-31 0001326190 srt:WeightedAverageMember us-gaap:MeasurementInputDiscountForLackOfMarketabilityMember us-gaap:FairValueInputsLevel3Member 2021-03-31 0001326190 alt:MeasurementInputProbabilityOfPaymentMember us-gaap:FairValueInputsLevel3Member 2021-03-31 0001326190 srt:WeightedAverageMember alt:MeasurementInputProbabilityOfPaymentMember us-gaap:FairValueInputsLevel3Member 2021-03-31 0001326190 srt:MinimumMember us-gaap:MeasurementInputMaturityMember us-gaap:FairValueInputsLevel3Member 2021-01-01 2021-03-31 0001326190 srt:MaximumMember us-gaap:MeasurementInputMaturityMember us-gaap:FairValueInputsLevel3Member 2021-01-01 2021-03-31 0001326190 srt:WeightedAverageMember us-gaap:MeasurementInputMaturityMember us-gaap:FairValueInputsLevel3Member 2021-01-01 2021-03-31 0001326190 us-gaap:FurnitureAndFixturesMember 2021-03-31 0001326190 us-gaap:FurnitureAndFixturesMember 2020-12-31 0001326190 alt:LaboratoryEquipmentMember 2021-03-31 0001326190 alt:LaboratoryEquipmentMember 2020-12-31 0001326190 us-gaap:ComputerEquipmentMember 2021-03-31 0001326190 us-gaap:ComputerEquipmentMember 2020-12-31 0001326190 us-gaap:SoftwareAndSoftwareDevelopmentCostsMember 2021-03-31 0001326190 us-gaap:SoftwareAndSoftwareDevelopmentCostsMember 2020-12-31 0001326190 us-gaap:LeaseholdImprovementsMember 2021-03-31 0001326190 us-gaap:LeaseholdImprovementsMember 2020-12-31 0001326190 us-gaap:ConstructionInProgressMember 2021-03-31 0001326190 alt:InternallyDevelopedPatentsMember srt:MinimumMember 2021-01-01 2021-03-31 0001326190 alt:InternallyDevelopedPatentsMember srt:MaximumMember 2021-01-01 2021-03-31 0001326190 alt:AcquiredLicensesMember srt:MinimumMember 2021-01-01 2021-03-31 0001326190 alt:AcquiredLicensesMember srt:MaximumMember 2021-01-01 2021-03-31 0001326190 alt:InternallyDevelopedPatentsMember 2021-03-31 0001326190 alt:AcquiredLicensesMember 2021-03-31 0001326190 us-gaap:InProcessResearchAndDevelopmentMember 2021-03-31 0001326190 alt:InternallyDevelopedPatentsMember srt:MinimumMember 2020-01-01 2020-12-31 0001326190 alt:InternallyDevelopedPatentsMember srt:MaximumMember 2020-01-01 2020-12-31 0001326190 alt:AcquiredLicensesMember srt:MinimumMember 2020-01-01 2020-12-31 0001326190 alt:AcquiredLicensesMember srt:MaximumMember 2020-01-01 2020-12-31 0001326190 alt:InternallyDevelopedPatentsMember 2020-12-31 0001326190 alt:AcquiredLicensesMember 2020-12-31 0001326190 us-gaap:InProcessResearchAndDevelopmentMember 2020-12-31 0001326190 us-gaap:ResearchAndDevelopmentExpenseMember 2021-01-01 2021-03-31 0001326190 us-gaap:ResearchAndDevelopmentExpenseMember 2020-01-01 2020-03-31 0001326190 alt:SpitfirePharmaIncMember 2019-07-12 2019-07-12 0001326190 alt:SpitfirePharmaIncMember us-gaap:CommonStockMember srt:MaximumMember 2019-07-12 0001326190 alt:SpitfirePharmaIncMember alt:InvestigationalNewDrugApplicationMilestoneMember 2019-07-12 0001326190 alt:SpitfirePharmaIncMember alt:InvestigationalNewDrugApplicationMilestoneMember 2019-07-12 2019-07-12 0001326190 alt:SpitfirePharmaIncMember alt:InvestigationalNewDrugApplicationAndRegulatoryMilestonesMember 2019-07-12 0001326190 alt:SpitfirePharmaIncMember alt:InvestigationalNewDrugApplicationAndRegulatoryMilestonesMember 2019-07-12 2019-07-12 0001326190 alt:SpitfirePharmaIncMember alt:SalesMilestoneMember 2019-07-12 0001326190 alt:SpitfirePharmaIncMember alt:SalesMilestoneMember 2019-07-12 2019-07-12 0001326190 alt:SpitfirePharmaIncMember alt:RegulatoryMilestoneMember 2019-07-12 2019-07-12 0001326190 us-gaap:IPOMember us-gaap:CommonStockMember 2020-07-15 2020-07-16 0001326190 us-gaap:IPOMember us-gaap:CommonStockMember 2020-07-16 0001326190 us-gaap:IPOMember us-gaap:CommonStockMember alt:PreFundedWarrantsMember 2020-07-16 0001326190 us-gaap:IPOMember alt:PreFundedWarrantsMember 2020-07-16 0001326190 us-gaap:IPOMember alt:PreFundedWarrantsMember 2020-07-15 2020-07-16 0001326190 us-gaap:IPOMember 2020-07-15 2020-07-16 0001326190 us-gaap:OverAllotmentOptionMember us-gaap:CommonStockMember 2020-07-15 2020-07-16 0001326190 alt:PreFundedWarrantsMember 2021-03-31 0001326190 alt:EquityDistributionAgreementMember alt:AtTheMarketOfferingMember alt:PiperSandlerCompanyAndEvercoreGroupLimitedLiabilityCompanyAndBRileySecuritiesIncMember 2021-02-25 0001326190 alt:EquityDistributionAgreementMember alt:AtTheMarketOfferingMember alt:PiperSandlerCompanyAndEvercoreGroupLimitedLiabilityCompanyAndBRileySecuritiesIncMember 2021-02-25 2021-02-25 0001326190 alt:EquityDistributionAgreementMember alt:AtTheMarketOfferingMember alt:PiperSandlerCompanyAndEvercoreGroupLimitedLiabilityCompanyAndBRileySecuritiesIncMember 2021-01-01 2021-03-31 0001326190 alt:EquityDistributionAgreementMember alt:AtTheMarketOfferingMember alt:PiperSandlerCompanyAndEvercoreGroupLimitedLiabilityCompanyAndBRileySecuritiesIncMember 2021-03-31 0001326190 alt:EquityDistributionAgreementMember alt:AtTheMarketOfferingMember alt:JMPSecuritiesLimitedLiabilityCompanyMember 2020-03-27 0001326190 alt:EquityDistributionAgreementMember alt:AtTheMarketOfferingMember alt:JMPSecuritiesLimitedLiabilityCompanyMember srt:MaximumMember 2020-03-26 2020-03-27 0001326190 alt:EquityDistributionAgreementMember alt:AtTheMarketOfferingMember alt:JMPSecuritiesLimitedLiabilityCompanyMember 2020-03-26 2020-03-27 0001326190 alt:ExchangeWarrantsMember 2021-02-25 2021-02-25 0001326190 alt:ExchangeWarrantsMember 2021-02-25 0001326190 alt:ExchangeWarrantsMember 2021-01-01 2021-03-31 0001326190 us-gaap:EmployeeStockOptionMember 2021-01-01 2021-03-31 0001326190 us-gaap:EmployeeStockOptionMember 2021-03-31 0001326190 us-gaap:RestrictedStockMember 2021-03-31 0001326190 us-gaap:RestrictedStockMember 2021-01-01 2021-03-31 0001326190 us-gaap:RestrictedStockUnitsRSUMember 2021-02-25 2021-02-25 0001326190 us-gaap:RestrictedStockUnitsRSUMember 2021-03-31 0001326190 us-gaap:RestrictedStockUnitsRSUMember 2021-01-01 2021-03-31 0001326190 alt:TwoThousandAndNineteenEmployeeStockPurchasePlanMember 2021-01-01 2021-03-31 0001326190 us-gaap:GeneralAndAdministrativeExpenseMember 2021-01-01 2021-03-31 0001326190 us-gaap:GeneralAndAdministrativeExpenseMember 2020-01-01 2020-03-31 0001326190 alt:MedicalTechnologyEnterpriseConsortiumCollaborativeArrangementMember 2020-06-01 2020-06-30 0001326190 us-gaap:GrantMember alt:MedicalTechnologyEnterpriseConsortiumCollaborativeArrangementMember 2021-01-01 2021-03-31 0001326190 alt:BARDAContractMember 2016-07-31 2016-07-31 0001326190 alt:BARDAContractMember 2016-07-31 0001326190 alt:BARDAContractMember us-gaap:InvestmentPerformanceMember 2016-07-31 2016-07-31 0001326190 alt:BARDAContractMember srt:MinimumMember 2021-01-01 0001326190 alt:BARDAContractMember srt:MaximumMember 2021-01-01 0001326190 alt:BARDAContractMember 2021-01-01 2021-01-01 0001326190 alt:BARDAContractMember us-gaap:GrantMember 2021-01-01 2021-03-31 0001326190 alt:BARDAContractMember us-gaap:GrantMember 2020-01-01 2020-03-31 0001326190 us-gaap:WarrantMember 2021-01-01 2021-03-31 0001326190 us-gaap:WarrantMember 2020-01-01 2020-03-31 0001326190 us-gaap:EmployeeStockOptionMember 2021-01-01 2021-03-31 0001326190 us-gaap:EmployeeStockOptionMember 2020-01-01 2020-03-31 0001326190 us-gaap:RestrictedStockMember 2021-01-01 2021-03-31 0001326190 us-gaap:RestrictedStockMember 2020-01-01 2020-03-31 0001326190 alt:JanssenVaccinesAndPreventionsBvMember us-gaap:LicenseMember srt:MaximumMember 2020-04-02 2020-04-02 0001326190 alt:JanssenVaccinesAndPreventionsBvMember us-gaap:LicenseMember srt:MaximumMember 2021-03-31 0001326190 alt:LonzaManufacturingAgreementMember alt:AdCOVIDMember 2021-01-01 2021-03-31 0001326190 alt:LonzaManufacturingAgreementMember alt:AdCOVIDMember 2021-03-31 0001326190 alt:SummitBiosciencesDevelopmentAndManufacturingAgreementMember 2021-03-31 10-Q false 2021-03-31 2021 Q1 ALT ALTIMMUNE, INC. 0001326190 --12-31 Non-accelerated Filer true false false Yes Yes 38396843 001-32587 20-2726770 DE 910 Clopper Road Suite 201S Gaithersburg MD 20878 (240) 654-1450 Common stock, par value $0.0001 per share NASDAQ true false 149932387 115917807 34174 34174 149966561 115951981 76574768 100005558 4801428 4610202 7898067 7762793 5950999 1926675 245191823 230257209 5198052 1056920 866336 903825 12879247 12823846 115300 73413 264250758 245115213 418243 612293 9405649 11408154 9823892 12020447 6270000 5390000 1719438 1828443 17813330 19238890 3810 3697 462417706 417337742 -210944707 -186420599 -5039381 -5044517 246437428 225876323 264250758 245115213 0.0001 0.0001 200000000 200000000 38257180 37142946 38257180 37142946 837516 2212694 11877900 7187531 3821420 2331917 15699320 9519448 -14861804 -7306754 11671 1885 42499 151569 -33132 25542 -2304 175226 -14864108 -7131528 -3245879 -14864108 -3885649 5136 -32435 -14858972 -3918084 -0.38 -0.26 38914990 15110585 37142946 3697 417337742 -186420599 -5044517 1218351 1218351 -6349 1 -92507 -92506 8733 1 106000 106001 -1000000 -100 -7539900 -9660000 -17200000 17200000 17200000 2110800 211 34178020 34178231 1050 10000 10000 5136 -14864108 38257180 3810 462417706 -210944707 -5039381 15312167 1508 187914916 -137376122 -5020156 45520146 214921 214921 -5974 1 -17080 -17079 38809 3 56736 56739 14500 2 39972 39974 -32435 -3885649 15359502 1514 188209465 -141261771 -5052591 41896617 -14864108 -3885649 880000 1750000 1218351 214921 74298 73356 -33376 -24939 191226 973557 4200624 214893 -194050 911397 -2189903 1112718 135274 3360633 -19569160 -4347401 30912000 13700000 7476074 7099263 4208790 18131 62041 19390 19165095 6563216 -134413 39974 34178231 106001 56739 34418645 96713 34014580 2312528 8996860 11309388 17200000 <p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">1. Nature of Business and Basis of Presentation</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Nature of Business</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:6.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Altimmune, Inc., headquartered in Gaithersburg, Maryland, United States, together with its subsidiaries (collectively, the &#8220;Company&#8221; or &#8220;Altimmune&#8221;) is a clinical stage biopharmaceutical company incorporated under the laws of the State of Delaware. </p> <p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company is focused on developing intranasal vaccines, immune modulating therapies, and treatments for liver disease. The Company&#8217;s diverse pipeline includes proprietary intranasal vaccines for COVID-19 (AdCOVID), anthrax (NasoShield) and influenza (NasoVAX); an intranasal immune modulating therapeutic for COVID-19 (T-COVID); and next generation peptide therapeutics for NASH (ALT-801) and chronic hepatitis B (HepTcell). Since its inception, the Company has devoted substantially all of its efforts to business planning, research and development, recruiting management and technical staff, and raising capital, and has financed its operations through the issuance of common and preferred stock, long-term debt, and proceeds from research grants and government contracts. The Company has not generated any revenues from the sale of any products to date, and there is no assurance of any future revenues from product sales.</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Basis of Presentation</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:6.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The accompanying unaudited consolidated financial statements are prepared pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (&#8220;SEC&#8221;) regarding interim financial reporting. Accordingly, they do not include all of the information and disclosures required by accounting principles generally accepted in the United States (&#8220;U.S. GAAP&#8221;) for complete consolidated financial statements and should be read in conjunction with the audited consolidated financial statements for the year ended December&#160;31, 2020 included in the Annual Report on Form&#160;10-K which was filed with the SEC on February 25, 2021. In the opinion of management, the Company has prepared the accompanying unaudited consolidated financial statements on the same basis as the audited consolidated financial statements, and these consolidated financial statements include all adjustments, consisting only of normal recurring adjustments, necessary for a fair presentation of the results of the interim periods presented. The operating results for the interim periods presented are not necessarily indicative of the results expected for the full year 2021 or any future years or periods.</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The accompanying unaudited consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation.</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The accompanying unaudited consolidated financial statements have been prepared on the basis of continuity of operations, realization of assets, and the satisfaction of liabilities in the ordinary course of business. The financial statements do not include any adjustments relating to the recoverability and classification of recorded assets and liabilities that might be necessary should we be unable to continue as a going concern.</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2. Summary of Significant Accounting Policies</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:6.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">During the three months ended March&#160;31, 2021, there have been no significant changes to the Company&#8217;s summary of significant accounting policies contained in the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2020 as filed with the SEC, except for the recently adopted accounting standard for income taxes.</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Use of Estimates</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:6.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of these financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. The extent to which the COVID-19 pandemic may directly or indirectly impact the Company&#8217;s business, financial condition, and results of operations is highly uncertain and subject to change. The Company considered the potential impact of the COVID-19 pandemic on the Company&#8217;s estimates and assumptions and determined that there was not a material impact to the Company&#8217;s unaudited consolidated financial statements as of and for the three months ended March&#160;31, 2021. However, actual results could differ from those estimates and there may be changes to the Company&#8217;s estimates in future periods.</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Recently Issued Accounting Pronouncements - Adopted</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:6.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In December 2019, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) No. 2019-12, <font style="font-style:italic;">Income Taxes</font> (Topic 740), <font style="font-style:italic;">Simplifying the Accounting for Income Taxes</font> (&#8220;ASU No. 2019-12&#8221;). ASU 2019-12 amends the approaches and methodologies in accounting for income taxes during interim periods and makes changes to certain income tax classifications. The new standard allows exceptions to the use of the incremental approach for intra-period tax allocation, when there is a loss from continuing operations and income or a gain from other items, and to the general methodology for calculating income taxes in an interim period, when a year-to-date loss exceeds the anticipated loss for the year. The standard also requires franchise or similar taxes partially based on income to be reported as income tax and the effects of enacted changes in tax laws or rates to be included in the annual effective tax rate computation from the date of enactment. Lastly, in any future acquisition, the Company would be required to evaluate when the step-up in the tax basis of goodwill is part of the business combination and when it should be considered a separate transaction. The Company adopted the standard as of January 1, 2021 and has evaluated the effects of this standard and determined that the adoption did not have a material impact on the Company&#8217;s consolidated financial statements.</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">3. Fair Value Measurements</p> <p style="text-align:justify;margin-bottom:12pt;margin-top:6pt;text-indent:6.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company&#8217;s assets and liabilities measured at fair value on a recurring basis at March&#160;31, 2021 consisted of the following:</p> <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:90%;"> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:42.82%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.16%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="14" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:54%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Fair Value Measurement at March&#160;31, 2021</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:42.82%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.16%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.82%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Level 1</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.82%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Level 2</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.82%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Level 3</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:42.82%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Assets:</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.16%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.02%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.82%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.82%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.82%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:42.82%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash equivalents - money market funds</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.16%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.02%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13,962,902</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.82%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13,962,902</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.82%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.82%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:42.82%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Short-term investments</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.16%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.02%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">76,574,768</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">76,574,768</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:42.82%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.16%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.02%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">90,537,670</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.82%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13,962,902</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.82%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">76,574,768</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.82%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:42.82%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Liabilities:</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.16%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.02%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.82%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.82%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.82%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:42.82%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Contingent consideration liability (see Note 8)</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.16%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.02%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,270,000</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,270,000</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:42.82%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.16%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.02%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,270,000</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.82%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.82%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.82%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,270,000</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> </table> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:6.25%;font-size:10pt;">&nbsp;</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:6.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company&#8217;s assets and liabilities measured at fair value on a recurring basis at December&#160;31, 2020 consisted of the following:</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p> <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:90%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:42.82%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.16%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="14" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:54%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Fair Value Measurement at December&#160;31, 2020</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:42.82%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.16%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.82%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Level&#160;1</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.82%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Level&#160;2</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.82%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Level&#160;3</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:42.82%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Assets:</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.16%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.02%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.82%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.82%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.82%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:42.82%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash equivalents - money market funds</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.16%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.02%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">90,389,473</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.82%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">90,389,473</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.82%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.82%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:42.82%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Short-term investments</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.16%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.02%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">100,005,558</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">100,005,558</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:42.82%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.16%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.02%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">190,395,031</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.82%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">90,389,473</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.82%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">100,005,558</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.82%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:42.82%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Liabilities:</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.16%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.02%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.82%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.82%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.82%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:42.82%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Contingent consideration liability (see Note 8)</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.16%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.02%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,390,000</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.82%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.82%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.82%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,390,000</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:42.82%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Warrant liability</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.16%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.02%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,000</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,000</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:42.82%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.16%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.02%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,400,000</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.82%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.82%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.82%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,400,000</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> </table></div></div> <p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The warrant liability is included in Other long-term liabilities in the consolidated balance sheet at December 31, 2020. The warrant liability was valued using the Monte Carlo simulation valuation model with Level 3 inputs.</p> <p style="text-align:justify;margin-bottom:12pt;margin-top:12pt;text-indent:6.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="Background-color:#FFFFFF;">Short-term investments have been initially valued at the transaction price and subsequently valued, at the end of each reporting period, utilizing third party pricing services or other market observable data (Level 2). The pricing services utilize industry standard valuation models, including both income and market-based approaches and observable market inputs to determine value.</font></p> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:6.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="Background-color:#FFFFFF;">Short-term investments had quoted prices at March&#160;31, 2021 as shown below:</font></p> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p> <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:90%;"> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:46.6%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:8.22%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="10" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.14%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">March&#160;31, 2021</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:46.6%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:8.22%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.96%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amortized Cost</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.6%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.96%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Unrealized Gain (Loss)</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.6%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.96%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Market Value</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:46.6%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">United States treasury securities</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.96%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16,029,965</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.96%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,995</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.96%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16,032,960</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:46.6%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Commercial paper and corporate debt securities</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.96%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">33,412,043</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.96%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,935</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.96%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">33,410,108</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:46.6%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Asset backed securities</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.96%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,111,239</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.96%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(278</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.96%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,110,961</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:46.6%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certificate of deposit</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:8.22%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.96%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">25,020,739</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.6%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.96%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.6%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.96%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">25,020,739</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:46.6%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:8.22%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.96%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">76,573,986</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.6%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.96%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">782</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.6%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.96%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">76,574,768</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> </table> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.25%;font-size:10pt;">&nbsp;</p> <p style="margin-bottom:12pt;margin-top:0pt;text-indent:6.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="Background-color:#FFFFFF;">Short-term investments had quoted prices at December 31, 2020 as shown below:</font></p> <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:90%;"> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:46.6%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:8.22%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="10" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.14%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31, 2020</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:46.6%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:8.22%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.96%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amortized Cost</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.6%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.96%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Unrealized Gain (Loss)</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.6%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.96%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Market Value</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:46.6%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">United States treasury securities</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.96%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20,052,757</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.96%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,843</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.96%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20,054,600</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:46.6%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Commercial paper and corporate debt securities</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.96%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">47,521,344</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.96%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(5,440</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.96%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">47,515,904</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:46.6%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Asset backed securities</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.96%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,414,619</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.96%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(757</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.96%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,413,862</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:46.6%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certificate of deposit</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:8.22%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.96%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">25,021,192</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.6%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.96%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.6%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.96%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">25,021,192</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:46.6%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:8.22%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.96%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">100,009,912</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.6%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.96%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(4,354</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.6%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.96%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">100,005,558</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> </table> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.25%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></div></div> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:6.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The fair value of contingent payments classified as a liability is based on the regulatory milestones described in Note 8 and estimated using the Monte Carlo simulation valuation model with Level 3 inputs.</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The assumptions used to estimate the fair value of contingent payments that are classified as a liability at March&#160;31, 2021 include the following significant unobservable inputs:</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p> <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:90%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:61.18%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Unobservable input</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.86%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.44%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Value or Range</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.86%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.62%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Weighted Average</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="middle" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:61.18%; border-top:solid 0.75pt #000000;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Expected volatility</p></td> <td valign="middle" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.86%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="middle" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.44%; border-top:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">117.4%</p></td> <td valign="middle" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="middle" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.86%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="middle" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.62%; border-top:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">117.4%</p></td> <td valign="middle" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:61.18%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Risk-free interest rate</p></td> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.86%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.44%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.09%</p></td> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.86%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.62%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.09%</p></td> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="middle" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:61.18%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cost of capital</p></td> <td valign="middle" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.86%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="middle" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.44%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">30%</p></td> <td valign="middle" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="middle" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.86%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="middle" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.62%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">30%</p></td> <td valign="middle" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:61.18%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Discount for lack of marketability</p></td> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.86%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.44%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16%-19%</p></td> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.86%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.62%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">18%</p></td> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="middle" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:61.18%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Probability of payment</p></td> <td valign="middle" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.86%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="middle" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.44%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">63%</p></td> <td valign="middle" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="middle" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.86%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="middle" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.62%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">63%</p></td> <td valign="middle" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:61.18%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Projected year of payment</p></td> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.86%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.44%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2022</p></td> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.86%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.62%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2022</p></td> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> </table></div> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:6.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If applicable, the Company will recognize transfers into and out of levels within the fair value hierarchy at the end of the reporting period in which the actual event or change in circumstance occurs. There were no transfers into and out of any of the levels of the fair value hierarchy as of March&#160;31, 2021 and December&#160;31, 2020.</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:6.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Separate disclosure is required for assets and liabilities measured at fair value on a recurring basis from those measured at fair value on a non-recurring basis. Assets recorded at fair value on a non-recurring basis, such as property and equipment and intangible assets are recognized at fair value when they are impaired. As of March&#160;31, 2021 and December 31, 2020, the Company had no significant assets or liabilities that were measured at fair value on a non-recurring basis. </p> <p style="margin-bottom:0pt;margin-top:8pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">4. Property and Equipment, Net</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10pt;">&nbsp;</p> <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:90%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:65.78%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.68%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.56%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">March&#160;31, 2021</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.68%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.24%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31, 2020</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:65.78%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Furniture, fixtures and equipment</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.56%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">185,878</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.24%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">125,538</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:65.78%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Laboratory equipment</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.56%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,041,752</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.24%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">959,585</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:65.78%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Computers and telecommunications</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.56%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">250,516</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.24%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">220,316</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:65.78%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Software</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.56%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">64,409</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.24%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">64,409</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:65.78%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Leasehold improvements</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.56%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,415,608</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.24%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,285,883</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:65.78%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Construction-in-progress</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.68%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.56%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,000,000</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.68%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.24%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:65.78%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Property and equipment, at cost</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.56%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,958,163</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.24%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,655,731</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:65.78%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Less: accumulated depreciation and amortization</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.68%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.56%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,760,111</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.68%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.24%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,598,811</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:65.78%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Property and equipment, net</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.68%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.56%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,198,052</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.68%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.24%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,056,920</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:12pt;font-family:Calibri;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.25%;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;">As of March 31, 2021, construction-in-progress primarily includes costs related to the procurement of long-lead equipment</font><font style="font-size:10pt;font-family:Times New Roman;"> and </font><font style="color:#000000;font-size:10pt;font-family:Times New Roman;">build out of the suite associated with the Company's manufacturing collaboration with Lonza Houston, Inc. (&#8220;Lonza&#8221;) described in Note 16. Depreciation expense related to property and equipment was approximately $67,658 and $59,505, for the three months ended March 31, 2021 and 2020, respectively.</font></p> <p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">5. Intangible Assets</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:6.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company&#8217;s intangible assets consisted of the following:</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p> <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:90%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:39.64%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="12" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.76%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">March&#160;31, 2021</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:39.64%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.4%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Estimated</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Useful Lives</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.54%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Gross</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Carrying</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Value</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.54%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Accumulated</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amortization</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-top:solid 0.75pt #000000;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.54%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Net Book</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Value</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:39.64%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Internally developed patents</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.4%; border-top:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6-20 years</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.54%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">946,828</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.54%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(486,548</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.54%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">460,280</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:39.64%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Acquired licenses</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:13.4%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16-20 years</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.54%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">285,000</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.54%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(285,000</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.54%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:39.64%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total intangible assets subject to amortization</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.4%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.54%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,231,828</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.54%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(771,548</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.54%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">460,280</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:39.64%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">IPR&amp;D assets</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:13.4%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Indefinite</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.54%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12,418,967</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.54%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.54%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12,418,967</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:39.64%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:13.4%; border-bottom:double 2.5pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.54%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13,650,795</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.54%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(771,548</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.54%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12,879,247</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> </table> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p> <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:90%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:39.84%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="12" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.56%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31, 2020</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:39.84%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.14%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Estimated</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Useful Lives</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.56%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Gross</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Carrying</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Value</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.56%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Accumulated</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amortization</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-top:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Net Book</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Value</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:39.84%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Internally developed patents</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.14%; border-top:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6-10 years</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.56%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">884,787</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.56%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(479,908</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.42%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">404,879</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:39.84%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Acquired licenses</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:14.14%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16-20 years</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.56%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">285,000</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.56%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(285,000</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.42%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:39.84%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total intangible assets subject to amortization</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.14%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.56%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,169,787</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.56%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(764,908</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.42%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">404,879</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:39.84%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">IPR&amp;D assets</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:14.14%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Indefinite</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.56%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12,418,967</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.56%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.42%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12,418,967</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:39.84%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:14.14%; border-bottom:double 2.5pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.56%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13,588,754</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.56%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(764,908</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.42%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12,823,846</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> </table></div> <p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Amortization expense of intangible assets was $6,640 and $13,851 for the three months ended March&#160;31, 2021 and 2020, respectively. As of March 31, 2021, the weighted average amortization period remaining for intangible assets was 12.3 years. Amortization expense was classified as research and development expenses in the accompanying unaudited consolidated statements of operations and comprehensive loss.</p></div> <p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">6. Operating Leases</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:6.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company rents office and laboratory space in the United States. The Company also leases office equipment under a non-cancellable equipment lease through December 2022. Rent expense during the three months ended March&#160;31, 2021 and 2020 under all of the Company&#8217;s operating leases was $130,138 and $87,599, respectively. Rent expense includes short-term leases and variable lease costs that are not included in the lease obligation. </p> <p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Short-term leases are leases having a term of twelve months or less. The Company recognizes short-term leases on a straight-line basis and does not record a related lease asset or liability for such leases.</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="Background-color:#FFFFFF;">The office space leases provide for increases in future minimum annual rental payments as defined in the lease agreements. The office space lease also includes an option to renew the lease as of the end of the term. The Company has determined that the lease renewal option is not reasonably certain of being exercised.</font></p> <p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The cash paid for operating lease liabilities for the three months ended March&#160;31, 2021 and 2020 was $117,354 and $95,714, respectively.</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Supplemental other information related to the operating leases balance sheet information was as follows: </p> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:6.25%;font-family:Times New Roman;font-size:6pt;">&nbsp;</p> <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:90%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">March&#160;31, 2021</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31, 2020</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating lease obligations (see Note 7 and 9)</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,739,559</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,824,840</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating lease right-of-use assets</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">866,336</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">903,825</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Weighted-average remaining lease term (years)</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.1</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.3</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Weighted-average discount rate</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7.3</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7.3</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td> </tr> </table> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</p></div> <p style="margin-bottom:0pt;margin-top:8pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">7. Accrued Expenses</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:6.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued expenses and other current liabilities consist of the following:</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p> <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:90%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:65.88%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.72%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">March&#160;31, 2021</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.96%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31, 2020</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:65.88%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued professional services</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.72%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">612,212</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.96%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,350,194</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:65.88%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued payroll and employee benefits</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.72%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,182,658</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.96%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,351,599</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:65.88%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued interest</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.72%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13,744</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.96%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13,016</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:65.88%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued research and development</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.72%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,211,778</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.96%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,316,876</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:65.88%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Lease obligation, current portion (see Note 6)</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.72%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">365,504</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.96%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">356,716</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:65.88%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred revenue</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.72%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19,753</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.96%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19,753</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:65.88%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total accrued expenses</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.72%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,405,649</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.96%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11,408,154</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> </table> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></div> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">8. Contingent Consideration</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:6.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company entered into an Agreement and Plan of Merger and Reorganization, dated July 8, 2019, by and among the Company, Springfield Merger Sub, Inc., Springfield Merger Sub, LLC, Spitfire Pharma, Inc. and David Collier, as the Stockholder Representative (the &#8220;Spitfire Merger Agreement&#8221;) to acquire all of the equity interests of Spitfire Pharma, Inc. (&#8220;Spitfire&#8221;). Spitfire was a privately held, preclinical pharmaceutical company developing a novel dual GLP-1/glucagon receptor agonist for the treatment of non-alcoholic steatohepatitis.&nbsp;&nbsp;</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:6.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The transaction closed on July 12, 2019. The Company issued 1,887,250 unregistered shares of its common stock (the &#8220;shares&#8221;) as upfront consideration to certain former securityholders of Spitfire (collectively, the &#8220;Spitfire Equityholders&#8221;), representing an amount equal to $5.0 million less working capital and transaction expense adjustment amounts as defined in the agreement.</p> <p style="text-align:justify;margin-bottom:12pt;margin-top:12pt;text-indent:6.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The acquisition of Spitfire was accounted for as an asset acquisition instead of a business combination because substantially all of the fair value of the gross assets acquired was concentrated in a single identifiable asset or group of similar identifiable assets, and therefore, the asset was not considered a business. The Company expensed the acquired intellectual property as of the acquisition date as in-process research and development with no alternative future uses.<font style="font-family:Calibri;">&#160;</font> </p> <p style="text-align:justify;margin-bottom:6pt;margin-top:0pt;text-indent:6.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Spitfire Merger Agreement also includes future contingent payments up to $88.0 million in cash and shares of the Company&#8217;s common stock as follows (each, a &#8220;Milestone Event&#8221;): <font style="margin-left:36pt;"></font></p> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:3.12%;white-space:nowrap"> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="top" style="width:3.12%;white-space:nowrap"> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-family:'Times New Roman';font-size:15pt;line-height:11pt;">&#x2022;</p></td> <td valign="top"> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">a one-time payment of $5.0 million (the &#8220;IND Milestone Consideration Amount&#8221;) within sixty days of the submission of an Investigational New Drug Application (&#8220;IND&#8221;) to the United States Food and Drug Administration (the &#8220;FDA&#8221;) or other applicable governmental authority in a foreign jurisdiction, which IND has not been rejected or placed on clinical hold by the FDA or such applicable foreign governmental authority within time specified in the Merger Agreement; </p></td></tr></table></div> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:3.12%;white-space:nowrap"> <p style="text-align:justify;margin-top:0pt;margin-bottom:0pt;margin-bottom:8pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="top" style="width:3.12%;white-space:nowrap"> <p style="text-align:justify;margin-top:0pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:15pt;line-height:11pt;">&#x2022;</p></td> <td valign="top"> <p style="text-align:justify;margin-top:0pt;margin-bottom:0pt;margin-bottom:8pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">a one-time payment of $3.0 million (the &#8220;Phase 2 Milestone Consideration Amount&#8221; and together with the IND Milestone Consideration Amount, the &#8220;Regulatory Milestones&#8221;) within sixty days of the initiation of a Phase 2 clinical trial of a product candidate anywhere in the world; and </p></td></tr></table></div> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:3.12%;white-space:nowrap"> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="top" style="width:3.12%;white-space:nowrap"> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-family:'Times New Roman';font-size:15pt;line-height:11pt;">&#x2022;</p></td> <td valign="top"> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">payments of up to $80.0 million upon the achievement of specified worldwide net sales (the &#8220;Sales Milestones&#8221;) of all products developed using the technology acquired in the License Agreement within ten years following the approval of a new drug application filed with the FDA.</p></td></tr></table></div> <p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:6.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Regulatory Milestones will be payable in shares of the Company&#8217;s Common Stock, with the number of shares of the Company&#8217;s Common Stock to be issued in connection with each milestone amount, if any, are dependent on the share price at the time of achievement. The number of any shares issued in consideration for the IND Milestone Consideration Amount will be determined based on lower of (A) the average of the closing prices of our Common Stock as reported on the Nasdaq Global Market for the twenty (20) consecutive trading days prior to the IND Reference Date or (B) $2.95. The value of any shares issued in consideration for the Phase 2 Milestone Consideration Amount shall be determined based the lower of (A) on the average of the closing trading prices of our Common Stock as reported on the Nasdaq Global Market for the twenty (20) consecutive trading days immediately preceding the date of the occurrence of the Phase 2 Milestone Event or (B) $3.54.</p> <p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:6.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The future contingent payments related to the Regulatory Milestones are stock-based payments accounted for under FASB Accounting Standards Codification Topic 480, <font style="font-style:italic;">Distinguishing Liabilities From Equity</font> (&#8220;ASC 480&#8221;). Such stock-based payments are subject to a lock-up whereby 50% of the shares are released at 3 months and 50% are released at 6 months. The future contingent payments related to the Sales Milestones are predominately cash-based payments accounted for under FASB Accounting Standards Codification Topic 450, <font style="font-style:italic;">Contingencies</font>. Accordingly, the Company will recognize the Sales Milestones when the contingency is resolved and the amount is paid or payable.</p> <p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:6.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company estimates the future contingent consideration for the Regulatory Milestones based upon a Monte Carlo simulation valuation model that is risk adjusted based on the probability of achieving the milestones and a discount for lack of marketability. The Company remeasures the fair value of the contingent consideration at each reporting period. During the fourth quarter of 2020, the Company achieved the IND Milestone and paid the obligation in shares according to the calculation above. Below is a summary of the contingent consideration activity:</p> <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:90%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:65.56%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="6" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:31.68%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Three Months Ended March&#160;31,</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:65.56%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.38%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.24%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.04%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:65.56%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Beginning balance</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.38%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,390,000</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.04%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,750,000</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:65.56%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Change in fair value</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.38%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">880,000</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.04%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,750,000</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:65.56%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Ending balance</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.38%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,270,000</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.24%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.04%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,500,000</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> </table> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:6.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of March 31, 2021, the increase in fair value was primarily attributable to an increase in the closing share price of the Company&#8217;s common stock and in the probability of milestone achievement. As of March 31, 2020, the increase in fair value was primarily due to an increase in the probability of milestone achievement. Any changes in fair value have been recorded within research and development expense during the respective periods presented.</p></div> <p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">9. Other Long-Term Liabilities</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:6.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company&#8217;s other long-term liabilities are summarized as follows:</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p> <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:90%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">March&#160;31,</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31,</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Lease obligation, long-term portion (see Note 6)</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,374,055</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,468,124</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Conditional economic incentive grants</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">250,000</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">250,000</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">95,383</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">110,319</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total other long-term liabilities</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,719,438</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,828,443</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> </table> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></div> <p style="margin-bottom:0pt;margin-top:8pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">10. Common Stock</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Public Offering</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:6.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On July 16, 2020, the Company offered and sold (i) 3,369,564 shares of common stock, at a price to the public of $23.00 per share, and (ii) pre-funded warrants of the Company to purchase 1,630,436 shares of common stock at an exercise price equal to $0.0001 per share (the &#8220;Pre-Funded Warrants&#8221;), at a price to the public of $22.9999 per share of common stock underlying the Pre-Funded Warrants (equal to the public offering price per share of Common Stock, minus the exercise price of each Pre-Funded Warrant). The Pre-Funded Warrants are exercisable at any time, provided that each Pre-Funded Warrant holder will be prohibited from exercising such Pre-Funded Warrants into shares of the Company&#8217;s common stock if, as a result of such exercise, the holder, together with its affiliates, would own more than 4.99% of the total number of shares of the Company&#8217;s common stock then issued and outstanding, which percentage may change at the holders&#8217; election to any other number less than or equal to 19.99% upon 61 days&#8217; notice to the Company. The gross proceeds of this offering were approximately $132.2 million, which includes the exercise in full of the underwriters&#8217; option to purchase an additional 750,000 shares of common stock, before deducting underwriting discounts and commissions and offering expenses during the third quarter of 2020. The net proceeds of this offering were approximately $124.0 million, after deducting underwriting discounts and commissions and offering expenses payable by the Company. </p> <p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company has assessed the Pre-Funded Warrants for appropriate equity or liability classification and determined that the Pre-Funded Warrants are freestanding instruments that do not meet the definition of a liability pursuant to ASC 480 and do not meet the definition of a derivative pursuant to FASB Accounting Standards Codification Topic 815, <font style="font-style:italic;">Derivatives and Hedging</font> (&#8220;ASC 815&#8221;). The Pre-Funded Warrants are indexed to the Company&#8217;s common stock and meet all other conditions for equity classification under ASC 480 and ASC 815. Accordingly, the Pre-Funded Warrants are classified as equity and are accounted for as a component of additional paid-in capital at the time of issuance. As of March 31, 2021, no Pre-Funded Warrants were exercised.</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">At-the-Market Offerings</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.25%;">On February 25, 2021, the Company entered into an Equity Distribution Agreement (the &#8220;2021 Agreement&#8221;) with Piper Sandler &amp; Co., Evercore Group L.L.C., and B. Riley Securities, Inc., serving as sales agents (the &#8220;Sales Agents&#8221;) with respect to an at-the-market offering program under which the Company may offer and sell, from time to time at its sole discretion, shares of its common stock, par value $0.0001 per share (the &#8220;Common Stock&#8221;), having an aggregate offering price of up to $125.0 million (the &#8220;Shares&#8221;) through the Sale Agents (the &#8220;2021 Offering&#8221;). Any Shares offered and sold in the 2021 Offering will be issued pursuant to the Company&#8217;s Registration Statement on Form S-3 filed with the Securities and Exchange Commission (the &#8220;SEC&#8221;) on December 31, 2020, which was declared effective on January 11, 2021, the prospectus supplement relating to the 2021 Offering filed with the SEC on February 25, 2021 and any applicable additional prospectus supplements related to the 2021 Offering that form a part of the Registration Statement. </p> <p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.25%;">As of March 31, 2021, the Company has sold 2,110,800 shares of Common Stock under the 2021 Agreement resulting in approximately $34.2 million in net proceeds, with $89.7 million remaining available to be sold under the 2021 Agreement. As of March 31, 2021, the Company recorded approximately $0.1 million of offering costs which offset the proceeds received from the shares sold through March 31, 2021 and recognized approximately $0.1 million of deferred offering costs which will offset future proceeds received under the 2021 Agreement. </p> <p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">O<font style="font-size:10pt;">n March 27, 2020, the Company entered into an Equity Distribution Agreement (the &#8220;2020 Agreement&#8221;) with JMP Securities LLC, serving as placement agent (the &#8220;Placement Agent&#8221;) with respect to an at-the-market offering program under which the Company may offer and sell, from time to time at its sole discretion, shares of its common stock, par value $0.0001 per share (the &#8220;Common Stock&#8221;), having an aggregate offering price of up to $50.0 million (the &#8220;Shares&#8221;) through the Placement Agent (the &#8220;2020 Offering&#8221;).</font> Any Shares offered and sold in the 2020 Offering were issued pursuant to the Company&#8217;s Registration Statement on Form S-3 filed with the SEC on April 4, 2019, which was declared effective on April 12, 2019, the prospectus supplement relating to the 2020 Offering filed with the SEC on March 27, 2020 and any applicable additional prospectus supplements related to the 2020 Offering that form a part of the Registration Statement. The aggregate market value of Shares eligible for sale in the 2020 Offering and under the 2020 Agreement were subject to the limitations of General Instruction I.B.6 of Form S-3, to the extent required under such instruction. The Company offered Shares having an aggregate offering price of $18.9 million pursuant to the prospectus supplement filed with the SEC on March 27, 2020. On June 1, 2020, the Company filed an amendment to the 2020 Agreement which amended the prospectus supplement dated March 27, 2020 to increase the aggregate offering price to $50.0 million.<font style="font-family:Calibri;"> </font><font style="font-size:10pt;">No Shares were sold under the 2020 Agreement during the three months ended March 31, 2020. As of March 31, 2021, the 2020 Agreement was fully utilized and no Shares were sold under the 2020 Agreement during the three months ended March 31, 2021. </font><font style="font-size:10pt;font-family:Calibri;">&#160;</font><font style="font-size:10pt;"> </font><font style="font-family:Calibri;">&#160;</font></p> <p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Exchange Agreement</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:6.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On February 25, 2021, the Company entered into an exchange agreement (the &#8220;Exchange Agreement&#8221;) with an Investor and its affiliates (the &#8220;Exchanging Stockholders&#8221;), pursuant to which the Company exchanged an aggregate of 1,000,000 shares of the Company&#8217;s common stock, par value $0.0001 per share, owned by the Exchanging Stockholders for pre-funded warrants (the &#8220;Exchange Warrants&#8221;) to purchase an aggregate of 1,000,000 shares of common stock (subject to adjustment in the event of any stock dividends and splits, reverse stock split, recapitalization, reorganization or similar transaction, as described in the Exchange Warrants), with an exercise price of $0.0001 per share. The Exchange Warrants do not expire and are exercisable at any time except that the Exchange Warrants cannot be exercised by the Exchanging Stockholders if, after giving effect thereto, the Exchanging Stockholders would beneficially own more than 9.99% of the Company&#8217;s common stock, subject to certain exceptions. In accordance with FASB Accounting Standards Codification Topic 505, <font style="font-style:italic;">Equity</font>, the Company recorded the retirement of the common stock exchanged as a reduction of common shares outstanding and a corresponding debit to additional paid-in-capital and accumulated deficit at the fair value of the Exchange Warrants on the issuance date. The Exchange Warrants are classified as equity in accordance with ASC 480 and the fair value of the Exchange Warrants was recorded as a credit to additional paid-in-capital is not subject to remeasurement. The Company determined that the fair value of the Exchange Warrants is substantially similar to the fair value of the retired shares on the issuance date due to the negligible exercise price for the Exchange Warrants. As of March 31, 2021, none of the Exchange Warrants have been exercised.</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">11. Warrants</p> <p style="text-align:justify;margin-bottom:12pt;margin-top:6pt;text-indent:6.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A summary of warrant activity during the three months ended March&#160;31, 2021 is as follows:</p> <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:90%;"> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Warrants outstanding, December 31, 2020</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.32%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,777,611</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Exchanges (see Note 10)</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.32%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,000,000</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.02%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Exercises</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.8%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.32%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,420</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.8%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.02%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Warrants outstanding, March&#160;31, 2021</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.8%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.32%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,776,191</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.8%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> </table> <p style="margin-bottom:0pt;margin-top:12pt;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.25%;"><font style="font-size:10pt;">As of March 31, 2021, all of the common stock warrants that were previously classified as a liability were exercised in full. </font><font style="font-size:10pt;font-family:Calibri;">&#160;</font><font style="font-family:Calibri;font-size:11pt;">&#160;</font></p></div> <p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">12. Stock-Based Compensation</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Stock Options</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:6.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company&#8217;s stock option awards generally vest over four years and typically have a contractual life of ten years. At March&#160;31, 2021, there was $10.1 million of unrecognized compensation cost related to stock options, which is expected to be recognized over a weighted-average period of 2.9&#160;years. During the three months ended March&#160;31, 2021, the Company granted 669,000 stock options with a weighted average exercise price of $16.73 and per share weighted average grant date fair value of $13.76. </p> <p style="text-align:justify;margin-bottom:12pt;margin-top:12pt;text-indent:6.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Information related to stock options outstanding at March&#160;31, 2021 is as follows:</p> <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:90%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Number</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">of Stock</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Options</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Weighted-</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">average</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exercise</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Price</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Weighted-</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">average</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Remaining</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Contractual</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Term</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Years)</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Aggregate</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Intrinsic</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Value</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Outstanding</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,293,367</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8.11</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6.0</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16,651,695</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Exercisable</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">773,781</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5.35</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5.8</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,855,753</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr style="height:9.6pt;"> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Unvested</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,519,586</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9.51</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6.0</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,795,942</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> </table> <p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Restricted Stock</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:6.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">At March&#160;31, 2021, the Company had unvested restricted stock of 134,545 shares with total unrecognized compensation expense of $0.5 million, which the Company expects to recognize over a weighted average period of approximately 1.7&#160;years. During the three months ended March&#160;31, 2021, the Company released 20,181&#160;shares of common stock from restriction as a result of the vesting of restricted stock. </p> <p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In February 2021, the Company granted 181,279 shares of restricted stock units which vest over four years. At March&#160;31, 2021, the Company had unvested restricted stock units of 196,279 shares with total unrecognized compensation expense of $2.8 million, which the Company expects to recognize over a weighted average period of approximately 3.8 years. </p> <p style="text-align:justify;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">2019 Employee Stock Purchase Plan</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:6.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Under the Employee Stock Purchase Plan, employees purchased 8,733 shares for $0.1 million during the three months ended March&#160;31, 2021. During the three months ended March&#160;31, 2021, the Company recognized compensation expense of $0.1 million.</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Stock-based Compensation Expense</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:6.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stock-based compensation expense is classified in the unaudited consolidated statements of operations and comprehensive loss for the three months ended March&#160;31, 2021 and 2020 as follows:</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:6.25%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p> <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:90%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="6" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.54%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">For the Three Months Ended</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">March&#160;31,</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Research and development</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">321,338</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">29,000</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">General and administrative</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">897,013</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">185,921</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,218,351</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">214,921</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> </table></div></div> <p style="margin-bottom:0pt;margin-top:8pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">13. U.S. Government Contracts and Grants</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:6.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In June 2020, the Company was awarded $4.7 million from the U.S. Army Medical Research &amp; Development Command (&#8220;USAMRDC&#8221;) to fund our Phase 1/2 clinical trial of T-COVID. The competitive award was granted by USAMRDC in collaboration with the Medical Technology Enterprise Consortium (&#8220;MTEC&#8221;), a 501(c)(3) biomedical technology consortium working in partnership with the Department of Defense (&#8220;DoD&#8221;). Under the contract, MTEC will pay the Company a firm fixed fee based upon the achievement of certain milestones for conduct and completion of a Phase 1/2 study and research and development work on the replication-deficient adenovirus 5 (&#8220;RD-Ad5&#8221;) vector vaccine platform. For the three months ended March&#160;31, 2021, the Company has recognized approximately $0.5 million of grant revenue under the contract.</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In July 2016, the Company signed a five-year contract with BARDA. The contract, as amended, has a total value of up to $133.7 million and is used to fund clinical development of NasoShield. Under the contract, BARDA pays the Company a fixed fee and reimburses certain costs for the research and development of an Ad5-vectored, protective antigen-based intranasal anthrax vaccine through cGMP manufacture and conduct of a Phase 1 clinical trial dose ranging assessment of safety and immunogenicity. The contract consists of an initial base performance period providing approximately $27.8 million in funding for the period July 2016 through June 2021. BARDA has seven options to extend the contract to fund certain continued development and manufacturing activities for the anthrax vaccine, including Phase 2 clinical studies. Each option, if exercised by BARDA, would provide additional funding ranging from approximately $1.1 million to $34.4 million for a three-year period beginning in 2021. For the three months ended March 31, 2021 and 2020, the Company has recognized approximately $0.2 million and $1.6 million, respectively, of grant revenue under the current BARDA contract.</p> <p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">14. Income Taxes</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:6.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Due to a full valuation allowance, the Company did not record an income tax benefit for the three months ended March 31, 2021.&nbsp;&nbsp;</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">With respect to the prior year, on March 27, 2020, President Donald Trump signed into law the Coronavirus Aid, Relief, and Economic Security Act (the &#8220;CARES Act&#8221;). The CARES Act provided both stimulus measures and a number of tax provisions, including: temporary changes regarding the utilization and carry back of net operating losses, temporary changes to the prior and future limitations on interest deductions, technical corrections from prior tax legislation for tax depreciation of qualified improvement property, and certain refundable employee retention credits. As of March 31, 2020, the Company recognized a tax benefit of $3.2 million related to the carry back of losses back to obtain a refund of its 2016 tax liability.</p> <p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">15. Net Loss Per Share</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:6.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Because the Company has reported a net loss attributable to common stockholders for all periods presented, basic and diluted net loss per share attributable to common stockholders are the same for all periods presented. </p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:6.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Basic net loss per share attributable to common stockholders is computed by dividing the net loss attributable to common stockholders by the weighted average numbers of shares of common stock outstanding for the period. Basic shares outstanding includes the weighted average effect of the Company&#8217;s outstanding pre-funded warrants, the exercise of which requires little or no consideration for the delivery of shares of common stock.</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:6.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Diluted net loss per share is calculated by adjusting weighted average shares outstanding for the dilutive effect of common stock equivalents outstanding for the period. As such, all unvested restricted stock, common stock warrants, and stock options have been excluded from the computation of diluted weighted average shares outstanding because such securities would have an anti-dilutive impact for all periods presented.</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Potential common shares issuable upon conversion, vesting or exercise of unvested restricted stock, common stock warrants, and stock options that are excluded from the computation of diluted weighted-average shares outstanding, as they are anti-dilutive, are as follows:</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:6.25%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p> <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:90%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:63.14%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="6" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:34.2%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">For the Three Months Ended</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">March&#160;31,</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:63.14%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.22%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.34%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:63.14%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Common stock warrants</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.22%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">145,755</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.34%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,370,206</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:63.14%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Common stock options</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.22%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,307,264</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.34%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,423,612</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:63.14%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Restricted stock</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.22%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">330,824</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.34%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">215,413</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> </table> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></div> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">16. Commitments and Contingencies</p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Spitfire Acquisition</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:6.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As disclosed in Note 8, the Company is obligated to make payments of up to $80.0 million upon the achievement of specified worldwide net sales of all products developed using the technology acquired from Spitfire Pharma Inc. within ten years following the approval of a new drug application filed with the FDA.</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">PER.C6 License Agreement Expansion</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:6.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="Background-color:#FFFFFF;">On April 2, 2020, the Company entered into Amendment No. 3 to the Second Restated License Agreement (the &#8220;Amendment&#8221;), by and between the Company and Janssen Vaccines &amp; Prevention B.V. (formerly known as Crucell Holland B.V.) (as amended by Amendment No. 1 to Second Restated License Agreement and Amendment No. 2 to Second Restated License Agreement, together with the Amendment, the &#8220;License Agreement&#8221;). Pursuant to the Amendment, the field of licenses granted to the Company for the use of the PER.C6 cell line under the License Agreement is expanded to cover COVID-19 caused by SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2), in addition to the existing licenses related to Bacillus anthracis and influenza virus. All capitalized terms not defined herein shall have the meanings assigned to them in the Amendment or the License Agreement, as applicable.</font></p> <p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="Background-color:#FFFFFF;">Pursuant to the Amendment, the Company agreed to pay certain additional development-based milestone payments through approval of licensed products by the FDA for the treatment or prevention of COVID-19, up to an aggregate amount of $1.2 million. The Company also agreed to pay royalty payments as a percentage of net sales of products to a royalty stacking reduction and minimum annual royalty payments, until the expiration of the term of the License Agreement, as amended. As of March&#160;31, 2021, no payments were made under the License Agreement.</font></p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Lonza Manufacturing Agreement</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;text-indent:6.25%;"><font style="font-style:normal;">In March 2021, the Company expanded its manufacturing collaboration with Lonza in connection with the Manufacturing Agreement entered into in November 2020 for the manufacture of AdCOVID. Under the expanded agreement, the Company has committed approximately $23.0 million to Lonza to procure long-lead equipment and construct a dedicated manufacturing suite for clinical and commercial production of AdCOVID. This work is expected to be completed during the fourth quarter of 2021. As of March 31, 2021, the Company capitalized approximately $4.0 million to construction-in-progress related to the equipment purchase and build out of the suite under the expanded agreement</font>.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Summit Biosciences Development and Manufacturing Agreement</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:6.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In March 2021, the Company entered into a development and manufacturing agreement with Summit Biosciences, Inc. (&#8220;Summit&#8221;) to manufacture a metered nasal spray presentation of AdCOVID. Under the agreement, the Company has committed approximately $6.7 million to Summit for the clinical manufacturing of AdCOVID multidose nasal spray. This work is expected to be completed by the end of 2021. As of March 31, 2021, the Company recorded approximately $1.4 million to prepaid expenses under the agreement.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Litigation</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:6.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In December 2019, a complaint was filed by Dr. De-Chu Christopher Tang (&#8220;Plaintiff&#8221;) against the Company, which the Company removed to the United States District Court for the Eastern District of Texas. The Plaintiff amended the complaint in February 2020 to include Vipin K. Garg and David J. Drutz as defendants, in addition to the Company (Dr. Garg, Dr. Drutz, and the Company are collectively referred to as &#8220;Defendants&#8221;). On November 6, 2020, Defendants filed a motion for summary judgment on the basis of lack of personal jurisdiction, insufficient service of process, and failure to state a claim. The court ruled on that motion<font style="font-family:Calibri;font-size:11pt;"> </font>on March 25, 2021, which dismissed the case on the basis of lack of personal jurisdiction. As the outcome of this legal proceeding is certain at this time, the Company has not accrued any liability associated with this action. </p> <p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company is a party in various other contractual disputes, litigation, and potential claims arising in the ordinary course of business none of which are currently reasonably possible or probable of material loss.</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Use of Estimates</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:6.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of these financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. The extent to which the COVID-19 pandemic may directly or indirectly impact the Company&#8217;s business, financial condition, and results of operations is highly uncertain and subject to change. The Company considered the potential impact of the COVID-19 pandemic on the Company&#8217;s estimates and assumptions and determined that there was not a material impact to the Company&#8217;s unaudited consolidated financial statements as of and for the three months ended March&#160;31, 2021. However, actual results could differ from those estimates and there may be changes to the Company&#8217;s estimates in future periods.</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Recently Issued Accounting Pronouncements - Adopted</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:6.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In December 2019, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) No. 2019-12, <font style="font-style:italic;">Income Taxes</font> (Topic 740), <font style="font-style:italic;">Simplifying the Accounting for Income Taxes</font> (&#8220;ASU No. 2019-12&#8221;). ASU 2019-12 amends the approaches and methodologies in accounting for income taxes during interim periods and makes changes to certain income tax classifications. The new standard allows exceptions to the use of the incremental approach for intra-period tax allocation, when there is a loss from continuing operations and income or a gain from other items, and to the general methodology for calculating income taxes in an interim period, when a year-to-date loss exceeds the anticipated loss for the year. The standard also requires franchise or similar taxes partially based on income to be reported as income tax and the effects of enacted changes in tax laws or rates to be included in the annual effective tax rate computation from the date of enactment. Lastly, in any future acquisition, the Company would be required to evaluate when the step-up in the tax basis of goodwill is part of the business combination and when it should be considered a separate transaction. The Company adopted the standard as of January 1, 2021 and has evaluated the effects of this standard and determined that the adoption did not have a material impact on the Company&#8217;s consolidated financial statements.</p> <p style="text-align:justify;margin-bottom:12pt;margin-top:6pt;text-indent:6.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company&#8217;s assets and liabilities measured at fair value on a recurring basis at March&#160;31, 2021 consisted of the following:</p> <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:90%;"> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:42.82%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.16%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="14" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:54%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Fair Value Measurement at March&#160;31, 2021</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:42.82%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.16%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.82%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Level 1</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.82%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Level 2</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.82%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Level 3</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:42.82%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Assets:</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.16%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.02%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.82%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.82%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.82%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:42.82%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash equivalents - money market funds</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.16%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.02%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13,962,902</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.82%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13,962,902</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.82%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.82%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:42.82%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Short-term investments</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.16%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.02%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">76,574,768</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">76,574,768</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:42.82%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.16%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.02%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">90,537,670</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.82%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13,962,902</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.82%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">76,574,768</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.82%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:42.82%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Liabilities:</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.16%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.02%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.82%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.82%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.82%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:42.82%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Contingent consideration liability (see Note 8)</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.16%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.02%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,270,000</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,270,000</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:42.82%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.16%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.02%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,270,000</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.82%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.82%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.82%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,270,000</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> </table> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:6.25%;font-size:10pt;">&nbsp;</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:6.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company&#8217;s assets and liabilities measured at fair value on a recurring basis at December&#160;31, 2020 consisted of the following:</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p> <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:90%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:42.82%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.16%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="14" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:54%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Fair Value Measurement at December&#160;31, 2020</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:42.82%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.16%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.82%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Level&#160;1</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.82%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Level&#160;2</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.82%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Level&#160;3</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:42.82%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Assets:</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.16%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.02%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.82%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.82%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.82%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:42.82%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash equivalents - money market funds</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.16%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.02%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">90,389,473</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.82%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">90,389,473</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.82%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.82%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:42.82%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Short-term investments</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.16%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.02%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">100,005,558</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">100,005,558</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:42.82%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.16%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.02%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">190,395,031</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.82%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">90,389,473</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.82%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">100,005,558</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.82%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:42.82%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Liabilities:</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.16%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.02%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.82%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.82%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.82%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:42.82%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Contingent consideration liability (see Note 8)</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.16%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.02%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,390,000</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.82%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.82%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.82%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,390,000</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:42.82%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Warrant liability</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.16%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.02%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,000</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,000</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:42.82%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.16%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.02%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,400,000</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.82%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.82%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.82%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,400,000</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> </table></div></div> <font style="Background-color:#FFFFFF;">Short-term investments had quoted prices at March&#160;31, 2021 as shown below:</font> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p> <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:90%;"> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:46.6%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:8.22%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="10" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.14%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">March&#160;31, 2021</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:46.6%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:8.22%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.96%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amortized Cost</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.6%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.96%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Unrealized Gain (Loss)</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.6%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.96%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Market Value</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:46.6%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">United States treasury securities</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.96%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16,029,965</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.96%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,995</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.96%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16,032,960</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:46.6%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Commercial paper and corporate debt securities</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.96%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">33,412,043</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.96%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,935</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.96%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">33,410,108</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:46.6%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Asset backed securities</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.96%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,111,239</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.96%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(278</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.96%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,110,961</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:46.6%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certificate of deposit</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:8.22%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.96%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">25,020,739</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.6%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.96%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.6%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.96%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">25,020,739</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:46.6%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:8.22%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.96%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">76,573,986</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.6%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.96%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">782</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.6%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.96%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">76,574,768</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> </table> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.25%;font-size:10pt;">&nbsp;</p> <p style="margin-bottom:12pt;margin-top:0pt;text-indent:6.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="Background-color:#FFFFFF;">Short-term investments had quoted prices at December 31, 2020 as shown below:</font></p> <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:90%;"> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:46.6%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:8.22%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="10" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.14%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31, 2020</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:46.6%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:8.22%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.96%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amortized Cost</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.6%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.96%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Unrealized Gain (Loss)</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.6%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.96%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Market Value</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:46.6%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">United States treasury securities</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.96%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20,052,757</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.96%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,843</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.96%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20,054,600</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:46.6%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Commercial paper and corporate debt securities</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.96%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">47,521,344</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.96%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(5,440</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.96%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">47,515,904</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:46.6%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Asset backed securities</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.96%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,414,619</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.96%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(757</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.96%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,413,862</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:46.6%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certificate of deposit</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:8.22%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.96%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">25,021,192</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.6%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.96%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.6%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.96%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">25,021,192</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:46.6%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:8.22%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.96%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">100,009,912</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.6%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.96%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(4,354</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.6%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.96%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">100,005,558</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.25%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></div> <p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The assumptions used to estimate the fair value of contingent payments that are classified as a liability at March&#160;31, 2021 include the following significant unobservable inputs:</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p> <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:90%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:61.18%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Unobservable input</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.86%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.44%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Value or Range</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.86%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.62%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Weighted Average</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="middle" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:61.18%; border-top:solid 0.75pt #000000;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Expected volatility</p></td> <td valign="middle" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.86%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="middle" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.44%; border-top:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">117.4%</p></td> <td valign="middle" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="middle" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.86%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="middle" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.62%; border-top:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">117.4%</p></td> <td valign="middle" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:61.18%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Risk-free interest rate</p></td> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.86%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.44%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.09%</p></td> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.86%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.62%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.09%</p></td> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="middle" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:61.18%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cost of capital</p></td> <td valign="middle" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.86%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="middle" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.44%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">30%</p></td> <td valign="middle" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="middle" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.86%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="middle" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.62%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">30%</p></td> <td valign="middle" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:61.18%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Discount for lack of marketability</p></td> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.86%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.44%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16%-19%</p></td> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.86%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.62%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">18%</p></td> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="middle" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:61.18%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Probability of payment</p></td> <td valign="middle" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.86%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="middle" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.44%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">63%</p></td> <td valign="middle" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="middle" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.86%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="middle" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.62%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">63%</p></td> <td valign="middle" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:61.18%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Projected year of payment</p></td> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.86%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.44%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2022</p></td> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.86%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.62%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2022</p></td> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10pt;">&nbsp;</p> <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:90%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:65.78%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.68%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.56%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">March&#160;31, 2021</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.68%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.24%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31, 2020</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:65.78%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Furniture, fixtures and equipment</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.56%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">185,878</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.24%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">125,538</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:65.78%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Laboratory equipment</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.56%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,041,752</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.24%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">959,585</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:65.78%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Computers and telecommunications</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.56%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">250,516</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.24%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">220,316</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:65.78%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Software</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.56%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">64,409</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.24%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">64,409</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:65.78%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Leasehold improvements</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.56%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,415,608</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.24%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,285,883</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:65.78%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Construction-in-progress</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.68%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.56%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,000,000</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.68%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.24%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:65.78%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Property and equipment, at cost</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.56%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,958,163</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.24%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,655,731</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:65.78%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Less: accumulated depreciation and amortization</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.68%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.56%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,760,111</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.68%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.24%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,598,811</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:65.78%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Property and equipment, net</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.68%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.56%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,198,052</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.68%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.24%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,056,920</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> </table></div> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:6.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company&#8217;s intangible assets consisted of the following:</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p> <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:90%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:39.64%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="12" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.76%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">March&#160;31, 2021</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:39.64%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.4%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Estimated</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Useful Lives</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.54%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Gross</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Carrying</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Value</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.54%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Accumulated</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amortization</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-top:solid 0.75pt #000000;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.54%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Net Book</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Value</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:39.64%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Internally developed patents</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.4%; border-top:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6-20 years</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.54%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">946,828</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.54%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(486,548</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.54%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">460,280</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:39.64%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Acquired licenses</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:13.4%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16-20 years</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.54%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">285,000</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.54%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(285,000</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.54%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:39.64%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total intangible assets subject to amortization</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.4%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.54%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,231,828</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.54%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(771,548</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.54%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">460,280</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:39.64%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">IPR&amp;D assets</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:13.4%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Indefinite</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.54%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12,418,967</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.54%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.54%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12,418,967</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:39.64%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:13.4%; border-bottom:double 2.5pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.54%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13,650,795</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.54%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(771,548</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.54%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12,879,247</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> </table> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p> <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:90%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:39.84%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="12" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.56%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31, 2020</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:39.84%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.14%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Estimated</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Useful Lives</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.56%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Gross</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Carrying</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Value</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.56%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Accumulated</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amortization</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-top:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Net Book</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Value</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:39.84%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Internally developed patents</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.14%; border-top:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6-10 years</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.56%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">884,787</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.56%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(479,908</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.42%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">404,879</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:39.84%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Acquired licenses</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:14.14%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16-20 years</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.56%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">285,000</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.56%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(285,000</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.42%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:39.84%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total intangible assets subject to amortization</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.14%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.56%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,169,787</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.56%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(764,908</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.42%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">404,879</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:39.84%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">IPR&amp;D assets</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:14.14%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Indefinite</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.56%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12,418,967</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.56%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.42%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12,418,967</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:39.84%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:14.14%; border-bottom:double 2.5pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.56%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13,588,754</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.56%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(764,908</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.42%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12,823,846</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> </table></div></div> <p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Supplemental other information related to the operating leases balance sheet information was as follows: </p> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:6.25%;font-family:Times New Roman;font-size:6pt;">&nbsp;</p> <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:90%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">March&#160;31, 2021</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31, 2020</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating lease obligations (see Note 7 and 9)</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,739,559</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,824,840</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating lease right-of-use assets</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">866,336</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">903,825</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Weighted-average remaining lease term (years)</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.1</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.3</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Weighted-average discount rate</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7.3</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7.3</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td> </tr> </table></div> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:6.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued expenses and other current liabilities consist of the following:</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p> <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:90%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:65.88%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.72%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">March&#160;31, 2021</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.96%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31, 2020</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:65.88%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued professional services</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.72%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">612,212</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.96%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,350,194</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:65.88%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued payroll and employee benefits</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.72%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,182,658</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.96%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,351,599</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:65.88%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued interest</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.72%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13,744</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.96%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13,016</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:65.88%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued research and development</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.72%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,211,778</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.96%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,316,876</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:65.88%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Lease obligation, current portion (see Note 6)</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.72%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">365,504</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.96%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">356,716</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:65.88%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred revenue</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.72%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19,753</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.96%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19,753</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:65.88%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total accrued expenses</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.72%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,405,649</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.96%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11,408,154</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p> Below is a summary of the contingent consideration activity: <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:90%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:65.56%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="6" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:31.68%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Three Months Ended March&#160;31,</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:65.56%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.38%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.24%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.04%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:65.56%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Beginning balance</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.38%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,390,000</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.04%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,750,000</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:65.56%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Change in fair value</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.38%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">880,000</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.04%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,750,000</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:65.56%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Ending balance</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.38%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,270,000</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.24%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.04%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,500,000</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> </table></div> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:6.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company&#8217;s other long-term liabilities are summarized as follows:</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p> <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:90%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">March&#160;31,</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31,</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Lease obligation, long-term portion (see Note 6)</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,374,055</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,468,124</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Conditional economic incentive grants</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">250,000</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">250,000</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">95,383</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">110,319</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total other long-term liabilities</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,719,438</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,828,443</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> </table></div> <p style="text-align:justify;margin-bottom:12pt;margin-top:6pt;text-indent:6.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A summary of warrant activity during the three months ended March&#160;31, 2021 is as follows:</p> <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:90%;"> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Warrants outstanding, December 31, 2020</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.32%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,777,611</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Exchanges (see Note 10)</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.32%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,000,000</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.02%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Exercises</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.8%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.32%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,420</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.8%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.02%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Warrants outstanding, March&#160;31, 2021</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.8%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.32%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,776,191</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.8%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> </table></div> <p style="text-align:justify;margin-bottom:12pt;margin-top:12pt;text-indent:6.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Information related to stock options outstanding at March&#160;31, 2021 is as follows:</p> <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:90%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Number</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">of Stock</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Options</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Weighted-</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">average</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exercise</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Price</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Weighted-</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">average</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Remaining</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Contractual</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Term</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Years)</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Aggregate</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Intrinsic</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Value</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Outstanding</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,293,367</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8.11</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6.0</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16,651,695</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Exercisable</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">773,781</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5.35</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5.8</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,855,753</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr style="height:9.6pt;"> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Unvested</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,519,586</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9.51</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6.0</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,795,942</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> </table></div> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:6.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stock-based compensation expense is classified in the unaudited consolidated statements of operations and comprehensive loss for the three months ended March&#160;31, 2021 and 2020 as follows:</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:6.25%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p> <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:90%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="6" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.54%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">For the Three Months Ended</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">March&#160;31,</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Research and development</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">321,338</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">29,000</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">General and administrative</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">897,013</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">185,921</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,218,351</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">214,921</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> </table></div> <p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Potential common shares issuable upon conversion, vesting or exercise of unvested restricted stock, common stock warrants, and stock options that are excluded from the computation of diluted weighted-average shares outstanding, as they are anti-dilutive, are as follows:</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:6.25%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p> <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:90%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:63.14%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="6" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:34.2%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">For the Three Months Ended</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">March&#160;31,</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:63.14%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.22%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.34%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:63.14%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Common stock warrants</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.22%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">145,755</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.34%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,370,206</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:63.14%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Common stock options</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.22%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,307,264</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.34%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,423,612</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:63.14%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Restricted stock</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.22%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">330,824</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.34%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">215,413</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> </table></div> 13962902 13962902 76574768 76574768 90537670 13962902 76574768 6270000 6270000 6270000 6270000 90389473 90389473 100005558 100005558 190395031 90389473 100005558 5390000 5390000 10000 10000 5400000 5400000 16029965 33412043 2111239 25020739 76573986 2995 -1935 -278 782 16032960 33410108 2110961 25020739 76574768 20052757 47521344 7414619 25021192 100009912 1843 -5440 -757 -4354 20054600 47515904 7413862 25021192 100005558 117.4 117.4 0.09 0.09 30 30 16 19 18 63 63 2022 2022 2022 0 0 0 0 0 0 0 0 0 0 185878 125538 1041752 959585 250516 220316 64409 64409 1415608 1285883 4000000 6958163 2655731 1760111 1598811 67658 59505 P6Y P20Y P16Y P20Y 946828 285000 1231828 486548 285000 771548 460280 460280 12418967 12418967 13650795 P6Y P10Y P16Y P20Y 884787 285000 1169787 479908 285000 764908 404879 404879 12418967 12418967 13588754 6640 13851 P12Y3M18D 2022-12 130138 87599 117354 95714 1739559 1824840 P4Y1M6D P4Y3M18D 0.073 0.073 612212 1350194 1182658 2351599 13744 13016 7211778 7316876 365504 356716 19753 19753 9405649 11408154 2019-07-08 1887250 5000000 88000000 5000000 P60D 3000000 P60D 80000000 P10Y P20D P20D 2.95 3.54 0.50 0.50 5390000 2750000 6270000 4500000 1374055 1468124 250000 250000 95383 110319 1719438 1828443 3369564 23.00 1630436 0.0001 22.9999 0.0499 0.1999 P61D 132200000 750000 124000000 0 0.0001 125000000 2110800 34200000 89700000 100000 100000 0.0001 50000000 18900000 1000000 0.0001 1000000 0.0001 0 0.0999 1777611 1000000 1420 2776191 P4Y P10Y 10100000 P2Y10M24D 669000 16.73 13.76 2293367 773781 1519586 8.11 5.35 9.51 P6Y P5Y9M18D P6Y 16651695 7855753 8795942 134545 500000 P1Y8M12D 20181 181279 P4Y 196279 2800000 P3Y9M18D 8733 100000 100000 321338 29000 897013 185921 1218351 214921 4700000 500000 P5Y 133700000 27800000 1100000 34400000 P3Y 200000 1600000 3200000 0 145755 10370206 2307264 1423612 330824 215413 1200000 0 23000000 4000000 1400000 EX-101.SCH 10 alt-20210331.xsd XBRL TAXONOMY EXTENSION SCHEMA 00000 - Document - Template Link link:presentationLink link:calculationLink link:definitionLink 100000 - Document - Document and Entity Information link:calculationLink link:presentationLink link:definitionLink 100010 - Statement - Consolidated Balance Sheets link:calculationLink link:presentationLink link:definitionLink 100020 - Statement - Consolidated Balance Sheets (Parenthetical) link:calculationLink link:presentationLink link:definitionLink 100030 - Statement - Consolidated Statements of Operations and Comprehensive Loss link:calculationLink link:presentationLink link:definitionLink 100040 - Statement - Consolidated Statements of changes in Stockholders' Equity link:calculationLink link:presentationLink link:definitionLink 100050 - Statement - Consolidated Statements of Cash Flows link:calculationLink link:presentationLink link:definitionLink 100060 - Disclosure - Nature of Business and Basis of Presentation link:calculationLink link:presentationLink link:definitionLink 100070 - Disclosure - Summary of Significant Accounting Policies link:calculationLink link:presentationLink link:definitionLink 100080 - Disclosure - Fair Value Measurements link:calculationLink link:presentationLink link:definitionLink 100090 - Disclosure - Property and Equipment, Net link:calculationLink link:presentationLink link:definitionLink 100100 - Disclosure - Intangible Assets link:calculationLink link:presentationLink link:definitionLink 100110 - Disclosure - Operating Leases link:calculationLink link:presentationLink link:definitionLink 100120 - Disclosure - Accrued Expenses link:calculationLink link:presentationLink link:definitionLink 100130 - Disclosure - Contingent Consideration link:calculationLink link:presentationLink link:definitionLink 100140 - Disclosure - Other Long-Term Liabilities link:calculationLink link:presentationLink link:definitionLink 100150 - Disclosure - Common Stock link:calculationLink link:presentationLink link:definitionLink 100160 - Disclosure - Warrants link:calculationLink link:presentationLink link:definitionLink 100170 - Disclosure - Stock-Based Compensation link:calculationLink link:presentationLink link:definitionLink 100180 - Disclosure - U.S. Government Contracts and Grants link:calculationLink link:presentationLink link:definitionLink 100190 - Disclosure - Income Taxes link:calculationLink link:presentationLink link:definitionLink 100200 - Disclosure - Net Loss Per Share link:calculationLink link:presentationLink link:definitionLink 100210 - Disclosure - Commitments and Contingencies link:calculationLink link:presentationLink link:definitionLink 100220 - Disclosure - Summary of Significant Accounting Policies (Policies) link:calculationLink link:presentationLink link:definitionLink 100230 - Disclosure - Fair Value Measurements (Tables) link:calculationLink link:presentationLink link:definitionLink 100240 - Disclosure - Property and Equipment, Net (Tables) link:calculationLink link:presentationLink link:definitionLink 100250 - Disclosure - Intangible Assets (Tables) link:calculationLink link:presentationLink link:definitionLink 100260 - Disclosure - Operating Leases (Tables) link:calculationLink link:presentationLink link:definitionLink 100270 - Disclosure - Accrued Expenses (Tables) link:calculationLink link:presentationLink link:definitionLink 100280 - Disclosure - Contingent Consideration (Tables) link:calculationLink link:presentationLink link:definitionLink 100290 - Disclosure - Other Long-Term Liabilities (Tables) link:calculationLink link:presentationLink link:definitionLink 100300 - Disclosure - Warrants (Tables) link:calculationLink link:presentationLink link:definitionLink 100310 - Disclosure - Stock-Based Compensation (Tables) link:calculationLink link:presentationLink link:definitionLink 100320 - Disclosure - Net Loss Per Share (Tables) link:calculationLink link:presentationLink link:definitionLink 100330 - Disclosure - Fair Value Measurements - Schedule of Fair Value Assets and Liabilities Measured on Recurring Basis (Detail) link:calculationLink link:presentationLink link:definitionLink 100340 - Disclosure - Fair Value Measurements - Schedule of Short Term Investments (Detail) link:calculationLink link:presentationLink link:definitionLink 100350 - Disclosure - Fair Value Measurements - Summary of Assumptions Used to Estimate Fair Value of Contingent Payments (Detail) link:calculationLink link:presentationLink link:definitionLink 100360 - Disclosure - Fair Value Measurements - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 100370 - Disclosure - Property and Equipment, Net - Summary of Property and Equipment, Net (Detail) link:calculationLink link:presentationLink link:definitionLink 100380 - Disclosure - Property and Equipment, Net - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 100390 - Disclosure - Intangible Assets - Schedule of Intangible Assets (Detail) link:calculationLink link:presentationLink link:definitionLink 100400 - Disclosure - Intangible Assets - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 100410 - Disclosure - Operating Leases - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 100420 - Disclosure - Operating Leases - Summary of Supplemental other Information Related to Operating Leases Balance Sheet (Detail) link:calculationLink link:presentationLink link:definitionLink 100430 - Disclosure - Accrued Expenses - Schedule of Accrued Expenses and Other Current Liabilities (Detail) link:calculationLink link:presentationLink link:definitionLink 100440 - Disclosure - Contingent Consideration - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 100450 - Disclosure - Contingent Consideration - Summary of Fair Value of Contingent Consideration (Detail) link:calculationLink link:presentationLink link:definitionLink 100460 - Disclosure - Other Long-Term Liabilities - Summary of Other Long-Term Liabilities (Detail) link:calculationLink link:presentationLink link:definitionLink 100470 - Disclosure - Common Stock - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 100480 - Disclosure - Warrants - Summary of Warrant Activity (Detail) link:calculationLink link:presentationLink link:definitionLink 100490 - Disclosure - Stock-Based Compensation - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 100500 - Disclosure - Stock-Based Compensation - Schedule of Information Related to Stock Options Outstanding (Detail) link:calculationLink link:presentationLink link:definitionLink 100510 - Disclosure - Stock-Based Compensation - Schedule of Stock-based Compensation Expense (Detail) link:calculationLink link:presentationLink link:definitionLink 100520 - Disclosure - U.S. Government Contracts and Grants - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 100530 - Disclosure - Income Taxes - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 100540 - Disclosure - Net Loss Per Share - Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Detail) link:calculationLink link:presentationLink link:definitionLink 100550 - Disclosure - Commitments and Contingencies - Additional Information (Details) link:calculationLink link:presentationLink link:definitionLink EX-101.CAL 11 alt-20210331_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 12 alt-20210331_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 13 alt-20210331_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Entity Central Index Key Cover [Abstract] Document Type Document Type Amendment Flag Amendment Flag Document Period End Date Document Period End Date Document Fiscal Year Focus Document Fiscal Year Focus Document Fiscal Period Focus Document Fiscal Period Focus Trading Symbol Trading Symbol Entity Registrant Name Entity Registrant Name Entity Central Index Key Current Fiscal Year End Date Current Fiscal Year End Date Entity Filer Category Entity Filer Category Entity Small Business Entity Small Business Entity Emerging Growth Company Entity Emerging Growth Company Entity Shell Company Entity Shell Company Entity Current Reporting Status Entity Current Reporting Status Entity Interactive Data Current Entity Interactive Data Current Entity Common Stock, Shares Outstanding Entity Common Stock Shares Outstanding Entity File Number Entity File Number Entity Tax Identification Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Incorporation State Country Code Entity Address, Address Line One Entity Address Address Line1 Entity Address, Address Line Two Entity Address Address Line2 Entity Address, City or Town Entity Address City Or Town Entity Address, State or Province Entity Address State Or Province Entity Address, Postal Zip Code Entity Address Postal Zip Code City Area Code City Area Code Local Phone Number Local Phone Number Title of 12(b) Security Security12b Title Security Exchange Name Security Exchange Name Document Quarterly Report Document Quarterly Report Document Transition Report Document Transition Report Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Also includes the aggregate carrying amount, as of the balance sheet date, of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered and of liabilities not separately disclosed in the balance sheet. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Statement Of Financial Position [Abstract] ASSETS Assets [Abstract] Current assets: Assets Current [Abstract] Cash and cash equivalents Cash And Cash Equivalents At Carrying Value Restricted cash Restricted Cash Current Total cash, cash equivalents and restricted cash Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Short-term investments Short Term Investments Accounts receivable Accounts Receivable Gross Current Tax refund receivable Income Taxes Receivable Prepaid expenses and other current assets Prepaid Expense And Other Assets Current Total current assets Assets Current Property and equipment, net Property Plant And Equipment Net Right of use asset Operating Lease Right Of Use Asset Intangible assets, net Intangible Assets Net Excluding Goodwill Other assets Other Assets Noncurrent Total assets Assets LIABILITIES AND STOCKHOLDERS’ EQUITY Liabilities And Stockholders Equity [Abstract] Current liabilities: Liabilities Current [Abstract] Accounts payable Accounts Payable Current Accrued expenses and other current liabilities Accrued Expenses And Other Current Liabilities Total current liabilities Liabilities Current Contingent consideration Business Combination Contingent Consideration Liability Noncurrent Other long-term liabilities Other Long Term Debt Noncurrent Total liabilities Liabilities Commitments and contingencies (Note 16) Commitments And Contingencies Stockholders’ equity: Stockholders Equity [Abstract] Common stock, $0.0001 par value; 200,000,000 shares authorized; 38,257,180 and 37,142,946 shares issued and outstanding at March 31, 2021 and December 31, 2020, respectively Common Stock Value Additional paid-in capital Additional Paid In Capital Accumulated deficit Retained Earnings Accumulated Deficit Accumulated other comprehensive loss, net Accumulated Other Comprehensive Income Loss Net Of Tax Total stockholders’ equity Stockholders Equity Total liabilities and stockholders’ equity Liabilities And Stockholders Equity Common stock, par or stated value per share Common Stock Par Or Stated Value Per Share Common stock, shares authorized Common Stock Shares Authorized Common stock, shares issued Common Stock Shares Issued Common stock, shares outstanding Common Stock Shares Outstanding Income Statement [Abstract] Revenues Revenue From Contract With Customer Excluding Assessed Tax Operating expenses: Operating Expenses [Abstract] Research and development Research And Development Expense General and administrative General And Administrative Expense Total operating expenses Operating Expenses Loss from operations Operating Income Loss Other income (expense): Nonoperating Income Expense [Abstract] Interest expense Interest Expense Interest income Investment Income Interest Other (expense) income, net Other Nonoperating Income Expense Total other (expense) income, net Nonoperating Income Expense Net loss before income tax benefit Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest Income tax benefit Income Tax Expense Benefit Net loss Net Income Loss Other comprehensive income (loss) – unrealized gain (loss) on investments Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax Comprehensive loss Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest Net loss per share, basic and diluted Earnings Per Share Basic And Diluted Weighted-average common shares outstanding, basic and diluted Weighted Average Number Of Share Outstanding Basic And Diluted Retirement of common stock in exchange for common stock warrant shares. Retirement of common stock in exchange for common stock warrant. Issuance of common stock warrant in exchange for retirement of common stock. Stock issued during period share exercise of warrants. Stock issued during period value exercise of warrants. Stock issued during period value common stock and pre funded warrants in public offering net Statement Of Stockholders Equity [Abstract] Statement [Table] Statement [Table] Equity Components Statement Equity Components [Axis] Equity Component Equity Component [Domain] Common Stock [Member] Common Stock [Member] Additional Paid-In Capital [Member] Additional Paid In Capital [Member] Accumulated Deficit [Member] Retained Earnings [Member] Accumulated Other Comprehensive Loss [Member] Accumulated Other Comprehensive Income [Member] Sale of Stock Subsidiary Sale Of Stock [Axis] Sale of Stock Sale Of Stock Name Of Transaction [Domain] Market offering. Market Offering [Member] Market Offering [Member] Statement [Line Items] Statement [Line Items] Beginning Balance Beginning Balance (in shares) Shares Outstanding Stock-based compensation Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value Issuance of common stock from exercise of stock options Stock Issued During Period Value Stock Options Exercised Issuance of common stock from exercise of stock options (in shares) Stock Issued During Period Shares Stock Options Exercised Vesting of restricted stock awards including withholding, net Restricted Stock Value Shares Issued Net Of Tax Withholdings Vesting of restricted stock awards including withholding, net (in shares) Restricted Stock Shares Issued Net Of Shares For Tax Withholdings Issuance of common stock from Employee Stock Purchase Plan Stock Issued During Period Value Employee Stock Purchase Plan Issuance of common stock from Employee Stock Purchase Plan (in shares) Stock Issued During Period Shares Employee Stock Purchase Plans Issuance of common stock and pre-funded warrants in public offering, net Stock Issued During Period Value Common Stock And Pre Funded Warrants In Public Offering Net Stock issued during period shares common stock and pre funded warrants in public offering net Issuance of common stock and pre-funded warrants in public offering, net (in shares) Stock Issued During Period Shares Common Stock And Pre Funded Warrants In Public Offering Net Issuance of common stock, net Stock Issued During Period Value New Issues Issuance of common stock, net (in shares) Stock Issued During Period Shares New Issues Retirement of common stock in exchange for common stock warrant Retirement Of Common Sock In Exchange For Common Stock Warrant Retirement of common stock in exchange for common stock warrant (in Shares) Retirement Of Common Sock In Exchange For Common Stock Warrant Shares Issuance of common stock warrant in exchange for retirement of common stock Issuance Of Common Stock Warrant In Exchange For Retirement Of Common Stock Issuance of common stock for acquired in-process research and development Stock Issued During Period Value Acquisitions Issuance of common stock for acquired in-process research and development (in shares) Stock Issued During Period Shares Acquisitions Issuance of common stock upon cashless exercise of warrants Stock Issued During Period Value Exercise Of Warrants Issuance of common stock upon cashless exercise of warrants (in shares) Stock Issued During Period Share Exercise Of Warrants Net loss Ending Balance Ending Balance (in shares) Payments of deferred offering costs. Statement Of Cash Flows [Abstract] CASH FLOWS FROM OPERATING ACTIVITIES: Net Cash Provided By Used In Operating Activities [Abstract] Net loss Profit Loss Adjustments to reconcile net loss to net cash used in operating activities: Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities [Abstract] Change in fair value of contingent consideration liability Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 Stock-based compensation expense Share Based Compensation Depreciation and amortization Depreciation Depletion And Amortization Unrealized losses on foreign currency exchange Foreign Currency Transaction Gain Loss Unrealized Changes in operating assets and liabilities: Increase Decrease In Operating Capital [Abstract] Accounts receivable Increase Decrease In Accounts Receivable Prepaid expenses and other current assets Increase Decrease In Prepaid Deferred Expense And Other Assets Accounts payable Increase Decrease In Accounts Payable Accrued expenses and other liabilities Increase Decrease In Accrued Liabilities And Other Operating Liabilities Tax refund receivable Increase Decrease In Income Taxes Receivable Net cash used in operating activities Net Cash Provided By Used In Operating Activities CASH FLOWS FROM INVESTING ACTIVITIES: Net Cash Provided By Used In Investing Activities [Abstract] Proceeds from sales and maturities of short-term investments Proceeds From Sale And Maturity Of Available For Sale Securities Purchases of short-term investments Payments To Acquire Available For Sale Securities Debt Purchases of property and equipment, net Payments To Acquire Property Plant And Equipment Cash paid for internally developed patents Payments To Acquire Intangible Assets Net cash provided by investing activities Net Cash Provided By Used In Investing Activities CASH FLOWS FROM FINANCING ACTIVITIES: Net Cash Provided By Used In Financing Activities [Abstract] Payments of deferred offering costs Payments Of Deferred Offering Costs Proceeds from exercises of warrants Proceeds From Warrant Exercises Proceeds from issuance of common stock in at the market offering, net Proceeds From Issuance Of Common Stock Proceeds from issuance of common stock from Employee Stock Purchase Plan Proceeds From Stock Plans Net cash provided by financing activities Net Cash Provided By Used In Financing Activities Net increase in cash and cash equivalents and restricted cash Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect Cash, cash equivalents and restricted cash at beginning of period Cash, cash equivalents and restricted cash at end of period SUPPLEMENTAL NON-CASH FINANCING ACTIVITIES: Cash Flow Noncash Investing And Financing Activities Disclosure [Abstract] Fair value of common stock retired in exchange for issuance of common stock warrant Conversion Of Stock Amount Converted1 Accounting Policies [Abstract] Nature of Business and Basis of Presentation Business Description And Basis Of Presentation [Text Block] Summary of Significant Accounting Policies Significant Accounting Policies [Text Block] Fair Value Disclosures [Abstract] Fair Value Measurements Fair Value Disclosures [Text Block] Property Plant And Equipment [Abstract] Property and Equipment, Net Property Plant And Equipment Disclosure [Text Block] Goodwill And Intangible Assets Disclosure [Abstract] Intangible Assets Intangible Assets Disclosure [Text Block] Leases [Abstract] Operating Leases Lessee Operating Leases [Text Block] Payables And Accruals [Abstract] Accrued Expenses Accounts Payable And Accrued Liabilities Disclosure [Text Block] Business Combinations [Abstract] Contingent consideration Business Combination Disclosure [Text Block] Other Liabilities Disclosure [Abstract] Other Long-Term Liabilities Other Liabilities Disclosure [Text Block] The entire disclosure of common stock. Text Block [Abstract] Common Stock Common Stock [Text Block] Equity [Abstract] Warrants Stockholders Equity Note Disclosure [Text Block] Disclosure Of Compensation Related Costs Sharebased Payments [Abstract] Stock-Based Compensation Disclosure Of Compensation Related Costs Share Based Payments [Text Block] U.S. government contracts and grants. U.S. government contracts and grants disclosures abstract. U S Government Contracts And Grants Disclosures [Abstract] U.S. Government Contracts and Grants U S Government Contracts And Grants [Text Block] Income Tax Disclosure [Abstract] Income Taxes Income Tax Disclosure [Text Block] Earnings Per Share [Abstract] Net Loss Per Share Earnings Per Share [Text Block] Commitments And Contingencies Disclosure [Abstract] Commitments and Contingencies Commitments And Contingencies Disclosure [Text Block] Use of Estimates Use Of Estimates New Accounting Pronouncements - Adopted New Accounting Pronouncements Policy Policy [Text Block] Schedule of Fair Value Assets and Liabilities Measured on Recurring Basis Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Table [Text Block] Schedule of Short Term Investments Schedule Of Available For Sale Securities Reconciliation Table [Text Block] Summary of Assumptions Used to Estimate Fair Value of Contingent Payments Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques Table [Text Block] Summary of Property and Equipment, Net Property Plant And Equipment [Text Block] Schedule of intangible assets. Schedule of Intangible Assets Schedule Of Intangible Assets Table [Text Block] Schedule of supplemental balance sheet information related to Operating leases. Summary of Supplemental other Information Related to Operating Leases Balance Sheet Schedule Of Supplemental Balance Sheet Information Related To Operating Leases Table [Text Block] Schedule of Accrued Expenses and Other Current Liabilities Schedule Of Accrued Liabilities Table [Text Block] Summary of Fair Value of Contingent Consideration Schedule Of Business Acquisitions By Acquisition Contingent Consideration [Text Block] Summary of Other Long-Term Liabilities Other Noncurrent Liabilities Table [Text Block] Summary of Warrant Activity Schedule Of Stockholders Equity Note Warrants Or Rights [Text Block] Schedule of Information Related to Stock Options Outstanding Schedule Of Other Share Based Compensation Activity Table [Text Block] Schedule of Stock-based Compensation Expense Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Text Block] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Text Block] Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table] Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table] Cash and Cash Equivalents Cash And Cash Equivalents [Axis] Cash and Cash Equivalents Restricted Cash And Cash Equivalents Cash And Cash Equivalents [Member] Money Market Funds [Member] Money Market Funds [Member] Measurement Frequency Fair Value By Measurement Frequency [Axis] Measurement Frequency Fair Value Measurement Frequency [Domain] Fair Value, Measurements, Recurring [Member] Fair Value Measurements Recurring [Member] Fair Value Hierarchy and NAV Fair Value By Fair Value Hierarchy Level [Axis] Fair Value Hierarchy and NAV Fair Value Measurements Fair Value Hierarchy [Domain] Level 1 [Member] Fair Value Inputs Level1 [Member] Level 2 [Member] Fair Value Inputs Level2 [Member] Level 3 [Member] Fair Value Inputs Level3 [Member] Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] Cash equivalents Investments Fair Value Disclosure Total Assets Fair Value Disclosure Contingent consideration liability (see Note 8) Business Combination Contingent Consideration Liability Total Liabilities Fair Value Disclosure Warrant liability Derivative Liabilities Debt Securities Available For Sale [Table] Debt Securities Available For Sale [Table] Financial Instrument Financial Instrument [Axis] Financial Instruments Transfers And Servicing Of Financial Instruments Types Of Financial Instruments [Domain] United States Treasury Securities [Member] U S Treasury Securities [Member] Commercial Paper And Corporate Debt Securities [Member]. Commercial Paper and Corporate Debt Securities [Member] Commercial Paper And Corporate Debt Securities [Member] Asset Backed Securities [Member] Asset Backed Securities [Member] Certificates Of Deposit [Member] Certificates Of Deposit [Member] Schedule Of Available For Sale Securities [Line Items] Schedule Of Available For Sale Securities [Line Items] Amortized Cost Available For Sale Debt Securities Amortized Cost Basis Unrealized Gain (Loss) Debt Securities Available For Sale Accumulated Gross Unrealized Gain Loss Before Tax Market Value Available For Sale Securities Debt Securities Business combination, contingent consideration, liability, payment year. Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Table] Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Table] Statistical Measurement Range [Axis] Statistical Measurement Range [Member] Minimum [Member] Minimum [Member] Maximum [Member] Maximum [Member] Weighted Average [Member] Weighted Average [Member] Measurement Input Type Measurement Input Type [Axis] Measurement Input Type Measurement Input Type [Domain] Expected Volatility [Member] Measurement Input Price Volatility [Member] Risk-free Interest Rate [Member] Measurement Input Risk Free Interest Rate [Member] Measurement input cost of capital. Cost of Capital [Member] Measurement Input Cost Of Capital [Member] Discount for Lack of Marketability [Member] Measurement Input Discount For Lack Of Marketability [Member] Measurement input, probability of payment. Probability of Payment [Member] Measurement Input Probability Of Payment [Member] Projected Year of Payment [Member] Measurement Input Maturity [Member] Assumptions used to estimate fair value of contingent payments Business Combination Contingent Consideration Liability Measurement Input Assumptions used to estimate fair value of contingent payments Business Combination Contingent Consideration Liability Payment Year Fair value transfers, Level 1 to Level 2 assets Fair Value Assets Level1 To Level2 Transfers Amount Fair value transfers, Level 2 to Level 1 assets Fair Value Assets Level2 To Level1 Transfers Amount Fair value transfers, Level 1 to Level 2 liabilities Fair Value Liabilities Level1 To Level2 Transfers Amount Fair value transfers, Level 2 to Level 1 liabilities Fair Value Liabilities Level2 To Level1 Transfers Amount Assets or liabilities that were measured at fair value on a non-recurring basis. Assets or liabilities measured at fair value on a non-recurring basis. Assets Or Liabilities Measured At Fair Value On Non Recurring Basis Schedule Of Property Plant And Equipment [Table] Schedule Of Property Plant And Equipment [Table] Long-Lived Tangible Asset Property Plant And Equipment By Type [Axis] Long-Lived Tangible Asset Property Plant And Equipment Type [Domain] Furniture, Fixtures and Equipment [Member] Furniture And Fixtures [Member] Laboratory equipment. Laboratory Equipment [Member] Laboratory Equipment [Member] Computers and Telecommunications [Member] Computer Equipment [Member] Software [Member] Software And Software Development Costs [Member] Leasehold Improvements Leasehold Improvements [Member] Construction-In-Progress [Member] Construction In Progress [Member] Property Plant And Equipment [Line Items] Property Plant And Equipment [Line Items] Property and equipment, at cost Property Plant And Equipment Gross Less: accumulated depreciation and amortization Accumulated Depreciation Depletion And Amortization Property Plant And Equipment Property and equipment, net Depreciation Depreciation Schedule of intangible assets. Schedule Of Intangible Assets [Table] Schedule Of Intangible Assets [Table] Schedule Of Intangible Assets [Table] Finite-Lived Intangible Assets by Major Class Finite Lived Intangible Assets By Major Class [Axis] Finite-Lived Intangible Assets, Major Class Name Finite Lived Intangible Assets Major Class Name [Domain] Internally developed patents. Internally Developed Patents [Member] Internally Developed Patents [Member] Acquired licenses. Acquired Licenses [Member] Acquired Licenses [Member] Indefinite-lived Intangible Assets Indefinite Lived Intangible Assets By Major Class [Axis] Indefinite-lived Intangible Assets, Major Class Name Indefinite Lived Intangible Assets Major Class Name [Domain] IPR&D [Member] In Process Research And Development [Member] Schedule Of Intangible Assets [Line Items] Schedule Of Intangible Assets [Line Items] Estimated Useful Lives Finite Lived Intangible Asset Useful Life Intangible assets subject to amortization, Gross Carrying Value Finite Lived Intangible Assets Gross Intangible assets subject to amortization, Accumulated Amortization Finite Lived Intangible Assets Accumulated Amortization Intangible assets subject to amortization, Net Book Value Finite Lived Intangible Assets Net Total intangible assets, Gross Carrying Value Intangible Assets Gross Excluding Goodwill Total intangible assets, Net Book Value Indefinite Lived Intangible Assets Excluding Goodwill Total intangible assets, Net Book Value Income Statement Location Income Statement Location [Axis] Income Statement Location Income Statement Location [Domain] Research and Development [Member] Research And Development Expense [Member] Amortization expense of intangible assets Amortization Of Intangible Assets Weighted average amortization period remaining for intangible assets Acquired Finite Lived Intangible Assets Weighted Average Useful Life Non-cancellable lease maturity period. Non-cancellable lease maturity period Non Cancellable Lease Maturity Period Operating lease rent expense Lease And Rental Expense Cash paid for operating lease liabilities Operating Lease Payments Operating lease obligations (see Note 7 and 9) Operating Lease Liability Operating lease right-of-use assets Weighted-average remaining lease term (years) Operating Lease Weighted Average Remaining Lease Term1 Weighted-average discount rate Operating Lease Weighted Average Discount Rate Percent Accrued research and development. Accrued Liabilities And Other Liabilities [Abstract] Accrued professional services Accrued Professional Fees Current Accrued payroll and employee benefits Employee Related Liabilities Current Accrued interest Interest Payable Current Accrued research and development Accrued Research And Development Lease obligation, current portion (see Note 6) Operating Lease Liability Current Deferred revenue Deferred Revenue Current Total accrued expenses Accrued Liabilities Current Schedule Of Business Acquisitions By Acquisition [Table] Schedule Of Business Acquisitions By Acquisition [Table] Business Acquisition Business Acquisition [Axis] Business Acquisition, Acquiree Business Acquisition Acquiree [Domain] Spitfire Pharma, Inc. Spitfire Pharma, Inc. [Member] Spitfire Pharma Inc [Member] Contingent Consideration by Type Contingent Consideration By Type [Axis] Contingent Consideration Type Contingent Consideration Type [Domain] Investigational New Drug Application milestone. Investigational New Drug Application Milestone [Member] Investigational New Drug Application Milestone [Member] Investigational New Drug Application and Regulatory milestones. Investigational New Drug Application and Regulatory Milestones [Member] Investigational New Drug Application And Regulatory Milestones [Member] Sales milestone. Sales Milestones [Member] Sales Milestone [Member] Regulatory milestone. Regulatory Milestones [Member] Regulatory Milestone [Member] Business Acquisition [Line Items] Business Acquisition [Line Items] Agreement date Business Acquisition Date Of Acquisition Agreement1 Unregistered shares of common stock Business Acquisition Equity Interests Issued Or Issuable Number Of Shares Issued Up-front consideration Payments To Acquire Businesses Gross Estimated future contingent consideration Business combination contingent consideration payment term. Estimated future contingent consideration term Business Combination Contingent Consideration Payment Term Business acquisition term of license agreement. License agreement term Business Acquisition Term Of License Agreement Number of consecutive trading days. Number of consecutive trading days Number Of Consecutive Trading Days Consideration amount Business Acquisition Share Price Percentage of upfront consideration release at period four. Percentage of upfront consideration release at period one. Upfront consideration release at 3 months Percentage Of Upfront Consideration Release At Period Four Upfront consideration release at 9 months Percentage Of Upfront Consideration Release At Period One Beginning balance Ending balance Economic conditional incentive grants. Lease obligation, long-term portion (see Note 6) Operating Lease Liability Noncurrent Conditional economic incentive grants Economic Conditional Incentive Grants Other Other Liabilities Noncurrent Total other long-term liabilities Long Term Debt Noncurrent Class of warrant or right, issuance price per warrant or right. Ownership percentage on exercise of warrants without notice, minimum. Ownership percentage on exercise of warrants with notice, maximum. Notice period to increase ownership percentage on exercise of warrants. Changes In Equity And Comprehensive Income Line Items [Line Items] Schedule Of Stock By Class [Table] Schedule Of Stock By Class [Table] Public Offering [Member] I P O [Member] Over-Allotment Option [Member] Over Allotment Option [Member] Class of Warrant or Right Class Of Warrant Or Right [Axis] Class of Warrant or Right Class Of Warrant Or Right [Domain] Pre-funded warrants. Pre-Funded Warrants [Member] Pre Funded Warrants [Member] Collaborative Arrangement and Arrangement Other than Collaborative Type Of Arrangement [Axis] Collaborative Arrangement and Arrangement Other than Collaborative Arrangements And Nonarrangement Transactions [Member] Equity Distribution Agreement. Equity Distribution Agreement [Member] Equity Distribution Agreement [Member] At-the-market offering. At-The-Market Offering [Member] At The Market Offering [Member] Counterparty Name Counterparty Name [Axis] Counterparty Name Repurchase Agreement Counterparty Name [Domain] Piper Sandler company and evercore group limited liability company and B Riley Securities inc Member. Piper Sandler company and evercore group limited liability company and B Riley Securities inc [Member] Piper Sandler Company And Evercore Group Limited Liability Company And B Riley Securities Inc [Member] JMP securities limited liability company. JMP Securities LLC [Member] J M P Securities Limited Liability Company [Member] Exchange Warrants [Member]. Exchange Warrants [Member] Exchange Warrants [Member] Changes In Equity And Comprehensive Income Line Items [Line Items] Changes In Equity And Comprehensive Income Line Items [Line Items] Shares of common stock sold Public offering price, per share Shares Issued Price Per Share Number of securities called by warrants or rights Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights Exercise price of warrants or rights Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 Purchase price of warrants issued Class Of Warrant Or Right Issuance Price Per Warrant Or Right Ownership percentage on exercise of warrants without notice, minimum Ownership Percentage On Exercise Of Warrants Without Notice Minimum Ownership percentage on exercise of warrants with notice, maximum Ownership Percentage On Exercise Of Warrants With Notice Maximum Notice period to increase ownership percentage on exercise of warrants Notice Period To Increase Ownership Percentage On Exercise Of Warrants Gross proceeds from offering including exercise of underwriter's option Proceeds From Issuance Or Sale Of Equity Proceeds from issuance of common stock in public offering, net Aggregate offering price. Common stock, par or stated value per share Aggregate offering price Aggregate Offering Price Common stock, value of capital shares reserved for future issuance. Common stock available to be sold Common Stock Value Of Capital Shares Reserved For Future Issuance Deferred offering costs Deferred Offering Costs Issuance costs Payments Of Stock Issuance Costs The number of shares exchanged for pre-funded warrants. Number of warrants exercised. Common stock exchanged for pre-funded warrants Stock Exchanged For Pre Funded Warrants Number of warrants exercised Number Of Warrants Exercised Ownership percentage Equity Method Investment Ownership Percentage Number of warrants exercised for conversion of securities. Warrants outstanding, December 31, 2020 Class Of Warrant Or Right Outstanding Exchanges (see Note 10) Debt Conversion Converted Instrument Warrants Or Options Issued1 Exercises Number Of Warrants Exercised For Conversion Of Securities Warrants outstanding, March 31, 2021 Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table] Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table] Award Type Award Type [Axis] Award Type Share Based Compensation Arrangements By Share Based Payment Award Award Type And Plan Name [Domain] Stock Options [Member] Employee Stock Option [Member] Restricted Stock [Member] Restricted Stock [Member] Restricted Stock Units [Member] Restricted Stock Units R S U [Member] Plan Name Plan Name [Axis] Plan Name Plan Name [Domain] Two thousand and nineteen employee stock purchase plan. 2019 Employee Stock Purchase Plan [Member] Two Thousand And Nineteen Employee Stock Purchase Plan [Member] Share Based Compensation Arrangement By Share Based Payment Award [Line Items] Share Based Compensation Arrangement By Share Based Payment Award [Line Items] Vesting Period Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1 Stock option expiration Period Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period Unrecognized compensation cost, stock options Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options Unrecognized stock-based compensation expense, period for recognition Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 Number of Stock Options, Granted Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross Stock options granted, weighted-average exercise price Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price Weighted-average grant date fair value of stock options granted Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value Number of Stock Options, Outstanding Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number Number of Stock Options, Exercisable Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number Number of Stock Options, Unvested Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares Share based compensation arrangement by share based payment award options unvested outstanding weighted average exercise price. Weighted-average Exercise Price, Outstanding Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price Weighted-average Exercise Price, Exercisable Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price Weighted-average Exercise Price, Unvested Share Based Compensation Arrangement By Share Based Payment Award Options Unvested Outstanding Weighted Average Exercise Price Share based compensation arrangement by share based payment award options unvested outstanding weighted average remaining contractual term. Weighted-average Remaining Contractual Term, Outstanding Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 Weighted-average Remaining Contractual Term, Exercisable Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 Weighted-average Remaining Contractual Term, Unvested Share Based Compensation Arrangement By Share Based Payment Award Options Unvested Outstanding Weighted Average Remaining Contractual Term Share based compensation arrangement by share based payment award options nonvested outstanding intrinsic value. Aggregate Intrinsic Value, Outstanding Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value Aggregate Intrinsic Value, Exercisable Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 Aggregate Intrinsic Value, Unvested Share Based Compensation Arrangement By Share Based Payment Award Options Nonvested Outstanding Intrinsic Value Unvested restricted stock, shares Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number Unrecognized compensation expense Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options Common stock issued as result of vesting of restricted stock Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures Shares granted Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Employees purchased, shares Employees purchased, value Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Table] Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Table] General and Administrative [Member] General And Administrative Expense [Member] Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items] Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items] Stock based compensation expense Allocated Share Based Compensation Expense Product and Service Product Or Service [Axis] Product and Service Products And Services [Domain] Grant [Member] Grant [Member] Medical Technology Enterprise Consortium collaborative arrangement. Collaborative Arrangement [Member] Medical Technology Enterprise Consortium Collaborative Arrangement [Member] BARDA Contract [Member]. BARDA Contract [Member] B A R D A Contract [Member] Investment Performance [Member] Investment Performance [Member] Duration of contract. Duration of contract Duration Of Contract Amount used to fund clinical development Purchase Commitment Remaining Minimum Amount Committed Additional funding for development and manufacturing activities Government Contract Receivable Income tax, refund claim Income Tax Examination Liability Refund Adjustment From Settlement With Taxing Authority Income tax benefit Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table] Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table] Antidilutive Securities Antidilutive Securities Excluded From Computation Of Earnings Per Share By Antidilutive Securities [Axis] Antidilutive Securities, Name Antidilutive Securities Name [Domain] Option Indexed to Issuer's Equity Option Indexed To Issuers Equity Equity [Axis] Option Indexed to Issuer's Equity, Type Option Indexed To Issuers Equity Type [Domain] Common Stock Warrants [Member] Warrant [Member] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items] Antidilutive securities excluded from computation of earnings per share Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount Commitments and contingencies. Commitments and contingencies. Commitments And Contingencies [Table] Commitments And Contingencies [Table] Janssen Vaccines and Preventions BV. Janssen Vaccines and Prevention BV [Member] Janssen Vaccines And Preventions Bv [Member] License [Member] License [Member] Lonza manufacturing agreement member Lonza Manufacturing Agreement [Member] Lonza Manufacturing Agreement [Member] AdCOVID member AdCOVID [Member] Ad C O V I D [Member] Summit biosciences development and manufacturing agreement member Summit Biosciences Development and Manufacturing Agreement [Member] Summit Biosciences Development And Manufacturing Agreement [Member] Commitments And Contingencies [Line Items] Commitments And Contingencies [Line Items] License agreement term Development-based milestone payments. Payment made under license agreement Development Based Milestone Payments Development Based Milestone Payments Payment Made Under License Agreement Payment Made Under License Agreement Commitment to procure equipment and construction Commitment To Procure Equipment and Construction Commitment To Procure Equipment And Construction Construction-in-progress capitalized Construction In Progress Gross Prepaid Expense under the agreement Prepaid Expense Current And Noncurrent EX-101.PRE 14 alt-20210331_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 15 R1.htm IDEA: XBRL DOCUMENT v3.21.1
Document and Entity Information - shares
3 Months Ended
Mar. 31, 2021
May 14, 2021
Cover [Abstract]    
Document Type 10-Q  
Amendment Flag false  
Document Period End Date Mar. 31, 2021  
Document Fiscal Year Focus 2021  
Document Fiscal Period Focus Q1  
Trading Symbol ALT  
Entity Registrant Name ALTIMMUNE, INC.  
Entity Central Index Key 0001326190  
Current Fiscal Year End Date --12-31  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Common Stock, Shares Outstanding   38,396,843
Entity File Number 001-32587  
Entity Tax Identification Number 20-2726770  
Entity Incorporation, State or Country Code DE  
Entity Address, Address Line One 910 Clopper Road  
Entity Address, Address Line Two Suite 201S  
Entity Address, City or Town Gaithersburg  
Entity Address, State or Province MD  
Entity Address, Postal Zip Code 20878  
City Area Code (240)  
Local Phone Number 654-1450  
Title of 12(b) Security Common stock, par value $0.0001 per share  
Security Exchange Name NASDAQ  
Document Quarterly Report true  
Document Transition Report false  
XML 16 R2.htm IDEA: XBRL DOCUMENT v3.21.1
Consolidated Balance Sheets - USD ($)
Mar. 31, 2021
Dec. 31, 2020
Current assets:    
Cash and cash equivalents $ 149,932,387 $ 115,917,807
Restricted cash 34,174 34,174
Total cash, cash equivalents and restricted cash 149,966,561 115,951,981
Short-term investments 76,574,768 100,005,558
Accounts receivable 4,801,428 4,610,202
Tax refund receivable 7,898,067 7,762,793
Prepaid expenses and other current assets 5,950,999 1,926,675
Total current assets 245,191,823 230,257,209
Property and equipment, net 5,198,052 1,056,920
Right of use asset 866,336 903,825
Intangible assets, net 12,879,247 12,823,846
Other assets 115,300 73,413
Total assets 264,250,758 245,115,213
Current liabilities:    
Accounts payable 418,243 612,293
Accrued expenses and other current liabilities 9,405,649 11,408,154
Total current liabilities 9,823,892 12,020,447
Contingent consideration 6,270,000 5,390,000
Other long-term liabilities 1,719,438 1,828,443
Total liabilities 17,813,330 19,238,890
Commitments and contingencies (Note 16)
Stockholders’ equity:    
Common stock, $0.0001 par value; 200,000,000 shares authorized; 38,257,180 and 37,142,946 shares issued and outstanding at March 31, 2021 and December 31, 2020, respectively 3,810 3,697
Additional paid-in capital 462,417,706 417,337,742
Accumulated deficit (210,944,707) (186,420,599)
Accumulated other comprehensive loss, net (5,039,381) (5,044,517)
Total stockholders’ equity 246,437,428 225,876,323
Total liabilities and stockholders’ equity $ 264,250,758 $ 245,115,213
XML 17 R3.htm IDEA: XBRL DOCUMENT v3.21.1
Consolidated Balance Sheets (Parenthetical) - $ / shares
Mar. 31, 2021
Dec. 31, 2020
Statement Of Financial Position [Abstract]    
Common stock, par or stated value per share $ 0.0001 $ 0.0001
Common stock, shares authorized 200,000,000 200,000,000
Common stock, shares issued 38,257,180 37,142,946
Common stock, shares outstanding 38,257,180 37,142,946
XML 18 R4.htm IDEA: XBRL DOCUMENT v3.21.1
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Income Statement [Abstract]    
Revenues $ 837,516 $ 2,212,694
Operating expenses:    
Research and development 11,877,900 7,187,531
General and administrative 3,821,420 2,331,917
Total operating expenses 15,699,320 9,519,448
Loss from operations (14,861,804) (7,306,754)
Other income (expense):    
Interest expense (11,671) (1,885)
Interest income 42,499 151,569
Other (expense) income, net (33,132) 25,542
Total other (expense) income, net (2,304) 175,226
Net loss before income tax benefit (14,864,108) (7,131,528)
Income tax benefit 0 3,245,879
Net loss (14,864,108) (3,885,649)
Other comprehensive income (loss) – unrealized gain (loss) on investments 5,136 (32,435)
Comprehensive loss $ (14,858,972) $ (3,918,084)
Net loss per share, basic and diluted $ (0.38) $ (0.26)
Weighted-average common shares outstanding, basic and diluted 38,914,990 15,110,585
XML 19 R5.htm IDEA: XBRL DOCUMENT v3.21.1
Consolidated Statements of changes in Stockholders' Equity - USD ($)
Total
Market Offering [Member]
Common Stock [Member]
Common Stock [Member]
Market Offering [Member]
Additional Paid-In Capital [Member]
Additional Paid-In Capital [Member]
Market Offering [Member]
Accumulated Deficit [Member]
Accumulated Other Comprehensive Loss [Member]
Beginning Balance at Dec. 31, 2019 $ 45,520,146   $ 1,508   $ 187,914,916   $ (137,376,122) $ (5,020,156)
Beginning Balance (in shares) at Dec. 31, 2019     15,312,167          
Stock-based compensation 214,921       214,921      
Vesting of restricted stock awards including withholding, net (17,079)   $ 1   (17,080)      
Vesting of restricted stock awards including withholding, net (in shares)     (5,974)          
Issuance of common stock from Employee Stock Purchase Plan 56,739   $ 3   56,736      
Issuance of common stock from Employee Stock Purchase Plan (in shares)     38,809          
Issuance of common stock upon cashless exercise of warrants 39,974   $ 2   39,972      
Issuance of common stock upon cashless exercise of warrants (in shares)     14,500          
Other comprehensive income (loss) – unrealized gain (loss) on investments (32,435)             (32,435)
Net loss (3,885,649)           (3,885,649)  
Ending Balance at Mar. 31, 2020 41,896,617   $ 1,514   188,209,465   (141,261,771) (5,052,591)
Ending Balance (in shares) at Mar. 31, 2020     15,359,502          
Beginning Balance at Dec. 31, 2020 225,876,323   $ 3,697   417,337,742   (186,420,599) (5,044,517)
Beginning Balance (in shares) at Dec. 31, 2020     37,142,946          
Stock-based compensation 1,218,351       1,218,351      
Vesting of restricted stock awards including withholding, net (92,506)   $ 1   (92,507)      
Vesting of restricted stock awards including withholding, net (in shares)     (6,349)          
Issuance of common stock from Employee Stock Purchase Plan 106,001   $ 1   106,000      
Issuance of common stock from Employee Stock Purchase Plan (in shares)     8,733          
Issuance of common stock, net   $ 34,178,231   $ 211   $ 34,178,020    
Issuance of common stock, net (in shares)       2,110,800        
Retirement of common stock in exchange for common stock warrant (17,200,000)   $ (100)   (7,539,900)   (9,660,000)  
Retirement of common stock in exchange for common stock warrant (in Shares)     (1,000,000)          
Issuance of common stock warrant in exchange for retirement of common stock 17,200,000       17,200,000      
Issuance of common stock upon cashless exercise of warrants 10,000       10,000      
Issuance of common stock upon cashless exercise of warrants (in shares)     1,050          
Other comprehensive income (loss) – unrealized gain (loss) on investments 5,136             5,136
Net loss (14,864,108)           (14,864,108)  
Ending Balance at Mar. 31, 2021 $ 246,437,428   $ 3,810   $ 462,417,706   $ (210,944,707) $ (5,039,381)
Ending Balance (in shares) at Mar. 31, 2021     38,257,180          
XML 20 R6.htm IDEA: XBRL DOCUMENT v3.21.1
Consolidated Statements of Cash Flows - USD ($)
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net loss $ (14,864,108) $ (3,885,649)
Adjustments to reconcile net loss to net cash used in operating activities:    
Change in fair value of contingent consideration liability 880,000 1,750,000
Stock-based compensation expense 1,218,351 214,921
Depreciation and amortization 74,298 73,356
Unrealized losses on foreign currency exchange 33,376 24,939
Changes in operating assets and liabilities:    
Accounts receivable (191,226) (973,557)
Prepaid expenses and other current assets (4,200,624) (214,893)
Accounts payable (194,050) 911,397
Accrued expenses and other liabilities (2,189,903) 1,112,718
Tax refund receivable (135,274) (3,360,633)
Net cash used in operating activities (19,569,160) (4,347,401)
CASH FLOWS FROM INVESTING ACTIVITIES:    
Proceeds from sales and maturities of short-term investments 30,912,000 13,700,000
Purchases of short-term investments (7,476,074) (7,099,263)
Purchases of property and equipment, net (4,208,790) (18,131)
Cash paid for internally developed patents (62,041) (19,390)
Net cash provided by investing activities 19,165,095 6,563,216
CASH FLOWS FROM FINANCING ACTIVITIES:    
Payments of deferred offering costs 134,413  
Proceeds from exercises of warrants   39,974
Proceeds from issuance of common stock in at the market offering, net 34,178,231  
Proceeds from issuance of common stock from Employee Stock Purchase Plan 106,001 56,739
Net cash provided by financing activities 34,418,645 96,713
Net increase in cash and cash equivalents and restricted cash 34,014,580 2,312,528
Cash, cash equivalents and restricted cash at beginning of period 115,951,981 8,996,860
Cash, cash equivalents and restricted cash at end of period 149,966,561 $ 11,309,388
SUPPLEMENTAL NON-CASH FINANCING ACTIVITIES:    
Fair value of common stock retired in exchange for issuance of common stock warrant $ 17,200,000  
XML 21 R7.htm IDEA: XBRL DOCUMENT v3.21.1
Nature of Business and Basis of Presentation
3 Months Ended
Mar. 31, 2021
Accounting Policies [Abstract]  
Nature of Business and Basis of Presentation

1. Nature of Business and Basis of Presentation

Nature of Business

Altimmune, Inc., headquartered in Gaithersburg, Maryland, United States, together with its subsidiaries (collectively, the “Company” or “Altimmune”) is a clinical stage biopharmaceutical company incorporated under the laws of the State of Delaware.

The Company is focused on developing intranasal vaccines, immune modulating therapies, and treatments for liver disease. The Company’s diverse pipeline includes proprietary intranasal vaccines for COVID-19 (AdCOVID), anthrax (NasoShield) and influenza (NasoVAX); an intranasal immune modulating therapeutic for COVID-19 (T-COVID); and next generation peptide therapeutics for NASH (ALT-801) and chronic hepatitis B (HepTcell). Since its inception, the Company has devoted substantially all of its efforts to business planning, research and development, recruiting management and technical staff, and raising capital, and has financed its operations through the issuance of common and preferred stock, long-term debt, and proceeds from research grants and government contracts. The Company has not generated any revenues from the sale of any products to date, and there is no assurance of any future revenues from product sales.

Basis of Presentation

The accompanying unaudited consolidated financial statements are prepared pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”) regarding interim financial reporting. Accordingly, they do not include all of the information and disclosures required by accounting principles generally accepted in the United States (“U.S. GAAP”) for complete consolidated financial statements and should be read in conjunction with the audited consolidated financial statements for the year ended December 31, 2020 included in the Annual Report on Form 10-K which was filed with the SEC on February 25, 2021. In the opinion of management, the Company has prepared the accompanying unaudited consolidated financial statements on the same basis as the audited consolidated financial statements, and these consolidated financial statements include all adjustments, consisting only of normal recurring adjustments, necessary for a fair presentation of the results of the interim periods presented. The operating results for the interim periods presented are not necessarily indicative of the results expected for the full year 2021 or any future years or periods.

The accompanying unaudited consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation.

The accompanying unaudited consolidated financial statements have been prepared on the basis of continuity of operations, realization of assets, and the satisfaction of liabilities in the ordinary course of business. The financial statements do not include any adjustments relating to the recoverability and classification of recorded assets and liabilities that might be necessary should we be unable to continue as a going concern.

XML 22 R8.htm IDEA: XBRL DOCUMENT v3.21.1
Summary of Significant Accounting Policies
3 Months Ended
Mar. 31, 2021
Accounting Policies [Abstract]  
Summary of Significant Accounting Policies

2. Summary of Significant Accounting Policies

During the three months ended March 31, 2021, there have been no significant changes to the Company’s summary of significant accounting policies contained in the Company’s Annual Report on Form 10-K for the year ended December 31, 2020 as filed with the SEC, except for the recently adopted accounting standard for income taxes.

Use of Estimates

The preparation of these financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. The extent to which the COVID-19 pandemic may directly or indirectly impact the Company’s business, financial condition, and results of operations is highly uncertain and subject to change. The Company considered the potential impact of the COVID-19 pandemic on the Company’s estimates and assumptions and determined that there was not a material impact to the Company’s unaudited consolidated financial statements as of and for the three months ended March 31, 2021. However, actual results could differ from those estimates and there may be changes to the Company’s estimates in future periods.

Recently Issued Accounting Pronouncements - Adopted

In December 2019, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2019-12, Income Taxes (Topic 740), Simplifying the Accounting for Income Taxes (“ASU No. 2019-12”). ASU 2019-12 amends the approaches and methodologies in accounting for income taxes during interim periods and makes changes to certain income tax classifications. The new standard allows exceptions to the use of the incremental approach for intra-period tax allocation, when there is a loss from continuing operations and income or a gain from other items, and to the general methodology for calculating income taxes in an interim period, when a year-to-date loss exceeds the anticipated loss for the year. The standard also requires franchise or similar taxes partially based on income to be reported as income tax and the effects of enacted changes in tax laws or rates to be included in the annual effective tax rate computation from the date of enactment. Lastly, in any future acquisition, the Company would be required to evaluate when the step-up in the tax basis of goodwill is part of the business combination and when it should be considered a separate transaction. The Company adopted the standard as of January 1, 2021 and has evaluated the effects of this standard and determined that the adoption did not have a material impact on the Company’s consolidated financial statements.

XML 23 R9.htm IDEA: XBRL DOCUMENT v3.21.1
Fair Value Measurements
3 Months Ended
Mar. 31, 2021
Fair Value Disclosures [Abstract]  
Fair Value Measurements

3. Fair Value Measurements

The Company’s assets and liabilities measured at fair value on a recurring basis at March 31, 2021 consisted of the following:

 

 

Fair Value Measurement at March 31, 2021

 

 

 

Total

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

Assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash equivalents - money market funds

 

$

13,962,902

 

 

$

13,962,902

 

 

$

 

 

$

 

Short-term investments

 

 

76,574,768

 

 

 

 

 

 

76,574,768

 

 

 

 

Total

 

 

90,537,670

 

 

 

13,962,902

 

 

 

76,574,768

 

 

 

 

Liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Contingent consideration liability (see Note 8)

 

 

6,270,000

 

 

 

 

 

 

 

 

 

6,270,000

 

Total

 

$

6,270,000

 

 

$

 

 

$

 

 

$

6,270,000

 

 

The Company’s assets and liabilities measured at fair value on a recurring basis at December 31, 2020 consisted of the following:

 

 

 

Fair Value Measurement at December 31, 2020

 

 

 

Total

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

Assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash equivalents - money market funds

 

$

90,389,473

 

 

$

90,389,473

 

 

$

 

 

$

 

Short-term investments

 

 

100,005,558

 

 

 

 

 

 

100,005,558

 

 

 

 

Total

 

 

190,395,031

 

 

 

90,389,473

 

 

 

100,005,558

 

 

 

 

Liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Contingent consideration liability (see Note 8)

 

 

5,390,000

 

 

 

 

 

 

 

 

 

5,390,000

 

Warrant liability

 

 

10,000

 

 

 

 

 

 

 

 

 

10,000

 

Total

 

$

5,400,000

 

 

$

 

 

$

 

 

$

5,400,000

 

The warrant liability is included in Other long-term liabilities in the consolidated balance sheet at December 31, 2020. The warrant liability was valued using the Monte Carlo simulation valuation model with Level 3 inputs.

Short-term investments have been initially valued at the transaction price and subsequently valued, at the end of each reporting period, utilizing third party pricing services or other market observable data (Level 2). The pricing services utilize industry standard valuation models, including both income and market-based approaches and observable market inputs to determine value.

Short-term investments had quoted prices at March 31, 2021 as shown below:

 

 

 

March 31, 2021

 

 

 

Amortized Cost

 

 

Unrealized Gain (Loss)

 

 

Market Value

 

United States treasury securities

 

$

16,029,965

 

 

$

2,995

 

 

$

16,032,960

 

Commercial paper and corporate debt securities

 

 

33,412,043

 

 

 

(1,935

)

 

 

33,410,108

 

Asset backed securities

 

 

2,111,239

 

 

 

(278

)

 

 

2,110,961

 

Certificate of deposit

 

 

25,020,739

 

 

 

 

 

 

25,020,739

 

Total

 

$

76,573,986

 

 

$

782

 

 

$

76,574,768

 

 

Short-term investments had quoted prices at December 31, 2020 as shown below:

 

 

December 31, 2020

 

 

 

Amortized Cost

 

 

Unrealized Gain (Loss)

 

 

Market Value

 

United States treasury securities

 

$

20,052,757

 

 

$

1,843

 

 

$

20,054,600

 

Commercial paper and corporate debt securities

 

 

47,521,344

 

 

 

(5,440

)

 

 

47,515,904

 

Asset backed securities

 

 

7,414,619

 

 

 

(757

)

 

 

7,413,862

 

Certificate of deposit

 

 

25,021,192

 

 

 

 

 

 

25,021,192

 

Total

 

$

100,009,912

 

 

$

(4,354

)

 

$

100,005,558

 

 

The fair value of contingent payments classified as a liability is based on the regulatory milestones described in Note 8 and estimated using the Monte Carlo simulation valuation model with Level 3 inputs.

The assumptions used to estimate the fair value of contingent payments that are classified as a liability at March 31, 2021 include the following significant unobservable inputs:

 

Unobservable input

 

Value or Range

 

 

Weighted Average

 

Expected volatility

 

117.4%

 

 

117.4%

 

Risk-free interest rate

 

0.09%

 

 

0.09%

 

Cost of capital

 

30%

 

 

30%

 

Discount for lack of marketability

 

16%-19%

 

 

18%

 

Probability of payment

 

63%

 

 

63%

 

Projected year of payment

 

2022

 

 

2022

 

 

If applicable, the Company will recognize transfers into and out of levels within the fair value hierarchy at the end of the reporting period in which the actual event or change in circumstance occurs. There were no transfers into and out of any of the levels of the fair value hierarchy as of March 31, 2021 and December 31, 2020.

 

Separate disclosure is required for assets and liabilities measured at fair value on a recurring basis from those measured at fair value on a non-recurring basis. Assets recorded at fair value on a non-recurring basis, such as property and equipment and intangible assets are recognized at fair value when they are impaired. As of March 31, 2021 and December 31, 2020, the Company had no significant assets or liabilities that were measured at fair value on a non-recurring basis.

XML 24 R10.htm IDEA: XBRL DOCUMENT v3.21.1
Property and Equipment, Net
3 Months Ended
Mar. 31, 2021
Property Plant And Equipment [Abstract]  
Property and Equipment, Net

4. Property and Equipment, Net

 

 

 

March 31, 2021

 

 

December 31, 2020

 

Furniture, fixtures and equipment

 

$

185,878

 

 

$

125,538

 

Laboratory equipment

 

 

1,041,752

 

 

 

959,585

 

Computers and telecommunications

 

 

250,516

 

 

 

220,316

 

Software

 

 

64,409

 

 

 

64,409

 

Leasehold improvements

 

 

1,415,608

 

 

 

1,285,883

 

Construction-in-progress

 

 

4,000,000

 

 

 

 

Property and equipment, at cost

 

 

6,958,163

 

 

 

2,655,731

 

Less: accumulated depreciation and amortization

 

 

(1,760,111

)

 

 

(1,598,811

)

Property and equipment, net

 

$

5,198,052

 

 

$

1,056,920

 

As of March 31, 2021, construction-in-progress primarily includes costs related to the procurement of long-lead equipment and build out of the suite associated with the Company's manufacturing collaboration with Lonza Houston, Inc. (“Lonza”) described in Note 16. Depreciation expense related to property and equipment was approximately $67,658 and $59,505, for the three months ended March 31, 2021 and 2020, respectively.

XML 25 R11.htm IDEA: XBRL DOCUMENT v3.21.1
Intangible Assets
3 Months Ended
Mar. 31, 2021
Goodwill And Intangible Assets Disclosure [Abstract]  
Intangible Assets

5. Intangible Assets

The Company’s intangible assets consisted of the following:

 

 

 

March 31, 2021

 

 

 

Estimated

Useful Lives

 

Gross

Carrying

Value

 

 

Accumulated

Amortization

 

 

Net Book

Value

 

Internally developed patents

 

6-20 years

 

$

946,828

 

 

$

(486,548

)

 

$

460,280

 

Acquired licenses

 

16-20 years

 

 

285,000

 

 

 

(285,000

)

 

 

 

Total intangible assets subject to amortization

 

 

 

 

1,231,828

 

 

 

(771,548

)

 

 

460,280

 

IPR&D assets

 

Indefinite

 

 

12,418,967

 

 

 

 

 

 

12,418,967

 

Total

 

 

 

$

13,650,795

 

 

$

(771,548

)

 

$

12,879,247

 

 

 

 

December 31, 2020

 

 

 

Estimated

Useful Lives

 

Gross

Carrying

Value

 

 

Accumulated

Amortization

 

 

Net Book

Value

 

Internally developed patents

 

6-10 years

 

$

884,787

 

 

$

(479,908

)

 

$

404,879

 

Acquired licenses

 

16-20 years

 

 

285,000

 

 

 

(285,000

)

 

 

 

Total intangible assets subject to amortization

 

 

 

 

1,169,787

 

 

 

(764,908

)

 

 

404,879

 

IPR&D assets

 

Indefinite

 

 

12,418,967

 

 

 

 

 

 

12,418,967

 

Total

 

 

 

$

13,588,754

 

 

$

(764,908

)

 

$

12,823,846

 

Amortization expense of intangible assets was $6,640 and $13,851 for the three months ended March 31, 2021 and 2020, respectively. As of March 31, 2021, the weighted average amortization period remaining for intangible assets was 12.3 years. Amortization expense was classified as research and development expenses in the accompanying unaudited consolidated statements of operations and comprehensive loss.

XML 26 R12.htm IDEA: XBRL DOCUMENT v3.21.1
Operating Leases
3 Months Ended
Mar. 31, 2021
Leases [Abstract]  
Operating Leases

6. Operating Leases

The Company rents office and laboratory space in the United States. The Company also leases office equipment under a non-cancellable equipment lease through December 2022. Rent expense during the three months ended March 31, 2021 and 2020 under all of the Company’s operating leases was $130,138 and $87,599, respectively. Rent expense includes short-term leases and variable lease costs that are not included in the lease obligation.

Short-term leases are leases having a term of twelve months or less. The Company recognizes short-term leases on a straight-line basis and does not record a related lease asset or liability for such leases.

The office space leases provide for increases in future minimum annual rental payments as defined in the lease agreements. The office space lease also includes an option to renew the lease as of the end of the term. The Company has determined that the lease renewal option is not reasonably certain of being exercised.

The cash paid for operating lease liabilities for the three months ended March 31, 2021 and 2020 was $117,354 and $95,714, respectively.

Supplemental other information related to the operating leases balance sheet information was as follows:

 

 

 

March 31, 2021

 

 

December 31, 2020

 

Operating lease obligations (see Note 7 and 9)

 

$

1,739,559

 

 

$

1,824,840

 

Operating lease right-of-use assets

 

$

866,336

 

 

$

903,825

 

Weighted-average remaining lease term (years)

 

 

4.1

 

 

 

4.3

 

Weighted-average discount rate

 

 

7.3

%

 

 

7.3

%

  

XML 27 R13.htm IDEA: XBRL DOCUMENT v3.21.1
Accrued Expenses
3 Months Ended
Mar. 31, 2021
Payables And Accruals [Abstract]  
Accrued Expenses

7. Accrued Expenses

Accrued expenses and other current liabilities consist of the following:

 

 

 

March 31, 2021

 

 

December 31, 2020

 

Accrued professional services

 

$

612,212

 

 

$

1,350,194

 

Accrued payroll and employee benefits

 

 

1,182,658

 

 

 

2,351,599

 

Accrued interest

 

 

13,744

 

 

 

13,016

 

Accrued research and development

 

 

7,211,778

 

 

 

7,316,876

 

Lease obligation, current portion (see Note 6)

 

 

365,504

 

 

 

356,716

 

Deferred revenue

 

 

19,753

 

 

 

19,753

 

Total accrued expenses

 

$

9,405,649

 

 

$

11,408,154

 

 

XML 28 R14.htm IDEA: XBRL DOCUMENT v3.21.1
Contingent Consideration
3 Months Ended
Mar. 31, 2021
Business Combinations [Abstract]  
Contingent consideration

8. Contingent Consideration

The Company entered into an Agreement and Plan of Merger and Reorganization, dated July 8, 2019, by and among the Company, Springfield Merger Sub, Inc., Springfield Merger Sub, LLC, Spitfire Pharma, Inc. and David Collier, as the Stockholder Representative (the “Spitfire Merger Agreement”) to acquire all of the equity interests of Spitfire Pharma, Inc. (“Spitfire”). Spitfire was a privately held, preclinical pharmaceutical company developing a novel dual GLP-1/glucagon receptor agonist for the treatment of non-alcoholic steatohepatitis.  

The transaction closed on July 12, 2019. The Company issued 1,887,250 unregistered shares of its common stock (the “shares”) as upfront consideration to certain former securityholders of Spitfire (collectively, the “Spitfire Equityholders”), representing an amount equal to $5.0 million less working capital and transaction expense adjustment amounts as defined in the agreement.

The acquisition of Spitfire was accounted for as an asset acquisition instead of a business combination because substantially all of the fair value of the gross assets acquired was concentrated in a single identifiable asset or group of similar identifiable assets, and therefore, the asset was not considered a business. The Company expensed the acquired intellectual property as of the acquisition date as in-process research and development with no alternative future uses. 

The Spitfire Merger Agreement also includes future contingent payments up to $88.0 million in cash and shares of the Company’s common stock as follows (each, a “Milestone Event”):

 

a one-time payment of $5.0 million (the “IND Milestone Consideration Amount”) within sixty days of the submission of an Investigational New Drug Application (“IND”) to the United States Food and Drug Administration (the “FDA”) or other applicable governmental authority in a foreign jurisdiction, which IND has not been rejected or placed on clinical hold by the FDA or such applicable foreign governmental authority within time specified in the Merger Agreement;

 

a one-time payment of $3.0 million (the “Phase 2 Milestone Consideration Amount” and together with the IND Milestone Consideration Amount, the “Regulatory Milestones”) within sixty days of the initiation of a Phase 2 clinical trial of a product candidate anywhere in the world; and

 

payments of up to $80.0 million upon the achievement of specified worldwide net sales (the “Sales Milestones”) of all products developed using the technology acquired in the License Agreement within ten years following the approval of a new drug application filed with the FDA.

The Regulatory Milestones will be payable in shares of the Company’s Common Stock, with the number of shares of the Company’s Common Stock to be issued in connection with each milestone amount, if any, are dependent on the share price at the time of achievement. The number of any shares issued in consideration for the IND Milestone Consideration Amount will be determined based on lower of (A) the average of the closing prices of our Common Stock as reported on the Nasdaq Global Market for the twenty (20) consecutive trading days prior to the IND Reference Date or (B) $2.95. The value of any shares issued in consideration for the Phase 2 Milestone Consideration Amount shall be determined based the lower of (A) on the average of the closing trading prices of our Common Stock as reported on the Nasdaq Global Market for the twenty (20) consecutive trading days immediately preceding the date of the occurrence of the Phase 2 Milestone Event or (B) $3.54.

The future contingent payments related to the Regulatory Milestones are stock-based payments accounted for under FASB Accounting Standards Codification Topic 480, Distinguishing Liabilities From Equity (“ASC 480”). Such stock-based payments are subject to a lock-up whereby 50% of the shares are released at 3 months and 50% are released at 6 months. The future contingent payments related to the Sales Milestones are predominately cash-based payments accounted for under FASB Accounting Standards Codification Topic 450, Contingencies. Accordingly, the Company will recognize the Sales Milestones when the contingency is resolved and the amount is paid or payable.

The Company estimates the future contingent consideration for the Regulatory Milestones based upon a Monte Carlo simulation valuation model that is risk adjusted based on the probability of achieving the milestones and a discount for lack of marketability. The Company remeasures the fair value of the contingent consideration at each reporting period. During the fourth quarter of 2020, the Company achieved the IND Milestone and paid the obligation in shares according to the calculation above. Below is a summary of the contingent consideration activity:

 

 

Three Months Ended March 31,

 

 

 

2021

 

 

2020

 

Beginning balance

 

$

5,390,000

 

 

$

2,750,000

 

Change in fair value

 

 

880,000

 

 

 

1,750,000

 

Ending balance

 

$

6,270,000

 

 

$

4,500,000

 

 

As of March 31, 2021, the increase in fair value was primarily attributable to an increase in the closing share price of the Company’s common stock and in the probability of milestone achievement. As of March 31, 2020, the increase in fair value was primarily due to an increase in the probability of milestone achievement. Any changes in fair value have been recorded within research and development expense during the respective periods presented.

XML 29 R15.htm IDEA: XBRL DOCUMENT v3.21.1
Other Long-Term Liabilities
3 Months Ended
Mar. 31, 2021
Other Liabilities Disclosure [Abstract]  
Other Long-Term Liabilities

9. Other Long-Term Liabilities

The Company’s other long-term liabilities are summarized as follows:

 

 

 

March 31,

2021

 

 

December 31,

2020

 

Lease obligation, long-term portion (see Note 6)

 

$

1,374,055

 

 

$

1,468,124

 

Conditional economic incentive grants

 

 

250,000

 

 

 

250,000

 

Other

 

 

95,383

 

 

 

110,319

 

Total other long-term liabilities

 

$

1,719,438

 

 

$

1,828,443

 

 

XML 30 R16.htm IDEA: XBRL DOCUMENT v3.21.1
Common Stock
3 Months Ended
Mar. 31, 2021
Text Block [Abstract]  
Common Stock

10. Common Stock

Public Offering

On July 16, 2020, the Company offered and sold (i) 3,369,564 shares of common stock, at a price to the public of $23.00 per share, and (ii) pre-funded warrants of the Company to purchase 1,630,436 shares of common stock at an exercise price equal to $0.0001 per share (the “Pre-Funded Warrants”), at a price to the public of $22.9999 per share of common stock underlying the Pre-Funded Warrants (equal to the public offering price per share of Common Stock, minus the exercise price of each Pre-Funded Warrant). The Pre-Funded Warrants are exercisable at any time, provided that each Pre-Funded Warrant holder will be prohibited from exercising such Pre-Funded Warrants into shares of the Company’s common stock if, as a result of such exercise, the holder, together with its affiliates, would own more than 4.99% of the total number of shares of the Company’s common stock then issued and outstanding, which percentage may change at the holders’ election to any other number less than or equal to 19.99% upon 61 days’ notice to the Company. The gross proceeds of this offering were approximately $132.2 million, which includes the exercise in full of the underwriters’ option to purchase an additional 750,000 shares of common stock, before deducting underwriting discounts and commissions and offering expenses during the third quarter of 2020. The net proceeds of this offering were approximately $124.0 million, after deducting underwriting discounts and commissions and offering expenses payable by the Company.

The Company has assessed the Pre-Funded Warrants for appropriate equity or liability classification and determined that the Pre-Funded Warrants are freestanding instruments that do not meet the definition of a liability pursuant to ASC 480 and do not meet the definition of a derivative pursuant to FASB Accounting Standards Codification Topic 815, Derivatives and Hedging (“ASC 815”). The Pre-Funded Warrants are indexed to the Company’s common stock and meet all other conditions for equity classification under ASC 480 and ASC 815. Accordingly, the Pre-Funded Warrants are classified as equity and are accounted for as a component of additional paid-in capital at the time of issuance. As of March 31, 2021, no Pre-Funded Warrants were exercised.

At-the-Market Offerings

On February 25, 2021, the Company entered into an Equity Distribution Agreement (the “2021 Agreement”) with Piper Sandler & Co., Evercore Group L.L.C., and B. Riley Securities, Inc., serving as sales agents (the “Sales Agents”) with respect to an at-the-market offering program under which the Company may offer and sell, from time to time at its sole discretion, shares of its common stock, par value $0.0001 per share (the “Common Stock”), having an aggregate offering price of up to $125.0 million (the “Shares”) through the Sale Agents (the “2021 Offering”). Any Shares offered and sold in the 2021 Offering will be issued pursuant to the Company’s Registration Statement on Form S-3 filed with the Securities and Exchange Commission (the “SEC”) on December 31, 2020, which was declared effective on January 11, 2021, the prospectus supplement relating to the 2021 Offering filed with the SEC on February 25, 2021 and any applicable additional prospectus supplements related to the 2021 Offering that form a part of the Registration Statement.

As of March 31, 2021, the Company has sold 2,110,800 shares of Common Stock under the 2021 Agreement resulting in approximately $34.2 million in net proceeds, with $89.7 million remaining available to be sold under the 2021 Agreement. As of March 31, 2021, the Company recorded approximately $0.1 million of offering costs which offset the proceeds received from the shares sold through March 31, 2021 and recognized approximately $0.1 million of deferred offering costs which will offset future proceeds received under the 2021 Agreement.

On March 27, 2020, the Company entered into an Equity Distribution Agreement (the “2020 Agreement”) with JMP Securities LLC, serving as placement agent (the “Placement Agent”) with respect to an at-the-market offering program under which the Company may offer and sell, from time to time at its sole discretion, shares of its common stock, par value $0.0001 per share (the “Common Stock”), having an aggregate offering price of up to $50.0 million (the “Shares”) through the Placement Agent (the “2020 Offering”). Any Shares offered and sold in the 2020 Offering were issued pursuant to the Company’s Registration Statement on Form S-3 filed with the SEC on April 4, 2019, which was declared effective on April 12, 2019, the prospectus supplement relating to the 2020 Offering filed with the SEC on March 27, 2020 and any applicable additional prospectus supplements related to the 2020 Offering that form a part of the Registration Statement. The aggregate market value of Shares eligible for sale in the 2020 Offering and under the 2020 Agreement were subject to the limitations of General Instruction I.B.6 of Form S-3, to the extent required under such instruction. The Company offered Shares having an aggregate offering price of $18.9 million pursuant to the prospectus supplement filed with the SEC on March 27, 2020. On June 1, 2020, the Company filed an amendment to the 2020 Agreement which amended the prospectus supplement dated March 27, 2020 to increase the aggregate offering price to $50.0 million. No Shares were sold under the 2020 Agreement during the three months ended March 31, 2020. As of March 31, 2021, the 2020 Agreement was fully utilized and no Shares were sold under the 2020 Agreement during the three months ended March 31, 2021.    

Exchange Agreement

On February 25, 2021, the Company entered into an exchange agreement (the “Exchange Agreement”) with an Investor and its affiliates (the “Exchanging Stockholders”), pursuant to which the Company exchanged an aggregate of 1,000,000 shares of the Company’s common stock, par value $0.0001 per share, owned by the Exchanging Stockholders for pre-funded warrants (the “Exchange Warrants”) to purchase an aggregate of 1,000,000 shares of common stock (subject to adjustment in the event of any stock dividends and splits, reverse stock split, recapitalization, reorganization or similar transaction, as described in the Exchange Warrants), with an exercise price of $0.0001 per share. The Exchange Warrants do not expire and are exercisable at any time except that the Exchange Warrants cannot be exercised by the Exchanging Stockholders if, after giving effect thereto, the Exchanging Stockholders would beneficially own more than 9.99% of the Company’s common stock, subject to certain exceptions. In accordance with FASB Accounting Standards Codification Topic 505, Equity, the Company recorded the retirement of the common stock exchanged as a reduction of common shares outstanding and a corresponding debit to additional paid-in-capital and accumulated deficit at the fair value of the Exchange Warrants on the issuance date. The Exchange Warrants are classified as equity in accordance with ASC 480 and the fair value of the Exchange Warrants was recorded as a credit to additional paid-in-capital is not subject to remeasurement. The Company determined that the fair value of the Exchange Warrants is substantially similar to the fair value of the retired shares on the issuance date due to the negligible exercise price for the Exchange Warrants. As of March 31, 2021, none of the Exchange Warrants have been exercised.

XML 31 R17.htm IDEA: XBRL DOCUMENT v3.21.1
Warrants
3 Months Ended
Mar. 31, 2021
Equity [Abstract]  
Warrants

11. Warrants

A summary of warrant activity during the three months ended March 31, 2021 is as follows:

Warrants outstanding, December 31, 2020

 

 

1,777,611

 

 

Exchanges (see Note 10)

 

 

1,000,000

 

 

Exercises

 

 

(1,420

)

 

Warrants outstanding, March 31, 2021

 

 

2,776,191

 

 

As of March 31, 2021, all of the common stock warrants that were previously classified as a liability were exercised in full.   

XML 32 R18.htm IDEA: XBRL DOCUMENT v3.21.1
Stock-Based Compensation
3 Months Ended
Mar. 31, 2021
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
Stock-Based Compensation

12. Stock-Based Compensation

Stock Options

The Company’s stock option awards generally vest over four years and typically have a contractual life of ten years. At March 31, 2021, there was $10.1 million of unrecognized compensation cost related to stock options, which is expected to be recognized over a weighted-average period of 2.9 years. During the three months ended March 31, 2021, the Company granted 669,000 stock options with a weighted average exercise price of $16.73 and per share weighted average grant date fair value of $13.76.

Information related to stock options outstanding at March 31, 2021 is as follows:

 

 

Number

of Stock

Options

 

 

Weighted-

average

Exercise

Price

 

 

Weighted-

average

Remaining

Contractual

Term

(Years)

 

 

Aggregate

Intrinsic

Value

 

Outstanding

 

 

2,293,367

 

 

$

8.11

 

 

 

6.0

 

 

$

16,651,695

 

Exercisable

 

 

773,781

 

 

$

5.35

 

 

 

5.8

 

 

$

7,855,753

 

Unvested

 

 

1,519,586

 

 

$

9.51

 

 

 

6.0

 

 

$

8,795,942

 

Restricted Stock

At March 31, 2021, the Company had unvested restricted stock of 134,545 shares with total unrecognized compensation expense of $0.5 million, which the Company expects to recognize over a weighted average period of approximately 1.7 years. During the three months ended March 31, 2021, the Company released 20,181 shares of common stock from restriction as a result of the vesting of restricted stock.

In February 2021, the Company granted 181,279 shares of restricted stock units which vest over four years. At March 31, 2021, the Company had unvested restricted stock units of 196,279 shares with total unrecognized compensation expense of $2.8 million, which the Company expects to recognize over a weighted average period of approximately 3.8 years.

2019 Employee Stock Purchase Plan

Under the Employee Stock Purchase Plan, employees purchased 8,733 shares for $0.1 million during the three months ended March 31, 2021. During the three months ended March 31, 2021, the Company recognized compensation expense of $0.1 million.

Stock-based Compensation Expense

Stock-based compensation expense is classified in the unaudited consolidated statements of operations and comprehensive loss for the three months ended March 31, 2021 and 2020 as follows:

 

 

 

For the Three Months Ended

March 31,

 

 

 

2021

 

 

2020

 

Research and development

 

$

321,338

 

 

$

29,000

 

General and administrative

 

 

897,013

 

 

 

185,921

 

Total

 

$

1,218,351

 

 

$

214,921

 

XML 33 R19.htm IDEA: XBRL DOCUMENT v3.21.1
U.S. Government Contracts and Grants
3 Months Ended
Mar. 31, 2021
U S Government Contracts And Grants Disclosures [Abstract]  
U.S. Government Contracts and Grants

13. U.S. Government Contracts and Grants

In June 2020, the Company was awarded $4.7 million from the U.S. Army Medical Research & Development Command (“USAMRDC”) to fund our Phase 1/2 clinical trial of T-COVID. The competitive award was granted by USAMRDC in collaboration with the Medical Technology Enterprise Consortium (“MTEC”), a 501(c)(3) biomedical technology consortium working in partnership with the Department of Defense (“DoD”). Under the contract, MTEC will pay the Company a firm fixed fee based upon the achievement of certain milestones for conduct and completion of a Phase 1/2 study and research and development work on the replication-deficient adenovirus 5 (“RD-Ad5”) vector vaccine platform. For the three months ended March 31, 2021, the Company has recognized approximately $0.5 million of grant revenue under the contract.

In July 2016, the Company signed a five-year contract with BARDA. The contract, as amended, has a total value of up to $133.7 million and is used to fund clinical development of NasoShield. Under the contract, BARDA pays the Company a fixed fee and reimburses certain costs for the research and development of an Ad5-vectored, protective antigen-based intranasal anthrax vaccine through cGMP manufacture and conduct of a Phase 1 clinical trial dose ranging assessment of safety and immunogenicity. The contract consists of an initial base performance period providing approximately $27.8 million in funding for the period July 2016 through June 2021. BARDA has seven options to extend the contract to fund certain continued development and manufacturing activities for the anthrax vaccine, including Phase 2 clinical studies. Each option, if exercised by BARDA, would provide additional funding ranging from approximately $1.1 million to $34.4 million for a three-year period beginning in 2021. For the three months ended March 31, 2021 and 2020, the Company has recognized approximately $0.2 million and $1.6 million, respectively, of grant revenue under the current BARDA contract.

XML 34 R20.htm IDEA: XBRL DOCUMENT v3.21.1
Income Taxes
3 Months Ended
Mar. 31, 2021
Income Tax Disclosure [Abstract]  
Income Taxes

14. Income Taxes

Due to a full valuation allowance, the Company did not record an income tax benefit for the three months ended March 31, 2021.  

With respect to the prior year, on March 27, 2020, President Donald Trump signed into law the Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”). The CARES Act provided both stimulus measures and a number of tax provisions, including: temporary changes regarding the utilization and carry back of net operating losses, temporary changes to the prior and future limitations on interest deductions, technical corrections from prior tax legislation for tax depreciation of qualified improvement property, and certain refundable employee retention credits. As of March 31, 2020, the Company recognized a tax benefit of $3.2 million related to the carry back of losses back to obtain a refund of its 2016 tax liability.

XML 35 R21.htm IDEA: XBRL DOCUMENT v3.21.1
Net Loss Per Share
3 Months Ended
Mar. 31, 2021
Earnings Per Share [Abstract]  
Net Loss Per Share

15. Net Loss Per Share

Because the Company has reported a net loss attributable to common stockholders for all periods presented, basic and diluted net loss per share attributable to common stockholders are the same for all periods presented.

Basic net loss per share attributable to common stockholders is computed by dividing the net loss attributable to common stockholders by the weighted average numbers of shares of common stock outstanding for the period. Basic shares outstanding includes the weighted average effect of the Company’s outstanding pre-funded warrants, the exercise of which requires little or no consideration for the delivery of shares of common stock.

Diluted net loss per share is calculated by adjusting weighted average shares outstanding for the dilutive effect of common stock equivalents outstanding for the period. As such, all unvested restricted stock, common stock warrants, and stock options have been excluded from the computation of diluted weighted average shares outstanding because such securities would have an anti-dilutive impact for all periods presented.

Potential common shares issuable upon conversion, vesting or exercise of unvested restricted stock, common stock warrants, and stock options that are excluded from the computation of diluted weighted-average shares outstanding, as they are anti-dilutive, are as follows:

 

 

 

For the Three Months Ended

March 31,

 

 

 

2021

 

 

2020

 

Common stock warrants

 

 

145,755

 

 

 

10,370,206

 

Common stock options

 

 

2,307,264

 

 

 

1,423,612

 

Restricted stock

 

 

330,824

 

 

 

215,413

 

 

XML 36 R22.htm IDEA: XBRL DOCUMENT v3.21.1
Commitments and Contingencies
3 Months Ended
Mar. 31, 2021
Commitments And Contingencies Disclosure [Abstract]  
Commitments and Contingencies

16. Commitments and Contingencies

Spitfire Acquisition

As disclosed in Note 8, the Company is obligated to make payments of up to $80.0 million upon the achievement of specified worldwide net sales of all products developed using the technology acquired from Spitfire Pharma Inc. within ten years following the approval of a new drug application filed with the FDA.

PER.C6 License Agreement Expansion

On April 2, 2020, the Company entered into Amendment No. 3 to the Second Restated License Agreement (the “Amendment”), by and between the Company and Janssen Vaccines & Prevention B.V. (formerly known as Crucell Holland B.V.) (as amended by Amendment No. 1 to Second Restated License Agreement and Amendment No. 2 to Second Restated License Agreement, together with the Amendment, the “License Agreement”). Pursuant to the Amendment, the field of licenses granted to the Company for the use of the PER.C6 cell line under the License Agreement is expanded to cover COVID-19 caused by SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2), in addition to the existing licenses related to Bacillus anthracis and influenza virus. All capitalized terms not defined herein shall have the meanings assigned to them in the Amendment or the License Agreement, as applicable.

Pursuant to the Amendment, the Company agreed to pay certain additional development-based milestone payments through approval of licensed products by the FDA for the treatment or prevention of COVID-19, up to an aggregate amount of $1.2 million. The Company also agreed to pay royalty payments as a percentage of net sales of products to a royalty stacking reduction and minimum annual royalty payments, until the expiration of the term of the License Agreement, as amended. As of March 31, 2021, no payments were made under the License Agreement.

Lonza Manufacturing Agreement

In March 2021, the Company expanded its manufacturing collaboration with Lonza in connection with the Manufacturing Agreement entered into in November 2020 for the manufacture of AdCOVID. Under the expanded agreement, the Company has committed approximately $23.0 million to Lonza to procure long-lead equipment and construct a dedicated manufacturing suite for clinical and commercial production of AdCOVID. This work is expected to be completed during the fourth quarter of 2021. As of March 31, 2021, the Company capitalized approximately $4.0 million to construction-in-progress related to the equipment purchase and build out of the suite under the expanded agreement.

Summit Biosciences Development and Manufacturing Agreement

In March 2021, the Company entered into a development and manufacturing agreement with Summit Biosciences, Inc. (“Summit”) to manufacture a metered nasal spray presentation of AdCOVID. Under the agreement, the Company has committed approximately $6.7 million to Summit for the clinical manufacturing of AdCOVID multidose nasal spray. This work is expected to be completed by the end of 2021. As of March 31, 2021, the Company recorded approximately $1.4 million to prepaid expenses under the agreement.

Litigation

In December 2019, a complaint was filed by Dr. De-Chu Christopher Tang (“Plaintiff”) against the Company, which the Company removed to the United States District Court for the Eastern District of Texas. The Plaintiff amended the complaint in February 2020 to include Vipin K. Garg and David J. Drutz as defendants, in addition to the Company (Dr. Garg, Dr. Drutz, and the Company are collectively referred to as “Defendants”). On November 6, 2020, Defendants filed a motion for summary judgment on the basis of lack of personal jurisdiction, insufficient service of process, and failure to state a claim. The court ruled on that motion on March 25, 2021, which dismissed the case on the basis of lack of personal jurisdiction. As the outcome of this legal proceeding is certain at this time, the Company has not accrued any liability associated with this action.

The Company is a party in various other contractual disputes, litigation, and potential claims arising in the ordinary course of business none of which are currently reasonably possible or probable of material loss.

XML 37 R23.htm IDEA: XBRL DOCUMENT v3.21.1
Summary of Significant Accounting Policies (Policies)
3 Months Ended
Mar. 31, 2021
Accounting Policies [Abstract]  
Use of Estimates

Use of Estimates

The preparation of these financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. The extent to which the COVID-19 pandemic may directly or indirectly impact the Company’s business, financial condition, and results of operations is highly uncertain and subject to change. The Company considered the potential impact of the COVID-19 pandemic on the Company’s estimates and assumptions and determined that there was not a material impact to the Company’s unaudited consolidated financial statements as of and for the three months ended March 31, 2021. However, actual results could differ from those estimates and there may be changes to the Company’s estimates in future periods.

New Accounting Pronouncements - Adopted

Recently Issued Accounting Pronouncements - Adopted

In December 2019, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2019-12, Income Taxes (Topic 740), Simplifying the Accounting for Income Taxes (“ASU No. 2019-12”). ASU 2019-12 amends the approaches and methodologies in accounting for income taxes during interim periods and makes changes to certain income tax classifications. The new standard allows exceptions to the use of the incremental approach for intra-period tax allocation, when there is a loss from continuing operations and income or a gain from other items, and to the general methodology for calculating income taxes in an interim period, when a year-to-date loss exceeds the anticipated loss for the year. The standard also requires franchise or similar taxes partially based on income to be reported as income tax and the effects of enacted changes in tax laws or rates to be included in the annual effective tax rate computation from the date of enactment. Lastly, in any future acquisition, the Company would be required to evaluate when the step-up in the tax basis of goodwill is part of the business combination and when it should be considered a separate transaction. The Company adopted the standard as of January 1, 2021 and has evaluated the effects of this standard and determined that the adoption did not have a material impact on the Company’s consolidated financial statements.

XML 38 R24.htm IDEA: XBRL DOCUMENT v3.21.1
Fair Value Measurements (Tables)
3 Months Ended
Mar. 31, 2021
Fair Value Disclosures [Abstract]  
Schedule of Fair Value Assets and Liabilities Measured on Recurring Basis

The Company’s assets and liabilities measured at fair value on a recurring basis at March 31, 2021 consisted of the following:

 

 

Fair Value Measurement at March 31, 2021

 

 

 

Total

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

Assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash equivalents - money market funds

 

$

13,962,902

 

 

$

13,962,902

 

 

$

 

 

$

 

Short-term investments

 

 

76,574,768

 

 

 

 

 

 

76,574,768

 

 

 

 

Total

 

 

90,537,670

 

 

 

13,962,902

 

 

 

76,574,768

 

 

 

 

Liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Contingent consideration liability (see Note 8)

 

 

6,270,000

 

 

 

 

 

 

 

 

 

6,270,000

 

Total

 

$

6,270,000

 

 

$

 

 

$

 

 

$

6,270,000

 

 

The Company’s assets and liabilities measured at fair value on a recurring basis at December 31, 2020 consisted of the following:

 

 

 

Fair Value Measurement at December 31, 2020

 

 

 

Total

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

Assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash equivalents - money market funds

 

$

90,389,473

 

 

$

90,389,473

 

 

$

 

 

$

 

Short-term investments

 

 

100,005,558

 

 

 

 

 

 

100,005,558

 

 

 

 

Total

 

 

190,395,031

 

 

 

90,389,473

 

 

 

100,005,558

 

 

 

 

Liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Contingent consideration liability (see Note 8)

 

 

5,390,000

 

 

 

 

 

 

 

 

 

5,390,000

 

Warrant liability

 

 

10,000

 

 

 

 

 

 

 

 

 

10,000

 

Total

 

$

5,400,000

 

 

$

 

 

$

 

 

$

5,400,000

 

Schedule of Short Term Investments Short-term investments had quoted prices at March 31, 2021 as shown below:

 

 

 

March 31, 2021

 

 

 

Amortized Cost

 

 

Unrealized Gain (Loss)

 

 

Market Value

 

United States treasury securities

 

$

16,029,965

 

 

$

2,995

 

 

$

16,032,960

 

Commercial paper and corporate debt securities

 

 

33,412,043

 

 

 

(1,935

)

 

 

33,410,108

 

Asset backed securities

 

 

2,111,239

 

 

 

(278

)

 

 

2,110,961

 

Certificate of deposit

 

 

25,020,739

 

 

 

 

 

 

25,020,739

 

Total

 

$

76,573,986

 

 

$

782

 

 

$

76,574,768

 

 

Short-term investments had quoted prices at December 31, 2020 as shown below:

 

 

December 31, 2020

 

 

 

Amortized Cost

 

 

Unrealized Gain (Loss)

 

 

Market Value

 

United States treasury securities

 

$

20,052,757

 

 

$

1,843

 

 

$

20,054,600

 

Commercial paper and corporate debt securities

 

 

47,521,344

 

 

 

(5,440

)

 

 

47,515,904

 

Asset backed securities

 

 

7,414,619

 

 

 

(757

)

 

 

7,413,862

 

Certificate of deposit

 

 

25,021,192

 

 

 

 

 

 

25,021,192

 

Total

 

$

100,009,912

 

 

$

(4,354

)

 

$

100,005,558

 

 

Summary of Assumptions Used to Estimate Fair Value of Contingent Payments

The assumptions used to estimate the fair value of contingent payments that are classified as a liability at March 31, 2021 include the following significant unobservable inputs:

 

Unobservable input

 

Value or Range

 

 

Weighted Average

 

Expected volatility

 

117.4%

 

 

117.4%

 

Risk-free interest rate

 

0.09%

 

 

0.09%

 

Cost of capital

 

30%

 

 

30%

 

Discount for lack of marketability

 

16%-19%

 

 

18%

 

Probability of payment

 

63%

 

 

63%

 

Projected year of payment

 

2022

 

 

2022

 

XML 39 R25.htm IDEA: XBRL DOCUMENT v3.21.1
Property and Equipment, Net (Tables)
3 Months Ended
Mar. 31, 2021
Property Plant And Equipment [Abstract]  
Summary of Property and Equipment, Net

 

 

 

March 31, 2021

 

 

December 31, 2020

 

Furniture, fixtures and equipment

 

$

185,878

 

 

$

125,538

 

Laboratory equipment

 

 

1,041,752

 

 

 

959,585

 

Computers and telecommunications

 

 

250,516

 

 

 

220,316

 

Software

 

 

64,409

 

 

 

64,409

 

Leasehold improvements

 

 

1,415,608

 

 

 

1,285,883

 

Construction-in-progress

 

 

4,000,000

 

 

 

 

Property and equipment, at cost

 

 

6,958,163

 

 

 

2,655,731

 

Less: accumulated depreciation and amortization

 

 

(1,760,111

)

 

 

(1,598,811

)

Property and equipment, net

 

$

5,198,052

 

 

$

1,056,920

 

XML 40 R26.htm IDEA: XBRL DOCUMENT v3.21.1
Intangible Assets (Tables)
3 Months Ended
Mar. 31, 2021
Goodwill And Intangible Assets Disclosure [Abstract]  
Schedule of Intangible Assets

The Company’s intangible assets consisted of the following:

 

 

 

March 31, 2021

 

 

 

Estimated

Useful Lives

 

Gross

Carrying

Value

 

 

Accumulated

Amortization

 

 

Net Book

Value

 

Internally developed patents

 

6-20 years

 

$

946,828

 

 

$

(486,548

)

 

$

460,280

 

Acquired licenses

 

16-20 years

 

 

285,000

 

 

 

(285,000

)

 

 

 

Total intangible assets subject to amortization

 

 

 

 

1,231,828

 

 

 

(771,548

)

 

 

460,280

 

IPR&D assets

 

Indefinite

 

 

12,418,967

 

 

 

 

 

 

12,418,967

 

Total

 

 

 

$

13,650,795

 

 

$

(771,548

)

 

$

12,879,247

 

 

 

 

December 31, 2020

 

 

 

Estimated

Useful Lives

 

Gross

Carrying

Value

 

 

Accumulated

Amortization

 

 

Net Book

Value

 

Internally developed patents

 

6-10 years

 

$

884,787

 

 

$

(479,908

)

 

$

404,879

 

Acquired licenses

 

16-20 years

 

 

285,000

 

 

 

(285,000

)

 

 

 

Total intangible assets subject to amortization

 

 

 

 

1,169,787

 

 

 

(764,908

)

 

 

404,879

 

IPR&D assets

 

Indefinite

 

 

12,418,967

 

 

 

 

 

 

12,418,967

 

Total

 

 

 

$

13,588,754

 

 

$

(764,908

)

 

$

12,823,846

 

XML 41 R27.htm IDEA: XBRL DOCUMENT v3.21.1
Operating Leases (Tables)
3 Months Ended
Mar. 31, 2021
Leases [Abstract]  
Summary of Supplemental other Information Related to Operating Leases Balance Sheet

Supplemental other information related to the operating leases balance sheet information was as follows:

 

 

 

March 31, 2021

 

 

December 31, 2020

 

Operating lease obligations (see Note 7 and 9)

 

$

1,739,559

 

 

$

1,824,840

 

Operating lease right-of-use assets

 

$

866,336

 

 

$

903,825

 

Weighted-average remaining lease term (years)

 

 

4.1

 

 

 

4.3

 

Weighted-average discount rate

 

 

7.3

%

 

 

7.3

%

XML 42 R28.htm IDEA: XBRL DOCUMENT v3.21.1
Accrued Expenses (Tables)
3 Months Ended
Mar. 31, 2021
Payables And Accruals [Abstract]  
Schedule of Accrued Expenses and Other Current Liabilities

Accrued expenses and other current liabilities consist of the following:

 

 

 

March 31, 2021

 

 

December 31, 2020

 

Accrued professional services

 

$

612,212

 

 

$

1,350,194

 

Accrued payroll and employee benefits

 

 

1,182,658

 

 

 

2,351,599

 

Accrued interest

 

 

13,744

 

 

 

13,016

 

Accrued research and development

 

 

7,211,778

 

 

 

7,316,876

 

Lease obligation, current portion (see Note 6)

 

 

365,504

 

 

 

356,716

 

Deferred revenue

 

 

19,753

 

 

 

19,753

 

Total accrued expenses

 

$

9,405,649

 

 

$

11,408,154

 

 

XML 43 R29.htm IDEA: XBRL DOCUMENT v3.21.1
Contingent Consideration (Tables)
3 Months Ended
Mar. 31, 2021
Business Combinations [Abstract]  
Summary of Fair Value of Contingent Consideration Below is a summary of the contingent consideration activity:

 

 

Three Months Ended March 31,

 

 

 

2021

 

 

2020

 

Beginning balance

 

$

5,390,000

 

 

$

2,750,000

 

Change in fair value

 

 

880,000

 

 

 

1,750,000

 

Ending balance

 

$

6,270,000

 

 

$

4,500,000

 

 

XML 44 R30.htm IDEA: XBRL DOCUMENT v3.21.1
Other Long-Term Liabilities (Tables)
3 Months Ended
Mar. 31, 2021
Other Liabilities Disclosure [Abstract]  
Summary of Other Long-Term Liabilities

The Company’s other long-term liabilities are summarized as follows:

 

 

 

March 31,

2021

 

 

December 31,

2020

 

Lease obligation, long-term portion (see Note 6)

 

$

1,374,055

 

 

$

1,468,124

 

Conditional economic incentive grants

 

 

250,000

 

 

 

250,000

 

Other

 

 

95,383

 

 

 

110,319

 

Total other long-term liabilities

 

$

1,719,438

 

 

$

1,828,443

 

XML 45 R31.htm IDEA: XBRL DOCUMENT v3.21.1
Warrants (Tables)
3 Months Ended
Mar. 31, 2021
Equity [Abstract]  
Summary of Warrant Activity

A summary of warrant activity during the three months ended March 31, 2021 is as follows:

Warrants outstanding, December 31, 2020

 

 

1,777,611

 

 

Exchanges (see Note 10)

 

 

1,000,000

 

 

Exercises

 

 

(1,420

)

 

Warrants outstanding, March 31, 2021

 

 

2,776,191

 

 

XML 46 R32.htm IDEA: XBRL DOCUMENT v3.21.1
Stock-Based Compensation (Tables)
3 Months Ended
Mar. 31, 2021
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
Schedule of Information Related to Stock Options Outstanding

Information related to stock options outstanding at March 31, 2021 is as follows:

 

 

Number

of Stock

Options

 

 

Weighted-

average

Exercise

Price

 

 

Weighted-

average

Remaining

Contractual

Term

(Years)

 

 

Aggregate

Intrinsic

Value

 

Outstanding

 

 

2,293,367

 

 

$

8.11

 

 

 

6.0

 

 

$

16,651,695

 

Exercisable

 

 

773,781

 

 

$

5.35

 

 

 

5.8

 

 

$

7,855,753

 

Unvested

 

 

1,519,586

 

 

$

9.51

 

 

 

6.0

 

 

$

8,795,942

 

Schedule of Stock-based Compensation Expense

Stock-based compensation expense is classified in the unaudited consolidated statements of operations and comprehensive loss for the three months ended March 31, 2021 and 2020 as follows:

 

 

 

For the Three Months Ended

March 31,

 

 

 

2021

 

 

2020

 

Research and development

 

$

321,338

 

 

$

29,000

 

General and administrative

 

 

897,013

 

 

 

185,921

 

Total

 

$

1,218,351

 

 

$

214,921

 

XML 47 R33.htm IDEA: XBRL DOCUMENT v3.21.1
Net Loss Per Share (Tables)
3 Months Ended
Mar. 31, 2021
Earnings Per Share [Abstract]  
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share

Potential common shares issuable upon conversion, vesting or exercise of unvested restricted stock, common stock warrants, and stock options that are excluded from the computation of diluted weighted-average shares outstanding, as they are anti-dilutive, are as follows:

 

 

 

For the Three Months Ended

March 31,

 

 

 

2021

 

 

2020

 

Common stock warrants

 

 

145,755

 

 

 

10,370,206

 

Common stock options

 

 

2,307,264

 

 

 

1,423,612

 

Restricted stock

 

 

330,824

 

 

 

215,413

 

XML 48 R34.htm IDEA: XBRL DOCUMENT v3.21.1
Fair Value Measurements - Schedule of Fair Value Assets and Liabilities Measured on Recurring Basis (Detail) - USD ($)
Mar. 31, 2021
Dec. 31, 2020
Mar. 31, 2020
Dec. 31, 2019
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]        
Short-term investments $ 76,574,768 $ 100,005,558    
Contingent consideration liability (see Note 8) 6,270,000 5,390,000 $ 4,500,000 $ 2,750,000
Fair Value, Measurements, Recurring [Member]        
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]        
Short-term investments 76,574,768 100,005,558    
Total 90,537,670 190,395,031    
Contingent consideration liability (see Note 8) 6,270,000 5,390,000    
Total 6,270,000 5,400,000    
Warrant liability   10,000    
Fair Value, Measurements, Recurring [Member] | Level 1 [Member]        
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]        
Total 13,962,902 90,389,473    
Fair Value, Measurements, Recurring [Member] | Level 2 [Member]        
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]        
Short-term investments 76,574,768 100,005,558    
Total 76,574,768 100,005,558    
Fair Value, Measurements, Recurring [Member] | Level 3 [Member]        
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]        
Contingent consideration liability (see Note 8) 6,270,000 5,390,000    
Total 6,270,000 5,400,000    
Warrant liability   10,000    
Money Market Funds [Member] | Fair Value, Measurements, Recurring [Member]        
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]        
Cash equivalents 13,962,902 90,389,473    
Money Market Funds [Member] | Fair Value, Measurements, Recurring [Member] | Level 1 [Member]        
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]        
Cash equivalents $ 13,962,902 $ 90,389,473    
XML 49 R35.htm IDEA: XBRL DOCUMENT v3.21.1
Fair Value Measurements - Schedule of Short Term Investments (Detail) - USD ($)
Mar. 31, 2021
Dec. 31, 2020
Schedule Of Available For Sale Securities [Line Items]    
Amortized Cost $ 76,573,986 $ 100,009,912
Unrealized Gain (Loss) 782 (4,354)
Market Value 76,574,768 100,005,558
United States Treasury Securities [Member]    
Schedule Of Available For Sale Securities [Line Items]    
Amortized Cost 16,029,965 20,052,757
Unrealized Gain (Loss) 2,995 1,843
Market Value 16,032,960 20,054,600
Commercial Paper and Corporate Debt Securities [Member]    
Schedule Of Available For Sale Securities [Line Items]    
Amortized Cost 33,412,043 47,521,344
Unrealized Gain (Loss) (1,935) (5,440)
Market Value 33,410,108 47,515,904
Asset Backed Securities [Member]    
Schedule Of Available For Sale Securities [Line Items]    
Amortized Cost 2,111,239 7,414,619
Unrealized Gain (Loss) (278) (757)
Market Value 2,110,961 7,413,862
Certificates Of Deposit [Member]    
Schedule Of Available For Sale Securities [Line Items]    
Amortized Cost 25,020,739 25,021,192
Market Value $ 25,020,739 $ 25,021,192
XML 50 R36.htm IDEA: XBRL DOCUMENT v3.21.1
Fair Value Measurements - Summary of Assumptions Used to Estimate Fair Value of Contingent Payments (Detail) - Level 3 [Member]
3 Months Ended
Mar. 31, 2021
Expected Volatility [Member]  
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]  
Assumptions used to estimate fair value of contingent payments 117.4
Risk-free Interest Rate [Member]  
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]  
Assumptions used to estimate fair value of contingent payments 0.09
Cost of Capital [Member]  
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]  
Assumptions used to estimate fair value of contingent payments 30
Probability of Payment [Member]  
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]  
Assumptions used to estimate fair value of contingent payments 63
Minimum [Member] | Discount for Lack of Marketability [Member]  
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]  
Assumptions used to estimate fair value of contingent payments 16
Minimum [Member] | Projected Year of Payment [Member]  
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]  
Assumptions used to estimate fair value of contingent payments 2022
Maximum [Member] | Discount for Lack of Marketability [Member]  
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]  
Assumptions used to estimate fair value of contingent payments 19
Maximum [Member] | Projected Year of Payment [Member]  
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]  
Assumptions used to estimate fair value of contingent payments 2022
Weighted Average [Member] | Expected Volatility [Member]  
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]  
Assumptions used to estimate fair value of contingent payments 117.4
Weighted Average [Member] | Risk-free Interest Rate [Member]  
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]  
Assumptions used to estimate fair value of contingent payments 0.09
Weighted Average [Member] | Cost of Capital [Member]  
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]  
Assumptions used to estimate fair value of contingent payments 30
Weighted Average [Member] | Discount for Lack of Marketability [Member]  
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]  
Assumptions used to estimate fair value of contingent payments 18
Weighted Average [Member] | Probability of Payment [Member]  
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]  
Assumptions used to estimate fair value of contingent payments 63
Weighted Average [Member] | Projected Year of Payment [Member]  
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]  
Assumptions used to estimate fair value of contingent payments 2022
XML 51 R37.htm IDEA: XBRL DOCUMENT v3.21.1
Fair Value Measurements - Additional Information (Detail) - USD ($)
Mar. 31, 2021
Dec. 31, 2020
Fair Value Disclosures [Abstract]    
Fair value transfers, Level 1 to Level 2 assets $ 0 $ 0
Fair value transfers, Level 2 to Level 1 assets 0 0
Fair value transfers, Level 1 to Level 2 liabilities 0 0
Fair value transfers, Level 2 to Level 1 liabilities 0 0
Assets or liabilities measured at fair value on a non-recurring basis. $ 0 $ 0
XML 52 R38.htm IDEA: XBRL DOCUMENT v3.21.1
Property and Equipment, Net - Summary of Property and Equipment, Net (Detail) - USD ($)
Mar. 31, 2021
Dec. 31, 2020
Property Plant And Equipment [Line Items]    
Property and equipment, at cost $ 6,958,163 $ 2,655,731
Less: accumulated depreciation and amortization (1,760,111) (1,598,811)
Property and equipment, net 5,198,052 1,056,920
Furniture, Fixtures and Equipment [Member]    
Property Plant And Equipment [Line Items]    
Property and equipment, at cost 185,878 125,538
Laboratory Equipment [Member]    
Property Plant And Equipment [Line Items]    
Property and equipment, at cost 1,041,752 959,585
Computers and Telecommunications [Member]    
Property Plant And Equipment [Line Items]    
Property and equipment, at cost 250,516 220,316
Software [Member]    
Property Plant And Equipment [Line Items]    
Property and equipment, at cost 64,409 64,409
Leasehold Improvements    
Property Plant And Equipment [Line Items]    
Property and equipment, at cost 1,415,608 $ 1,285,883
Construction-In-Progress [Member]    
Property Plant And Equipment [Line Items]    
Property and equipment, at cost $ 4,000,000  
XML 53 R39.htm IDEA: XBRL DOCUMENT v3.21.1
Property and Equipment, Net - Additional Information (Detail) - USD ($)
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Property Plant And Equipment [Abstract]    
Depreciation $ 67,658 $ 59,505
XML 54 R40.htm IDEA: XBRL DOCUMENT v3.21.1
Intangible Assets - Schedule of Intangible Assets (Detail) - USD ($)
3 Months Ended 12 Months Ended
Mar. 31, 2021
Dec. 31, 2020
Schedule Of Intangible Assets [Line Items]    
Intangible assets subject to amortization, Gross Carrying Value $ 1,231,828 $ 1,169,787
Intangible assets subject to amortization, Accumulated Amortization (771,548) (764,908)
Intangible assets subject to amortization, Net Book Value 460,280 404,879
Total intangible assets, Gross Carrying Value 13,650,795 13,588,754
Total intangible assets, Net Book Value 12,879,247 12,823,846
IPR&D [Member]    
Schedule Of Intangible Assets [Line Items]    
Total intangible assets, Gross Carrying Value 12,418,967 12,418,967
Total intangible assets, Net Book Value 12,418,967 12,418,967
Internally Developed Patents [Member]    
Schedule Of Intangible Assets [Line Items]    
Intangible assets subject to amortization, Gross Carrying Value 946,828 884,787
Intangible assets subject to amortization, Accumulated Amortization (486,548) (479,908)
Intangible assets subject to amortization, Net Book Value $ 460,280 $ 404,879
Internally Developed Patents [Member] | Minimum [Member]    
Schedule Of Intangible Assets [Line Items]    
Estimated Useful Lives 6 years 6 years
Internally Developed Patents [Member] | Maximum [Member]    
Schedule Of Intangible Assets [Line Items]    
Estimated Useful Lives 20 years 10 years
Acquired Licenses [Member]    
Schedule Of Intangible Assets [Line Items]    
Intangible assets subject to amortization, Gross Carrying Value $ 285,000 $ 285,000
Intangible assets subject to amortization, Accumulated Amortization $ (285,000) $ (285,000)
Acquired Licenses [Member] | Minimum [Member]    
Schedule Of Intangible Assets [Line Items]    
Estimated Useful Lives 16 years 16 years
Acquired Licenses [Member] | Maximum [Member]    
Schedule Of Intangible Assets [Line Items]    
Estimated Useful Lives 20 years 20 years
XML 55 R41.htm IDEA: XBRL DOCUMENT v3.21.1
Intangible Assets - Additional Information (Detail) - USD ($)
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Schedule Of Intangible Assets [Line Items]    
Weighted average amortization period remaining for intangible assets 12 years 3 months 18 days  
Research and Development [Member]    
Schedule Of Intangible Assets [Line Items]    
Amortization expense of intangible assets $ 6,640 $ 13,851
XML 56 R42.htm IDEA: XBRL DOCUMENT v3.21.1
Operating Leases - Additional Information (Detail) - USD ($)
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Leases [Abstract]    
Non-cancellable lease maturity period 2022-12  
Operating lease rent expense $ 130,138 $ 87,599
Cash paid for operating lease liabilities $ 117,354 $ 95,714
XML 57 R43.htm IDEA: XBRL DOCUMENT v3.21.1
Operating Leases - Summary of Supplemental other Information Related to Operating Leases Balance Sheet (Detail) - USD ($)
Mar. 31, 2021
Dec. 31, 2020
Leases [Abstract]    
Operating lease obligations (see Note 7 and 9) $ 1,739,559 $ 1,824,840
Operating lease right-of-use assets $ 866,336 $ 903,825
Weighted-average remaining lease term (years) 4 years 1 month 6 days 4 years 3 months 18 days
Weighted-average discount rate 7.30% 7.30%
XML 58 R44.htm IDEA: XBRL DOCUMENT v3.21.1
Accrued Expenses - Schedule of Accrued Expenses and Other Current Liabilities (Detail) - USD ($)
Mar. 31, 2021
Dec. 31, 2020
Accrued Liabilities And Other Liabilities [Abstract]    
Accrued professional services $ 612,212 $ 1,350,194
Accrued payroll and employee benefits 1,182,658 2,351,599
Accrued interest 13,744 13,016
Accrued research and development 7,211,778 7,316,876
Lease obligation, current portion (see Note 6) 365,504 356,716
Deferred revenue 19,753 19,753
Total accrued expenses $ 9,405,649 $ 11,408,154
XML 59 R45.htm IDEA: XBRL DOCUMENT v3.21.1
Contingent Consideration - Additional Information (Detail) - USD ($)
Jul. 12, 2019
Mar. 31, 2021
Dec. 31, 2020
Mar. 31, 2020
Dec. 31, 2019
Business Acquisition [Line Items]          
Estimated future contingent consideration   $ 6,270,000 $ 5,390,000 $ 4,500,000 $ 2,750,000
Spitfire Pharma, Inc. [Member]          
Business Acquisition [Line Items]          
Agreement date Jul. 08, 2019        
Unregistered shares of common stock 1,887,250        
Up-front consideration $ 5,000,000        
Spitfire Pharma, Inc. [Member] | Investigational New Drug Application Milestone [Member]          
Business Acquisition [Line Items]          
Estimated future contingent consideration $ 5,000,000        
Estimated future contingent consideration term 60 days        
Number of consecutive trading days 20 days        
Consideration amount $ 2.95        
Spitfire Pharma, Inc. [Member] | Investigational New Drug Application and Regulatory Milestones [Member]          
Business Acquisition [Line Items]          
Estimated future contingent consideration $ 3,000,000        
Estimated future contingent consideration term 60 days        
Number of consecutive trading days 20 days        
Consideration amount $ 3.54        
Spitfire Pharma, Inc. [Member] | Sales Milestones [Member]          
Business Acquisition [Line Items]          
Estimated future contingent consideration $ 80,000,000        
License agreement term 10 years        
Spitfire Pharma, Inc. [Member] | Regulatory Milestones [Member]          
Business Acquisition [Line Items]          
Upfront consideration release at 3 months 50.00%        
Upfront consideration release at 9 months 50.00%        
Spitfire Pharma, Inc. [Member] | Common Stock [Member] | Maximum [Member]          
Business Acquisition [Line Items]          
Estimated future contingent consideration $ 88,000,000        
XML 60 R46.htm IDEA: XBRL DOCUMENT v3.21.1
Contingent Consideration - Summary of Fair Value of Contingent Consideration (Detail) - USD ($)
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Business Combinations [Abstract]    
Beginning balance $ 5,390,000 $ 2,750,000
Change in fair value of contingent consideration liability 880,000 1,750,000
Ending balance $ 6,270,000 $ 4,500,000
XML 61 R47.htm IDEA: XBRL DOCUMENT v3.21.1
Other Long-Term Liabilities - Summary of Other Long-Term Liabilities (Detail) - USD ($)
Mar. 31, 2021
Dec. 31, 2020
Other Liabilities Disclosure [Abstract]    
Lease obligation, long-term portion (see Note 6) $ 1,374,055 $ 1,468,124
Conditional economic incentive grants 250,000 250,000
Other 95,383 110,319
Total other long-term liabilities $ 1,719,438 $ 1,828,443
XML 62 R48.htm IDEA: XBRL DOCUMENT v3.21.1
Common Stock - Additional Information (Detail) - USD ($)
3 Months Ended
Feb. 25, 2021
Jul. 16, 2020
Mar. 27, 2020
Mar. 31, 2021
Dec. 31, 2020
Changes In Equity And Comprehensive Income Line Items [Line Items]          
Proceeds from issuance of common stock in public offering, net       $ 34,178,231  
Common stock, par or stated value per share       $ 0.0001 $ 0.0001
Pre-Funded Warrants [Member]          
Changes In Equity And Comprehensive Income Line Items [Line Items]          
Number of securities called by warrants or rights       0  
Exchange Warrants [Member]          
Changes In Equity And Comprehensive Income Line Items [Line Items]          
Number of securities called by warrants or rights 1,000,000        
Exercise price of warrants or rights $ 0.0001        
Common stock, par or stated value per share $ 0.0001        
Common stock exchanged for pre-funded warrants 1,000,000        
Number of warrants exercised       0  
Ownership percentage 9.99%        
Public Offering [Member]          
Changes In Equity And Comprehensive Income Line Items [Line Items]          
Gross proceeds from offering including exercise of underwriter's option   $ 132,200,000      
Public Offering [Member] | Pre-Funded Warrants [Member]          
Changes In Equity And Comprehensive Income Line Items [Line Items]          
Exercise price of warrants or rights   $ 0.0001      
Purchase price of warrants issued   $ 22.9999      
Ownership percentage on exercise of warrants without notice, minimum   4.99%      
Ownership percentage on exercise of warrants with notice, maximum   19.99%      
Notice period to increase ownership percentage on exercise of warrants   61 days      
Public Offering [Member] | Common Stock [Member]          
Changes In Equity And Comprehensive Income Line Items [Line Items]          
Shares of common stock sold   3,369,564      
Public offering price, per share   $ 23.00      
Public Offering [Member] | Common Stock [Member] | Pre-Funded Warrants [Member]          
Changes In Equity And Comprehensive Income Line Items [Line Items]          
Number of securities called by warrants or rights   1,630,436      
Over-Allotment Option [Member] | Common Stock [Member]          
Changes In Equity And Comprehensive Income Line Items [Line Items]          
Shares of common stock sold   750,000      
Proceeds from issuance of common stock in public offering, net   $ 124,000,000      
At-The-Market Offering [Member] | Equity Distribution Agreement [Member] | Piper Sandler company and evercore group limited liability company and B Riley Securities inc [Member]          
Changes In Equity And Comprehensive Income Line Items [Line Items]          
Shares of common stock sold       2,110,800  
Proceeds from issuance of common stock in public offering, net       $ 34,200,000  
Common stock, par or stated value per share $ 0.0001        
Aggregate offering price $ 125,000,000        
Common stock available to be sold       89,700,000  
Deferred offering costs       100,000  
Issuance costs       $ 100,000  
At-The-Market Offering [Member] | Equity Distribution Agreement [Member] | JMP Securities LLC [Member]          
Changes In Equity And Comprehensive Income Line Items [Line Items]          
Common stock, par or stated value per share     $ 0.0001    
Aggregate offering price     $ 18,900,000    
At-The-Market Offering [Member] | Equity Distribution Agreement [Member] | JMP Securities LLC [Member] | Maximum [Member]          
Changes In Equity And Comprehensive Income Line Items [Line Items]          
Aggregate offering price     $ 50,000,000    
XML 63 R49.htm IDEA: XBRL DOCUMENT v3.21.1
Warrants - Summary of Warrant Activity (Detail)
3 Months Ended
Mar. 31, 2021
shares
Equity [Abstract]  
Warrants outstanding, December 31, 2020 1,777,611
Exchanges (see Note 10) 1,000,000
Exercises (1,420)
Warrants outstanding, March 31, 2021 2,776,191
XML 64 R50.htm IDEA: XBRL DOCUMENT v3.21.1
Stock-Based Compensation - Additional Information (Detail) - USD ($)
3 Months Ended
Feb. 25, 2021
Mar. 31, 2021
Mar. 31, 2020
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]      
Employees purchased, value   $ 106,001 $ 56,739
Stock-based compensation expense   $ 1,218,351 $ 214,921
2019 Employee Stock Purchase Plan [Member]      
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]      
Employees purchased, shares   8,733  
Employees purchased, value   $ 100,000  
Stock-based compensation expense   $ 100,000  
Stock Options [Member]      
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]      
Vesting Period   4 years  
Stock option expiration Period   10 years  
Unrecognized compensation cost, stock options   $ 10,100,000  
Unrecognized stock-based compensation expense, period for recognition   2 years 10 months 24 days  
Number of Stock Options, Granted   669,000  
Stock options granted, weighted-average exercise price   $ 16.73  
Weighted-average grant date fair value of stock options granted   $ 13.76  
Restricted Stock [Member]      
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]      
Unrecognized stock-based compensation expense, period for recognition   1 year 8 months 12 days  
Unvested restricted stock, shares   134,545  
Unrecognized compensation expense   $ 500,000  
Common stock issued as result of vesting of restricted stock   20,181  
Restricted Stock Units [Member]      
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]      
Vesting Period 4 years    
Unrecognized stock-based compensation expense, period for recognition   3 years 9 months 18 days  
Unvested restricted stock, shares   196,279  
Unrecognized compensation expense   $ 2,800,000  
Shares granted 181,279    
XML 65 R51.htm IDEA: XBRL DOCUMENT v3.21.1
Stock-Based Compensation - Schedule of Information Related to Stock Options Outstanding (Detail)
3 Months Ended
Mar. 31, 2021
USD ($)
$ / shares
shares
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
Number of Stock Options, Outstanding | shares 2,293,367
Number of Stock Options, Exercisable | shares 773,781
Number of Stock Options, Unvested | shares 1,519,586
Weighted-average Exercise Price, Outstanding | $ / shares $ 8.11
Weighted-average Exercise Price, Exercisable | $ / shares 5.35
Weighted-average Exercise Price, Unvested | $ / shares $ 9.51
Weighted-average Remaining Contractual Term, Outstanding 6 years
Weighted-average Remaining Contractual Term, Exercisable 5 years 9 months 18 days
Weighted-average Remaining Contractual Term, Unvested 6 years
Aggregate Intrinsic Value, Outstanding | $ $ 16,651,695
Aggregate Intrinsic Value, Exercisable | $ 7,855,753
Aggregate Intrinsic Value, Unvested | $ $ 8,795,942
XML 66 R52.htm IDEA: XBRL DOCUMENT v3.21.1
Stock-Based Compensation - Schedule of Stock-based Compensation Expense (Detail) - USD ($)
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]    
Stock based compensation expense $ 1,218,351 $ 214,921
Research and Development [Member]    
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]    
Stock based compensation expense 321,338 29,000
General and Administrative [Member]    
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]    
Stock based compensation expense $ 897,013 $ 185,921
XML 67 R53.htm IDEA: XBRL DOCUMENT v3.21.1
U.S. Government Contracts and Grants - Additional Information (Detail) - USD ($)
1 Months Ended 3 Months Ended
Jan. 01, 2021
Jul. 31, 2016
Jun. 30, 2020
Mar. 31, 2021
Mar. 31, 2020
Revenues       $ 837,516 $ 2,212,694
BARDA Contract [Member]          
Duration of contract 3 years 5 years      
Amount used to fund clinical development   $ 133,700,000      
BARDA Contract [Member] | Minimum [Member]          
Additional funding for development and manufacturing activities $ 1,100,000        
BARDA Contract [Member] | Maximum [Member]          
Additional funding for development and manufacturing activities $ 34,400,000        
Collaborative Arrangement [Member]          
Revenues     $ 4,700,000    
Grant [Member] | BARDA Contract [Member]          
Revenues       200,000 $ 1,600,000
Grant [Member] | Collaborative Arrangement [Member]          
Revenues       $ 500,000  
Investment Performance [Member] | BARDA Contract [Member]          
Revenues   $ 27,800,000      
XML 68 R54.htm IDEA: XBRL DOCUMENT v3.21.1
Income Taxes - Additional Information (Detail) - USD ($)
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Income Tax Disclosure [Abstract]    
Income tax, refund claim   $ 3,200,000
Income tax benefit $ 0 $ (3,245,879)
XML 69 R55.htm IDEA: XBRL DOCUMENT v3.21.1
Net Loss Per Share - Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Detail) - shares
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Common Stock Warrants [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive securities excluded from computation of earnings per share 145,755 10,370,206
Stock Options [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive securities excluded from computation of earnings per share 2,307,264 1,423,612
Restricted Stock [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive securities excluded from computation of earnings per share 330,824 215,413
XML 70 R56.htm IDEA: XBRL DOCUMENT v3.21.1
Commitments and Contingencies - Additional Information (Details) - USD ($)
3 Months Ended
Apr. 02, 2020
Jul. 12, 2019
Mar. 31, 2021
Dec. 31, 2020
Mar. 31, 2020
Dec. 31, 2019
Commitments And Contingencies [Line Items]            
Estimated future contingent consideration     $ 6,270,000 $ 5,390,000 $ 4,500,000 $ 2,750,000
Janssen Vaccines and Prevention BV [Member] | License [Member] | Maximum [Member]            
Commitments And Contingencies [Line Items]            
Development Based Milestone Payments $ 1,200,000          
Payment Made Under License Agreement     0      
Lonza Manufacturing Agreement [Member] | AdCOVID [Member]            
Commitments And Contingencies [Line Items]            
Commitment To Procure Equipment and Construction     23,000,000      
Construction-in-progress capitalized     4,000,000      
Summit Biosciences Development and Manufacturing Agreement [Member]            
Commitments And Contingencies [Line Items]            
Prepaid Expense under the agreement     $ 1,400,000      
Spitfire Pharma, Inc. [Member] | Sales Milestones [Member]            
Commitments And Contingencies [Line Items]            
Estimated future contingent consideration   $ 80,000,000        
License agreement term   10 years        
EXCEL 71 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0 ( %@YL5('04UB@0 +$ 0 9&]C4')O<',O87!P+GAM M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGDK7A.YNJQ<&4GPZ4A!0W_J=0U[R;UEA_6\#MI7E!+ P04 M " !8.;%2^;.XWNX K @ $0 &1O8U!R;W!S+V-O&ULS9+! M:L,P#(9?9?B>R$[H"B;-9:6G#08K;.QF;+4UBV-C:R1]^SE9FS*V!]C1TN]/ MGT"-#E+[B,_1!XQD,=V-KNN3U&'#3D1! B1]0J=2F1-];AY\=(KR,QXA*/VA MC@@5Y_?@D)11I& "%F$ALK8Q6NJ(BGR\X(U>\.$S=C/,:, .'?:40)0"6#M- M#.>Q:^ &F&"$T:7O IJ%.%?_Q,X=8)?DF.R2&H:A'.HYEW<0\/;T^#*O6]@^ MD>HUYE_)2CH'W+#KY-?Z8;O?L;;BE2CXJA#K/5]+P66]>I]621A'^_1S80RY8-[9)-NIL\!"SI^\Y%1^?H.'GS[BYBZ(:(E/)X M8-DOV]:[MR_>X%#BVR]*+ M41B1%G\@M MNN01.+5)#3(3/PB=AIAJ4!P"I DQEJ&&^+3&K!'@$WVWO@C(WXV(]ZMOFCU7 MH5A)VH3X$$8:XIQSYG/1;/L'I4;1]E6\W*.76!4!EQC?-*HU+,76>)7 \:V< M/!T3$LV4"P9!AI@S M&L%&KQMUAVC2/'K^!?F<-0HACA*FNVB<5@$_9Y>PTG!Z(++9OVX?H;5,VPLCO='U!=*Y \FIS_I,C0' MHYI9";V$5FJ?JH,@H%\;D>/N5Z> HWEL:\4*Z">P'_T=HWPJOX@L Y M?RY]SZ7ON?0]H=*W-R-]9\'3BUO>1FY;Q/NN,=K7-"XH8U=RSTS0LS0[=R2^JVE+ZU)CA* M]+',<$X>RPP[9SR2';9WH!TU^_9==N0CI3!3ET.X&D*^ VVZG=PZ.)Z8D;D* MTU*0;\/YZ<5X&N(YV02Y?9A7;>?8T='[Y\%1L*/O/)8=QXCRHB'NH8:8S\-# MAWE[7YAGE<90-!1M;*PD+$:W8+C7\2P4X&1@+: '@Z]1 O)256 Q6\8#*Y"B M?$R,1>APYY=<7^/1DN/;IF6U;J\I=QEM(E(YPFF8$V>KRMYEL<%5'<]56_*P MOFH]M!5.S_Y9KF4Q9Z;RWRT,"2Q;B%D2XDU=[=7GFYRN>B)V^I=W MP6#R_7#)1P_E.^=?]%U#KG[VW>/Z;I,[2$R<><41 71% B.5' 86%S+D4.Z2 MD 83 >LX=SFWJXPD6L_UC6'ODRWSEPVSK> U[F M$RQ#I'[!?8J*@!&K8KZZKT_Y)9P[M'OQ@2";_-;;I/;=X Q\U*M:I60K$3]+ M!WP?D@9CC%OT-%^/%&*MIK&MQMHQ#'F 6/,,H68XWX=%FAHSU8NL.8T*;T'5 M0.4_V]0-:/8--!R1!5XQF;8VH^1."CS<_N\-L,+$CN'MB[\!4$L#!!0 ( M %@YL5(J_W_D604 !46 8 >&PO=V]R:W-H965T&UL MI9A=;]LV%(:ONU]!&+OH@#@2*7^E< PX3M(%:](T=C=TPRYHB;:$2J)&4G'\ M[W=I/HZ[Q^=$B^YXC3G53?=2B$(2])G.K+7FA,]L%QM!^*A.MS MF8D4[FRD2KB!4[5U=*8$#XJ@)':8ZXZ%9PYM4H0)2+5D4R)$IO+WIQ^ M6'B>#2B>^#T2._WJF-A764OYW9[Q^9)[GX5U0L-K9XO8UW\ M);ORV<&@1_Q<&YE4P4"01&GYG[]4B7@=P(X$L"J O0F@WI$ KPHH,N>49,5K M77/#9U,E=T39IT'-'A2Y*:+A;:+4#N/2*+@;09R974L_AU$QA* LD9E!]0K MA@K>%Y*!K+%;[3+0E' ^G;O\+0C&L*8:HS!P0@@+C-N;;-@P\?L-C+1". M4]Q+;R"Y6R-$#3UKG48<0 -W=WW]]N#DC=P^+N%B9*PA8ZC<(E?J[1S'%F&'7+]/6=_# MYA5MO)=ZIR3M-HK!@Q? LY6J/6.XSH-,^]SWH:E0(!*4@AAA8^44-^.*<)GP M."97N8;;NKV(XCI&Y9B9TL;5*6[+%=!-(M36+LJ/H&!"LI!)QM/VW/T_GZ>- MT5/1264*)S/D7S. MC3;08$(*V_JV2GE8*-OOCN>9-_$N1I.!-W6>VSK&QOK92=9OUS5YR)/UV]5= M]9VX"-AJWV/#R1AK8AO#9R<9_HJ_D+L QBS:1'[9:R. N"1S^VS,1N,Q9ORL M,7Z&.W4]R7RI8.87<&?%W!=$@M_*'&J5'>J@M0YTJ%_?8)!-"6 GE8!Y$, , MTV>' _()GB.?TW8R7/*"NF01RRR#HO(D.?K-TA0"=E(A:.=<[60K)RZYS",8 M">;2)4;85 9V4F6H"1?V#,9Y)7=I*QTN]Y%')A1*KW.UQ?B:\L!.*@\U7ST1 M'Y5\CE*_?:@[/@FN,;2F4+"3"D6-]BC!YV+R9Y0=7QU=7P.3\01C:TH%PXV] M&,:Y$OPX"B[PG@W<7S"4IC8PO#9\DL4722A3U(5QD=%PT*>#(69Q7E,7/-S2 M5Y&!BB WA++WZU_(4OBY@GRU874H505/EP4O@Q[YF<>Y(#^[Y[8?)]9,BBT4 MC+LI'A[N] =0[4[@WMYLY<"'WPZ*NHK0H6+'>TLG5<;;[:Q+O8C-?%MA2SW MX.JK]9[GO-CIV[[=FOWU%R)$>DY Q8@"22_?#TW(EWSQW/ M'[7YWFRDM.BI*NOF8K&Q=GNV6C7Y1E:B.=5;6<,W=]I4PL*MN5\U6R-%T2ZJ MRA7%.%Y50M6+]7G[V959G^N=+54MKPQJ=E4ES/,G6>K'BP59O'QPK>XWUGVP M6I]OQ;V\D?;;]LK W:JW4JA*UHW2-3+R[F+QD9Q=,NP6M(B_E'QL#JZ1<^56 MZ^_NYDMQL<".D2QE;IT) ?\>Y*4L2V<)>/S8&UWTSW0+#Z]?K/_:.@_.W(I& M7NKR;U78S<4B7:!"WHE=::_UXV]R[U#D[.6Z;-J_Z'&/Q0N4[QJKJ_UB8%"I MNOLOGO:!.%A ^,0"NE] W[J [1>PUM&.6>O69V'%^MSH1V0<&JRYBS8V[6KP M1M7N-=Y8 ]\J6&?7E[IN=*D*866!/HE2U+E$-\Y<@T[0MYO/Z/V[7\Y7%A[E M%JSRO=E/G5DZ8?:K,*>(D26BF)+ \LOYY9]EWB_'KY>OP,'>2]I[25M[;,K+ MG3&RMD@T#3AV-F.1]199:Y%/613-!HFZ0+F[D#]VZD&4\(@F%*O.5-R:C@,2P!)HHPD*1Z0K_CRGB^?Y7LM&VM4[MZR8QQBV1F(#I[- M.$GXB.$QU"MV4<\NFF7WI[:B;(DMO8"V43;'Z4<>,1?D.(YB,G(A@(0@1R1+ M2=B-N'D MYYK,9SF\,\>3$ M8M=N@3F>J1_0-$MQ/$ZP "Z):9*Q,,^LYYG-\KPR03Z&LCNTVK[48: M*.*'M2?$/?,XP6[$69:-N/LXDM$X3J(P=X('# MU+[45M3W"E)LOPFF8\K\4-$TR2@?)UP8"=+'XPFZ@Z21>4W[H\VOF>WJ:Q44 M>H;QF**/2T#4)DH"&42-O$759OCY0D1C3B.<1./R&H)"YI&(3M(<1(O$;VJ. M2B5N5:FLDK,=$AD4AKQ18K;B>:INDX!P0#GA7CWQ<3&A=*INDT%@R+S" $FS MD[.5^R P01=\35_!CA'TAR5Q&9EY! M#"B.Z\@YG^A&Z2 Y=%YR8.ZPJKYW;',8050AC7!S78@O];4$)-NU02.^ 6#$ MLE? UW0'R:'SDM.5FE+7]UU[=R3"-* D"EV MQ#&>OI+ K$$88UYH \@,]DR:3<5V4!UZ9)325:6Z5KF;J%ZV1@ZLT?O?M96( MQ,$A=-ZR.P(Y:[8BEQ>++4P0TCS(Q1J%QM'_P=!K[P<1HWRV^MY8G7_?Z!(2 MH/GYIY22Y$/;T]CGN2),!Q&B\R+DHJMKU+C'+-$[? K90* B&P3SU4Y^@!$; M+W'WBYJ-,*X$[BQ,,NH?67Q +%U"U[8D*6Y?#H-+3I<9CU_ JFE<_6S+YLXV MT$$4\/:0L.BK,/FF/P5H$3#8R^H64NEEN%^ZT6XKV\.<\CGXCGWI8RGQ]F< M%6=396K01CH_T7TL"N7*$J22Z^]/5 WSYU9!:@6I^M,:CRF,QPD>]W A*$D8 M2Q(^,3+107?I4=W=5;NR/=(IY)W*5;"'H[ZDGE"",ZCN>-S%A; DA68%1]E$ M/T\'":9');CGNU=>74&>;=QIX8.$LMM,=Z+4%]63"+.,I>.Q/XSDT$9-;9-! M?NE;Y+>93.4@<5]<*8\Y2_SA.@2E49K$C$[H!!N$F+UE]CO0B39/_YLK^T<< M'EM--;(AZ$0CNSHXU71'RE!.[E7=H%+>P5I\FD \3'=*V]U8O6T/.F^UM;IJ M+S=2@ L. -_?:9"2_8T[.^W/RM?_ E!+ P04 " !8.;%2>Z%-0'D" "I M!@ & 'AL+W=ORAJQ&A[*'J@I;5%A")5\KD/JP".+@8>%6[$IT"V$VK_D.UH!? MZY6A6=BS%*("9856S,!V$5S&%\NIB__5:6O_/#FWL9!:PO+&HJPY,"BJAVB>_[^IP!(C')P!)!TA>"D@[ M0.J-MLJ\K6N./)L;?6#&11.;&_C:>#2Y$?\09+;<0?*(;T MMH23(R'45-K?$\DOB7RD>M*KGKQ>M;"V&58\^4='>IY,9O'Y4\$#@;-XG'P8 M3X?U3GN]T]?KI:Y+AT050NV&1$]?*GH@<%AT>-1(7!.G.[L3RC()6X)&HQEQ MF+8QMA/4M>\M&XW4J?RPI&\)&!= [[=:X\/$M:O^ZY3]!5!+ P04 " !8 M.;%2!>*@8Z8$ Y$ & 'AL+W=O(OY+MNP)Z8_[1XDO'FME;RH&%>%X$BR]1O'\ M^63]1^L\./.<*;84Y>+N11' M)(TT6#,/-C96&[PIN#G&)RWA:P%Z>K$47(FRR#/-_J?^!#ZTCY.3('9DT^#&35XCB]XCX!#OP+-^N[D_ H6UBZO*_MA2>.89Q$L>I[_D#W8H1RC%*8[=8),6;#()]G>A :H8')H+ M:C(,;!BE*1U@'0JF(4Z#('%C35NLZ2166W+64E0GO%"97#C3P?:7.$@BG/A! M#ZA#,J9^%(!)QR21*.^$\ZC.1M&.L0."&2P=8!"=*TCW HAD-S\48@=@4: MTTF(]1&U9],@?8\X$1".@.S+ X23H7Z$/+4W:/C/H.-DI(73V BN7@:MXJHH&^07Z[AO@._P]VG.80LKB'VA# M-S!]G#Y#IU_P U02VY8Z'1W238AIO]UQ2%W"*="Q2M>1$IYFI==M\>AII(-V MRYQ&F*3QH( X1&D*[)6,L!+I6(GX;TM'X$^DMIF$R@$S4+&J^ZJBW.M^+]ZT MWK7=Y!R3?T7[%\DM-E9&2,=X9)KQ/MMAC.67V0&(?\/,A:K@9E@78%;9:Z7! M VA@WNK/D/9HDF)@GW[R.B2!?K ?#CC2.QO"*B8W=C95 '7/=3W&M*OM_'MK MI[[>^AW,Q?44VYFIAVH84C8%C&,E6X-)_RH&6+*>4^L7+79VU'L6&@9'^[B% MV9Y)(P#?UT+HTXO9H/UOP>)?4$L#!!0 ( %@YL5+$^9F&PO=V]R:W-H965T&ULO5I;;]LV%/XKA#=L*U#7(BGJ MTB4!FCAI#*QKT*S=P[ '1:)C(;JX$AVG^_4[DA7+XLU.NNPEEJQSCKYSX_E( MYVA=5G?U@G.!'O*LJ(]'"R&6;R>3.E[P/*K?E$M>P)-Y6>61@-OJ=E(O*QXE MK5*>38CC>),\2HO1R5'[W55U M+D3SQ>3D:!G=\FLN/B^O*KB;;*TD:@=?CNCI%%H);ZD?%WO M7*/&E9NRO&MN9LGQR&D0\8S'HC$1P<<]/^-9UE@"'%\[HZ/M.QO%W>M'ZQ>M M\^#,353SLS+[,TW$XG@4C%#"Y]$J$Y_*]27O'&*-O;C,ZO8O6F]D?6^$XE4M MRKQ3!@1Y6FP^HX2@QO M_:,44:91.[.K?8BJ.^C_C_,YK]+B%OWU@>6$W_RY)TF9)B#)T%:7)>%:@LVB90NQL1M]_M]$G>'"YYV5QO,I765M= M4SY/XU38K,T.M_91+'B%( &PQB^:Q?>>H]_*NC:8GT!?;)N#;)N#M.]S#>\[ MY;=I4301.(VRJ(@YB@2X$;]!%+]&Q,&AKO0W-KW69C-K[D]8 1-;;' 2,;@-&GQBP M7V#UJ!=1Q>M7AP1ONK'/!C&AF&#/UR-SM\A<*[*V12OWE#@Z/WUMOYZ+^?O;GGI MJLE3(;/0=_6(_2UBWXIX5M>KMK:;&;D9 !NX\ZK,T7F^S,IOG'=#X6I5P1RM M.;J"?M"EQU<@,L^GCJ&?@ZVKP0NYNB\S@0*7!H$3ZN&&6[CA M\^"NEG 91_4BXS A^ .OXK1NQ:#"J@@(CRXUH8HQW*V>C2>ADAIIM;W0VR%Z M7['3,S?GI;S=EYWNS8-EV&6.H=7Q#MG$5LB;H1T/AC9T=YG#H,A@>+]"/_T0 M$(Q_1:L"MFY9^@^L!;>P97M\#(ZEQ3VL$RU+U1)/K/8\)2YET@C<+S?TL><, MV$X:?H=EJ0&K!4(CD$V,]H;!_2YT4B41K@>X]3F3A:W.I8 M=G$0>A[VI6[H)(>D!DL][BGF-@.\EX"E_%ZNP'QAQ0)C.X P2'<'N>@.U$X3]G MK5@E"..0,$?>0W5R-MYJ,F4JH)YM8#O=>%'JBE76,/:H:?4G/6L@SV0-SV*O M1$,4',]QI!Q,.SE;FDRF#*2#]*2#V$G'RY%8HG*( )8\ ^"=4P<[@S !-C7+ M&5'W\Q06WX!0*K$A^TR<9S=BN[*R-6< MW,A2%SJ#/H.=A"QYJ9,$KN:8>ZDG&\1.-KXS4&V&KRT-I6,&CF-!WD][8I_V MQE7@$9J,OS*ZJDVW2@7TV;XX1'+H8T\:R#-/)IZW_R4:NJ!S:)_8T)N>4Y!G M'CY\__Z6J)0 .\R$N"<$Q$X(_H?M+5%I <-48D6S?5+#P]V>.U [=[!M;:DZ MOF&?!JP>RT?:EP>)#B'VPY[:A[U]JD1'1,,^V#7=Z0=UDPGRQP: @)#U'K&0>V,X_#=K2Z"4ZH>5M" M,!\KA\.3G5\JFQ_3P31LPFJ4\3FH.F]\L%%M?I_>W(ARV?YX>5,*4>;MY8)' M":\: 7@^+TOQ>-/\'KK]+X&3?P%02P,$% @ 6#FQ4CTVP870!@ \!@ M !@ !X;"]W;W)KE#34E#\LQP9LX, M<_DBU2^]X=R@UR(O]=5D8\SVTW2JTPTOF/XHM[R$+VNI"F;@43U-]59QEE63 MBGQ*/"^<%DR4D^O+ZMU275_*G*F%+)'BZZO)#'^:4VHG5!(_!7_1)V-D57F4 M\I=]N,NN)IY%Q'.>&KL$@Y]G/N=Y;E<"'/\TBTZ.>]J)I^/#ZK>5\J#,(]-\ M+O._1&8V5Y-X@C*^9KO&T.<3(!UW!-(,X%T)_@#$V@SH;+0+4E8:5K.#RC;5 M;-!&E/885T;!5P'SS/5^9 M^H@H_H"(1[ #S_S\Z=X(''HT(*W6HT,&G*W^1+=?O_VU0K??O]VC;\N;[[.' MN\7_T&S^,/[+. D,ZEUJX3J&>&U4P;M\_7%]B/ M0Q][\>7T^=0V#DD:QT'H)T?!-^B"([I@U JS[&_PU=IUC(3X3F69BIRCLH%M MW]IQ:IUJI\'91(D@&2EF1/E41[,P@NLQ6X5'-.&HK>8;5CYQN\.:"86>6;[C MUJ,!E-T-4-JA%EFU/2237+!'D0NS=UFWWBLXL5D<>_"O8]J^&(Z"-W)O=(F. MND2CNJR,3']=V$R5 >@"TK>N,?-7.^8NQ%$?"L$Q#7 '\W25.YLD,,)<_','G.G49I5 M@C<9*<&$=.WB$DPB&@31@&E(BY2,(ETJOF4B.X1);0]I-EPUYVH:0SGQDSXL MWU9&Q.\JX)"$((H3.J! RRN8GF?J+=L/VIFZ[.Q[03-.,Y\XGQ.[[[)[8+O2V*,283C ?0M:^%@%/T#>[6UZ XP_\:A M X>A:4"BGC\X!"D-O9 ..41+:GB42CAEG_P. $ME4PYSS1:*UD@S?+&+:'HWZG*2K88 MT!M@I0O#50&V?.9-]>*T7Y]ZJ ?9K%\#."0QC;SA*@"W1(7'F6JY4T!"^MW8 M^\QS$?E1Z/4]UR7I)0D)!SR7M#1%O/.Q;Y7U6[.OCH3_LQ-;"_Z#K0Y="C1+ M=U-Q'"5=X[LD<8SI@.>2EO3(..E5C5!%)E 9@,'![B7+\SVTB\_0!V\A&K?0 M. V< '%07$@\OUN,N>0PU @#GD-:)B3C3'C,&V#Y9ZAY,_2X;]SF][F#]/D- MB#P,O"3HXN]+AD%("1XHT4C+A.1]+=;MW6*VF)^?.4C+9F2-_!@L-! MWJ<=ZN,H)H/!V](.&>^?SL1B! W/B&P'JX'/QJ'?B^R^9!)&@][=4AH9IS0+ M7Y0I=&"Z:M8K52PK5 -+#="Y5^'(J@)-&R52>T]EOSM5!L_7C-L^8%2G/M]A'Y ":?1TPKUK*VA>O(3&0\?5 MDB,EH]RR^K%G);.-[5W78NI$Y2D.)&J+JR M/UPXU 7'4,YJ*,!I7-JW6$1CTY.ZXX.JINE+7J.H]ZTO9X]OCM?VLNJSN MO/^,/\WKR_=VF?IO ?=,@9=KE/,U+.E]C.#,57V]7C\8N:UNJ!^E,;*HAAO. M,JZL 'Q?2VD.#W:#XQ\YKO\/4$L#!!0 ( %@YL5* 1^S7^08 ,X0 8 M >&PO=V]R:W-H965T&ULM5AM;]PV$OXKQ!8XV,!ZW^Q< M<_4+L';2)N@E->(D=T#1#UQI)+&A2(6DLG9^?9\A*>TZ9PM#%T[X?NVE>[NDK3=GD^6DV'AC:J;P OS MB[-.UG1#X5UW[? U'[64JB7CE37"474^62]_NCSA\_' >T5;O_=;L"<;:S_P MQ\OR?+)@0*2I"*Q!XL\GNB*M61%@?,PZ)Z-)%MS_/6C_.?H.7S;2TY75_U%E M:,XG3R>BI$KV.KRQVQ>4_7G"^@JK??Q7;-/9DR<34?0^V#8+ T&K3/HK;W,< M]@2>+AX16&6!5<2=#$64SV20%V?.;H7CT]#&/Z*K41K@E.&DW 2'706YN5Y]=J1)Q,DA_!L'F"1Y>9%UGZ9M*\>T7XL7ED3 M&B^>FY+*^_)S(!WAK@:XEZNO*GPEW4P<+Z=BM5@MOZ+O>'3_..H[?D3?NBAL M;X(RM;BV6A6*O/A]O?'!@2Y_?,7 R6C@)!HX^3_%]^O:ES/Q=PP\='BM@VK; MWM!4O#3%;"H:E/;'7KI CDJAC/A%JM"0\YO>U5.!#-QI6)B*=T8%G+B!;O)3 M$6Q-? X$#HU0P:/0-UZ52CJ.Z@&8&DOQ$^D[G&Y(_..'IZO5XO3*MITT=_%K M>2JL&S9&:'GK4, E*0I$0152"Q_0-L1&V:Z1*-""^A#7BZ00V OK.NLDP^S! M0!?-:KF-D>'?$3Q_/",L2TT%;N&6:'ES^> M>FSBB"?1J8XX^>R3[DO$LW.V0V #TO$0FFC@ZK?W+Y\=+?\E#M9E_'W(.$+C MY*TX>"V]O6D4Z?(P@E.FTCV9SS)MO5__]_ 4&_O*'W,P!OX+BV^/DL73J-S0 M;1 U&9R.1.RH"ZJD??D$^?7ZY@7@_OOMT=/%,@$K&F>1LZ=91HP)P-BH*36=P+_7Y M; %:!*G3(@.LE)& 7T8PF+DI4, #[_NZB0XI[WL^Q)A!\I:G&L0QC2MR7*T8 M%\6'J=#6U$>HWQ90-V&:#]F"J(0A9]N=/S5R&U++J"VX9B+\PIK8 ?W]=0B'Z2EK9IS@2L3(N[!;]D4*; F97 G(._L#=4+"*S>XQ2)5'[O4 M?;U93]0-6 _W-P:+ DAP.L>Q#@R;77(]S*8,4AW9S\G)7>3=[ 8TI*)W($(^]ORV:*2I8_!:)([A'>3& M=O/\:FQI4"==F7L*.=7N@0,8$@B\[^L MU]>C2US'G --Z*W?$'= ](WM-4!QUF4T"+D_>Y.N;G&B,()O3R9C8(D[T%P0 MWS[0X@MJ-^BX^?ZP&&(W.K@VIH>:-S'LW/'YXB>6BZ-?Q;91J)9M+%0-B1$2 M&2%8R-@$MK@*0T MC]@2K9QO+U_BH-L.UQH.4%9<]0A&Y!WS@.\S>TV-USVO9;.S[^M90_P'TO1F M%YF!77&X8WG;6*YJNS5Y#@YW,W07(/:J-JJ"DR:DV S7J%%ONL)(XV61VE\C M$8X-D1&XG.!Q(G.SV.'&L>_T<&=CK)!,\LTP GA:*8,A'&FVFYT\G*56GT?Z M8-+0'L-1)KA-5,D;WM=*;I1./3RWA-ATF96( 5_$<&JX'B3''@3]96_F*.[( M#EC#]2D/%RIX]B;C*6&%!MB8C@$<'W+NGC"5$KT$=3!='%[$>\C5UZ/:>/8+OX8MW8@/=O_,FO$G)\ /N5 MQ5TN?["!\;\P+OX"4$L#!!0 ( %@YL5+.H<$Q6P0 $H* 8 >&PO M=V]R:W-H965T&ULM5;?;]LV$/Y7#AHP;(!CV7*ZIHUCP,Z/ M-AC:!7'=/0Q[H*63Q44D59**X_^^=Y0L:X&3[F4/B47I[KOON^,=.=T:^^ * M1 ]/JM3N(BJ\K]['L4L+5,(-386:ON3&*N%I:3>QJRR*+#BI,DY&H]]B):2. M9M/P[L[.IJ;VI=1X9\'52@F[6V!IMA?1.-J_N)>;PO.+>#:MQ :7Z%?5G:55 MW*%D4J%VTFBPF%]$\_'[Q2G;!X.O$K>N]PRL9&W, R]NLXMHQ(2PQ-0S@J"? M1[S$LF0@HO&MQ8RZD.S8?]ZCWP3MI&4M'%Z:\D^9^>(B.HL@PUS4I;\WVX_8 MZGG#>*DI7?@/V\;V=!)!6CMO5.M,#)34S:]X:O/0"0M Y)X-T$"BRO MA!>SJ35;L&Q-:/P0I 9O(BP)?#+:%PZN=8;9O_UCXMF13?9D%\FK M@)^$'<)D/(!DE(Q?P9MTXB+BJ+:]]@?1G$4$UI4$N#5!BTZ++[(#-+$(A'A'6B!JT =<+D!9" M;PC4FP!X:50E].[GG\Z2\=MSMV]PIM7W$@=:U9Y62BQHQ'&HY/?@292<-FAL*V.*TQ1K='NI8Q .,AE29^VTA?!?'E].0!\ M2K'R'80E/^W+'8C,5)ZL>UR=%SH3-@O&4J=&40K%$[HAK!RRR&OG)G&\E'A"P"TC42"(EO.)X5)%"4*+SG&9>$"84RW"$QOD[I/DH MGP!&PD,%6+HVGF6R*GSR+8-M(=,FDY=_?+V].AF_ [+/4,F4V.T@(]8IYS*D MJUM)0FU)/:_QNG:T!9P;]&A18C+)F@:!%B6"QJSCA-)YU&27$NB@H*E+Z+5. MT?)."M:N7O\3,F#:K=IH:.,RMI,9[? LT*D,2^.@+<>F:D?DF>-[].5R\#I# MCU1A':()W_;6EC8FI1<$L*?M17^AJ6HM:LH(H3!]ZI],\.)X(4.B./A^@_^P MYX?PT6SQ$>V #TINN7W*J1%*4B%I4UG(K5$$9MSS3=BHXOJO\4?SX>!)]=NMM_K0^,E>H;WOLU(E[Y[M"NPFWF% 9[9NCOGO;793F MS?W@8-[VC9@+[G MAMJE77" [OHX^PY02P,$% @ 6#FQ4O7<:D."!P ?Q0 !@ !X;"]W M;W)KOP*CQCCU#6[SIYMJ><9RV MVYFFFXG;YF%G'R 2$K$A"08@K2B_?K\#D#(M*VJR31\DD@#._3L7\FJC]'N3 M"]&PCV51F>M1WC3UY7ALTER4W%RH6E3862E=\@:/>CTVM18\LT1E,8Z"8#HN MN:Q&-U=V[8V^N5)M4\A*O-',M&7)]?:E*-3F>A2.^H6W,^$.*C1G<,[)DJ=1[>O@YNQX% MI) H1-H0!X[+@[@314&,H,:'CN=H)Y((A_<]]Q^M[;!ER8VX4\4[F37Y]6@^ M8IE8\;9HWJK-/T5GSX3XI:HP]I]MW-DX&;&T-8TJ.V)H4,K*7?G'S@\#@GGP M&8*H(XBLWDZ0U?(5;_C-E58;INDTN-&--=520SE945#N&XU=";KFYD&.NQ@V8TY%QVC%ZZ1A%GV$4L]>J:G+#?J@RD3VE'T.IG691 MK]G+Z"C#UUQ?L#CT611$X1%^\<[2V/*+_]S25]*DA2)C#?OW[=(T&N#XSQ$9 MR4Y&8F4D?]V;1QE1*EZ:FJ?B>H1<,T(_B-%-?,$^(X#]E@MVI\J:5]M_?#>/ MPMGWAG%C!+9XE;%"\J4L9"-A<.GH,L8;MB)V#Y8=90BR+&VUEM6:D"X-'4$8 MTGP7!Y8JY*-I0*Y6K('4E2J0V""Y] XK]YR)]YMJ>.'](AY$P<+N&G77V+NU M>E]Z=]SD3'QH)12T1IZS4E5B"_CK]RA7J[;*C/?""V-_,8W\11#M/UA71-\/ M[NYSI9OS1NB2R>I!F,:ZSYM-_[D@26G]B+P)_',G\Z"H; #QW]Y M=#J,07+ 2>0/Z\),:&[+4A^:+3LU0K!?52/8_,R;^M$L\(,@V+'KKX\[3I\7 M@Y5#)@_W_SZ8O!*I*)="]T$._D^D/./SC<&"Z,7SA9_,XOV'+P9+&) S)_YD M\ACK0VM.\9"$+"9^$(=#>8<(_A)@)I!R&#"/.^^XUAP,=RR@QD&2\"G )GX2 M' /8XSX!;+,OA0$BLDJ+%HT!-^Q?0(-FA:K6SKE#V&&;L$(FJT)FG/"SY 6O M4L'%-M>+M0EH6@QE>%N$JFUA#64<*9=&H 6 M/'8$?D\A*ILY@J-R:E%#+AE0"RT5#K4-+/SD3)(Z8S77L)[-%!+VN++0C#XEK/3+I_.G >?T3LQ F9EF$7TEID&>G,(W'.7\;L0VZH MF?2H2F>F$WY.TQ,<4M=:P2CA:LY HTY'YVO6*$Q7Y&FT1N>;(^[/V(=6$5:L M;P\U+B#!Y&I3(4RH0I?>7DNZ+7"&4D2[QN %.IJ6\C@(2J.%LS4CJ9^$"W0)29X0*=83+K%& _3 %E>ED*G M0 PBB-A:EZ1*(]S@"@:@H84 "H3>G8#9*YF2-* M ]",;+P(!2L*_!E(^C0? M+/5UP38]],#YE![F4;_D^N#7!.MY^]B/U_/&\#>%##8&D\B?3684*G^>Q/UB MXD^#KPY9,O,G4>C'2>*=HDXF =Q/:^$$ R)"B=9KX\20!]Q=/&A*5@F'/7U$][KM1S;X-F9]B7U9VL+_ M;6HV60--V[*FDZAII!FJ2R_'#2=_:FZ3 Z=Z?@8.=#;QJ?V!^V_^N4W0JNAR?@M,C] M_;RB3E' 2?"!;QW83:Z(J(MF1:)[]3O!^<#RIMM_>;'+@=&([N!<8#6YQV+[Z4HYKF M91KQ*:C?X#5@I54)A9411\DJ59WOD5XP-\?;J.KLB^E\3%"P'[[ 3(%040Y2 M!8%=M7NCJ"AVB,=:4BKU1FKQB)]]69M<6*QL[3$)R)&/2,,O=?A3M%*_J]23 MG._4H%0:N-H6& N3K_;>H4\7X\%'(32LM?WTA:I-:>R^#^U6=U_7;MU'IHTM[F@N.5A0Y@?Z50WKL' M$K#[YGCS/U!+ P04 " !8.;%2?-"]8=0# #^!P &0 'AL+W=O M@#1<2:)A-0MODJO;S-E[@S\Y;,S)F+A,EDI]$-+[O,<-C2.=X.CZ@O_>Y8RY+9N!.B;]X9>M96(2D@A7KA/VB-A]@GT_N M\$HEC/\GF]XVBT-2=L:J9N^,#!HN^R_;[G4X<2A>$R8J\^][Q%A6WE'P&.XTL M!G!F4;D'N^W!TE? AN23DK8VY)VLH'KN'R&Q([OTP.XV/0OXB>D!&2:4I'&: MG,$;'K,=>KSA?V6[$$Q:ULANF(1AE-(LGA\\#X.6JE:@(;UJM?H"+9S!@EN1T%!-*-65(J8X,1 MG>0%34;#(*6C/*?C88),C+G"?E%V32>8A0JO.7:\DK.^D2 2:Y2V_*=?"-Z@ M(*.8)DD2O'63?%+0PD]>BR[!29[3!"UCU/+"Z9HC%RS6C2%J19[7E"+9EU,F MK>;83;G8$2Y+T5586I>8P8[9<[>*V!K03I58>'_2$5\HN;X4V,6?:'F2RXYC M!;![.R/G9SIN@3!CE,L?\3;":5]0K;6 *3I M6QBX%O9+&;R;NU$4@YL6_(LB=H.7^D5TTI,;T&O_\KC:=-+V[?FX>GS<;OJ> M_F3>OXQ(8LVE(0)6Z!H/QGE(=/_:]!.K6M_AE\KB>^&'-986M#/ _95"(?<3 M%^#XY,__!5!+ P04 " !8.;%2Y=D69OD# !Y"0 &0 'AL+W=OR=QYX\L M):NA44PT1,)FX:["BZO8V%N#+PQVZFA-3"1K(;Z:S6VY< ,C"#@4VC!0_'N M:^#<$*&,;P.G.[HTP./U@?TG&SO&LJ8*K@7_C96Z6KBY2TK8T([K>['[&89X M$L-7"*[L+]GUMLG4)46GM*@',"JH6=/_T\?A'(X >? "(!H D=7=.[(J;ZBF MR[D4.R*--;*9A0W5HE$<:TQ2/FJ);QGB]/*VT;39LC4'LE(*M)K[&FG-2[\8 M**YZBN@%BBGY(!I=*?*N*:%\CO=1SJ@I.FBZBEXE_$#EA$Q#CT1!%+["-QUC MG%J^Z0M\[X4H=XQSLFI*\EW Y(:I@@O522"_K]9*2[PI?[SB-A[=QM9M_$^. M]G6*9')"[Z<*R+6H6]KLW_R01V%VJ0A[LJ*]52&P<)2&DH@-T0C9"(X5R)KM MA8,'7%3C"3OOE&9XO]'TLX)-Q\DO6"C*>2^%4N2:2KE'%/E">0?.JBBZNN/6 M>E4+J=E?U)27\RLVD"LLOL$.98-L*.=[K)$'K/T6 2W"&JV<],YZF7Q+GS%C=Q&GA1'J##;QV3".:LP%Z NL(C>)0G7A $SOEA M\=:Q9Q)=.I^$IOS$P:AN_2>V!*(%H<,*IER:!E\T2$^F3AS-CG&CASXWT=3+X]0Y/E$"CZT)V-36]U'LJ")GJ9?& :'8<>:L$.+KZ?8 ,P#I\;>Y9S9ZGX7;'JQ^F3>?]1@F>] M9>B=PP:AP21+7"+[0=]OM&CM<%T+C:/:+BO\-@)I#/#]1@A]V!@'X]?6\F]0 M2P,$% @ 6#FQ4H-YZ!9R! %0H !D !X;"]W;W)K&ULI59;;]LV%'[WKR"T;&@!Q[8D.[8SVT"2;MB =0V2=7T8]D!+ MQQ91BE1)RH[[ZWL.*2F.TP08]F"+EW,^?N=*+O;:?+8%@&,/I51V&17.59?# MHVA:.%X6I1\2W<@_M8W1J<#3N47)2@K-"*&=@L MHZOX\GI,\E[@;P%[>S1F9,E:Z\\T^3U?1B,B!!(R1P@8>#/,MWW/'5PN@],R2-:#3P MIGIM)"<4!>7>&=P5J.=6'RHPW FU97\ &F<70X>HM#?,&H3K@)"\@)"R]UJY MPK)?5 [Y4_TALNDH)2VEZ^15P/?<#%@:]UDR2N)7\-+.Q-3CI2_@!P3+":K)@=A"M+@;L%)G]50"[T67% MU0&K0#G+]&8C,F!F M;/$(8L>-\(8'^NX(YQ ^@=UP+DK<>#H%Y+L>74;P;L_CFR@798\!V9 MP)G?)U/W('>=C[1!07L2.0.9WBKQ];NLJ<,Q2G!J0^>4;=2M1# GURA!K G" MY"AI0'+*D$";6XO]GPY%JX44[L"PWV.GQA %_,"DR9>0:LW!E=$[D8-70*>8 ML(I>V=2N1H.Q:8FR+I&'JKGT*8R?BA]*G\P8/&RB2/?$DWR+*>-%7CHZ9'(7 M2*XP-7RG=YI.P0OA",VVZ839UP[)?4\]7'@VM.X)^8 _@GA0Y-X<(UJ762_N3]-Y M?S*9^_$L&?=GX^ WIS7;69;E)]=7/33] )'\U&*NI/>)W]C0W[.=PBP MI?C2*^81R)?7FP-P8]_VQH,8?^ESK5S83-?86I $]*8H\F/X9]^[9X9'5W4) M9NL?))9YA'!K=ZO=F^4" . M!@ &0 'AL+W=O:F/TP,'UW 4(=UB$-3XI/?-=;IX@WJY'MX#/8 MK^.U1BF>45H^@#1<2:*A6X=;>GZ1.W_O\(W#P3RX$U=)K=0O)[QOUV'B"(& MQCH$AL<-O 8A'!#2^'W$#.>4+O#A_83^UM>.M=3,P&LEOO/6]NMP$9(6.K87 M]I,ZO(-C/87#:Y0P_I<<)M\L"TFS-U8-QV!D,' YG>SVV(<' 8ODB8#T&)!Z MWE,BS_*26;99:74@VGDCFKOX4GTTDN/2/+-"J+19!B)(V*Y7*.Y-*"!F,#FD55 MGKLCH>5L1A-XX@ZYA1M<(".N QM4R(5&5;7 6T;+:%&5P0? T22J%GS'W+A' M_0>V(YEE"=%5.9+UQJ*PB*B1?ZO+RI^,*,#Z)W?1.[1]M).XSIKYV6W MG6;\WGW:E/B<.RX-$=!A:')6%2'1T_:9!*M&/_&ULK@__+7'A0W:.:"]4]B& MH^ 2S'\!FS]02P,$% @ 6#FQ4I/#L.]J"0 =A@ !D !X;"]W;W)K M&ULO5G;;ALY$GWW5Q":8.$ BJYVHB2. 5\F,UDD M@1%G=A\6^T!U4VK&W62'9%O1?OV<*O9-'LG.O.Q+W.HFZW*JZE21.=M8=^3&OQMD(91OQF.?9*J0?F1+9?!E95TA WZZ]=B73LF4-Q7Y>#:9O!P7 M4IO!^1F_NW'G9[8*N3;JQ@E?%85TVTN5V\V[P730O/BBUUF@%^/SLU*NU:T* M?Y0W#K_&K914%\IX;8UP:O5N<#%]_Q6;N'8^'XBD\L$6]6984&@3_\H?-0Z]#8O) M@0VS>L.,[8Z*V,IK&>3YF;,;X6@UI-$#N\J[89PV%)3;X/!58U\XO[(F:+-6 M)@@\>ITJ)PFNLW& =%HS3FI)EU'2[("DN?@$69D7OYI4I;O[Q["J-6W6F'8Y M>U3@)^E&8CX=BMED-GU$WKQU=<[RY@?D758>;[R'H\52&W;3B_]<+'UP2([_ M/J+BI%5QPBI.GD8S>0K-QR4M1N)0:,373)$/I31;@:_*J51H$ZR01ERLG5(% M[9$F%3ELMA^*#24:'OW[\>$4?=5AII\1-)E%.<0_KN9;W M.H6./-?*#87TK/,VV.0NLSG!PPWQCS0N9)Q:@Z43X@$\V4R4P"]J/.&V0 MZ<;+2(A);CU"CR>._G06PS_:R2_M?85%T^%B\6HX.YV(RCBUA@F<=1Y>*89. M T$XA8R!8@1N)T9Q61L0@%65*VEH K)%/L*HG"B# M6@LM3B1$8Q&E;1]+]0-=TB/!TF_@[%A_+-23M^@2*&\J4K92-BD:H>;D])KE M]/WCI$H2DH*]%'%Z 6N]1[/N[]*&@IW2;BF6#8&5"<%(F2)=DK&%=;UR@#2!]M MZHJP1]64[--7;Q\4)3Q;H6CLQHMC)9,,L#*GEV^/ M))A"O0B8R!K32.5.J?1K_L/G:]')W&U@%UP:+1\0D'#(ZQ^(2RJWK2_(U@($ M5!<&4O^#N8= O68QB.9G3'W7KEJ+B[($YT7IQYT%_1Y O\PFG+V%GT$B+VW M-HT-B$6D&*\TS0+AH2_OKR]:24AH2WDJ9%1).;P&<3M#D! U5"&S+O86P$OI MK-=&? ./^50GL>MN,HV,(HRR.KV72A'/?T.>$BD[4>9H%TS/;1,A(J/F3*;! M)EKE*\K,SI1&W0&3:J@YBKY4":JPXZ6'*?KVJ=C/#\0>[1-<,_NY^,?*MVO% MJ')1D:BG\V>'\K^H=96CW[EMM\L_G6$ %ES84*\4C>4MY,&!*N,W$$):)2 B M&*PC49CMABBK 1!=(D_9H1:YMHHAHBGD20^VJK1U4T@R#7)IL.V"PT)Q*%#" M@ V]A'.[ Q"_V>,T&9WGC=F^X2Z()/*,@UU0269L;M?;/E_RIX\ZX9;6,5:3 M/$C4+2BQX9)&%K+0V?L&+8/23*FN9*\T5[ R[6*,'(XLN3=Z6 ?SEYQRG-L4 MP4>Y[BIR'4^.PTZ-J8HE4HM0_>GM%"FHKL K3"/0 <+2CE ,:(67U-"8FV!!B *BF"+ N_!&2SFCJ;+7A.^;T"J(9!Y\N MFA;45*%K%3R6T*F6B0;!C"J/+Y['D()$<#1O *.)D:+-'C",MG*[L$EJF*5U M(4JD79^E3^5W\5MNET@.G.KN5&^ W<#CK3B>39ZS3YCWN)&"AE-2Q<4*?;3< MMCY^42N4':80G!U0A_AX?/E#"AU15-I4,)-:;:5-,'E'C.LW?\6')X46_?GH]"2B_\@P MXU3.8V,=S/V%3U7" \N+"&R[>W<(]\ M*J6.G^PRK^?%7O^@/'(Q[6,>HM4G#=IRB=EI)/C"DE"6S8WET\[1811@O3GZ MFJ%I[ER(4:G"[_ET>$3W6?3/Y.@21VECR X4LT2M'3T[.AW.7T^&D\D$S[/A MJ]/X?)5):"07.K"/%HOX<=HN@ZI=:2^'LU>-M)/AZ20^7S#=M!;Q#=NP'H@2 MIZC.=S3Q(0P\!10TG1L#QJ)E%;@KQWNG_KX^R?5;WD^=4$P[@#Q(X5ZO[??* M/:Y,_H8K:77(@Y]4CU1,.#;^@9X,M-],]91M]>"CS>$397.+D':E@+5EO..H M"X6,Y[L+E8[VW5B.>W?!!0WT=.--(*.\X[5P^[:]5+^(=\G=\G@C#U"1GE[D M:H6MD]&KTP$HAV^YXX]@2[Y97MH0;,&/F9(H!UJ [RMK0_.#%+3_U7#^)U!+ M P04 " !8.;%2T%Z(H9P" "V!0 &0 'AL+W=OR!^J0=1PUS*NEGZC=7<:AJILL"5J M(CKDYF4K9$NT<64=JDXBJ5Q0R\(DBD["EE#NKQ;N[DJN%F*G&>5X)4'MVI;( M^S4RL5_ZL?]P<4WK1MN+<+7H2(TWJ#]W5])XX/GP.F/*6W@H?W M_L[U;GHIB,*-8%]II9NEG_M0X9;LF+X6^_=$D]5"BCU(BS9LUG"MNFA3'.7V MH]QH:5ZIB=.K3[I!"1>"UZ]O4;9P04E!&=44U2+4)H&%A>5 MN[)DB?(4K@4 M7#<*WO(*J[_C0U/86%WR4-TZ.4IX2>0$TCB )$KB(WSIV&WJ^-+CW3[V".=4 ME4RHG43X=E8H+ MO5$@')Y9O+9X=H GIME>A/0W5D 4; 4SZE2GGAEXV8P3]\ZQQ+8P1,--Y%V@ MD0"(@M&:6%D%!SDZ(9W27BI$^"@TPLDK[[D7!^DL"Z+IU-G921[$2>9M!*^H MA1,&6 HN6EH"Y25R*U.H)>%:>(X"M)X[MT*;4B. M=.P2S^)YD*6YL_,D#[(L_==W#@^TU**LW<904(H=U[VLQMMQ*9WU6GR$]QO- M#+.F7 '#K0F-)K.I#[+?$KVC1>>460AM=.[,QBQ6E!9@WK?"#'%P;()Q5:_^ M %!+ P04 " !8.;%2_J SJ=T( ?&@ &0 'AL+W=OR&%Q?NG?W M^OI253:3A;C7S%1YSO7F1F1J?36(!LV++W*YLO1B='U9\J68"?MK>:_Q-&I1 M4IF+PDA5,"T65X-I]./-A.:["7^38FTZWQE),E?J&SV\3Z\&(1$2F4@L(7!\ M/(A;D64$!!I_U)B#=DM:V/W>H+]SLD.6.3?B5F6_R=2NK@;G Y:*!:\R^T6M M?Q:U/">$EZC,N/]L[>?&\8 EE;$JKQ>#02X+_\D?:SUT%IR'1Q;$]8+8\?8; M.99ON>77EUJMF:;90*,O3E2W&N1D04:968U1B77V^E;E.90SLRKY=CFR0*3W MHZ1>?>-7QT=6C]DG5=B587=%*M+^^A&8M'3BALY-_"3@)ZZ';!P%+ [CZ F\ M<2O>V.&-C^!]%8^6W600COU].C=6PPO^\03NI,6=.-S)OZFVIU='X9!U$=A] M-<]DPCXO%D++8LD^%^Q#E6U8=.HT$0;,K@0M*7FQ88JFB93Q(F5&92E[*5^Q M<3 ^O0A.3B?,K+@6!K-8XO6$==I<0X,I*)RM$!XN"TW$83,:G1W@X&@43CT(G M$O,](?%'Q3/">1&"1QAMF;"7M-,/?SF/X_#-/;B\\UQ^J[FXD>C-J^?DBX<7 M^.O@[O(B6)UM2/VT]L!6[&5+LX=>&\UOW=N@:^2 PK+(ZL.>K M(?MZA QM4>/P>2:\7F$+I,P N.I!TG2[POLCX&P%YP'=M\@@P3G;TQ?2W+!0P%\DCH!HF3UCCL1B/>TSTQ M?%=+@6>B:%=,DM2+A/9*;R,ANG"B5"56G48LY9L6K5"VX^6U'-Y3EEH!#)9, MA$AK4:79.ND:F8/Q$A,>)6J:0))Y$8WC80SOS#(P;*2319)5J=CQ5UFP105O MJ57H8F:MX3);4579"-KF!$C&TU32>\AV=A(&B/&C>6HN%F1.N%D%G8%SNPL] MI-(DJG(! +/02E@)P/ZYE5,\HFTQ@$\KW80T-*%3!OUJZ_V!4JM76X'VYSN5 M%D^&X59I?$&8_R7.)=^XD)YO]@W8<&G,54E)3@.-/9+9N0:UKU5Z5;:KZI$"C^/3@+VM@7R9OE9I$M:.;6OL>]K=";? M0*$IT89J]#LQU_"F#8M/?,?2K]-0@ZO3+D"^IQ,Q ,:YCXDZO73U1-G33?8=#3KTP!<@JF4NR]$GO(D* !H> MX0)*"^LB;YM&:+B?2DJNV0//*O%,7]&MT]N&8L6]9B#8$K984@3M5'OL"E53 MWQ+%)]M\T->>(]CJS:Y@GJ77 "FVUNN^_1M7:U8.V13*FC7B[O2 R,P$T%O9 M5O:ZD'4#Y% %_"*6Y)L^-! QUGLF'N@$Q&:OQPS5EQI!LKT3H/4GQ^3NL:Z" MMVV.ZZOB[K;5 X;>BD2X"EAW_&%3?-;PQE0@,Y&( M*XLQLM^< +%W%1U(TX M>)CS0[17IBK+S//6(N,N^&MQ^[K9E>3NU@FZ&]).+O)2Y%&T>[[5VA:S@SL; MOS6EST,[N\Q(YVGJ5U&,FFIZ6/TPN_-N)"!H9AP=RC14#)P7Q$$4A<%YK[KV M3AH^!EM.V_3C^S&?Q'=KW7BR[0]HN%LM Z_"%^<7P[-VCA9T'^""YX'+S"D- MJH G.I;'2/P94;5 CJ,JM,,Q'$;M]H!HXS11!O;P;H67IBXC;;$'GH!OU2TO M#=6:S5%"QA"9'/LC)A6A-;%'92A_B=EQAGUE1DXO/ M#IT5_Z,:%!ZK01\^W7=#_^/'VUXA*3.>>$!73/I'N';,Y;W_EY/#Y>0D_/YJ MLJ/:?6ON5Y1?5%-07(^['YT=%^BWTGB)8Y>[_!&N*^R%2/A4*._ 4K*G0\6& MP1TS'U P7/$_HA8-MV5J"_#]W9QH0/C!\-G?H^_J0'A?H->TROMI_W![",JW ML7"ISMG2>U:WKN_'0T,TW74]%M$Y;._--7\]R;%I+]7QCK+U=V3>'#]SL(5?+\@E7214J2^ MP3'H 2QJGL9,C?W]'/>67B:\E);#A[E/)EHHO>1%_4SG+B,1U% @RGQA>.*G MN6X'*4C.1=O([M[ZZ W'%Y*5U&] T>K4$25L&3B_V=SUP4. 8FDE/6Z%\ M770O@)YVY(XK)$);="RUP'0T'R(\&4^HV> %E.QT_UVGRI,0><37VT,WSJ/. MI7TN]-+]-$$4@>WO[]NW[:\?4W_IOYWN?SI!?H.F#,O$ DO#X=G)@&G_&PO=V]R:W-H965TV%(ZW=AO2 MSJ+(&E"IPB2*+L-22!TLYTWLWB[GIG)*:KRW0%59"ON^1F7J11 '^\"#W!;. M!\+E?">V^(CNY^[>\B[L63)9HB9I-%C,%\$JGJTG/K])^"6QIH,U>"<;8Y[] MYGNV""(O"!6FSC,(_GO%:U3*$[&,EXXSZ$MZX.%ZS_ZU\-H+PVJ@GF;EB M$5P%D&$N*N4>3/T-.S\7GB\UBII?J-O2<6[Y)*P5VM$\ M=,SF8V':(=OD).&=L",8QT-(HB0^ MP3?NK8T;OO$1OMN72KIW^+W:D+/\]O^ZC;9?K;>155;J+;@"^;&(4+;=1]]]X-ZE1=\\ MD 2"(#>*9XYF@[X$3R4YH3-F&L(-IEANT.YAT2 >3J?3X64<#V[?TD+H+1*< M$=?Z81Q"')US1A1%_N$,M*DDI,%9/)PP^/Q(F<_2!@G7N!S&7^+!BKS1S\=# M$$KYL/>9FI)- L] ^KQO"/&)<%"C1> ^ODI3D7J'5 DBF4MN!1L7H*382.7[ MUF1B)S8#J2&OE!K!OSZ&\&".2K3;YK8@UE%IUXY4'^TOI%4[AW_3V]N,;6VE M)E"8,S0:32\"L.T-T6ZDRUT% "0#0 &0 'AL+W=O-/IZ4QK2O MIE.=E[QF.I M;W!E+57-##ZJS52WBK/"*M75- [#^;1FHIF<'-EWE^KD2':F M$@V_5*"[NF9J=\8KN3V>1)/AQ978E(9>3$^.6K;AU]Q\:"\5/DU'E$+4O-%" M-J#X^GAR&KTZFY&\%?@H^%;OW0-9LI+R,SV\+8XG(1'B%<\-(3#\N^7GO*H( M"&G\W6-.QBU)+"11\S;K*7,GM;[RW)R6\ M7%;:7F'K9+-X GFGC:Q[9610B\;]L[O>#WL*B_ )A;A7B"UOMY%E^9H9=G*D MY!8422,:W5A3K3:2$PT%Y=HH7!6H9TZNCZ,,5JZH=W')M0-YR!6O9*=AQIC2PI@"S:T5N14IVRX%!CI$G MYW2L@DJL.<@U&-XXE0!.#6 P\W*,I@^FY!B'+=/P(@J#"%.[JH@$*G:-XKG< M-.(?-"C?-RC'\& G<+$R\@%][<.V%+B'T,#O6BQZ)[/BL =GK6&PM<7*BY=( M7V'O@98K(0O:/0Z6 ^W7G1+-AJCB3W$.M4MP3@E^R*+!O[!1K*']Y_.E'X;A M0Z)8X:;<(P$#"7['52XTLE$BMSY\$L MZGKU),CF ;QM7/=VC?2P^P [MC:X$YG,O@P8>15CM985=G']RON]JU=("/=X MD&3>I\&Q([F+P:A+,NJ P!6GLX-V/=_+HANN:OCI#PK$S][I9J/XANQ[BQ(" M3X09OTA3/TL3[T-#V<\++_+3:.FGBSDN+X-T0%WXV3+UE[/8 MNT(Y-(U\ZGQQ.-O'W"A9@2GNT#$:HW(?C35$R+:# 8-T/;$*5WR5K)>G24;528B_0"#U[;:!"2W$DL\/%+EU+ZPQN^4AT. M'<_4*C+PXVRYQ^)1<+I&H..<2P\UQZ_1&QV&TA(NZK>0.P^^*X+)#+S J^XHU\ %S05D.SXGYP/M5#6V_4 !66I(, MKL ^1@E^?UX4WY!]WY>K7U-X(Z_A5%X]/I4O>HU]@8.0V'+SBFDMU@)%1&/Y M= WK"F&L3J-E)0KF$@C_W*2"3'!D5\QU=3HZ"%WQDB9I/*UQ!')^_"HO6 "\ M"1^T_S>]^HU5WY_[[M4]4J=+2"V2V]<$5O!;_!1HB2SVT00=G234>V-[5'J_ MNO'#BK(")UY!-[MYBF?EAE'C1 CLO8M]025"']^-HX29_ M]V!D:V?NE30XP=O;$C^9N"(!7%]+:88'VF#\"#OY%U!+ P04 " !8.;%2 M6G2M57,% "E# &0 'AL+W=O&[:0/11]6Y%!<9+G+["XEJU_?F5V2 MDI+8S4-?9%[F'Z;&OL9UGBHE';G@]+[^LUHY+(2*^$24Z.F-X6Q ME?!T:]7"JU"@=CU^-*B'UX.(L/+NQ%V>F\4IJO+'@FJH2=G>)RFS/ M!Y-!]^!6KDO/#T879[58XQWZC_6-I;M1'R67%6HGC0:+Q?E@,7ES.6/[8/!) MXM8=7 -7LC+F,]]\R,\'8P:$"C//$03]V> 5*L6!",:7-N:@3\F.A]==]%]" M[53+2CB\,NI/F?OR?' Z@!P+T2A_:[:_8EO/G.-E1KGP"]MH._]Y %GCO*E: M9T)021W_BH>V#P<.I^-''-+6(0VX8Z* !DYI) MN?.6WDKR\Q"NW=V9MK!O$R?#'@M; +3R1#2<3IY(MZT+WL:XDT? M*QONOE_UHJ\:EM)ERKC&HH._%BL7+/Y^(OFL3SX+R6?_<\^?CCJ9)O CD>&# MAM\:C=S*\1!\B616U4+O8"O(<"LL<0;/9LEK$IQ2/#N%-56P# D6MMK!->8R M$PINT:&P60G/156_A25N:-#K-CL-.N5]\?RGTS0=O_UXM[B^75Z%N\G;E^ - M% V]-XV%FY)&"R:C%#(J+$3V5M*O*>#^Y.J/3Q^6"=P3@HRPHI<\RQ%K0+WF MT@CU:@=M%I":;)42*V-%6 !;ZFF67E\BE6;+!*6MI'0(CHV!*4?3=$9<""FDK^GF@MA2( M87?ET-34";8362F)JRYSAM;3"F?&D9:.)LW3QN=,>9/Y(!_NO,+02G(0!Y0Y MW^2[8&,[-?!-?J %[@.TJ2W6BEK&D4YH@=^ V^7)(I_W MBMG0+B=4&Y%EI'ZHE?#\74J -G0([4M+I59Q^2 O'[@.>+K=<2QXJH#09&:M MY3]D*NK:F@=)NQ[5#IZ-DWD_ 51QT!B9;U W",TW;"1QLL@S'4]>'2=R-N#I=1=IEM6JL(]5T M0LJ,\U%#D?)'=,%*TD )SU[U'B2 M^3%9W(%];P-RIHG*Q#W57S$SI HRU80"8NL/5CPO#O)-X!VMHQ8C.12$$6TF M7=SHH98AK9!&=5VC-'DNV9RB=/WIV M?JZ]Z.DDF?4MY9*:S9+;_O!%T$7=' MG,VVPRND>+I=W[&O/[QH0K.^_<3^U\9)C\:88+_J'@QYB.HX%VHW?'(C-=8R M7U$$_7[ZWM%E='!TK-"NPP&9IM@TVL=39/^T/X,OXM%S;QX/\%0_M&YKZ]X03]?R87_P)02P,$ M% @ 6#FQ4G::?KFK P L0< !D !X;"]W;W)K&ULG57;CMLV$/V5@5H4+6!8MNPDBXUMP'LIFH< B]UM\E#T@:)&$K&\ M*+RLU_GZ#$G9M9%F"_3%)JDY9\Y<.%SMC'UR/:*'%R6U6Q>]]\-E63K>HV)N M:@;4]*4U5C%/6]N5;K#(F@12LJQFL[>E8D(7FU4ZN[.;E0E>"HUW%EQ0BMG] M%4JS6Q?SXG!P+[K>QX-RLQI8AP_H_QSN+.W*(TLC%&HGC :+[;K8SB^OEM$^ M&7P2N',G:XB1U,8\QG#=J M!),")73^9R]C'DX %[,? *H14"7=V5%2><,\VZRLV8&-UL06%RG4A"9Q0L>B M/'A+7P7A_.:#YD8A/+(7=*O2$V,\+_F(OLKHZ@?H!7PTVO<.;G6#S3F^)"5' M.=5!SE7U*N%'9J>PF$^@FE7S5_@6Q_ 6B6_QG^'!C7!<&A,3^&S M\#V1N8%N3=0188,51+!'9B= 2C*D>I<@LPG18V.-B*9@+W* 6V$]+=P"TWVBC!X0%YL,+O84L:?HVX7WZZ MJ*K9^^OM_>U#/$W[^?O?IO 860_'I-0\BQA6;2@,YX4*DEPI9+'N+KEAH(.J MT8)I4Y(2)LX8-XFYDZ$1NKL$CVHPEN84\)[ICL 6.V;CQQ1*\$**KV-MB)8S M2[8UXT^16-,XI<%IZ3O94]LY)/KO.<\R'&G:X&.'2J&$3^0NIIR2B*3?T[QI M0AIGB8WW6G F@4IO\Y1ST%JC1KX8G<1..)EEMN-9@S2_N>/-D(8R-2J-^+3LZ4U%&PWH>VN,/VRB@^,KO?D& M4$L#!!0 ( %@YL5(QQ^8;!@0 $4* 9 >&PO=V]R:W-H965TE.FQ=; CCV6DEE9T'I7'T? M138OH>)VJ&M0^&6M3<4=3LTFLK4!7GBG2D9I'-]&%1_+3R"E 2$-#YWF$$? MDAR/QP?T=SYWS&7%+3QJ^;LH7#D+[@)6P)HWTCWIW<_0Y3,FO%Q+ZW_9KK7- MXH#EC76ZZIR10254^\]?.QV.'.XN.:2=0^IYMX$\RS?<\?G4Z!TS9(UH-/"I M>F\D)Q1MRK,S^%6@GYO_BOO^7EO+EF#8<\D-3".'N/0URCN,18N17L#(V >M M7&G96U5 <>H?(9^>5'H@M4BO G[@9LBR)&1IG"97\+(^R%A99[ F_KR"/^KQ1QY_])]$O(Z1C(?L:QRV@)PW%I@K@3WJJN9JSTIN ML1]J;1P4C#.%7I*\N'-&K!K'5Q(=-,MU56'A8PWE+Z66!1C+L(T9EY+58(0N M+,-.MJ 0**3B%CGCJF"%D UA]\AHS:SG\RTQR([X6E[!Y8!#MO !_V4086FY M]CQ7>Z2\%07NL0_\78J@,_GL?/^2H%LP>!PQU50K^J[7+2L_.@9@>,99AWI1 M6$J38-HT#[D='(\,A+-NJ.'8 MCAO#E;.A=X)7,+G DD&072GR$FOE+*B MR?C@?^!4@\ M)="N<)DWDG?[PHN_\! CPE_E>D:IPH3PEMN<0Z M.N]_V(4'B[=-7H:^ ANU!4L$,"J614Y##Q>>@G^1DWJAV^J:5++8>DAJ!:!0 M9K^/!5L;7?F@;3FV/!X+K-!,AJ'D_%XD,1A-HG#-+X]->S2':1A%D_"]'8T2,)1FH6W23IX M^H=Z@RR+P[MT-$B3<3A*LG,W471TM5=@-OX!0T=?HUQ[R_>K_1OIH7T:?#%O M'UB8Y$;@3DA8HVL\G(P#9MI'2SMQNO8/A95V^.SPPQ+?>6#( +^O-194-Z$ M_&ULK5AM4^-&$OXK4[ZM%*DRLC$L(5F@RIC=9.^R60IV MN0]7]V$LC:0)HQGMO&"\OSY/S\BR#('LI>X+2/+TV]/=3[=TNC+VSM5">/;0 M*.W.1K7W[4^3BG M\=F5/3\UP2NIQ95E+C0-M^L+H79:'[PT\41G8\';J58N<$UHTB6QMS1S?OB;#0EAX02N2<- M'/_NQ4(H18K@QI=.YZ@W28+#ZXWV=S%VQ++D3BR,^K,:X+MC#: M2UT)G4OA3B<>)NC@)._4721ULV?4';(/4% []E87HMB5G\"UWK_9QK^+V8L* M/W";L<.#,9M-9PI:KM=,.F:62E;%5S-"=[K_,,K>-KQ.6%9FO!K6.E46"=C3+> MPM8]5]$R'%FQPH:*'BN9\PA1*15Y"SU1XMWE/&-7;Z^SQ3'[5>;@(B!:69$B M?/L R"([?02XK96*S6*A3GHYH< M^XXW[1MV90&ZCJ%?9+<9VR.:%U:MV9TV*Y"F8PL;9ZO4DZ#ND6>JV@ :VPK72VN#8#-6!KN!%D6B@"T \2$>,L8W0"K5I^PN>H[<#48NO MP8(RD8S4I0I"?^4LJL[8'"'F'+W(E?Q*HL(VCFGC:3(B]((A2P+674V]7O-[ M$8TW@FO8AE;G9*5[6!OR="<=S#R#W)B*L^O=I1)_F=&^&TA!M =:0Y*LYP-T MP X=#Y'D/@W\@G@.Q6CT@ F!B@E5O<,I'9#%EM*0MXY&^CKQ6)W\)K!VVWZ0 MWV1]W)$LAUL5O"4R1K.9D%CUU4$VVU!OQCX-0U/./(K/FC57?KUUG$!CK;!P MU6/K(H4[E-S[3@[TXFC%_(Z*!3P6NGU*$S!:-J'!M0[ X+$Q!(+@5%=NL4J[ M4!.WVV9S_4QV$\%D-+EP$+M 7O?+P!AEM@UK10W1\.+%9LO8KX:*]P/7H<1H M#Y9"VO;B>]W92/IW.'S3HQ+&FAWYG(AQ:;K@(B,E,R@K,)GN]L^>JIZSOC,F MXGC&)%TB%IHH??UL;=P>J-EC 3]([+<" MK/]J=CB8Z_ C14+%9$U.-I71U;["^L\$YG';$SDBQ;Z$VD#5P#@-5.JT2M!]D:Q$ M^C;! NXO@5N 2KHHI<\5TA"=(9L]PN9H%YH^8MSO2[V/LP#<[?!HS$>/4QM@ M%XR2)G60-&&"W_1 0B>\D$=V$RAM[$(:AS5/Y[2R;MDJJOT[M3TL/#[DO]3D M.QJWSL2"?NK1..UB>]T(3@ME-L*YI@$R;CFH"!LC!:D!5IT1$]/ZF!; MY'^GMH^S'X;YZUS?-%9?DKOQ;LVS!F]ZLL#V/'3V6XNS&P4@M/^E&BUV(5L\ M#>4@.QJ& L!:+HMH/8[R\!0HD!\F7)5 135/(5LQ"9!8II$X;7 MEW@!NQ3[BSJP16VQ,YB6-J]/'.!LDGP5Y619]GGF%9XX/PQFS%:US.M'\35@ MN;Y5/FM)6-W0XA??QKR58)0%=7.?J+?&8>]+OY_&[/;! M@5G?B:4%,ZP3LT:VS57 [+B5+7[^5\9^YK:*Q7^))0K;,R"PP7^EH83%!FIY M'&]_LE9M(MLCW$C-."%(XN.HY76 _ M#B;$\>:U8WNP2R :S*0W&]-_BF&_AZ)**TA:MK#ER%B*"E,^+@'"NK@+_8XF M<"!S4D'ANE"6DAH=&X.P]QBPW:\)XWMNI<$R:N+.#]Z-+^:T<>!]ML42#-.J+^[D1HN7 M6Y0!SD3KT(=(J*&[!1-M)36!01ZEW7U)[YU$X)I6/3Q(]1IS%) 4[6.".$&S MQ&5KL+QB]4R;G%GR>%TR:E)+EO&F[;(_^WPP&7RPP>BKXF&ULE59A;]LV$/TK!P\86L"Q;"59T\8V M8"=-FP_MC+CN/@S[0$LGBXM$JB15)_]^CY2L>(%M;%]L4>*]]^[=G:CQ5IM' MFS,[>BH+92>]W+GJ0Q39).=2V(&N6.%)IDTI')9F$]G*L$A#4%E$\7#X6U0* MJ7K3<;BW,-.QKETA%2\,V;HLA7F>Y\S>BZ;@2&UZR6U4+ M@U74H:2R9&6E5F0XF_1FHP_S2[\_;/@N>6OWKLEGLM;ZT2_NTTEOZ 5QP8GS M" )_/_F&B\(#0<:/%K/74?K _>L=^EW(';FLA>4;7?PA4Y=/>E<]2CD3=>$> M]/8SM_D$@8DN;/BE;;/W\J)'26V=+MM@*"BE:O[%4^O#7L#5\$A W ;$07=# M%%3>"B>F8Z.W9/QNH/F+D&J(ACBI?%&6SN"I1)R;+IMBD,YH*3=*9C(1RM$L M272MG%0;6NA")I(MO=E=O1U'#M0>($I:FGE#$Q^A.:5\C#_X= WW(F3&(EC @=CH$0J4D M+.:W\GP6;,*1R#),F&C=M:5U;6&LM?T]63 FE3ZG?I %(S#4UAN*MU_C+@RTE&/&@5ZKA(W#&R_L MMO7Z[^" IB07:L--#BVOQ[8R90,[O)Q*^]0\::NQJ=J!]+0ZJ/]X.?PZ9<>H ML IL(CA@F+;">GM)D(\T>^P0?8BD5J*&(T#Q\C$0J?"+PX4,1GER-%= <[EA MIK*9>/833YA7U'$WL /ZK+?\DTW?OY9KX.TLQQ06R$*BJ0QE1I< T_9U$S99 M^?JON37='DOE)1+URFI7(Q)%E3JU@Q-S?=G-]>7)J?R*@V?_Y6&TTKX_&F_. M:);JRKU^Y37C?AKX@1- H-ON46(X^!](Z%[1+<+*-#(75>U/8RE M@Y'"I);F&G_TQAL6#Z_O9LMYN!Q=OT7+OZ9^"5M5OB>ZN-ERU85]U8- ?S:* M^]"$&6?Z)IY0@B7:KI!9F'H1JF.<*;A=-5.#;7VN$0#I&PO M=V]R:W-H965TLFY05^*O-0GHZ4QU=%DHM,E+Y@^E!4O86*L\P)%?F$$A)/ M"B;*T>FQHUVJTV-9FUR4_%(A71<%4YMSGLOUR<@?=80K<;_MXEUV,B+6 M()[SU%@-#!XK?L'SW"H",SZW.D<]I!4C*8C ME/$%JW-S)=>_\?8\D=67RER[?[1N>)-PA-):&UFTPF!!(%HK)07 'S S0>X18?+#%I8*U?. M2ELL4'"='7-KAV6!0*3+/A(HE5":VEBS%\@ ZD+F4.,@>7Z M9S'%,T*?+IPKZ"^#M^NE5.; <%4@4:ZX-B[QO23&41+B))[VG%M(C=DS@J,@ MP7%"AF!;V ?!AL- >8"3K#^<"S.NF.M076@V:*PY1[]+P]%TWXLQ30@FA/3J MNN?#3F//JP%EVY&'^S\N35[SE!=SKKH@DW^9*<_T_,_) M$+IC,<)L'3Q3-L$_E/"1("R/6$>=CXQI1@H[%6 &5M% M_,<)%N&0[$JP?G]'$XWZ)AI]?60*(ER]#G6MH4 MK91(^;9^QS322[DNT=Q^RAQY3SK960&:Q=^@X4)JX]V6\(V4N_6O\&V$QN^E MUOM6R.:@2WC@$1;QVC #B$:Y_-\@;6O*Q=YVL1@3.H/F$L$"&LPL:HD!+&(" MR5$47*6"Y:AB%52+K=Y4JDI"DG#X0)F;H<(@P*%/,0D#;^SC61!Y^PV-8)], MFQJ"4D[OP:Z!&,6^[V,:S+PQ3:8@8PD$#/"]"P['7HC4HD&@,EY)+8Q'(<\I MP0F(=-DQ('7IY'HEM,YI;!=3VI&:]OD]P7K>=9[&ZWD_^4$A@S.2B.(D2FRH M\#0,.F*(8_+=(0L3'%$?!V'HC:&\0@+NMS0_@NLF?#%D"005\'P(F;5DWQ$" M/(WISI#YV)_1QR%K2%W(FG8%&>G;:(U#'$0A:'\U[&,[BC_NBS_>7:C-E&#M M@Q/6164[GD:W&DYI)'JCC2BL_8/[ U@'K?*2;5[L$;NA[=7(!IAUB\D[3'>% M#2["A>W+'6[5X@(7I"53'*4Y: -_VQL49WQQ[[3.BU_I$H2L&AGF?W'P")IRMX/H PILO%4Q&0%C) M'*Z3Y@[PD\-PKWM<"7U_L%#<:H0BA.,CFZ >.22SO?;?%HYS *N$S8^ [+F? M_;*6-9@+&ULA55MC]LV#/[N7R%XQ= "ZEE^4M\V,A6B[W8P0/X/_9KBUHVH;12@7;2:&)ANTQO\YN[ M*MA'@S\E'-R93$(F&V,^!^77=IFR$!#TT/B ('#Y"O?0]P$(P_ARQ$PGRN!X M+I_0W\7<,9>-<'!O^K]DZ[ME6J>DA:T8>O_)'-[#,1\>\!K3N_A/#J-MQ5+2 M#,X;=73&")34XRH>CW4XR2*4;X17JP6UAR(#=:(%H28:O3& MX*0.E_+@+9Y*]/.KM<7[M?X;$;HE;[\,]BTX-[M<@\,@7[ MK#FBWHVHQ3.H)?EHM.\<>:M;:+_WSS#"*87H87SLQ6W*AUC\J M\655DG'\3&6.$-1OQDF%-6Y?2:%\F7)OU'[P8$=('YK,*#5HV8C0;"XI M.*,\GR5%P6B)ZX/9^H.PD,PJ6K'Y:?D V%&=Z5LBU=Z:KQ#X'!)6.:9Z\"@J?U[2.RG/L&D+).MBB*[NZYBFQX[@:%6_V<41LC,>!$\4. M)SS88(#G6V/\20D$TS=C]1]02P,$% @ 6#FQ4@+2?=M6 P X@< !D M !X;"]W;W)K&ULQ57?;]LV$'[77T%H1>$ :B31 M^N7$-F G71=@'8(D[1Z&/= 2;7&E2)6DZKI_?8^4K'AHDJ=B>Y%(ZK[OON/I M[N9[J3[IFE*#OC9A*$N:]H0?2Y;*N#+5JJ&&-BJ7:A;14GE0 T/ M<11E84.8\)=S=W:KEG/9&4C4 V4H.%RWK\6*]M]HP^+_!](.FVXZCWZ%0 MM/=.2:W1%5'J "CTD?".>JNR[)J..^M5(Y5AWX@M+^\/:"!K*+[!#N*D2A#. M#U C7Z#V6P"T !-&>]D;'*$#)4I[K[Q9D@4%+F U28HL2)/".X--DD4!+B)P M^+EC"L")R\WHH<\-G@9%DCW5!\*3 MOMM0M7/3Q99>)TS?@L?3<8"M^K[]:-Y//RC)'1,:<;H%:'2>ISY2_43I-T:V MKHMOI(&9X)8U#&&JK %\WTIICAOK8!SKR^]02P,$% @ 6#FQ4JSQJ,RP M @ YP4 !D !X;"]W;W)K&ULC91M3]LP$,?? MYU..,GE03AQ9KL4OOW.3AJ*"FQ2F]C. M_7]W9_MNOA7R7N6(&AY+7JF%FVM=GWJ>BG,LF>J+&BOZD@I9,DU3F7FJEL@2 M*RJY%_C^V"M94;G+N5V[D5'@C06W*DLFG%7*Q7;@#=[=P6V2Y-@O> MH?]0WDF9>1TF*$BM5B HDI@OW;'"Z&AI[:_"SP*W:&X/))!+BWDPN MDX7KFX"08ZP-@='K <^1#*/F';VOHNQ!NE1=F**8*RJ)HW>VSWX7\$02L( M;-R-(QOE!=-L.9=B"])8$\T,;*I63<$5E3F4M9;TM2"=7E[7*)DNJ@R^(B6G MX.@[BSBJX[FG"6^,O+A%K1I4\ 8JA"M1Z5S!IRK!Y*7>H["ZV()=;*O@7> 5 MDWT(!ST(_&#P#B_L<@TM+WR#UV;XZRQ26M)U^/T.<]@QAY8Y?(.Y;BXSB!36 MF[KF2!=6,PY"YRCALFK*QMR_6^1,8P):P,&FKQAG58RP-N?XVL[_*X@#S\6> M9_GLF;Z!Z+SSQGO4>F^ZP+YRRQ30+Q6=.G0B<=X=B7.!,981>6M7?.?Z M)1M$Q(O,LNAF*43X)C3"!%B5P.S8^> ,>I-PUAN-9G8\#8:]Z? 0(TUMG8CT M9$,3IA1J1?;3\;@7AF,:S?R0M"/GSA8A)B?L@0 9"=$TIF>01EG"T1,RJ8Z= M87] __!0E10J%IM* P6!SH1,/C;/URZ,MU=\)QIKL,%8)V\ DAG0.IU3X&\RCMFV7ZKU8EHYXUL M;N-3]6@4QZ5[E >K\98CSNX/=:U':,C')WQF X:\_\HJ >;#-K9([YSB>J:Z MF:C25Z@R\EE)VQGR43;0_!?6[D(!OB$V?"D+\.E;$:OXZ_WPB1+R%R'R)_)<0#-DTS"B"J)?\K M+<.PO]D.-+D=M09IR2?.*BZXY6!^5.^W8YWYX9)?>?YZYAZ6PH=W$$-?84L\TD2G",-6K5@7#\R00SH1UZ#"=X%)4VC ME*:XHU%6)!'=Y"\8]JPQE!<'_2#4,P"I0$++K4%_NDZCLE@'*2)I5&PV"Y)+ M"QJ,#6@6K?+<+0DMEVN\ B_<,3?PB/-EP&EA@Q5JH=%JM<9=1LMHO2J#3X"= M2U0E^)&Y:1 M)1J4]N/AO4%=ORH+I/P09&41%4D>9$49K3#F';2 [B[H(\@1 M KJ)5D5V7KXJBP5AW[T'EF,3Y4D1E?G&E8:BL8YHD?_H.XLO6K@'??2#RCW: M*.W4S&UL?511;]HP$'[G5YRB/6P2(B% M82A$*FS5]E )E:Y[F/9@D@NQZMB9[93VW^_L0 I2X26YL^^^[[ZSS\E>Z6=3 M(EIXK80TBZ"TMIZ'HAJ36RW"=5(HRCZ":L&)=! MFOBUM4X3U5C!):XUF*:JF'Y;HE#[13 ,C@L/?%=:MQ"F2<52L.5!(W%(K@=SI=C%^\#GCCNS8D-3LE6J6?G_,P70>0*0H&9=0B,?B^X M0B$<$)7Q[X 9=)0N\=0^HM]Y[:1ERPRNE/C-39=*6FYW*&T0*;A.6KFV_7YD6T%FB]) M:(G&!8?9 7+90L87($=P3Z"E@>\RQ_P\/Z3RNAKC8XW+^"K@/=,#& W[$$?Q M\ K>J-,\\GBC"WC+QM"*,:2XVG+I]1KX<[LU5M,M^7N%8MQ1C#W%^ +%IKWC MH JX8US#$Q,-.N]2OS]J\W4*/U# #;#C1#E\6R)D[QS9V9GZ$>#V;=Y[+#7B MV3D!=3DK79M[KLWN$_66N.-2$A;=?,%DAKU/O4E_]#7J1U%$=MR?3EI[53)B M!"ZA<'I?G-[>;-9N#KLPHCI'N^G'TR/:N#^)O/W1 80G=[Q"O?.3;$A@(VU[ MW;O5[K&X;6?D/;Q]:4@IR3(@L*#4:#"=!*#;Z6T=JVH_,5ME:?Z\6=*#A]H% MT'ZAE#TZCJ![0M/_4$L#!!0 ( %@YL5)'4R\%IP( *L% 9 >&PO M=V]R:W-H965T1BJLH&6JA/L0)B;#"6U8VV!^%BUM$:[D!_[6ZDV84C2L5: M$(JA(!(V<_\B/E]FUM\Y?&.P4WLVL4H*Q'N[^53-_<@F!!Q*;1&H67[#"CBW M0":-7P.F/U+:P'W["?V#TVZT%%3!"OEW5NEF[N<^J6!#MUS?XNXC#'HF%J]$ MKMR7['K?+/))N54:VR'89- RT:_T8:C#7D#^4D R!"0N[Y[(97E)-5W,).Z( MM-X&S1I.JHLVR3%A?\J=EN:6F3B]^*(;D.0*1?UV#;(E5XP6C#/-0)&C-2TX MJ.-9J V3]0_+ 779HR8OH*;D&H5N%'DO*JC^CP]-AF.:R5.:R^0@X#65)R2- M Y)$27P +QUEIPXO/2Q[3^PE4R5'M95 ?EP42DOS7GX>8,I&ILPQ92\PW?6O MG>"&'*CU9!G&3>"D7%K#OE!$H4V+*2,%&"L+U):DF%5EXR MB8(HBL;5UY$&6I<_]TW"O M@5J0M1L3BI2X%;KOI?%TG$07?0/^<^_'F"EFS80B'#8F-#J93GPB^]'0;S1V MKAT+U*:YG=F8:0K2.IC[#9HB#AM+,,[GQ5]02P,$% @ 6#FQ4MZX/@AC M @ +04 !D !X;"]W;W)K&UL?91+3]M $,?O M^10CGT"*\".!4)1$2H"J/8 0M.50];"QQ_:*?83==0W?OK-KQPT2R<'V/N;_ MFX=W=MYJ\V)K1 =O4BB[B&KGME=Q;/,:);-G>HN*=DIM)',T-55LMP99$412 MQ%F27,22<14MYV'MP2SGNG&"*WPP8!LIF7E?H]#M(DJCW<(CKVKG%^+E?,LJ M?$+W<_M@:!8/E()+5)9K!0;+1;1*K]93;Q\,?G%L[=X8?"8;K5_\Y'NQB!(? M$ K,G2=?L-^WS./2_7PH8WM)UM1L9Y8YV6O9@BD%QU7_;6UV%/<)D<$&2]( MQ M=XY"E#?,L>73SBV?F3%,.0LG/]A&H#V= MQXZP?C/.>\2Z0V0'$!.XT\K5%FY5@<5'?4SA##%ENYC6V5'@'3-G,$G'D"59 M>H0W&7*'N'7ZO-M89.@9_CC"G W,:F-,#S*?N$(,NH2\AK/P! M(T>?5? X;+7K"8]K>QSK<5 TAJL*7(WT&$207;G1EQNH6'D]5 NX!6:AU(*Z MS5Z-AM]+_6@=4P61QG"#.U;7C-5(9T(2[[NM4-( MDU.R2)+$/V2!)N<6[>@D'4])?'K S$99HJM"H%G+= M*->=YF%UN M670O\-^\N$G);<65!8$G2Y&QV'H'IFK.;.+T-#;'1CMHK#&NZ MS]!X ]HO-27=3[R#X89<_@-02P,$% @ 6#FQ4C3;6AJI P _P< !D M !X;"]W;W)K&ULC55;;]LV%'[7KR"$/;2 :MTL M2PYL W&:KGWH8CAIBV'8 RT=6T0HTB,I._WW.Z1L1=D2;R\2+^=\Y^.YSHY2 M/>H:P)"GA@L]]VMC]E=AJ,L:&JI'<@\";[92-=3@5NU"O5= *Z?4\#")HDG8 M4";\QK(E]R4;*1[OY4LW]R!("#J6Q M"!1_![@!SBT0TOCKA.GW)JWB<'U&_^3>CF_94 TWDO]@E:GG?N&3"K:TY68M MCY_A]!Y'L)1G3R0\#A2)Z0R$Y*22.=V?( ML?Q(#5W,E#P29:41S2[<4YTVDF/"!N7>*+QEJ&<6]T:6CQ^6^*Z*W,@&8ZVI M<]>[![KAH-_/0H-FK'!8GB"7'63R!F1*ODIA:DUN10752_T0Z?4^@;>1Z9++G6K@-QM7[YZ#9P:YPIM-+FOJ8*- M\\V*_L14Q+,_KC?:*$RF/R\P&?=,QH[)^"WO8XU5+0+6AG09XLR&<+A!J"OB_KWOF$:4(UV4J. MQ:ROO-_:9@/*LG]!T_OAB@&J#X0>0&%QD]LG4"730%:*E?"*P!IL"[%6;S![ MK(-;RLD#J(:\^QVHTN^]Z]U.P0YIHZ^,8M@82O*=\A:\@5N\)$BF:9!.WF>!GD1HT V2C/\%+C,@R++@CQ+O6_B M !IY>G&0Q=,@*R9X/1UE9]0BR*=9,!TG%Y(AZY,A^]_)T)7EYM]E>?MDU_!: M\/\#?8!8#A&A0[2A+3G5FFT9BC!!3 VD%;2MF'$Z0DO.*I&C2X8PM6P0$GS]Z2Q7BE21RDJ8UQ,@VB*/)^!8'DN1.E%398 M9JO;3@JOF.9!%*=>7&"$$?M!&LIM)@5)7 1I9I,FBQ3)3'=* MWYL:T<)C(Z29A;6U[44(5".""B\6O #,>0SO%PO4?_X+63EC4S>*7$=U[9>A:>AU#AAG7"WJK= M1QST3!Q>J83QO[ ;;),0RLY8U0S.Q*#ALO^RQR$/_^.0#0Z9Y]T'\BS?,\OF M4ZUVH)TUH;F%E^J]B1R7[E%65M,M)S\[_T+O_ED9 TO4L*J91GASQ]8"S=MI M;"F ,XO+ >RR!\M> @0O']7F'B]_!>^:: 5_13U3=0)!;6 A M+:^XZ%S5P0K+3G/+D7+S6(J.T@,;K1JX4DW;6>8KE)S^)?C2*QPGL506*383 M4*JF(5SC< QP8SKWLM"U=%@J^8#:]58$#V@L106E 1]1E]QX!9UT%\24O*WF MI5M209;WT8CL=K!C6C-I301,#A:@6B?)@*V9!9=G?";;UN@P#J7[7-']SC<2 M5N\8\:.YL*=/$\58"D!$*9!#QB>/3*'YNWVFH_[(P$8)&CCF(J#F]>'N:HWX MK$"!RJNL77T%KK[<3Q)^KEE*&6=M'USCZ?C M:%ST$^&/>3]72>26TTL(W)!K,"C'\8\]]02P,$% @ 6#FQ4LS# M1+! "A8 !D !X;"]W M;W)K&ULS5C?;^(X$/Y7+'0/7:G;Q$Y"R J0VM+J M5FKOJG*[^[#:!T,&L)K$K.W 5KH__IR0)H'\(%>Q$CQ G,PW_CPSGH]XN.7B M1:X %/H5!I$<]59*K3\9AIRO(*3RBJ\ATD\67(14Z:%8&G(M@/HI* P,8II] M(Z0LZHV'Z;TG,1[R6 4L@B>!9!R&5+S>0,"WHQ[NO=UX9LN52FX8X^&:+F$* MZLOZ2>B1D7OQ60B19#Q" A:CWC7^=$>\!)!:?&6PE:5KE"QEQOE+,OCLCWIF MP@@"F*O$!=4_&[B%($@\:1X_,Z>]?,X$6+Y^\WZ?+EXO9D8EW/+@&_/5:M0; M]) /"QH'ZIEO_X1L04[B;\X#F7ZC;69K]M \EHJ'&5@S"%FT^Z6_LD"4 -AN M ) ,0+H"K Q@=078&<#N"G R0+IT8[?V-' 3JNAX*/@6B<1:>TLNTNBG:!TO M%B6%,E5"/V4:I\;WE GTE08QH$>@,A:@JT!)]!%-=4WZ<0"(+U#)ZEI*T,]I MY*,'1F:Q$"Q:HALJF407$U"4!1^TTR_3";KXX\/04)I[ MPL"89SQO=CQ) \]'*JZ0A2\1,0FN@=^VPR8UJXGIJ74_-^]R[S.NZRJMWA+MM; 38+G33?%]X, M=YQ:C:%CFRW<2AJ.6[E]HT)0'=P\G+4"B>LKKV'R0HLP.5G#0/^B!]A @'"7 M'H(+Q<'6&7817*@,;I>9YN*IJ@*VO#[Q3')8/55+O3D'GNU:#1DL.CX^7F&L-6W22E5Y5V>6@LQ S7 M@5O5L%4W22$;I/U-I9-N9CXZZB8I-(&T:\(CC^ 5Z3?+%U#H/HY\6:[X$_T- M)X4($.<<=T,A$*3?OANH7"'X&;,-#9I:;^:B@YK66+:K*2F4@K0KQ>GR^O_^ M+9%"&\C@'%-=B ,Y\KK0)=5>]4B@(=55RX94&Z5CM.245.=PR2*) EAHJ'GE MZG(1NX/'W4#Q=7JR-N-*\3"]7 '5?3HQT,\77+?F;) @T$ "7$ &0 'AL+W=OX&:+!!W;2'8@^T/8Z%2**7 MI.VVOWZ'LB(YEN2T<) <8E)Z,WR<>7X2/=A*]:B7B(9]S])<7_:6QJS>.XZ> M+3$3^D*N,*<["ZDR86BJ'AR]4BCF15"6.MQU0R<32=X;#HIK=VHXD&N3)CG> M*:;762;4CVM,Y?:R![VG"Y^2AZ6Q%YSA8"4><(+F?G6G:.946>9)AKE.9,X4 M+BY[5_!^Q'T;4""^)+C5>V-FMS*5\M%.;N:7/=#^^"G[AV+SM)FIT#B2Z==D;I:7O7Z/S7$AUJGY)+=_8[FAP.:; MR507_]FVQ+H]-EMK([,RF!AD2;[[%-_+0NP%@-\1P,L _JL!7AG@%1O=,2NV M-19&# =*;IFR:,IF!T5MBFC:39+;-DZ,HKL)Q9GA!Y$H]D6D:V2W*/1:(?7( M:';.)J28^3I%)A=LLI3*L,^H,G:3;U";'>ALC$8DZ3M"WT_&[.R/=P/'$"F; MVIF5!*YW!'@'@5NA+I@'?S+N?ASM4BJH>O*H'+_)Y'?FJ M7?^S8%<;VIR8TH04PR:"!A.!1$[8V(*XKQ M*ZDY;C*(XT.:31#T?:^=(KBU/;LGZ;D,/RBCQ^/0/>#7@K1U]$/7[2"Y]PR! MHR1',LM0S1*1LCNQ0L5$;ONN5E*1R-D8I^8W]0VU7\,;&S;4C@VG6G:98+_F MGN<#=_>$47:GB?2C@(/G=Q@BU*8-K^7:T&+)$'N'2F^#!;[?):/:NN$T[X:F M)]MJNN >FG<+DJH)0>QV5;-V;SANWU=:$\=K,7NT)OY[HJY=&][8MJ'V;3C5 MN*'%D & >_%A%YK R <_A+BC";5SPVM9-S1M^9Q'#;VTH#J?+[PV;WZ:>?,6 M2P9PXQ .^+4 J9)>/^QXH>.U=?,7K!NIVXMD5KR,D-K&N)(Z,;\B9[[W3OW& M'LUKC^:G>C1O.B\/Z# 1-?3<@02(N]I0>S0_[M$O*L5OO--WD6Q'MI!T]DZ- M]LA.'!Z27+,4%Q3J7D2T4;4[!>\F1JZ*@^14&CJ6%L,EBCDJ"Z#["RG-T\2> M3:O?(H;_ U!+ P04 " !8.;%2?CD[.H8$ !G' &0 'AL+W=OO33M39/+@5L[FQ#X+A8,%G< ?FR^)& MX5U06TE$!KD6,B<*IJ>=L^CC>1S;#D6+>P%KW;@F=BAC*1_LS>?DM!-:1)#" MQ%@3'/]6< %I:BTACG\KHYW:I^W8O-Y8_U0,'@LJ[9AATR6VLBLZHP(,I&7__RQFHA&![2SO0.M M.M "=^FH0'G)#1\.E%P395NC-7M1#+7HC>!$;EFY,PK?"NQGAI^X4.2>ITL@ M(^!ZJ0"GW&CR@=R5/!$Y)6<:25O86=3DBX:$&$FNM!$X*4 :%K#IA0+)\_X!#KZ> ;J9@7/J-3CBZHBPZ#="0QIY[+%Z1EEA+]YA[^IQ@2L. M)^E>IMR(5)BG'<-]9CZNS<>%>?8Z84@+X/2>Y0FY%GQL70G0&QX3\F=.;F&R M5 H)*5K](7-5/SCG6FCR[1KMD\\&,NU#=URC._8.OKE2EM5*@:/DN)RR(E94JK\754Y2 M(]9&JIPF1_&AJ8I?4-5E.ZARXASYU7DD.]@U?DA#?JMI%)I]I1[]!,]EXP&75W,.GD._+K]Q8F\3O\ITP\ M_@*NOO=3=(H<]5M(('6J3L,#$_B*0TP;J0^YTWOJU_L1?WR?KY,Z+:>TC>2Z M.$#]N?4[D,M>?IT[DA;JP@'UAX,M3/[0UTF=PM/C-A+HY)_Z$^]W(-#O\+6O MTP4&Z@\,7XO]/2(^6X'B,VB2^\8M'W5R3T_:2*L+"M2?I[\#K?WOV?DWE\%GB<[*# M4A<'F#\.^"A]>YT@=NH>M[&D$SOQCP]=THE?EG1VU0EB%P-B?PQXA<:W)[*Q M$_>XC16?N%&%/W3%YQ6'NQ+9H''VDX&:%2=&ULK57O:]LP$/U7#K,/+;1Q[/P:)3&D"66%%4)#NP]C M'Q3[G(C*4B;)2???[R2[;@*I,T:_Q#KYWKUWS\IIO%?ZQ6P0+;P60II)L+%V M>Q.&)MU@P4Q';5'2FUSI@ED*]3HT6XTL\Z!"A'&W.PP+QF60C/W>0B=C55K! M)2XTF+(HF/YSBT+M)T$4O&T\\O7&NHTP&6_9&I=HG[8+35'85,EX@=)P)4%C M/@FFT MM,NF:F[AO?%HZH9+]Q675M-;3CB;W#&NX9F)$N$!F2DUTB>R!JYAFF7<.7E/&TG,/%E\MQ:$F(*Q>F->EM11I_0/K = =ZT17$W3@Z M 9^UP^>8-O#N,3RD]AL/XL:#V-?KG?=@SDTJE+/!P,_IREA-Y^Q7"T>OX>AY MCGX;Q\YS4$UIO Y7@O.5ES0*<>3T@=GI;=E'$D? M-M*'GV/X&>G#L]+;,HZDCQKIHU;I4W\$0.E#;5!40R4#9B%_;\X-<)!*7FM, M2ZVY7+MAS$WG5#.CLP>_+:-J)CP8D>YZHA&TYM* P)PPW(FWLW^0M02P,$% @ 6#FQ4G 2=FZ M P !P\ !D !X;"]W;W)K&ULM5=-;]LX$/TK MA+"'%D@BD1+U$=@&6F>##9 NC+KM'HH]T#)M$Y5$EZ3BM+]^24J19%M1O86= M0TQ*,\,W;\@GSFC'Q3>YH52!YSPKY-C9*+6]=5V9;FA.Y W?TD*_67&1$Z6G M8NW*K:!D:9WRS$6>%[HY884S&=EG,S$9\5)EK* S 629YT3\>$\SOAL[T'EY M\)&M-\H\<">C+5G3.56?MS.A9VX39<4"U SK5P:\=+'-NA=*Z+=,^ZG)3.@=(=0/0(HE^/-[R;:Z1NH*_*UWT#685\4%? 6&#-_< M4458]E9[?)[?@3=_O!VY2H,S2[AI#>1]!02] N0#$3? AU< >0CVN$^'W>]H MVKA[^^ZNIJ3A!36\(!O/_Q4OLXP4"KSK)@V^/FIK\*!H+O\=6,MOUO+M6L$I M-: MM42!E$O5QV45,+0!S4E]FH0)CF'HC]RG+FG'=BC$./)A8[>'.&@0!X.( M'ZF4M_H(IF5>9D31I3XY6D521JJSJ?,@.1>*_;0/^C*H%L =9-)V91]:,,&;3B(]KX4 M!5.EH%?@GCV;@=P_B>#K!YHOJ!C:D%&S6'3QS1\W:\7GWOSQ,<4QCJ/XH!(] M9@AC/^XO1-+@38:W/EEP0137JOB_N(=>J\C>Q=F''?V'Y^:_CKB_QP,8'9V% M'L,$:YW"_26 K3A#- AZRO-MJ:BHSL G5X6++5Z(T\J2"O/T+]\05II MA: M!Z.S\QX=\1D&@9<E\I/K^NN'9$CSD6\&?J $LA\AH10XF M%Z<>M8J'O'-37T?9T!_+F*_GW[4*B<:5LZI%AHE2MN. M7#\4USJ+M?XLGR0^J',/O?Q%%+52A\Y^%47'=\S LW\'!+N=+L6TB/K&OV9: MJS.ZTI[>3:2+*:JNJYHHOK6-RX(KW0;9X49WJE08 _U^Q;EZF9A>J.E])_\! M4$L#!!0 ( %@YL5+D2)MH/@( !T% 9 >&PO=V]R:W-H965TY:%?]^QDTU3"K27Q#.>[YNWTX,V][8$0/94265G08E87X2AS4NHN!WH M&A3=;+6I.))H=J&M#?#"@RH9QE$T"2LN5)"E7K@489;6? >W@'?UVI 4=BR%J$!9H14SL)T%\^'%R=<%;,@<@&!A!P= Z??(RQ!2D=$83RTG$'GT@'[YR/[9Y\[ MY;+A%I9:?A<%EK/@/& %;/E>XHT^?($VG['CR[6T_LL.C>TT#EB^MZBK%DP1 M5$(U?_[4UJ$'()[7 7$+B%\"1F\ DA:0^$2;R'Q:*XX\2XT^,..LB[8B:MXT7C.'[#<<*NM<+2LDM50/$G/J0D MNDSB8R:+^%W":VX&+!F>L3B*AZ_$L_Q_>/1..$E7V,3S)?\J[%IRA6S>+R_[ M,=]8-#3"/]_Q-.H\C;RGT1N>5D#[FPO?FM?ZT* G'NV6^C&;3"?C\S1\[%?G M;ZOQIW$T[JR:T,+>I%5@=GX!+&ULO5AK;]LV%/TKA#$,+=!$(O7N' ..W74!DBU(ENY#L0^T3-M: M)=$EJ3@9^N-+/2+Z0=-*X.1+;$GWW'L/+W5.S/Z*LF]\08@ #UF:\[/>0HCE M1\OB\8)DF)_2)&_2K>]=LT*>% M2).<7#/ BRS#[/& MC$B:EIED']^;I+VV9@E<__Z4_?>*O"0SP9R,:/I/,A6+LU[8 U,RPT4J;NCJ M#](0\LI\,4UY]1>LZE@_ZH&XX()F#5AVD"5Y_8D?FH58 \@\>@!J &@;X.\! M. V@6CFK[JRB-<8"#_J,K@ KHV6V\DNU-A5:LDGR!M[=CL&[7][W+2$[*?-9<5/U MO*Z*]E1UP!7-Q8*#3_F43#7XD1D/D2&!)9>@70?TM [GR)CQ"K-3X, / -D( MZAHRP\SDR!X8H[%OWZZNJB8-^%(1!&[?!R&L9><=B-(SC(BM2+,@4#->>Z%C51;VU M;D^" 'KN-BM=G.]&=JAGY;>L_&.Q^E,:P+G4SOT3\G=Z='T;A?86%4V8[89! MI&<2M$P"(Y._J< I2+;Y=-]?P4Y;T/$].XB\K?YU@5X8!IZK9Q"V#,*7,3B\ M\N%N2TBN*'*#K=ZU@<@)75_?>]3V'IGWT?7-KSA;_C8&7Z](-B',)"+05DYB MO[YFP37C@J^[AYK\F^OKPC#RMP?1)7*3!5(LT&OMHR9SE_X[1&[VKWP*.HXX MF14IN)0_Z[AN+ <2^>"18*9#CEZ"W*2C7 F97:GSZ/!#U]$A928(O<'HE/8C ML_8_8W3F1,@VS,X,A5KH)B%E,GD8$A9"O+>8#Q* M[='1U+ZK@S45UQ4/A9YM;ROCX;A-3DKGT=%T_CD.AG:5_$1/['#@)C.E^N=80G\@$30H_8N@FX24U#MFJ3=/K+N^.TK?G3?0 M=V?M#.I8^GX@D4G?7P2M"5EKQYX98?/J-)B#F!:YJ$] V[OMB?.P.F>U5'A] M7'V%V3S).4C)3$+MTT J.:M/@.L+09?5(>J$"D&SZNN"X"EA98!\/J-4/%V4 M!=IS^,%/4$L#!!0 ( %@YL5*T& TJ ( -4& 9 >&PO=V]R:W-H M965TMG%EF3R\9$4GWM;I1]-CFAA)PII^D%N M;7D5AF:1HV#F0I4HZFIM M"R[Q1H-9"\'TTP@+M>T'47 XN.6KW+J#<- KV0IG:._*&TV[L$;)N$!IN)*@ M<=D/AM'5N.OLO<%/CEMSM :7R5RI1[>99OV@Y0AA@0OK$!B]-CC&HG! 1./W M'C.H0SK'X_4!_:O/G7*9,X-C5=SSS.;]X#* #)=L7=A;M?V&^WPZ#F^A"N.? ML*ULT\\!+-;&*K%W)@:"R^K-=OLZ'#G$Z0F'>.\0OW"(VB</%.5GL?$O6:?WS@/XH; :^9OH D^@AQ*X[>X#-^OWNK@4Y2ES/Q>,D)O!E- M6;:F8OY8PNO2/GPG-8GA"I@TD(*I>1I>0L2?3D%&GSJC3 MB'V+AJ 7.3"9P00W)#(E28:%AVL4<]1-54OK&.G_;U&W#M9M3&AXW!'#-*T3;=TDV97$/L-4@D^CM.+20(%+@FQ==*G5NA+1:F-5Z75HKBRI MFE_F]-]![0SH^U(I>]BX /6?;/ 74$L#!!0 ( %@YL5(3P03 CP( &<& M 9 >&PO=V]R:W-H965T:4Q]Y?LZ+Z&B^ES6(/!D(55%#9IJZ>M: 2T_P3S5 M]PHMOV,I6 5",RF(@L78FX17L\3Z.X>?##9Z9TUL)G,IGZUQ4XR]P H"#KFQ M#!1?:Y@!YY8(9?QM.;TNI 7NKK?L7UWNF,N<:IA)_HL5IAQ[%QXI8$%7W#S( MS3=H\QE:OEQR[9YDT_@F&#%?:2.K%HQVQ43SIB]M'78 R',8$+6 :!\P. *( M6T#L$FV4N;2NJ:%9JN2&*.N-;';A:N/0F T3]A8?C<)3ACB3_:A!4?211$X0$]L_^'!SURXJZ: ML>.+C_"U-?P]F6NCL$/_]' ..LZ!XQP,$YH^&0KH8M<6QVR*RS M, ["^"+UU[LW]]'M8C2\O.R\WFE-.JU)K]89U26I*2L(-C:1>\HYHW/&L?E! M'Q*>?!0>CN+A8$_X1[?+X2@<[ GW=[[9"M32C3)-;EA,W)/;V MISA%FZ'W1M.,8.SN)1,:DUL@97 ^PI*J9JPUAI&UFPQS:7#.N&6)?P)0U@'/ M%U*:K6$#=/^6[!]02P,$% @ 6#FQ4K&EN=.X @ 0 < !D !X;"]W M;W)K&ULE55=;]HP%/TK5]$F46F0D$" "I!:JFF3 M]E$5=7V8]F"2"['JQ)EMH/WWNW;2C+:!K2_$CN\YG'-LWTSW4MWK#-' 0RX* M/?,R8\ISW]=)ACG3/5EB02MKJ7)F:*HVOBX5LM2!.%-Y^Z=]=J M/I5;(WB!UPKT-L^9>KQ$(?*9G[#DO(< M"\UE 0K7,^^B?[Z(;;TK^,%QKP_&8)VLI+RWD\_IS NL(!28&,O Z+'#!0IA MB4C&[YK3:_[2 @_'3^P?G7?RLF(:%U+<\=1D,V_L08IKMA7F1NX_8>UG:/D2 M*;3[A7U=&WB0;+61>0TF!3DOJB=[J',X (31$4!8 \*7@.$10%0#(F>T4N9L M73'#YE,E]Z!L-;'9@HF*&%QOX@I2&ABXLJPT% MN:9A60JD33-,@#09*OA<5$?'[L$-"F8P!2/A%<\E$ZQ($);N+':NT# NSHC^ M=GD%G7=G4]^0?"O"3VJIEY74\(C4KTSU(.I_@# (^RWPQ6GX%28-/'@.]RFT M)KFP22YT?-$1OMKGSXN5-HI.XZ\3G%'#&3G.P3]W0UAVD"O!-RYK#1V-"-^D M01@!*U*8M$98\<>.W][@W;P_BB;#X63J[PZS:JD;AX/Q(&CJGAD8- 8&;S*@ M["WJRG5W2Q.F-1K=IGKP2LTXCJ,H?B'Z==DDB,;AL%WSL-$\/*GYSEUU3+ML M1^(W)!IM^_MKPJ#*H?.(3.G6S$_3#\ AH0^Y+$P&,:3LL2V%Q?_Q1!4/$8Y; MF)XE$#<)Q&]+(.4ZD=O" &TFMED^S3?J1<'[-H=OAE5V_(/^9K\MU DVG*Z$ MP#41!;T1):>J?EU-C"Q=RUM)0PW4#3/ZQ*&R!;2^EG2/ZHGMHLU'<_X'4$L# M!!0 ( %@YL5*YJPM-$P, ,4( 9 >&PO=V]R:W-H965T\YNB+HFZ_:F\O\7OO+UQM@%?SYMV1INP7QO;Q3._-Y+R6MH-)<-45#-O"OZ9I%; M>V?P@\->'XV)C60EY1\[^5C.O, "@8#"6 \,'SM8@!#6$6+\[7QZ_9%6>#S^ M[_V]BQUC63$-"RE^\M)L9M[$(R54;"O,5[G_ %T\B?572*'=+]EWMH%'BJTV MLN[$2%#SYO!D=UT>C@0T?D00=H+PN8*H$T0NT .9"VO)#)M/E=P39:W1FQVX MW#@U1L,;^R_>&H6[''5F?E44:@LE>7>'=:%!D]?D%BNEW H@LB*#;=:4Y(O9 M@"*+K5+0&'+-V8H+;CCN7BS!,"Y>HI?OMTMR\>+EU#=(:<_RBX[H[8$H?(3H M$U.7)**O2!B$=$2^."]?0M'+@X=R'W/3)RCL$Q0Z?]$3"3H.\ZI/PO'JKZN5 M-@KK\O>98Z/^V,@=&S]Q;*MD!=J^,TP0#6K'"]!C23VX2YT[^^KNYBD-0QI. M_=UQ\H9F-$H"FL>]W0/-GX?+[I44PI4)U*V0]P!D!0U4W(QB']PFQSQT M$J;)Y(1[:!=&"4WR?)P[Z;F39W'SQH ";<80DR%BE,7Q">"854#3<;RTQTN? MA8=HP%2Q<7DM88?-M\56.HJ;#D"RD-(L.\WHB%U$TTGV"'+6(V=GD:\!FRJ1 M*\'7S#;J5]C%#HVBERSCDQY_ M&ULO5A1;]LV M$'[N?@5A;$ +I)9$6;9<. ;BN,$R-$40(]M#L0=&HFTBDJB25)P ^_$[2HJH MU#+M-?'R$),2O[LC[[[/9TXV7-S+-:4*/:9))D][:Z7R3XXCHS5-B>SSG&;P M9LE%2A1,Q)/1C>R-49Z*W> MB@JI>%J#(8*49=4G>:P/H@4 .]T 7 /PCX#!#H!? _Q# 8,:,#@4$-2 X%# ML 8,R[.O#JL\Z3E19#H1?(.$7@W6]*!,5XF& V:9KJR%$O"6 4Y-SWFF6+:B MF4(PE"RF@I0I_XC.XICI(4G095;5L'[Q?DX58]WE[W2!PM]==;*_#H^#%NA=G,6C.8F ]BT7.U)+!&5RO"7#B M!,@!"?UV1=,[*FR''30.@J,E=-CX&%HW<;82E*8Z?3&DM8O =GQ)X/#DEW?O M]E3QJ EH9#5XFPFZ8E)1 44FX62I1'P)Q96FL'N0P>B^*\K*:-#*L1>&(QSL MR''81!/:H\D_+@4_H+AGX7;1NN[N(ALW 8Q?463H'Y@_4"#EBM0*_16^P^>B M6*&S/$]85$GU%4M@$8?".: \/==\9;A'*U"O]<7D'4US9K7M@_/B&;7U\-N$ MA:"6T\[8[ Z&+G#R2=K.T,BV9]?MKX7.>D6D3-*HT&T<4H+$$'&'FSI NU&\ M/T"CI9Y=3%_V'"3E1:8Z0ZK,A&TQ[X^#'#*L MDP?1SDBV-SP>[8P.>W8A?AWM1ENT\ZVT,X+LV17Y#6AG=W [8QX>W;U_DG: MV8WNIQTV"H[=-Z%=;:9-.[\?#+J3B8VT8[NT[Z7=@@"%_B.1<*MA/E['C(WV MXN/US#.\W;R&KHU)V$@NMDON%Q91*$I$FA9P%V/V&/)<]$2)L%:D46+\2B7^ M:8'%1F#Q\006&X'%>SK=O*.U1((FE.BL*.0C:'G5NE,C]M@.W+[K_F8+TP@N MWM<"[PES; O3;GM_F$9J\2L;Y?/J%\1"_X)H/[\BCRPMTD,JR#>ZZA^O,_:- M?/I'[(S][+_D7#U/]-U5&ULC551;YLP$/XK%MI# M*VV!0$*[BB UZ:KMH5+4J-W#M <'CF#5V)EMDO;?[VP(31J2+0_!-O=]]WW' M<21;J5YT"6#(:\6%GGBE,>L;W]=9"175 [D&@7<*J2IJ<*M6OEXKH+D#5=P/ M@R#V*\J$ER;N;*[21-:&,P%S171=552]38'+[<0;>KN#1[8JC3WPTV1-5[ M\[2>*]SY'4O.*A":24$4%!/O=G@SBVV\"WAFL-5[:V*=+*5\L9L?^<0+K"#@ MD!G+0/&R@1EP;HE0QI^6T^M26N#^>L=^[[RCER75,)/\)\M-.?&N/9)#06MN M'N7V.[1^QI8ODUR[?[)M8P./9+4VLFK!J*!BHKG2U[8.>P#DZ0>$+2#\"!B= M $0M(')&&V7.UATU-$V4W!)EHY'-+EQM'!K=,&&?XL(HO,L09]*9%(:)%0A# M<*E9#HJZ^GXAB^;!$EF0>\H4>::\!KL[B;FX T,9OT3PT^*.7'RZ3'R#(FTJ M/VL%31M!X0E!$7E ^E*3;R*'_!#OH[G.8;AS. W/$CY0-2#1\#,)@W#8HV?V M__#@C)RH*WCD^*(3?--:XXG66+IJR80KG":_;I?:*.SIWV=2C+H4(Y=B="H% MK)@0^(2PP3D5&?0]A88B=A3V5=^DX^AK@+_$W^Q7YS@NO!H?Q!UH''<:QVHLSNF2+\=APW->XLY+ M?-8+=NH_BAT?%3$.KWH$'L>-G+Z/ OV]%[X"M7)S4&/%:F&:-Z,[[4;MK9LP M'\ZG.(*;B?E.T\QO['OL(DTX%$@9#*ZP;*J9BZENA9V[G94,J M8))PA@1LY\Z5?[E(C+TU^$[@('MC9)2L.7\TD\^;N>,90D A5\8#UI\]+(!2 MXTC3^-WZ=+J0!M@?/WO_:+5K+6LL8<'I#[)1Y=R9.F@#6[RCZHX?/D&K)S;^ M$TH4 M 8G.T*HY6\2W:,QPL@2%"3W1B(?5$DT^G*2NTN1,"#=OB5PW1()WB'S!XAR% M_BD*O, ?@"_&X4O(.[CW&N[JE'1Y";J\!-9?.)Z7GL@ED3GE3%<>KN^SDCK.T1#[&*WX2;Q>$T M/"+UULKWO="?#9-*.E+)**E[KG02N:V^ESJ@+W4X1#AY>ZP7_BP*IT>4!^RF MP32*PB/.;J^?F%ZN[V9!F$04MAKIG5]HU:+IC\U$\=JVF#57NF'98:E_*2", M@=[?XGE?T%4$L#!!0 ( %@YL5(ZC&]-AP8 /@A 9 M>&PO=V]R:W-H965TT=+:)2*)+478"[,./E&51J67:3M.Y+QK)TI%_\HZ_ M.](^70CYD$T!%'I,XC0[:TV5FKUKM[-P"@G+3L0,4OUD+&3"E+Z5DW8VD\"B MPBB)V\3S.NV$\;1U?EI\=B?/3T6N8I["G419GB1,/EU"+!9G+=Q:??"93Z;* M?- ^/YVQ"=R#^C*[D_JN7;42\032C(L421B?M2[PN^N &(/BC;\X+++:-3)# M&0GQ8&YNHK.69Q1!#*$R33#]9PX#B&/3DM;QK6RT5?5I#.O7J]:OB\'KP8Q8 M!@,1?^61FIZU>BT4P9CEL?HL%G] .:# M!>*."O^1XOR7:^%PCQ3(BF-M8*$ MI\N_[+&![)<('=(PNHH@; MC[,8W:3+N#7^?S,$Q7C\5K_QY7Z(WOSR]K2M=.^FC798]G2Y[(ELZ.D:1B>( M!$>(> 0WF _:W3.K>NQO-KW8P]_%&\==N\R&$E?EW MO;>UPRJODA2 !] MT*;H1D&2H;_M]3\.$7XEPB]$T TB[J0( :(,C:5($,^RG*4A(#%&X3*HLB*H M>(IF^2CFH7XR!LG3R1%*037Y8-E?I^C/('%^[E/<[1%?3_F\02FME%*GTD%- MSQ&:,8F$AJMB"B(T9W$.: ;Z@RF3T"1KV7BW)LL[\3S/BEJ&P-;7GFD/*NW! MEEF&X^L\C;34KTQ*EBKMR%M(1B!=3NQ4S7<.%TG=2D37.<:/N1F.B9P,PEQJ M FE%(8MC/>C1$UJLQJV])DVFR)J\M.PBJ$]_\\SW*E4]IZJKQ["8G+WFO5\U MWC_:Q%; M[F+R$TER6;:^LRZ+8NQF<5T7@C)P(Z0SN)XZ.!XO ;*:O$9I_IY.M/#%;OK: M&*NK M8# 18N)4+C2'0/ZFU_C,5)^-M6)OK53 /B&N>+5DQOT7N0;]BUZ8C(GE,?$. MYSEBN4M^"G<'9#_NDEJ]Z^;N72XUTQH%F<*S$20#LDY;0O0*[OY$FC8G>W= M^B&4R<3-Y[P%8]>QQ MHWIWGW@;/8G%.7%S^&,AQFCG(D)*&)I(,/$A]AA8XQC<'7OY-Y:2>#[G7[0H1M6 MLH4]V0GV55HJ^'+DK.(&99/UY$/\9B&^);_OKL3WC8:79R/?I@$?'_"8P<+? M=\/_-38I@[*/9_5MQ_>HW]G@N=HQR)9D, =Y?!''0B6:-^A34;3\R&KV+<9] M>D '61S[;BKNN9K+UNJNZ :;*S??$M7?0M37/I$:E!T^JS,)=>V+?(MBWWWJ M<:&._YS"\2V3#Z :%W[ITR'/E.2CO(BKBXD$* *M3@)N@'7/TBC6?_5@9RQ] M0OH6@0[.4$A $RGR&8IYPLU>->9LQ&/3>/WE2_29Q_"$[NTRTXEUIY"UY/=[ M!PQ9RWW?S?W]0O:J;*T>L@1CK[LU$, MID =P<;8HNLG+[U^UZ6G=N[M+KF'H&=#:N=4TQ**K/GXE*Z?NF"7!ILG/7P;I'7%W;?$#=^> 5"?O^]JZ.Q0\?!KM@D=ID0 ]8EU-+9^JNRW]L M@0_+UG=>X!;7U(WK/1;XD*Z7Y[C7=P148&$=N&']_P24?GJ[W&7O$F.!I7=P MP'(^L+ .7@W6PV =UB6JO_=EN_8=N/E-A/;1A*<9BF&L3;V3KH:,7/[,8'FC MQ*SX6GPDE!))<3D%%H$T+^CG8R'4ZL9\TU[]V./\/U!+ P04 " !8.;%2 M"#'V-V," #G!0 &0 'AL+W=OUEP* M+ ^Q*)'G'(HBHZV0SZH 0+*K2JXF3H%8W[FN2@JHJ+H5-7!]D@E94=2FS%U5 M2Z"I#:I*-_"\L5M1QITXLGM+&4>BP9)Q6$JBFJJB\G4&I=A.'-_9;SRRO$"S MX<9137-8 ?ZLEU);;H^2L@JX8H(3"=G$F?IWL]#X6X=?#+;J8$U,)FLAGHWQ M/9TXGA$$)21H$*C^;. >RM( :1DO':;34YK P_4>_:O-7>>RI@KN1?G$4BPF MSF>'I)#1IL1'L?T&73XC@Y>(4ME_LFU]A]HY:12*J@O6"BK&VR_==?=P$!!X M9P*"+B"PNELBJW).D<:1%%LBC;=&,PN;JHW6XA@W15FAU*=,QV'\1*6D'!6Y M(:NV+D1DI-LE4W-G#%_)U1R0LO)3Y*(F-:%NTA',6H+@#,& / B.A2(+GD+Z M;[RKQ?:*@[WB67 1\('*6S+PKTG@!;XJJ 1U 770W\/ H@[.H"Y>&I/G[^E: MH=1/Y<\%S&&/.;28PX_N5C>#0LI3QO-K,H<$JC7(?0[>J3MM@4<6V/35)O;# M,!S[?N1N3B@:]8I&%Q4M=DE!>0Z*7"D \D,@$-\[6=71L0+/_DXK&/<*QA\H M )DP];YF+>?XB//&'P9G&,.>,?R/*NA7E!3],SHE)CP2$Y@*?'E? O>@^2J0 MN1TQBB2BX=CV8;_;3[%IV[Q_W=L1J$7EC"M20J9#O=M0L\MVK+0&BMJV\EJ@ M'@QV6>A)#-(XZ/-,Z(IVAB'H9WO\!E!+ P04 " !8.;%2C&Z*5,D$ ] M%0 &0 'AL+W=OWM7:7L7M>KNP^H>'' 25,"<[23-_?JS#<&D :>[VM.U#XT! MS_CSYYEO!B8[RI[XFA !GO.LX)>#M1#E1\?A\9KDF ]I20KY9$E9CH6\9"N' MEXS@1!OEF8-<-W!RG!:#Z43?F[/IA&Y$EA9DS@#?Y#EF^QG)Z.YR >'&_?I M:BW4#6)X^_:Z:!94QFVQP?OG_3FY686 MF)-KFGU-$[&^'(0#D) EWF3BGNY^)_6&1LI?3#.N_X-=-7<<#4"\X8+FM;%$ MD*=%]8N?:R):!M#O,4"U 7IA@((> Z\V\%Z[@E\;^)J9:BN:AQLL\'3"Z XP M-5MZ4P--IK:6VT\+=>X/@LFGJ;03TP=!XZ/QX0:\^^7]Q!$2B?+GQ/6JLVI5U+/J)[(8 C2Z M ,A%L,/\VFY^A]D0>+#7_.;UYNZQN2/I:SA$#8=(^_/Z.%QC1D 'AU>,X6)% M9)H(,-N#]KPYWNO;5SO,$O#MLW0);@7)^5\60%X#R-. _!Y O^9E1O>$<%!N M6+Q6"UZ +@?2F9V$ZA&[BN)';;YO1TVB@8>U$SZPBIWR#UK4BK M\%MH2N(V=>19C3OQ^J=X$0R]T4O I_,0]",$NQ&/&L0C*V+DP@@<" 8:/YC7 M+(-YA@OP[8[D"\)L!QDTBP5O([+&#:#Q]T<65ZOSKJ.JG(U:1Q"./:_[ ,(& M0O@3@SOL"&[UUXTA:C!$/SULH^]" ETCX.YY+.#/4JW/7Q-\L%4;X-L(/VBD M%B+K;K\0+M)B!>:$I33I+!UV!S[8$\RX#8R166C7V8IZ6AZ./F45/19P=H?0 M/8_.2"NT:^MCP4A,5T7ZS\LHC2D7,FU;Z#NS%W8HK6L-6B.BT*ZB1]CXF6RZ M *4F%,@F!-1VZGDGYC/J7?$+)-$Y+<2: ^2#!.^MC!NUAH'5^Q\;E7N +L%1 M4EZ WV2Z"-(=$<&)1@9!U$^Q46IHE^IV<'*PJA!<@)WNA$GR 6\)DYV]))FP M.)7%JV1IW*E<]4)A.PZ"X;A'QZ$1F#E-O35;"U/['!U%E#_R1]TAA4SQ0':M M[Y=G2Q.!.KIPBR C4RR0O5C(L).,UXF6TRU/_ M0^)0^SQZXPTMZN"9:N#955E'NJWPSFH'1TR$\)0)I_6I2GU8O,-LEK@E."%,3Y/,EI>)PH3Z(-5],I_\"4$L# M!!0 ( %@YL5))G:7JE , /8+ 9 >&PO=V]R:W-H965TR1KP $>BJ+BH^LE1#K=[;-DQ64 MA _H&BKY9DE9281\9)G-UPQ(JH7*PG8=)[!+DE?6>*C79FP\I+4H\@IF#/&Z M+ E[GD!!MR,+6_N%VSQ;";5@CX=KDL$PY9U[I%Q94/JH'CZE(\M11%! (I0*(O\V,(6B4)HDQX^=4JNU MJ02[]WOM'[3STID%X3"EQ4.>BM7(BBR4PI+4A;BEVX^P*IK24R>9$A^L"S>4)2.L"$%VB3U5S M -2;6RB(D-L%15H:W:S5.D""5&E>9>CU-0B2%V^&MI"4RI:=[(@F#9%[ MALA#GVDE5AR]KU)(C^5MZ5WKHKMW<>(:%7XF;( \_!:YCHOOYM?H]:LWKY"- M^(HPX,W58,9K(^EI,]X9,]Y0F7 M:]^N%EPP>42_&T@N6Y)+37)YAN1+72Z J;0=Y>?M48)^HC[/FW@VZGVM7GW6 MF['KQIX7A$-[T\/EMUS^WW&]?P*6Y)PLY&$SY;ZWOII-!>@9"#.5/-SI M'OC_87<.02^VV93?8*,8E4U_P!%*R;/1#_?@A_O__-@?E5XGS'9^(_:'?H,] MHZZK+&.0R<8BN[-@N1R4$G1/BOJT./2"-LJ#;N$* A\'\9DO#1_:#S;W'P/8 MBSK0"W;:?<+(]T/?.\-U:#_8W'\,7-VOOQ?*/XE6%,9^?.F^@+([HU@)+-,# M)T<)K2O13&7M:CO47C6CW&%[,Q'+N263D*B I11U!J%D8,V0V3P(NM:#W8(* M.2;JVY4&ULS5;);MLP$/T50N@A M 9IH\QK8!KRD;8 $-6RD/00]T-+8(D*)*DG;2;^^0TI6%-LQ4IZIOI-HG5^YKHH22*FZ%#ED^&4I9$HU3N7*5;D$&EM0 MRMW \UIN2EGF#'IV;2H'/;'6G&4PE42MTY3*YQ%PL>T[OK-;F+%5HLV".^CE M= 5ST/?Y5.+,K5ABED*FF,B(A&7?&?I78]\S &OQB\%6U<;$N+(0XM%,;N*^ MXQE%P"'2AH+B:P-CX-PPH8Z_):E3[6F ]?&._9MU'IU94 5CP7^S6"=]I^.0 M&)9TS?5,;'] Z5#3\$6"*_LDV]+6*7&2S" 2JXS]0ZLI2":,L=**/-SB!N1&0ZK^G)#7J.0UK+S&J:- BAQ'=350 MY/A80@O&EF4T%6,S\ ._$S8QVIMZH _M K_1#5[,7BEN5HJ;)Q7/0 &544)H M%I,);+ HY5AB-'FX@W0!\E146M4>K<^8M'8EK_WA22L8F[5DA($?AIV]G!V: M!5W/\XZGK%/I[9S4^QTRD)3;C UC+&A,:4E-*7]/TKK5+MW/F#3?>ZFZWH>G MK:2L_T2=;MOSP[V\';'S.\W#G\VM=8T4Y,HV4X5RUIDN:FRU6C7LH6U3>^LC MT\AM-WJA*6X!6$%7+%.$PQ(IO]-":.QT=IC@902D,<#O M2R'T;F(VJ*XW@_]02P,$% @ 6#FQ4AD'4Q!] P &0T !D !X;"]W M;W)K&ULO5??;]HP$/Y7K&@/K;21.+^@$R!16+=. MJE2UZO8P[<$D!T1+;.8XT$K[XWN6R8K*%C9$VO@^&8A9,$43N72+=<26&I 1>[ZGA>[!#HBR"%1 MV@7#GPU,(<^U)XSC9^W4:=;4P/;XT?N%21Z3F;,2IB+_FJ5J-7(&#DEAP:I< MW8CM)Z@3BK2_1.2E^4^VM:WGD*0JE2AJ,$909'SWR^YK(EH &CX#\&N ?RP@ MJ '!L8"P!H3' J(:$!T+B&M ;+C?D668GC'%QD,IMD1J:_2F!Z9)7W2&#@-.Z S_X&Q]4#SZSN=< _V.%73#ZNWAG\Q?'P/U9WL9!--?VF MFK[Q%S[C[P8VP"LHNQ+9(6.#U'JS&0^"?J0YV[0#/C3S?>K'9V%C]R2RH(DL ML$9V/KF939KN(M^NH)B#_&[).6P\AU;/LTKNFE$L2%+[[^I"NY> / "37<1- M[<"H"_@DD:A))+)ZFA2BPAU8E9 2)OOSQ+,&BT=\SN9"[\D-D(G$$V0))L8C&*&M8XN^5.EF-;2=76C;"W0OK]2N MK^8\;%?[WV6-[A63VB73)N8U-&K+]-,,Z^,G..S_V$;%7G6I7?<.J'A=X?TJ:67E4 8C6[)[$:1V%;SD&RB52>8:I+G_\ 1>V0A[5:1V6;2D/*6' N?W M!UU)NZU+HOYHP+O',N,ER6&!4*_71_+D[AZ^FRBQ-O?&N5!X"S7#%7Z[@-0& M^'XAA'J&ULC53=;]HP$/]7K&@/K=022*!T58C$ MQZ;UH1(JZ_8P[<$D!['J#V8[A/[W.SLA992R\I#8SOT^SMQ=4BG]; H 2W:" M2S,*"FLW=V%HL@($-1VU 8E?5DH+:G&KUZ'9:*"Y!PD>1MWN32@HDT&:^+.Y M3A-56LXDS#4QI1!4OTR JVH4](+]P2-;%]8=A&FRH6M8@'W:S#7NPI8E9P*D M84H2#:M1,.[=30G:;^WP4=)TAX)!9QT#QM84I<.Z( MT,:?AC-H)1WP<+UG_^ISQUR6U,!4\9\LM\4HN U(#BM:)L>B\S)8!\ISLPY)J,\YRYZZ6< MW,NZ1MQE7\S 4L8O,>)I,2,7GRZ3T**ZXPBS1FE2*T7O*,7D04E;&/)%YI#_ MBP_1=6L]VEN?1&<)'ZCND+AW1:)NU#OA9_IQ>/>,G;B]R=CSQ?^]23)C)N/* ME!K(K_'26(W%^ON,1+^5Z'N)_GD)2W=7KH-*F9.,4R9.)5\SW7@FU\K;-,;. MQE\2;D]8&+06!A^T0)8@8<7LJ4H8O!%_E:WMO8VXCJ/^X';X^%#; O3: MM[PAF2JEK6NE/6VGRM@WT]'Y!*=-/1Q>:>I1A96P9M(0#BND[':&:$[7[5]O MK-KX#EHJB_WHEP5.3- N +^OE++[C1-H9W#Z%U!+ P04 " !8.;%229(P MAN@" "Y"0 &0 'AL+W=OV4]I_OVLGI($"ZL.D]H78 MSKWGGN-CJ)&3:5V>N:Y*,N!4G8@2"GRS%))3C5.Y=NX'D]EU-6...A79O)\5!4.F<%S"11%>=4/D\@%^N1XSN;A5NVRK19 M<,?#DJY@#OI7.9,X?^V=2W"3;B-X.UZHR)D;(0XL%, MKM*1XQE&D$.B#03%QR-,(<\-$O+XVX Z;4V3V!UOT+]9\2AF015,17['4IV- MG(%#4EC2*M>W8OT=&D&QP4M$KNPO63>QGD.22FG!FV1DP%E1/^E3LQ&=!,39 MGQ T"<%N0G0@(6P20BNT9F9E75!-QT,IUD2::$0S [LW-AO5L,+8.-<2WS+, MT^,?>%*NA5)D!I+,,RJ!?"5S/"QIE0,12W)>:):RO#*[3>:05))I!HI^B[E9\L!$_"8X"WE!Y0D+_"PF\P-_#9_KV=.\(G;#U M(K1XT0$\W$2.^S?7(GD@=U1*6FA%[F^ +T#^.5(@:@M$MD!XH,#_\O+^&H') ME0:NCM&*6UKQ4=U;M-0++=BBE6S3@@VM$FG9$[7O0-6%8UO8?-$>QWX4]^-X MZ#YV?=X3YH5]=+77!FXIZ[7*>D>5U5;^+ WI-SG9;X'['\G)04MK\%Y.#EY9 M%(1>/^A%.U:^CO.C(.SYP7XG3UMEIT>5W8+2DB4:-=2FOL%,WWOY"'L?R4Z_ MTQW\]S*TJ=QU*@R]0;!KZ)ZXP(\C/]PQU.TT00YR9>\&"KE5A:Y;0KO:WC_. M;=?=69^8>XEMKB\P]:4&/_@KAG_D')8(Z9WTD92L[PGU1(O2MMJ%T-BX[3## MNQ5($X#OET+HS<04:&]KXW]02P,$% @ 6#FQ4EN:&L@&! B X !D M !X;"]W;W)K&ULO5=-;]LX$/TKA+&'%F@B4?Y, M81MP["2;(L$:]29[*'I@I+%-5")5DHJ3HC]^A[(B*6N9$;!H()R TEX(H6$\Z,_KQBHXL(+>XY[#3M6=BE_(@Y3?[%_/ -,QE_ ^/S';2 M&75(!&N6Q>:SW/T)Q8+ZUE\H8YW_)[O"UN^0,--&)@48&21<['_94Y&(&H#V MC@"" A"T!70+0+FT!_0+0;PL8%(!!6\"P SS8NVSFY=FP0R;CI7< M$66MT9M]R.N;H[$B7%@IKHS"68XX,YW+).$&M64T82(B0C_7JA47L\WWLX$CL6:I. MB1]\(($?^ WPN1O^*8M/"!/YR_;1 MF^!7K:/_=^T>*J"405#*(,C]=5O(8'8@@R\W:$ZN#23ZJR-8MPS6S8/UC@2[ MT(:CCB BZ\QD"DCX$LW81\TC4+G,FHJZ=SW(7=L^^S@=!$,?_\;>8[UZAW;] M[MFAW>6A7:_O']I='=H%P_XKNU>YZ)6YZ#ES\8D)K4&0>Q:&.+7?A$L%CY@, MN]'.[\F76T@>0'TE/\D-#_$4@/K0+7OB29:40X[Z]$M._5\OAD$9;.!,P *7 M&LO41B/G>*9$Y);'@'T/@RS9<\ZBJ;4,#NI! _]X/88EG:&33A$2TQH!N1.H MQ#+ILXT"L)--LMQ[[=?H'"$R*HF,G$1NI/C!D(;(UGA<9PH+4#&H"V 6S?^Z MOUZT$C M56831LZYU%@1$6)1ZMO(YNLMX;@*5_5QVOT-.JE:)77W2FR+*>,1N7A*\PV9 MY=O3;($PU]8LO+YJ%3U7':H^2?ON.F#]UQRUNMPRO!E]P"L2'LNUO;EBV,JJ MAJ9;I;_JG'3P&])?=4;J;HW_Y]B>%[[K11CYSMU0-4KZ1J6QE3'.>ENM+UP];,(;5TC^ZY1W?GRF18F[5@MPO& M3+0JA:Q'9&%,]3&.Z]F"E;0^5Q63%BF4+JFQ4SV/ZTHSFM?@5(JXU^FD<4FY M)..A7);7I:FCF5I*,R(7K2GRMR_YB'33"Q)YNHG*V8C<=>*+-#,?KT9?3/D6/4E_O4S7++M/%TCG&3 MV_&P4'*;XH1X@V6F)8L>J!B1"15\JCEX%;3D8NW-/3#,E% Z,K:V-E07+/6C MA[M^!F5O>$HNE7:Q?03_=]HL/P V,Q#(A6@%]H@WC(<5-89I>6TG;K$S/H&B M9GRWKJS"N:;K;J]/M@[N9H-,EAH_ ?Y=-L^]2_LZ MWJCB#\I\7MKM2#>'+F,WFA5\Y>:KHA6 L7=Q=EI58OU)\+DLF=_\BP..AW3C M%RV4YH\V&K3*S!J8)M$#TX;/=BV_-*WNV,ILVFE5X)I[1ZCY[^9YSB335.R* MMKW_EK/\:L7)Y;^2[/ZK' H.:FP.NK+7Q#GF^#[": M/MP"/+PM7&XH '5@6L=R!^. [T5-@G2:"JF#;L"<:1 M+,,0Z,5PCZ8IDIT4/N'Z8$])DF19& $LK"!), 2>1AS!%( &#$D2=PX>G$?Q MYIR*M[\!C7\#4$L#!!0 ( %@YL5*7BKL

-8?20$3;8T.P M6BP^0"X99K>]9!:GSGQ4R)*ECX?BN<[)/WI69O'!ZT?V4M3 M*SN+*N?6IY.)+2K1<'NLUT+!F:4V#7=P:%83NS:"E[82PC7U))E.3R8-ERKZ M_&FXUZV9A ?:B<))K:#1-]Q+\6S_.^\/V9.T\D'6TGV?1=W_M8A8(Y5LY ]1 MSJ)IQ®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end XML 72 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 73 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 74 FilingSummary.xml IDEA: XBRL DOCUMENT 3.21.1 html 153 316 1 false 63 0 false 4 false false R1.htm 100000 - Document - Document and Entity Information Sheet http://www.altimmune.com/20210331/taxonomy/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 100010 - Statement - Consolidated Balance Sheets Sheet http://www.altimmune.com/20210331/taxonomy/role/StatementConsolidatedBalanceSheets Consolidated Balance Sheets Statements 2 false false R3.htm 100020 - Statement - Consolidated Balance Sheets (Parenthetical) Sheet http://www.altimmune.com/20210331/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 100030 - Statement - Consolidated Statements of Operations and Comprehensive Loss Sheet http://www.altimmune.com/20210331/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss Consolidated Statements of Operations and Comprehensive Loss Statements 4 false false R5.htm 100040 - Statement - Consolidated Statements of changes in Stockholders' Equity Sheet http://www.altimmune.com/20210331/taxonomy/role/StatementConsolidatedStatementsOfChangesInStockholdersEquity Consolidated Statements of changes in Stockholders' Equity Statements 5 false false R6.htm 100050 - Statement - Consolidated Statements of Cash Flows Sheet http://www.altimmune.com/20210331/taxonomy/role/StatementConsolidatedStatementsOfCashFlows Consolidated Statements of Cash Flows Statements 6 false false R7.htm 100060 - Disclosure - Nature of Business and Basis of Presentation Sheet http://www.altimmune.com/20210331/taxonomy/role/DisclosureNatureOfBusinessAndBasisOfPresentation Nature of Business and Basis of Presentation Notes 7 false false R8.htm 100070 - Disclosure - Summary of Significant Accounting Policies Sheet http://www.altimmune.com/20210331/taxonomy/role/DisclosureSummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 8 false false R9.htm 100080 - Disclosure - Fair Value Measurements Sheet http://www.altimmune.com/20210331/taxonomy/role/DisclosureFairValueMeasurements Fair Value Measurements Notes 9 false false R10.htm 100090 - Disclosure - Property and Equipment, Net Sheet http://www.altimmune.com/20210331/taxonomy/role/DisclosurePropertyAndEquipmentNet Property and Equipment, Net Notes 10 false false R11.htm 100100 - Disclosure - Intangible Assets Sheet http://www.altimmune.com/20210331/taxonomy/role/DisclosureIntangibleAssets Intangible Assets Notes 11 false false R12.htm 100110 - Disclosure - Operating Leases Sheet http://www.altimmune.com/20210331/taxonomy/role/DisclosureOperatingLeases Operating Leases Notes 12 false false R13.htm 100120 - Disclosure - Accrued Expenses Sheet http://www.altimmune.com/20210331/taxonomy/role/DisclosureAccruedExpenses Accrued Expenses Notes 13 false false R14.htm 100130 - Disclosure - Contingent Consideration Sheet http://www.altimmune.com/20210331/taxonomy/role/DisclosureContingentConsideration Contingent Consideration Notes 14 false false R15.htm 100140 - Disclosure - Other Long-Term Liabilities Sheet http://www.altimmune.com/20210331/taxonomy/role/DisclosureOtherLongTermLiabilities Other Long-Term Liabilities Notes 15 false false R16.htm 100150 - Disclosure - Common Stock Sheet http://www.altimmune.com/20210331/taxonomy/role/DisclosureCommonStock Common Stock Notes 16 false false R17.htm 100160 - Disclosure - Warrants Sheet http://www.altimmune.com/20210331/taxonomy/role/DisclosureWarrants Warrants Notes 17 false false R18.htm 100170 - Disclosure - Stock-Based Compensation Sheet http://www.altimmune.com/20210331/taxonomy/role/DisclosureStockBasedCompensation Stock-Based Compensation Notes 18 false false R19.htm 100180 - Disclosure - U.S. Government Contracts and Grants Sheet http://www.altimmune.com/20210331/taxonomy/role/DisclosureUSGovernmentContractsAndGrants U.S. Government Contracts and Grants Notes 19 false false R20.htm 100190 - Disclosure - Income Taxes Sheet http://www.altimmune.com/20210331/taxonomy/role/DisclosureIncomeTaxes Income Taxes Notes 20 false false R21.htm 100200 - Disclosure - Net Loss Per Share Sheet http://www.altimmune.com/20210331/taxonomy/role/DisclosureNetLossPerShare Net Loss Per Share Notes 21 false false R22.htm 100210 - Disclosure - Commitments and Contingencies Sheet http://www.altimmune.com/20210331/taxonomy/role/DisclosureCommitmentsAndContingencies Commitments and Contingencies Notes 22 false false R23.htm 100220 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://www.altimmune.com/20210331/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://www.altimmune.com/20210331/taxonomy/role/DisclosureSummaryOfSignificantAccountingPolicies 23 false false R24.htm 100230 - Disclosure - Fair Value Measurements (Tables) Sheet http://www.altimmune.com/20210331/taxonomy/role/DisclosureFairValueMeasurementsTables Fair Value Measurements (Tables) Tables http://www.altimmune.com/20210331/taxonomy/role/DisclosureFairValueMeasurements 24 false false R25.htm 100240 - Disclosure - Property and Equipment, Net (Tables) Sheet http://www.altimmune.com/20210331/taxonomy/role/DisclosurePropertyAndEquipmentNetTables Property and Equipment, Net (Tables) Tables http://www.altimmune.com/20210331/taxonomy/role/DisclosurePropertyAndEquipmentNet 25 false false R26.htm 100250 - Disclosure - Intangible Assets (Tables) Sheet http://www.altimmune.com/20210331/taxonomy/role/DisclosureIntangibleAssetsTables Intangible Assets (Tables) Tables http://www.altimmune.com/20210331/taxonomy/role/DisclosureIntangibleAssets 26 false false R27.htm 100260 - Disclosure - Operating Leases (Tables) Sheet http://www.altimmune.com/20210331/taxonomy/role/DisclosureOperatingLeasesTables Operating Leases (Tables) Tables http://www.altimmune.com/20210331/taxonomy/role/DisclosureOperatingLeases 27 false false R28.htm 100270 - Disclosure - Accrued Expenses (Tables) Sheet http://www.altimmune.com/20210331/taxonomy/role/DisclosureAccruedExpensesTables Accrued Expenses (Tables) Tables http://www.altimmune.com/20210331/taxonomy/role/DisclosureAccruedExpenses 28 false false R29.htm 100280 - Disclosure - Contingent Consideration (Tables) Sheet http://www.altimmune.com/20210331/taxonomy/role/DisclosureContingentConsiderationTables Contingent Consideration (Tables) Tables http://www.altimmune.com/20210331/taxonomy/role/DisclosureContingentConsideration 29 false false R30.htm 100290 - Disclosure - Other Long-Term Liabilities (Tables) Sheet http://www.altimmune.com/20210331/taxonomy/role/DisclosureOtherLongTermLiabilitiesTables Other Long-Term Liabilities (Tables) Tables http://www.altimmune.com/20210331/taxonomy/role/DisclosureOtherLongTermLiabilities 30 false false R31.htm 100300 - Disclosure - Warrants (Tables) Sheet http://www.altimmune.com/20210331/taxonomy/role/DisclosureWarrantsTables Warrants (Tables) Tables http://www.altimmune.com/20210331/taxonomy/role/DisclosureWarrants 31 false false R32.htm 100310 - Disclosure - Stock-Based Compensation (Tables) Sheet http://www.altimmune.com/20210331/taxonomy/role/DisclosureStockBasedCompensationTables Stock-Based Compensation (Tables) Tables http://www.altimmune.com/20210331/taxonomy/role/DisclosureStockBasedCompensation 32 false false R33.htm 100320 - Disclosure - Net Loss Per Share (Tables) Sheet http://www.altimmune.com/20210331/taxonomy/role/DisclosureNetLossPerShareTables Net Loss Per Share (Tables) Tables http://www.altimmune.com/20210331/taxonomy/role/DisclosureNetLossPerShare 33 false false R34.htm 100330 - Disclosure - Fair Value Measurements - Schedule of Fair Value Assets and Liabilities Measured on Recurring Basis (Detail) Sheet http://www.altimmune.com/20210331/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetail Fair Value Measurements - Schedule of Fair Value Assets and Liabilities Measured on Recurring Basis (Detail) Details 34 false false R35.htm 100340 - Disclosure - Fair Value Measurements - Schedule of Short Term Investments (Detail) Sheet http://www.altimmune.com/20210331/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfShortTermInvestmentsDetail Fair Value Measurements - Schedule of Short Term Investments (Detail) Details 35 false false R36.htm 100350 - Disclosure - Fair Value Measurements - Summary of Assumptions Used to Estimate Fair Value of Contingent Payments (Detail) Sheet http://www.altimmune.com/20210331/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfAssumptionsUsedToEstimateFairValueOfContingentPaymentsDetail Fair Value Measurements - Summary of Assumptions Used to Estimate Fair Value of Contingent Payments (Detail) Details 36 false false R37.htm 100360 - Disclosure - Fair Value Measurements - Additional Information (Detail) Sheet http://www.altimmune.com/20210331/taxonomy/role/DisclosureFairValueMeasurementsAdditionalInformationDetail Fair Value Measurements - Additional Information (Detail) Details 37 false false R38.htm 100370 - Disclosure - Property and Equipment, Net - Summary of Property and Equipment, Net (Detail) Sheet http://www.altimmune.com/20210331/taxonomy/role/DisclosurePropertyAndEquipmentNetSummaryOfPropertyAndEquipmentNetDetail Property and Equipment, Net - Summary of Property and Equipment, Net (Detail) Details 38 false false R39.htm 100380 - Disclosure - Property and Equipment, Net - Additional Information (Detail) Sheet http://www.altimmune.com/20210331/taxonomy/role/DisclosurePropertyAndEquipmentNetAdditionalInformationDetail Property and Equipment, Net - Additional Information (Detail) Details 39 false false R40.htm 100390 - Disclosure - Intangible Assets - Schedule of Intangible Assets (Detail) Sheet http://www.altimmune.com/20210331/taxonomy/role/DisclosureIntangibleAssetsScheduleOfIntangibleAssetsDetail Intangible Assets - Schedule of Intangible Assets (Detail) Details 40 false false R41.htm 100400 - Disclosure - Intangible Assets - Additional Information (Detail) Sheet http://www.altimmune.com/20210331/taxonomy/role/DisclosureIntangibleAssetsAdditionalInformationDetail Intangible Assets - Additional Information (Detail) Details 41 false false R42.htm 100410 - Disclosure - Operating Leases - Additional Information (Detail) Sheet http://www.altimmune.com/20210331/taxonomy/role/DisclosureOperatingLeasesAdditionalInformationDetail Operating Leases - Additional Information (Detail) Details 42 false false R43.htm 100420 - Disclosure - Operating Leases - Summary of Supplemental other Information Related to Operating Leases Balance Sheet (Detail) Sheet http://www.altimmune.com/20210331/taxonomy/role/DisclosureOperatingLeasesSummaryOfSupplementalOtherInformationRelatedToOperatingLeasesBalanceSheetDetail Operating Leases - Summary of Supplemental other Information Related to Operating Leases Balance Sheet (Detail) Details 43 false false R44.htm 100430 - Disclosure - Accrued Expenses - Schedule of Accrued Expenses and Other Current Liabilities (Detail) Sheet http://www.altimmune.com/20210331/taxonomy/role/DisclosureAccruedExpensesScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetail Accrued Expenses - Schedule of Accrued Expenses and Other Current Liabilities (Detail) Details 44 false false R45.htm 100440 - Disclosure - Contingent Consideration - Additional Information (Detail) Sheet http://www.altimmune.com/20210331/taxonomy/role/DisclosureContingentConsiderationAdditionalInformationDetail Contingent Consideration - Additional Information (Detail) Details 45 false false R46.htm 100450 - Disclosure - Contingent Consideration - Summary of Fair Value of Contingent Consideration (Detail) Sheet http://www.altimmune.com/20210331/taxonomy/role/DisclosureContingentConsiderationSummaryOfFairValueOfContingentConsiderationDetail Contingent Consideration - Summary of Fair Value of Contingent Consideration (Detail) Details 46 false false R47.htm 100460 - Disclosure - Other Long-Term Liabilities - Summary of Other Long-Term Liabilities (Detail) Sheet http://www.altimmune.com/20210331/taxonomy/role/DisclosureOtherLongTermLiabilitiesSummaryOfOtherLongTermLiabilitiesDetail Other Long-Term Liabilities - Summary of Other Long-Term Liabilities (Detail) Details 47 false false R48.htm 100470 - Disclosure - Common Stock - Additional Information (Detail) Sheet http://www.altimmune.com/20210331/taxonomy/role/DisclosureCommonStockAdditionalInformationDetail Common Stock - Additional Information (Detail) Details 48 false false R49.htm 100480 - Disclosure - Warrants - Summary of Warrant Activity (Detail) Sheet http://www.altimmune.com/20210331/taxonomy/role/DisclosureWarrantsSummaryOfWarrantActivityDetail Warrants - Summary of Warrant Activity (Detail) Details 49 false false R50.htm 100490 - Disclosure - Stock-Based Compensation - Additional Information (Detail) Sheet http://www.altimmune.com/20210331/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetail Stock-Based Compensation - Additional Information (Detail) Details 50 false false R51.htm 100500 - Disclosure - Stock-Based Compensation - Schedule of Information Related to Stock Options Outstanding (Detail) Sheet http://www.altimmune.com/20210331/taxonomy/role/DisclosureStockBasedCompensationScheduleOfInformationRelatedToStockOptionsOutstandingDetail Stock-Based Compensation - Schedule of Information Related to Stock Options Outstanding (Detail) Details 51 false false R52.htm 100510 - Disclosure - Stock-Based Compensation - Schedule of Stock-based Compensation Expense (Detail) Sheet http://www.altimmune.com/20210331/taxonomy/role/DisclosureStockBasedCompensationScheduleOfStockBasedCompensationExpenseDetail Stock-Based Compensation - Schedule of Stock-based Compensation Expense (Detail) Details 52 false false R53.htm 100520 - Disclosure - U.S. Government Contracts and Grants - Additional Information (Detail) Sheet http://www.altimmune.com/20210331/taxonomy/role/DisclosureUSGovernmentContractsAndGrantsAdditionalInformationDetail U.S. Government Contracts and Grants - Additional Information (Detail) Details 53 false false R54.htm 100530 - Disclosure - Income Taxes - Additional Information (Detail) Sheet http://www.altimmune.com/20210331/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail Income Taxes - Additional Information (Detail) Details 54 false false R55.htm 100540 - Disclosure - Net Loss Per Share - Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Detail) Sheet http://www.altimmune.com/20210331/taxonomy/role/DisclosureNetLossPerShareScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareDetail Net Loss Per Share - Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Detail) Details 55 false false R56.htm 100550 - Disclosure - Commitments and Contingencies - Additional Information (Details) Sheet http://www.altimmune.com/20210331/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails Commitments and Contingencies - Additional Information (Details) Details 56 false false All Reports Book All Reports alt-20210331.xml alt-20210331.xsd alt-20210331_cal.xml alt-20210331_def.xml alt-20210331_lab.xml alt-20210331_pre.xml http://fasb.org/us-gaap/2020-01-31 http://fasb.org/srt/2020-01-31 http://xbrl.sec.gov/dei/2020-01-31 true true ZIP 76 0001564590-21-028166-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001564590-21-028166-xbrl.zip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end